-- Data for Name: publication; Type: TABLE DATA; Schema: cpic; Owner: -
--

COPY cpic.publication (id, guidelineid, title, authors, journal, month, page, volume, year, pmid, pmcid, doi, url, version, highlightedonsite, fulltextfile) FROM stdin;
113658	\N	Allele and Haplotype Frequencies of Human Leukocyte Antigen-A, -B, -C, -DRB1, and -DQB1 From Sequence-Based DNA Typing Data in Koreans.	{"In Ji Won","Roh Eun Youn","Oh Sohee","Shin Sue","Park Kyoung Un","Song Eun Young"}	Annals of laboratory medicine	7	\N	\N	2015	26131415	\N	\N	\N	2	f	\N
871408	\N	\N	{"Karczewski KJ et al."}	\N	\N	\N	\N	2020	33536625	\N	\N	\N	1	f	\N
871411	\N	\N	{"Bhalla S et al."}	\N	\N	\N	\N	2009	19465004	\N	\N	\N	1	f	\N
871418	\N	\N	{"Guo Y-F et al."}	\N	\N	\N	\N	2008	18274916	\N	\N	\N	1	f	\N
871421	\N	\N	{"Ji Y-B et al."}	\N	\N	\N	\N	2011	21162657	\N	\N	\N	1	f	\N
871423	\N	\N	{"Wang Q-J et al."}	\N	\N	\N	\N	2011	21329993	\N	\N	\N	1	f	\N
871425	\N	\N	{"Jiang Y et al."}	\N	\N	\N	\N	2015	26252218	\N	\N	\N	1	f	\N
871427	\N	\N	{"Cao Y et al."}	\N	\N	\N	\N	2010	20123042	\N	\N	\N	1	f	\N
871429	\N	\N	{"Bae et al."}	\N	\N	\N	\N	2008	18636170	\N	\N	\N	1	f	\N
871433	\N	\N	{"Malik SG et al."}	\N	\N	\N	\N	2003	12955586	\N	\N	\N	1	f	\N
871437	\N	\N	{"Du W et al."}	\N	\N	\N	\N	2014	24804242	\N	\N	\N	1	f	\N
871441	\N	\N	{"Yang X-L et al."}	\N	\N	\N	\N	2013	23834103	\N	\N	\N	1	f	\N
871465	\N	\N	{"Abreu-Silva RS et al."}	\N	\N	\N	\N	2006	164703009	\N	\N	\N	1	f	\N
871467	\N	\N	{"Kokotas H et al."}	\N	\N	\N	\N	2009	19835846	\N	\N	\N	1	f	\N
871469	\N	\N	{"Igumnova V et al."}	\N	\N	\N	\N	2019	30523288	\N	\N	\N	1	f	\N
871471	\N	\N	{"Rydzanicz M et al."}	\N	\N	\N	\N	2009	19371214	\N	\N	\N	1	f	\N
871473	\N	\N	{"Danilenko N et al."}	\N	\N	\N	\N	2012	22567152	\N	\N	\N	1	f	\N
871476	\N	\N	{"Human et al."}	\N	\N	\N	\N	2010	20171168	\N	\N	\N	1	f	\N
871479	\N	\N	{"Ramsebner R et al."}	\N	\N	\N	\N	2007	17955603	\N	\N	\N	1	f	\N
871481	\N	\N	{"Usami S-I et al."}	\N	\N	\N	\N	1997	9111378	\N	\N	\N	1	f	\N
871485	\N	\N	{"Baysal E et al."}	\N	\N	\N	\N	2008	18560174	\N	\N	\N	1	f	\N
871488	\N	\N	{"Nahili et al."}	\N	\N	\N	\N	2010	20637512	\N	\N	\N	1	f	\N
871491	\N	\N	{"Fassad MR et al."}	\N	\N	\N	\N	2014	25755848	\N	\N	\N	1	f	\N
871494	\N	\N	{"Tekin M et al."}	\N	\N	\N	\N	2003	12655418	\N	\N	\N	1	f	\N
871496	\N	\N	{"Mkaouar-Rebai E et al."}	\N	\N	\N	\N	2006	16406239	\N	\N	\N	1	f	\N
871499	\N	\N	{"Montazer Zohour et al."}	\N	\N	\N	\N	2012	22077646	\N	\N	\N	1	f	\N
871502	\N	\N	{"Bardien S et al."}	\N	\N	\N	\N	2009	19144107	\N	\N	\N	1	f	\N
871504	\N	\N	{"Kabahuma RJ et al."}	\N	\N	\N	\N	2011	21392827	\N	\N	\N	1	f	\N
1045981	\N	\N	{NaKorn}	\N	\N	\N	\N	2020	32581780	\N	\N	\N	1	f	\N
1552823	\N	\N	{"Chittoor G. et al."}	\N	\N	\N	\N	2019	31784582	\N	\N	\N	1	f	\N
1552830	\N	\N	{"Phipps-Green AJ et al."}	\N	\N	\N	\N	2010	20858603	\N	\N	\N	1	f	\N
116044	\N	A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants.	{"Sim Sarah C","Risinger Carl","Dahl Marja-Liisa","Aklillu Eleni","Christensen Magnus","Bertilsson Leif","Ingelman-Sundberg Magnus"}	Clinical pharmacology and therapeutics	1	\N	\N	2006	16413245	\N	\N	\N	2	f	\N
116046	\N	ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment.	{"Crettol Séverine","Déglon Jean-Jacques","Besson Jacques","Croquette-Krokar Marina","Hämmig Robert","Gothuey Isabelle","Monnat Martine","Eap Chin B"}	Clinical pharmacology and therapeutics	12	\N	\N	2006	17178267	\N	\N	\N	2	f	\N
114119	\N	Genetic polymorphism of cytochrome P450s and P-glycoprotein in the Finnish population.	{"Hilli Johanna","Rane Anders","Lundgren Stefan","Bertilsson Leif","Laine Kari"}	Fundamental & clinical pharmacology	8	\N	\N	2007	17635176	\N	\N	\N	2	f	\N
116290	\N	Proguanil disposition and toxicity in malaria patients from Vanuatu with high frequencies of CYP2C19 mutations.	{"Kaneko A","Bergqvist Y","Taleo G","Kobayakawa T","Ishizaki T","Björkman A"}	Pharmacogenetics	6	\N	\N	1999	10471063	\N	\N	\N	2	f	\N
110012	\N	CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network	{"Relling M V","Klein T E"}	Clinical pharmacology and therapeutics	3	464-7	89	2011	21270786	PMC3098762	10.1038/clpt.2010.279	\N	3	t	\N
110020	\N	Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process	{"Caudle Kelly E","Klein Teri E","Hoffman James M","Müller Daniel J","Whirl-Carrillo Michelle","Gong Li","McDonagh Ellen M","Sangkuhl Katrin","Thorn Caroline F","Schwab Matthias","Agunder Jose A G","Freimuth Robert R","Huser Vojtech","Lee Ming Ta Michael","Iwuchukwu Otito F","Crews Kristine R","Scott Stuart A","Wadelius Mia","Swen Jesse J","Tyndale Rachel F","Stein C Michael","Roden Dan","Relling Mary V","Williams Marc S","Johnson Samuel G"}	Current drug metabolism	1			2014	24479687	PMC3977533	10.2174/1389200215666140130124910	\N	3	t	\N
110025	\N	Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)	{"Caudle Kelly E","Dunnenberger Henry M","Freimuth Robert R","Peterson Josh F","Burlison Jonathan D","Whirl-Carrillo Michelle","Scott Stuart A","Rehm Heidi L","Williams Marc S","Klein Teri E","Relling Mary V","Hoffman James M"}	Genetics in medicine : official journal of the American College of Medical Genetics	7			2016	27441996	PMC5253119	10.1038/gim.2016.87	\N	3	t	\N
110073	\N	Developing knowledge resources to support precision medicine: principles from the Clinical Pharmacogenetics Implementation Consortium (CPIC).	{"Hoffman James M","Dunnenberger Henry M","Kevin Hicks J","Caudle Kelly E","Whirl Carrillo Michelle","Freimuth Robert R","Williams Marc S","Klein Teri E","Peterson Josh F"}	Journal of the American Medical Informatics Association : JAMIA	7			2016	27026620	\N	\N	\N	2	t	\N
110074	\N	Evidence and resources to implement pharmacogenetic knowledge for precision medicine.	{"Caudle Kelly E","Gammal Roseann S","Whirl-Carrillo Michelle","Hoffman James M","Relling Mary V","Klein Teri E"}	American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists	12			2016	27864205	\N	\N	\N	2	t	\N
114885	\N	\N	{"ensembl: NHLBI Exome Sequencing Project"}	\N	\N	\N	\N	\N	\N	\N	\N	http://grch37.ensembl.org/Homo_sapiens/Variation/Population?db=core;r=6:18143449-18144449;v=rs111901354;vdb=variation;vf=19493939	1	f	\N
110075	\N	The Clinical Pharmacogenetics Implementation Consortium: 10 Years Later.	{"Relling Mary V","Klein Teri E","Gammal Roseann S","Whirl-Carrillo Michelle","Hoffman James M","Caudle Kelly E"}	Clinical pharmacology and therapeutics	1			2020	31562822	\N	\N	\N	1	t	\N
113556	\N	HLA in North Colombia Chimila Amerindians.	{"Arnaiz-Villena Antonio","Palacio-Grüber Jose","Juarez Ignacio","Hernández Ennio","Muñiz Ester","Bayona Brayan","Campos Cristina","Nieto Jorge","Martin-Villa Manuel","Silvera Carlos"}	Human immunology	4	\N	\N	2018	29454071	\N	\N	\N	2	f	\N
3070386	\N	Pharmacogenomics implementation: " a little less conversation, a little more action, please".	{"Caudle Kelly E","Hoffman James M","Gammal Roseann S"}	Pharmacogenomics	3	\N	\N	2023	36946361	\N	10.2217/pgs-2023-0020	\N	2	t	\N
113561	\N	A study of HLA-B∗15:02 in a Sri Lankan population: Implications for pharmacogenomic testing.	{"Gunathilake K M D","Wettasinghe K T","Dissanayake V H W"}	Human immunology	5	\N	\N	2016	27060780	\N	\N	\N	2	f	\N
113862	\N	Effect of CYP2C9, VKORC1, CYP4F2 and GGCX genetic variants on warfarin maintenance dose and explicating a new pharmacogenetic algorithm in South Indian population.	{"Krishna Kumar Dhakchinamoorthi","Shewade Deepak Gopal","Loriot Marie-Anne","Beaune Philippe","Balachander Jayaraman","Sai Chandran B V","Adithan Chandrasekaran"}	European journal of clinical pharmacology	1	\N	\N	2014	24019055	\N	\N	\N	2	f	\N
113876	\N	Warfarin dosage response related pharmacogenetics in Chinese population.	{"Li Siyue","Zou Yuangao","Wang Xia","Huang Xunbei","Sun Yong","Wang Yuqing","Dong Li","Jiang Hong"}	PloS one	0	\N	\N	2015	25594941	\N	\N	\N	2	f	\N
113925	\N	Genotype-phenotype associations for common CYP3A4 and CYP3A5 variants in the basal and induced metabolism of midazolam in European- and African-American men and women.	{"Floyd Michael D","Gervasini Guillermo","Masica Andrew L","Mayo Gail","George Alfred L","Bhat Kolari","Kim Richard B","Wilkinson Grant R"}	Pharmacogenetics	10	\N	\N	2003	14515058	\N	\N	\N	2	f	\N
113933	\N	The International HapMap Project.	{"International HapMap Consortium"}	Nature	12	\N	\N	2003	14685227	\N	\N	\N	2	f	\N
113935	\N	Association of CYP3A5 polymorphisms with hypertension and antihypertensive response to verapamil.	{"Langaee T Y","Gong Y","Yarandi H N","Katz D A","Cooper-DeHoff R M","Pepine C J","Johnson J A"}	Clinical pharmacology and therapeutics	3	\N	\N	2007	17339868	\N	\N	\N	2	f	\N
113941	\N	CYP3A5*3 and *6 single nucleotide polymorphisms in three distinct Asian populations.	{"Balram C","Zhou Qingyu","Cheung Yin Bun","Lee Edmund J D"}	European journal of clinical pharmacology	6	\N	\N	2003	12756511	\N	\N	\N	2	f	\N
113946	\N	Effect of gene polymorphisms on the levels of calcineurin inhibitors in Indian renal transplant recipients.	{"Ashavaid T","Raje H","Shalia K","Shah B"}	Indian journal of nephrology	7	\N	\N	2010	21072155	\N	\N	\N	2	f	\N
113957	\N	CYP3A5*3 and CYP3A4*18 single nucleotide polymorphisms in a Chinese population.	{"Hu Yong-Fang","He Jun","Chen Guo-Lin","Wang Dan","Liu Zhong-Qi","Zhang Che","Duan Li-Fang","Zhou Hong-Hao"}	Clinica chimica acta; international journal of clinical chemistry	3	\N	\N	2005	15698606	\N	\N	\N	2	f	\N
113964	\N	Polymorphisms in CYP3A5*3 and MDR1, and haplotype modulate response to plasma levels of tacrolimus in Chinese renal transplant patients.	{"Wu Ping","Ni Xuefeng","Wang Mingli","Xu Xianlin","Luo Guanghua","Jiang Yan"}	Annals of transplantation	0	\N	\N	2011	21436775	\N	\N	\N	2	f	\N
113884	\N	Genetic factors associated with patient-specific warfarin dose in ethnic Indonesians.	{"Suriapranata Ivet M","Tjong Wen Ye","Wang Tingliang","Utama Andi","Raharjo Sunu B","Yuniadi Yoga","Tai Susan Sw"}	BMC medical genetics	6	\N	\N	2011	21639946	\N	\N	\N	2	f	\N
113972	\N	Influence of CYP3A4, CYP3A5 and MDR-1 polymorphisms on tacrolimus pharmacokinetics and early renal dysfunction in liver transplant recipients.	{"Shi Yunying","Li Yi","Tang Jiangtao","Zhang Junlong","Zou Yuangao","Cai Bei","Wang Lanlan"}	Gene	1	\N	\N	2013	23107770	\N	\N	\N	2	f	\N
113978	\N	Tacrolimus dosing in Chinese renal transplant recipients: a population-based pharmacogenetics study.	{"Li Liang","Li Chuan-Jiang","Zheng Lei","Zhang Yan-Jun","Jiang Hai-Xia","Si-Tu Bo","Li Zhong-Hai"}	European journal of clinical pharmacology	8	\N	\N	2011	21331500	\N	\N	\N	2	f	\N
113984	\N	Value of CYP3A5 genotyping on determining initial dosages of tacrolimus for Chinese renal transplant recipients.	{"Zhang J","Zhang X","Liu L","Tong W"}	Transplantation proceedings	11	\N	\N	2010	21094797	\N	\N	\N	2	f	\N
113992	\N	Tacrolimus dose requirement in relation to donor and recipient ABCB1 and CYP3A5 gene polymorphisms in Chinese liver transplant patients.	{"Wei-lin Wang","Jing Jin","Shu-sen Zheng","Li-hua Wu","Ting-bo Liang","Song-feng Yu","Sheng Yan"}	Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society	5	\N	\N	2006	16628701	\N	\N	\N	2	f	\N
113998	\N	Population pharmacokinetics and pharmacogenetics of tacrolimus in healthy Chinese volunteers.	{"Xue Ling","Zhang Hua","Ma Sheng","Rui Jian-Zhong","Miao Li-Yan"}	Pharmacology	0	\N	\N	2011	22075549	\N	\N	\N	2	f	\N
113841	\N	Race-Specific Influence of CYP4F2 on Dose and Risk of Hemorrhage Among Warfarin Users.	{"Shendre Aditi","Brown Todd M","Liu Nianjun","Hill Charles E","Beasley T Mark","Nickerson Deborah A","Limdi Nita A"}	Pharmacotherapy	3	\N	\N	2016	26877068	\N	\N	\N	2	f	\N
113910	\N	Influence of genetics and non-genetic factors on acenocoumarol maintenance dose requirement in Moroccan patients.	{"Smires F Z","Moreau C","Habbal R","Siguret V","Fadili S","Golmard J L","Assaidi A","Beaune P","Loriot M A","Nadifi S"}	Journal of clinical pharmacy and therapeutics	10	\N	\N	2012	22486182	\N	\N	\N	2	f	\N
113663	\N	High-resolution HLA-A, -B and -DRB1 allele and haplotype frequencies in 7823 Han marrow donors of Liaoning province, China.	{"Shao L-N","Zhang S-T","Yu W-J","Zhou S-H","Duan Y","Pan L-Z","Wang N","Liu M"}	HLA	5	\N	\N	2017	28296231	\N	\N	\N	2	f	\N
113671	\N	HLA polymorphism in Bulgarians defined by high-resolution typing methods in comparison with other populations.	{"Ivanova M","Rozemuller E","Tyufekchiev N","Michailova A","Tilanus M","Naumova E"}	Tissue antigens	12	\N	\N	2002	12542743	\N	\N	\N	2	f	\N
113755	\N	HLA-A, HLA-B and HLA-DRB1 allele and haplotype diversity among volunteer bone marrow donors from Croatia.	{"Grubic Z","Burek Kamenaric M","Mikulic M","Stingl Jankovic K","Maskalan M","Zunec R"}	International journal of immunogenetics	6	\N	\N	2014	24762167	\N	\N	\N	2	f	\N
113780	\N	Molecular analysis of HLA allelic frequencies and haplotypes in Jordanians and comparison with other related populations.	{"Sánchez-Velasco P","Karadsheh N S","García-Martín A","Ruíz de Alegría C","Leyva-Cobián F"}	Human immunology	9	\N	\N	2001	11543892	\N	\N	\N	2	f	\N
113912	\N	Effect of the VKORC1 D36Y variant on warfarin dose requirement and pharmacogenetic dose prediction.	{"Kurnik Daniel","Qasim Husam","Sominsky Sophie","Lubetsky Aharon","Markovits Noa","Li Chun","Stein C Michael","Halkin Hillel","Gak Eva","Loebstein Ronen"}	Thrombosis and haemostasis	10	\N	\N	2012	22871975	\N	\N	\N	2	f	\N
115276	\N	Thiopurine S-methytransferase gene polymorphism in rheumatoid arthritis.	{"Elawi Asma M","Irshaid Yacoub M","Ismail Said I","Mustafa Khader N"}	Archives of medical research	2	\N	\N	2013	23398787	\N	\N	\N	2	f	\N
113864	\N	Therapeutic dosing of acenocoumarol: proposal of a population specific pharmacogenetic dosing algorithm and its validation in north Indians.	{"Rathore Saurabh Singh","Agarwal Surendra Kumar","Pande Shantanu","Singh Sushil Kumar","Mittal Tulika","Mittal Balraj"}	PloS one	0	\N	\N	2012	22629463	\N	\N	\N	2	f	\N
114013	\N	Personalized tacrolimus dose requirement by CYP3A5 but not ABCB1 or ACE genotyping in both recipient and donor after pediatric liver transplantation.	{"Chen Yi-kuan","Han Long-zhi","Xue Feng","Shen Cong-huan","Lu Jun","Yang Tai-hua","Zhang Jian-jun","Xia Qiang"}	PloS one	0	\N	\N	2014	25310192	\N	\N	\N	2	f	\N
114021	\N	Novel detection assay by PCR-RFLP and frequency of the CYP3A5 SNPs, CYP3A5*3 and *6, in a Japanese population.	{"Fukuen Shuichi","Fukuda Tsuyoshi","Maune Hiromi","Ikenaga Yuka","Yamamoto Isamu","Inaba Tadanobu","Azuma Junichi"}	Pharmacogenetics	6	\N	\N	2002	12042671	\N	\N	\N	2	f	\N
114031	\N	Impact of the CYP3A4*1G polymorphism and its combination with CYP3A5 genotypes on tacrolimus pharmacokinetics in renal transplant patients.	{"Miura Masatomo","Satoh Shigeru","Kagaya Hideaki","Saito Mitsuru","Numakura Kazuyuki","Tsuchiya Norihiko","Habuchi Tomonori"}	Pharmacogenomics	7	\N	\N	2011	21635144	\N	\N	\N	2	f	\N
114039	\N	Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients.	{"Fukudo Masahide","Yano Ikuko","Yoshimura Atsushi","Masuda Satohiro","Uesugi Miwa","Hosohata Keiko","Katsura Toshiya","Ogura Yasuhiro","Oike Fumitaka","Takada Yasutsugu","Uemoto Shinji","Inui Ken-ichi"}	Pharmacogenetics and genomics	5	\N	\N	2008	18408564	\N	\N	\N	2	f	\N
114045	\N	Effect of intestinal CYP3A5 on postoperative tacrolimus trough levels in living-donor liver transplant recipients.	{"Uesugi Miwa","Masuda Satohiro","Katsura Toshiya","Oike Fumitaka","Takada Yasutsugu","Inui Ken-ichi"}	Pharmacogenetics and genomics	2	\N	\N	2006	16424824	\N	\N	\N	2	f	\N
114057	\N	Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of amlodipine in healthy Korean subjects.	{"Kim Kyoung-Ah","Park Pil-Whan","Lee Ock-Je","Choi Sang-Hyun","Min Bon Hong","Shin Kyung-Ho","Chun Boe-Gwun","Shin Jae-Gook","Park Ji-Young"}	Clinical pharmacology and therapeutics	12	\N	\N	2006	17178265	\N	\N	\N	2	f	\N
114061	\N	Association of CYP2B6, CYP3A5, and CYP2C19 genetic polymorphisms with sibutramine pharmacokinetics in healthy Korean subjects.	{"Kim K A","Song W K","Park J Y"}	Clinical pharmacology and therapeutics	11	\N	\N	2009	19693007	\N	\N	\N	2	f	\N
114069	\N	Impact of tacrolimus intraindividual variability and CYP3A5 genetic polymorphism on acute rejection in kidney transplantation.	{"Ro Han","Min Sang-Il","Yang Jaeseok","Moon Kyung Chul","Kim Yon Su","Kim Sang Joon","Ahn Curie","Ha Jongwon"}	Therapeutic drug monitoring	12	\N	\N	2012	23149441	\N	\N	\N	2	f	\N
114077	\N	CYP3A5*3 genotype associated with intrasubject pharmacokinetic variation toward tacrolimus in bioequivalence study.	{"Yong Chung Jae","Jung Lee Yoon","Bok Jang Seong","Ahyoung Lim Lay","Soo Park Min","Hwan Kim Kyung"}	Therapeutic drug monitoring	2	\N	\N	2010	20010459	\N	\N	\N	2	f	\N
114083	\N	Population pharmacokinetic-pharmacogenetic model of tacrolimus in the early period after kidney transplantation.	{"Han Nayoung","Ha Soojung","Yun Hwi-yeol","Kim Myeong Gyu","Min Sang-Il","Ha Jongwon","Lee Jangik Ike","Oh Jung Mi","Kim In-Wha"}	Basic & clinical pharmacology & toxicology	5	\N	\N	2014	24238261	\N	\N	\N	2	f	\N
114101	\N	The role of CYP3A5 genotypes in dose requirements of tacrolimus and everolimus after heart transplantation.	{"Kniepeiss Daniela","Renner Wilfried","Trummer Olivia","Wagner Doris","Wasler Andrä","Khoschsorur Gholam A","Truschnig-Wilders Martie","Tscheliessnigg Karl-Heinz"}	Clinical transplantation	0	\N	\N	2011	20041908	\N	\N	\N	2	f	\N
114110	\N	Genotyping of CYP3A5 polymorphisms among Bulgarian patients with sporadic colorectal cancer and controls.	{"Petrova Darinka Todorova","Yaramov Nikolay","Toshev Svetoslav","Nedeva Petya","Maslyankov Svilen","von Ahsen Nicolas","Oellerich Michael","Toncheva Draga"}	Onkologie	11	\N	\N	2007	17992026	\N	\N	\N	2	f	\N
114114	\N	CYP3A5 variant allele frequencies in Dutch Caucasians.	{"van Schaik Ron H N","van der Heiden Ilse P","van den Anker John N","Lindemans Jan"}	Clinical chemistry	10	\N	\N	2002	12324482	\N	\N	\N	2	f	\N
114128	\N	MDR1 haplotypes derived from exons 21 and 26 do not affect the steady-state pharmacokinetics of tacrolimus in renal transplant patients.	{"Mai Ingrid","Perloff Elke S","Bauer Steffen","Goldammer Mark","Johne Andreas","Filler Guido","Budde Klemens","Roots Ivar"}	British journal of clinical pharmacology	11	\N	\N	2004	15521904	\N	\N	\N	2	f	\N
114138	\N	Frequencies and roles of CYP3A5, CYP3A4 and ABCB1 single nucleotide polymorphisms in Italian teenagers after kidney transplantation.	{"Turolo Stefano","Tirelli Amedea S","Ferraresso Mariano","Ghio Luciana","Belingheri Mirco","Groppali Elena","Torresani Erminio","Edefonti Alberto"}	Pharmacological reports : PR	0	\N	\N	2010	21273673	\N	\N	\N	2	f	\N
114148	\N	Frequency of common CYP3A5 gene variants in healthy Polish newborn infants.	{"Adler Grazyna","Łoniewska Beata","Parczewski Miłosz","Kordek Agnieszka","Ciechanowicz Andrzej"}	Pharmacological reports : PR	0	\N	\N	2009	19904021	\N	\N	\N	2	f	\N
114153	\N	Genetic polymorphisms of CYP1A2, CYP3A4, CYP3A5, pregnane/steroid X receptor and constitutive androstane receptor in 207 healthy Spanish volunteers.	{"Oliver Paloma","Lubomirov Rubin","Carcas Antonio"}	Clinical chemistry and laboratory medicine	5	\N	\N	2010	20218903	\N	\N	\N	2	f	\N
114889	\N	\N	{gnomAD}	\N	\N	\N	\N	\N	\N	\N	\N	http://gnomad.broadinstitute.org/variant/6-18143955-C-G	1	f	\N
114891	\N	\N	{gnomAD}	\N	\N	\N	\N	\N	\N	\N	\N	http://gnomad.broadinstitute.org/variant/6-18131012-C-T	1	f	\N
114161	\N	A search for new CYP3A4 variants as determinants of tacrolimus dose requirements in renal-transplanted patients.	{"Tavira Beatriz","Coto Eliecer","Diaz-Corte Carmen","Alvarez Victoria","López-Larrea Carlos","Ortega Francisco"}	Pharmacogenetics and genomics	8	\N	\N	2013	23778326	\N	\N	\N	2	f	\N
114165	\N	Effect of CYP3A5, CYP3A4, and ABCB1 genotypes as determinants of tacrolimus dose and clinical outcomes after heart transplantation.	{"Díaz-Molina B","Tavira B","Lambert J L","Bernardo M J","Alvarez V","Coto E"}	Transplantation proceedings	11	\N	\N	2012	23146479	\N	\N	\N	2	f	\N
114200	\N	The investigation of allele and genotype frequencies of CYP3A5 (1/3) and P2Y12 (T744C) in Iran.	{"Azarpira N","Namazi S","Khalili A","Tabesh M"}	Molecular biology reports	11	\N	\N	2011	21153923	\N	\N	\N	2	f	\N
114206	\N	Genetic polymorphisms of the CYP3A4, CYP3A5, CYP3A7 and CYP1A2 among the Jordanian population.	{"Salameh Ghada","Al Hadidi Kamal","El Khateeb Mohammad"}	Environmental toxicology and pharmacology	7	\N	\N	2012	22426036	\N	\N	\N	2	f	\N
114215	\N	Patterns of pharmacogenetic diversity in African populations: role of ancient and recent history.	{"Oliveira Elisabete","Pereira Rui","Amorim António","McLeod Howard","Prata Maria João"}	Pharmacogenomics	9	\N	\N	2009	19761365	\N	\N	\N	2	f	\N
114361	\N	Characterization and PCR-based detection of two different hybrid CYP2D7P/CYP2D6 alleles associated with the poor metabolizer phenotype.	{"Daly A K","Fairbrother K S","Andreassen O A","London S J","Idle J R","Steen V M"}	Pharmacogenetics	8	\N	\N	1996	8873218	\N	\N	\N	2	f	\N
114367	\N	Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans.	{"Gaedigk Andrea","Bradford L DiAnne","Marcucci Kenda A","Leeder J Steven"}	Clinical pharmacology and therapeutics	7	\N	\N	2002	12152006	\N	\N	\N	2	f	\N
114423	\N	Phenotypes and genotypes for CYP2D6 and CYP2C19 in a black Tanzanian population.	{"Bathum L","Skjelbo E","Mutabingwa T K","Madsen H","Hørder M","Brøsen K"}	British journal of clinical pharmacology	9	\N	\N	1999	10510152	\N	\N	\N	2	f	\N
114375	\N	CYP2D6 genetic variation in healthy adults and psychiatric African-American subjects: implications for clinical practice and genetic testing.	{"Cai W-M","Nikoloff D M","Pan R-M","de Leon J","Fanti P","Fairchild M","Koch W H","Wedlund P J"}	The pharmacogenomics journal	0	\N	\N	2006	16550211	\N	\N	\N	2	f	\N
114387	\N	The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype.	{"Gaedigk A","Simon S D","Pearce R E","Bradford L D","Kennedy M J","Leeder J S"}	Clinical pharmacology and therapeutics	2	\N	\N	2008	17971818	\N	\N	\N	2	f	\N
114395	\N	Frequency of CYP2D6 Alleles Including Structural Variants in the United States.	{"Del Tredici Andria L","Malhotra Alka","Dedek Matthew","Espin Frank","Roach Dan","Zhu Guang-Dan","Voland Joseph","Moreno Tanya A"}	Frontiers in pharmacology	0	\N	\N	2018	29674966	\N	\N	\N	2	f	\N
114406	\N	Characterization of the CYP2D6 gene locus and metabolic activity in Indo- and Afro-Trinidadians: discovery of novel allelic variants.	{"Montané Jaime Lazara Karelia","Lalla Anthony","Steimer Werner","Gaedigk Andrea"}	Pharmacogenomics	2	\N	\N	2013	23394389	\N	\N	\N	2	f	\N
114414	\N	Evidence for environmental influence on CYP2D6-catalysed debrisoquine hydroxylation as demonstrated by phenotyping and genotyping of Ethiopians living in Ethiopia or in Sweden.	{"Aklillu Eleni","Herrlin Karin","Gustafsson Lars L","Bertilsson Leif","Ingelman-Sundberg Magnus"}	Pharmacogenetics	7	\N	\N	2002	12142727	\N	\N	\N	2	f	\N
114410	\N	Molecular diversity at the CYP2D6 locus in healthy and schizophrenic southern Brazilians.	{"Kohlrausch Fabiana B","Gama Clarissa S","Lobato Maria Inês","Belmonte-de-Abreu Paulo","Gesteira Alejandro","Barros Francisco","Carracedo Angel","Hutz Mara H"}	Pharmacogenomics	9	\N	\N	2009	19761369	\N	\N	\N	2	f	\N
114421	\N	CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure.	{"Sistonen Johanna","Sajantila Antti","Lao Oscar","Corander Jukka","Barbujani Guido","Fuselli Silvia"}	Pharmacogenetics and genomics	2	\N	\N	2007	17301689	\N	\N	\N	2	f	\N
114435	\N	A novel mutant variant of the CYP2D6 gene (CYP2D6*17) common in a black African population: association with diminished debrisoquine hydroxylase activity.	{"Masimirembwa C","Persson I","Bertilsson L","Hasler J","Ingelman-Sundberg M"}	British journal of clinical pharmacology	12	\N	\N	1996	8971426	\N	\N	\N	2	f	\N
114439	\N	CYP2D6 Genotype Predicts Plasma Concentrations of Tamoxifen Metabolites in Ethiopian Breast Cancer Patients.	{"Ahmed Jemal Hussien","Makonnen Eyasu","Fotoohi Alan","Aseffa Abraham","Howe Rawleigh","Aklillu Eleni"}	Cancers	9	\N	\N	2019	31547390	\N	\N	\N	2	f	\N
114451	\N	CYP2D6 phenotype and genotype in a Canadian Native Indian population.	{"Nowak M P","Tyndale R F","Sellers E M"}	Pharmacogenetics	4	\N	\N	1997	9170152	\N	\N	\N	2	f	\N
114463	\N	CYP2D6 gene polymorphisms and predicted phenotypes in eight indigenous groups from northwestern Mexico.	{"Lazalde-Ramos Blanca Patricia","Martínez-Fierro Margarita de la Luz","Galaviz-Hernández Carlos","Garza-Veloz Idalia","Naranjo María Eugenia G","Sosa-Macías Martha","Llerena Adrián"}	Pharmacogenomics	2	\N	\N	2014	24533713	\N	\N	\N	2	f	\N
114472	\N	Interethnic relationships of CYP2D6 variants in native and Mestizo populations sharing the same ecosystem.	{"Perez-Paramo Yadira Xitlalli","Hernandez-Cabrera Francisco","Dorado Pedro","Llerena Adrian","Muñoz-Jimenez Sergio","Ortiz-Lopez Rocio","Rojas-Martinez Augusto"}	Pharmacogenomics	0	\N	\N	2015	25941923	\N	\N	\N	2	f	\N
114491	\N	CYP2D6 polymorphism in a Mexican American population.	{"Mendoza R","Wan Y J","Poland R E","Smith M","Zheng Y","Berman N","Lin K M"}	Clinical pharmacology and therapeutics	12	\N	\N	2001	11753272	\N	\N	\N	2	f	\N
114493	\N	The effect of CYP2D6 polymorphisms on dextromethorphan metabolism in Mexican Americans.	{"Casner Paul R"}	Journal of clinical pharmacology	11	\N	\N	2005	16239355	\N	\N	\N	2	f	\N
114175	\N	Influence of CYP3A5 polymorphism on tacrolimus maintenance doses and serum levels after renal transplantation: age dependency and pharmacological interaction with steroids.	{"Ferraris Jorge R","Argibay Pablo F","Costa Lucas","Jimenez Graciela","Coccia Paula A","Ghezzi Lidia F R","Ferraris Verónica","Belloso Waldo H","Redal María A","Larriba Julián M"}	Pediatric transplantation	8	\N	\N	2011	21711429	\N	\N	\N	2	f	\N
114893	\N	\N	{gnomAD}	\N	\N	\N	\N	\N	\N	\N	\N	http://gnomad.broadinstitute.org/variant/6-18134076-T-A	1	f	\N
114895	\N	\N	{gnomAD}	\N	\N	\N	\N	\N	\N	\N	\N	http://gnomad.broadinstitute.org/variant/6-18130956-A-T	1	f	\N
114182	\N	CYP3A5 3, CYP3A4 1B and MDR1 C3435T genotype distributions in Ecuadorians.	{"Sinués Blanca","Vicente Jorge","Fanlo Ana","Mayayo-Sinués Esteban","González-Andrade Fabricio","Sánchez-Q Dora","Martínez-Jarreta Begoña"}	Disease markers	0	\N	\N	2008	18688081	\N	\N	\N	2	f	\N
114837	\N	CYP2C9, CYPC19 and CYP2D6 gene profiles and gene susceptibility to drug response and toxicity in Turkish population.	{"Arici Merve","Özhan Gül"}	Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society	3	\N	\N	2017	28344492	\N	\N	\N	2	f	\N
116051	\N	Cytochrome P450 2C19 loss-of-function polymorphism is associated with an increased treatment-related mortality in patients undergoing allogeneic transplantation.	{"Elmaagacli A H","Koldehoff M","Steckel N K","Trenschel R","Ottinger H","Beelen D W"}	Bone marrow transplantation	10	\N	\N	2007	17680025	\N	\N	\N	2	f	\N
114510	\N	Genetic Variants of Cytochrome CYP2D6 in Two Mixed Chilean Populations.	{"Acuña Mónica","Pinto Eric","Olivares Paulina","Ríos Carolina"}	Human heredity	0	\N	\N	2016	28728153	\N	\N	\N	2	f	\N
114521	\N	CYP2D6 genotype and dextromethorphan hydroxylation phenotype in an Ecuadorian population.	{"Dorado Pedro","Heras Natalia","Machín Esther","Hernández Francisco","Teran Enrique","Llerena Adrián"}	European journal of clinical pharmacology	5	\N	\N	2012	22083166	\N	\N	\N	2	f	\N
114531	\N	Molecular heterogeneity at the CYP2D gene locus in Nicaraguans: impact of gene-flow from Europe.	{"Agúndez J A","Ramirez R","Hernandez M","Llerena A","Benítez J"}	Pharmacogenetics	8	\N	\N	1997	9295063	\N	\N	\N	2	f	\N
114540	\N	Single-step assays to analyze CYP2D6 gene polymorphisms in Asians: allele frequencies and a novel *14B allele in mainland Chinese.	{"Ji Ling","Pan Shixiu","Marti-Jaun Jacqueline","Hänseler Edgar","Rentsch Katharina","Hersberger Martin"}	Clinical chemistry	7	\N	\N	2002	12089164	\N	\N	\N	2	f	\N
114550	\N	Systematic polymorphism analysis of the CYP2D6 gene in four different geographical Han populations in mainland China.	{"Qin Shengying","Shen Lu","Zhang Aiping","Xie Jing","Shen Wen","Chen Lingling","Tang Jimin","Xiong Yuyu","Yang Lun","Shi Yongyong","Feng Guoyin","He Lin","Xing Qinghe"}	Genomics	9	\N	\N	2008	18632250	\N	\N	\N	2	f	\N
114569	\N	Analysis of Genetic Variation in CYP450 Genes for Clinical Implementation.	{"Goh Liuh Ling","Lim Chia Wei","Sim Wey Cheng","Toh Li Xian","Leong Khai Pang"}	PloS one	0	\N	\N	2017	28046094	\N	\N	\N	2	f	\N
114580	\N	A new variant CYP2D6 allele (CYP2D6*21) with a single base insertion in exon 5 in a Japanese population associated with a poor metabolizer phenotype.	{"Chida M","Yokoi T","Nemoto N","Inaba M","Kinoshita M","Kamataki T"}	Pharmacogenetics	6	\N	\N	1999	10471060	\N	\N	\N	2	f	\N
114645	\N	\N	{"Jittikoon et al"}	\N	\N	\N	\N	2015	26423923	\N	\N	\N	1	f	\N
114586	\N	CYP2D6 genotypes in a Japanese population: low frequencies of CYP2D6 gene duplication but high frequency of CYP2D6*10.	{"Nishida Y","Fukuda T","Yamamoto I","Azuma J"}	Pharmacogenetics	8	\N	\N	2000	10975611	\N	\N	\N	2	f	\N
114590	\N	Common mutant alleles of CYP2D6 causing the defect of CYP2D6 enzyme activity in a Japanese population.	{"Ishiguro Akihiro","Kubota Takahiro","Sasaki Hiroshi","Yamada Yasuhiko","Iga Tatsuji"}	British journal of clinical pharmacology	4	\N	\N	2003	12680892	\N	\N	\N	2	f	\N
114596	\N	Two novel single nucleotide polymorphisms (SNPs) of the CYP2D6 gene in Japanese individuals.	{"Ebisawa Aiko","Hiratsuka Masahiro","Sakuyama Kanako","Konno Yumiko","Sasaki Takamitsu","Mizugaki Michinao"}	Drug metabolism and pharmacokinetics	8	\N	\N	2005	16141609	\N	\N	\N	2	f	\N
114610	\N	Dose-adjustment study of tamoxifen based on CYP2D6 genotypes in Japanese breast cancer patients.	{"Kiyotani Kazuma","Mushiroda Taisei","Imamura Chiyo K","Tanigawara Yusuke","Hosono Naoya","Kubo Michiaki","Sasa Mitsunori","Nakamura Yusuke","Zembutsu Hitoshi"}	Breast cancer research and treatment	1	\N	\N	2012	21947681	\N	\N	\N	2	f	\N
114620	\N	Sequence-based CYP2D6 genotyping in the Korean population.	{"Lee Soo-Youn","Sohn Kwang Min","Ryu Ji Young","Yoon Young Ran","Shin Jae Gook","Kim Jong-Won"}	Therapeutic drug monitoring	6	\N	\N	2006	16778723	\N	\N	\N	2	f	\N
114574	\N	Differences in genotype and allele frequency distributions of polymorphic drug metabolizing enzymes CYP2C19 and CYP2D6 in mainland Chinese Mongolian, Hui and Han populations.	{"Yin S-J","Ni Y-B","Wang S-M","Wang X","Lou Y-Q","Zhang G-L"}	Journal of clinical pharmacy and therapeutics	6	\N	\N	2012	21913948	\N	\N	\N	2	f	\N
114613	\N	Combination analysis in genetic polymorphisms of drug-metabolizing enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A5 in the Japanese population.	{"Ota Tomoko","Kamada Yuka","Hayashida Mariko","Iwao-Koizumi Kyoko","Murata Shigenori","Kinoshita Kenji"}	International journal of medical sciences	0	\N	\N	2015	25552922	\N	\N	\N	2	f	\N
114627	\N	Copy number variation and gene rearrangements in CYP2D6 genotyping using multiplex ligation-dependent probe amplification in Koreans.	{"Kim Juwon","Lee Soo-Youn","Lee Kyung-A"}	Pharmacogenomics	6	\N	\N	2012	22676200	\N	\N	\N	2	f	\N
114634	\N	CYP2D6 Genetic Polymorphisms and Phenotypes in Different Ethnicities of Malaysian Breast Cancer Patients.	{"Chin Fee Wai","Chan Soon Choy","Abdul Rahman Sabariah","Noor Akmal Sharifah","Rosli Rozita"}	The breast journal	0	\N	\N	2016	26510986	\N	\N	\N	2	f	\N
114651	\N	CYP2D6 genotype analysis of a Thai population: platform comparison.	{"Chamnanphon Monpat","Gaedigk Andrea","Vanwong Natchaya","Nuntamool Nopphadol","Hongkaew Yaowaluck","Puangpetch Apichaya","Sukasem Chonlaphat"}	Pharmacogenomics	7	\N	\N	2018	29992861	\N	\N	\N	2	f	\N
114659	\N	Single nucleotide and structural variants of CYP2D6 gene in Kinh Vietnamese population.	{"Nguyen Ha Hai","Ma Thuong Thi Huyen","Vu Nhung Phuong","Bach Quynh Thi Nhu","Vu Thang Hong","Nguyen Ton Dang","Nong Hai Van"}	Medicine	5	\N	\N	2019	31145348	\N	\N	\N	2	f	\N
114677	\N	Frequency of single nucleotide polymorphisms of CYP2D6 in the Czech population.	{"Buzková Helena","Pechandová Kristina","Slanar Ondrej","Perlík Frantisek"}	Cell biochemistry and function	0	\N	\N	2008	17311358	\N	\N	\N	2	f	\N
114679	\N	Tramadol efficacy in patients with postoperative pain in relation to CYP2D6 and MDR1 polymorphisms.	{"Slanar O","Dupal P","Matouskova O","Vondrackova H","Pafko P","Perlik F"}	Bratislavske lekarske listy	0	\N	\N	2012	22428763	\N	\N	\N	2	f	\N
114897	\N	\N	{gnomAD}	\N	\N	\N	\N	\N	\N	\N	\N	http://gnomad.broadinstitute.org/variant/6-18130993-C-T	1	f	\N
114899	\N	\N	{gnomAD}	\N	\N	\N	\N	\N	\N	\N	\N	http://gnomad.broadinstitute.org/variant/6-18143837-T-G	1	f	\N
114690	\N	GenoChip CYP2D6 macroarray as a method to genotype for CYP2D6 variants: results of a validation study in a Caucasian population.	{"Bank Paul C D","Swen Jesse J","Guchelaar Henk-Jan","van der Straaten Tahar"}	Pharmacogenomics	0	\N	\N	2015	25929855	\N	\N	\N	2	f	\N
114191	\N	Molecular diversity and population structure at the Cytochrome P450 3A5 gene in Africa.	{"Bains Ripudaman K","Kovacevic Mirna","Plaster Christopher A","Tarekegn Ayele","Bekele Endashaw","Bradman Neil N","Thomas Mark G"}	BMC genetics	5	\N	\N	2013	23641907	\N	\N	\N	2	f	\N
116771	\N	Genetic polymorphism of the CYP2C9 subfamily of 3 different races in warfarin maintenance dose.	{"Gan Gin Gin","Phipps Maude Elvira","Ku Chee Seng","Teh Alan","Sangkar Vijaya"}	International journal of hematology	10	\N	\N	2004	15540908	\N	\N	\N	2	f	\N
114802	\N	Impact of variable CYP genotypes on breast cancer relapse in patients undergoing adjuvant tamoxifen therapy.	{"Mwinyi Jessica","Vokinger Kerstin","Jetter Alexander","Breitenstein Urs","Hiller Christian","Kullak-Ublick Gerd A","Trojan Andreas"}	Cancer chemotherapy and pharmacology	6	\N	\N	2014	24682508	\N	\N	\N	2	f	\N
114698	\N	High Frequency of CYP2D6 Ultrarapid Metabolizer Genotype in the Finnish Population.	{"Pietarinen Paavo","Tornio Aleksi","Niemi Mikko"}	Basic & clinical pharmacology & toxicology	9	\N	\N	2016	27038154	\N	\N	\N	2	f	\N
114823	\N	Low frequency of defective alleles of cytochrome P450 enzymes 2C19 and 2D6 in the Turkish population.	{"Aynacioglu A S","Sachse C","Bozkurt A","Kortunay S","Nacak M","Schröder T","Kayaalp S O","Roots I","Brockmöller J"}	Clinical pharmacology and therapeutics	8	\N	\N	1999	10460072	\N	\N	\N	2	f	\N
114705	\N	Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences.	{"Sachse C","Brockmöller J","Bauer S","Roots I"}	American journal of human genetics	2	\N	\N	1997	9012401	\N	\N	\N	2	f	\N
114711	\N	A silent mutation (2939G>A, exon 6; CYP2D6*59) leading to impaired expression and function of CYP2D6.	{"Toscano Claudia","Raimundo Sebastian","Klein Kathrin","Eichelbaum Michel","Schwab Matthias","Zanger Ulrich M"}	Pharmacogenetics and genomics	10	\N	\N	2006	17001296	\N	\N	\N	2	f	\N
114727	\N	Genetic variability of CYP2D6, CYP2B6, CYP2C9 and CYP2C19 genes across the Italian Peninsula.	{"Carano Francesco","Sarno Stefania","De Fanti Sara","Serventi Patrizia","Bini Carla","Luiselli Donata","Pelotti Susi"}	Annals of human biology	2	\N	\N	2018	28971704	\N	\N	\N	2	f	\N
114736	\N	Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data.	{"Gaedigk A","Gotschall R R","Forbes N S","Simon S D","Kearns G L","Leeder J S"}	Pharmacogenetics	12	\N	\N	1999	10634130	\N	\N	\N	2	f	\N
114755	\N	CYP2D6 extensive, intermediate, and poor phenotypes and genotypes in a Polish population.	{"Niewinski P","Orzechowska-Juzwenko K","Hurkacz M","Rzemislawska Z","Jaźwinska-Tarnawska E","Milejski P","Forkasiewicz Z"}	European journal of clinical pharmacology	11	\N	\N	2002	12536989	\N	\N	\N	2	f	\N
114761	\N	CYP2D6 Pharmacogenetics Testing and Post-Cesarean Section Pain Scores-a Preliminary Study.	{"Ribeiro Carolina","Quinta Rosa","Raposo Ana","Valentim Ana","Albuquerque José","Grazina Manuela"}	Pain medicine (Malden, Mass.)	2	\N	\N	2019	29546421	\N	\N	\N	2	f	\N
114874	\N	\N	{"Nazir et al"}	\N	\N	\N	\N	2015	\N	\N	\N	http://jpmi.org.pk/index.php/jpmi/article/viewFile/1691/1611	1	f	\N
114774	\N	Characterization of variant alleles of cytochrome CYP2D6 in a Spanish population.	{"Menoyo Anna","del Rio Elisabeth","Baiget Montserrat"}	Cell biochemistry and function	0	\N	\N	2006	16130179	\N	\N	\N	2	f	\N
114785	\N	Relationship between genotypes Sult1a2 and Cyp2d6 and tamoxifen metabolism in breast cancer patients.	{"Fernández-Santander Ana","Gaibar María","Novillo Apolonia","Romero-Lorca Alicia","Rubio Margarita","Chicharro Luis Miguel","Tejerina Armando","Bandrés Fernando"}	PloS one	0	\N	\N	2013	23922954	\N	\N	\N	2	f	\N
114793	\N	Fatal intoxication cases: cytochrome P450 2D6 and 2C19 genotype distributions.	{"Zackrisson A L","Holmgren P","Gladh A B","Ahlner J","Lindblom B"}	European journal of clinical pharmacology	10	\N	\N	2004	15349706	\N	\N	\N	2	f	\N
114811	\N	Identification of new alleles and the determination of alleles and genotypes frequencies at the CYP2D6 gene in Emiratis.	{"Qumsieh Rula Y","Ali Bassam R","Abdulrazzaq Yousef M","Osman Ossama","Akawi Nadia A","Bastaki Salim M A"}	PloS one	0	\N	\N	2011	22216145	\N	\N	\N	2	f	\N
114818	\N	Frequent occurrence of CYP2D6 gene duplication in Saudi Arabians.	{"McLellan R A","Oscarson M","Seidegård J","Evans D A","Ingelman-Sundberg M"}	Pharmacogenetics	6	\N	\N	1997	9241658	\N	\N	\N	2	f	\N
114825	\N	CYP2D6 and CYP1A1 mutations in the Turkish population.	{"Aydin Muge","Hatirnaz Ozden","Erensoy Nevin","Ozbek Ugur"}	Cell biochemistry and function	0	\N	\N	2005	15648054	\N	\N	\N	2	f	\N
114829	\N	Distribution of HLA-B27 and CYP2D6*4 mutations in the middle Black Sea area (Tokat) of Turkey.	{"Sahin S","Aydogan L","Benli I","Ozyurt H"}	Genetics and molecular research : GMR	12	\N	\N	2011	22180068	\N	\N	\N	2	f	\N
114847	\N	CYP2D6 genotyping analysis and functional characterization of novel allelic variants in a Ni-Vanuatu and Kenyan population by assessing dextromethorphan O-demethylation activity.	{"Gutiérrez Rico Evelyn Marie","Kikuchi Aoi","Saito Takahiro","Kumondai Masaki","Hishinuma Eiji","Kaneko Akira","Chan Chim Wai","Gitaka Jesse","Nakayoshi Tomoki","Oda Akifumi","Saito Sakae","Hirasawa Noriyasu","Hiratsuka Masahiro"}	Drug metabolism and pharmacokinetics	2	\N	\N	2020	32037159	\N	\N	\N	2	f	\N
114861	\N	Genetic association of phase I and phase II detoxification genes with recurrent miscarriages among North Indian women.	{"Parveen F","Faridi R M","Das V","Tripathi G","Agrawal S"}	Molecular human reproduction	3	\N	\N	2010	19892789	\N	\N	\N	2	f	\N
114867	\N	CYP 2D6*4 polymorphism and interindividual response variation to metoprolol in stage 1 hypertensive patients: no association in a rural Indian population?	{"Ayyappadihas Rajagopal","Dhanalekshmi Unnikrishnan","Jestin Helliah"}	Turkish journal of medical sciences	0	\N	\N	2015	26084127	\N	\N	\N	2	f	\N
114878	\N	Genotype and allele frequency of CYP2D6 in Tamilian population.	{"Adithan C","Gerard N","Naveen A T","Koumaravelou K","Shashindran C H","Krishnamoorthy R"}	European journal of clinical pharmacology	10	\N	\N	2003	12942225	\N	\N	\N	2	f	\N
114901	\N	\N	{gnomAD}	\N	\N	\N	\N	\N	\N	\N	\N	http://gnomad.broadinstitute.org/variant/6-18139941-G-A	1	f	\N
114903	\N	\N	{gnomAD}	\N	\N	\N	\N	\N	\N	\N	\N	http://gnomad.broadinstitute.org/variant/6-18134121-C-T	1	f	\N
114905	\N	\N	{gnomAD}	\N	\N	\N	\N	\N	\N	\N	\N	http://gnomad.broadinstitute.org/variant/6-18148076-C-T	1	f	\N
114907	\N	\N	{gnomAD}	\N	\N	\N	\N	\N	\N	\N	\N	http://gnomad.broadinstitute.org/variant/6-18130925-T-C	1	f	\N
114909	\N	\N	{gnomAD}	\N	\N	\N	\N	\N	\N	\N	\N	http://gnomad.broadinstitute.org/variant/6-18148082-G-C	1	f	\N
114911	\N	\N	{gnomAD}	\N	\N	\N	\N	\N	\N	\N	\N	http://gnomad.broadinstitute.org/variant/6-18139200-C-T	1	f	\N
114913	\N	\N	{gnomAD}	\N	\N	\N	\N	\N	\N	\N	\N	http://gnomad.broadinstitute.org/variant/6-18134115-G-C	1	f	\N
114915	\N	\N	{gnomAD}	\N	\N	\N	\N	\N	\N	\N	\N	http://gnomad.broadinstitute.org/variant/6-18134078-C-A	1	f	\N
114917	\N	\N	{gnomAD}	\N	\N	\N	\N	\N	\N	\N	\N	http://gnomad.broadinstitute.org/variant/6-18132367-A-G	1	f	\N
114919	\N	\N	{gnomAD}	\N	\N	\N	\N	\N	\N	\N	\N	http://gnomad.broadinstitute.org/variant/6-18149357-A-G	1	f	\N
114921	\N	\N	{gnomAD}	\N	\N	\N	\N	\N	\N	\N	\N	http://gnomad.broadinstitute.org/variant/6-18149253-C-T	1	f	\N
114923	\N	\N	{gnomAD}	\N	\N	\N	\N	\N	\N	\N	\N	http://gnomad.broadinstitute.org/variant/6-18132378-A-G	1	f	\N
114925	\N	\N	{gnomAD}	\N	\N	\N	\N	\N	\N	\N	\N	http://gnomad.broadinstitute.org/variant/6-18143853-C-T	1	f	\N
114927	\N	\N	{gnomAD}	\N	\N	\N	\N	\N	\N	\N	\N	http://gnomad.broadinstitute.org/variant/6-18139201-G-A	1	f	\N
114929	\N	\N	{gnomAD}	\N	\N	\N	\N	\N	\N	\N	\N	http://gnomad.broadinstitute.org/variant/6-18143949-G-A	1	f	\N
114931	\N	\N	{gnomAD}	\N	\N	\N	\N	\N	\N	\N	\N	http://gnomad.broadinstitute.org/variant/6-18130989-A-T	1	f	\N
114933	\N	\N	{gnomAD}	\N	\N	\N	\N	\N	\N	\N	\N	http://gnomad.broadinstitute.org/variant/6-18134101-A-G	1	f	\N
114935	\N	\N	{gnomAD}	\N	\N	\N	\N	\N	\N	\N	\N	http://gnomad.broadinstitute.org/variant/6-18148069-G-A	1	f	\N
114937	\N	\N	{gnomAD}	\N	\N	\N	\N	\N	\N	\N	\N	http://gnomad.broadinstitute.org/variant/6-18130960-C-T	1	f	\N
114977	\N	\N	{"ensembl: HapMap"}	\N	\N	\N	\N	\N	\N	\N	\N	http://grch37.ensembl.org/Homo_sapiens/Variation/Population?db=core;r=6:18148858-18149858;v=rs9333569;vdb=variation;vf=5163632	1	f	\N
114945	\N	Genotype frequencies of drug-metabolizing enzymes responsible for purine and pyrimidine antagonists in a healthy Asian-Indian population.	{"Iyer Sandhya N","Tilak Ashwini V","Mukherjee Manjari S","Singhal Rekha S"}	Biochemical genetics	10	\N	\N	2012	22580794	\N	\N	\N	2	f	\N
114949	\N	Thiopurine S-methyltransferase gene polymorphism and 6-mercaptopurine dose intensity in Indian children with acute lymphoblastic leukemia.	{"Kapoor Gauri","Sinha Rupal","Naithani Rahul","Chandgothia Meenal"}	Leukemia research	8	\N	\N	2010	20153897	\N	\N	\N	2	f	\N
114955	\N	Thiopurine methyltransferase and treatment outcome in the UK acute lymphoblastic leukaemia trial ALL2003.	{"Lennard Lynne","Cartwright Cher S","Wade Rachel","Vora Ajay"}	British journal of haematology	8	\N	\N	2015	25940902	\N	\N	\N	2	f	\N
114963	\N	Thiopurine S-methyltransferase alleles, TPMT(*)2, (*)3B and (*)3C, and genotype frequencies in an Indian population.	{"Murugesan Raju","Vahab Saadi Abdul","Patra Satyajit","Rao Rekha","Rao Jyothi","Rai Padmalatha","Gopinath P M","Satyamoorthy Kapaettu"}	Experimental and therapeutic medicine	1	\N	\N	2010	23136604	\N	\N	\N	2	f	\N
115002	\N	The multidrug-resistance protein 4 polymorphism is a new factor accounting for thiopurine sensitivity in Japanese patients with inflammatory bowel disease.	{"Ban Hiromistu","Andoh Akira","Imaeda Hirotsugu","Kobori Ayako","Bamba Shigeki","Tsujikawa Tomoyuki","Sasaki Masaya","Saito Yasuharu","Fujiyama Yoshihide"}	Journal of gastroenterology	10	\N	\N	2010	20393862	\N	\N	\N	2	f	\N
115012	\N	Detection assay of rare variants of the thiopurine methyltransferase gene by PCR-RFLP using a mismatch primer in a Japanese population.	{"Hiratsuka M","Inoue T","Omori F","Agatsuma Y","Kishikawa Y","Mizugaki M"}	Biological & pharmaceutical bulletin	9	\N	\N	2000	10993211	\N	\N	\N	2	f	\N
115018	\N	Thiopurine S-methyltransferase polymorphisms and the relationship between the mutant alleles and the adverse effects in systemic lupus erythematosus patients taking azathioprine.	{"Jun J B","Cho D Y","Kang C","Bae S C"}	Clinical and experimental rheumatology	0	\N	\N	2005	16396707	\N	\N	\N	2	f	\N
115030	\N	Frequencies of thiopurine S-methyltransferase mutant alleles (TPMT*2, *3A, *3B and *3C) in 151 healthy Japanese subjects and the inheritance of TPMT*3C in the family of a propositus.	{"Kubota T","Chiba K"}	British journal of clinical pharmacology	5	\N	\N	2001	11422006	\N	\N	\N	2	f	\N
115034	\N	Allelotype frequency of the thiopurine methyltransferase (TPMT) gene in Japanese.	{"Kumagai K","Hiyama K","Ishioka S","Sato H","Yamanishi Y","McLeod H L","Konishi F","Maeda H","Yamakido M"}	Pharmacogenetics	4	\N	\N	2001	11337944	\N	\N	\N	2	f	\N
115041	\N	Thiopurine S-Methyltransferase Polymorphisms in Korean Dermatologic Patients.	{"Lee Minseok","Seo Jimyung","Bang Dongsik","Kim Do Young"}	Annals of dermatology	10	\N	\N	2017	28966507	\N	\N	\N	2	f	\N
115046	\N	Molecular analysis of thiopurine S-methyltransferase alleles in Taiwan aborigines and Taiwanese.	{"Lu H-F","Shih M-C","Chang Y-S","Chang J-Y","Ko Y-C","Chang S-J","Chang J-G"}	Journal of clinical pharmacy and therapeutics	2	\N	\N	2006	16476125	\N	\N	\N	2	f	\N
115116	\N	\N	{"ensembl: NHLBI Exome Sequencing Project"}	\N	\N	\N	\N	\N	\N	\N	\N	http://grch37.ensembl.org/Homo_sapiens/Variation/Population?db=core;r=6:18130503-18131503;v=rs377085266;vdb=variation;vf=58847509	1	f	\N
115062	\N	Thiopurine S-methyltransferase and inosine triphosphate pyrophosphohydrolase genes in Japanese patients with inflammatory bowel disease in whom adverse drug reactions were induced by azathioprine/6-mercaptopurine treatment.	{"Uchiyama Kan","Nakamura Makoto","Kubota Takahiro","Yamane Tateki","Fujise Kiyotaka","Tajiri Hisao"}	Journal of gastroenterology	0	\N	\N	2009	19214663	\N	\N	\N	2	f	\N
115068	\N	Association between inosine triphosphate pyrophosphohydrolase deficiency and azathioprine-related adverse drug reactions in the Chinese kidney transplant recipients.	{"Xiong Hui","Xin Hua-Wen","Wu Xiao-Chun","Li Qing","Xiong Lei","Yu Ai-Rong"}	Fundamental & clinical pharmacology	6	\N	\N	2010	19682085	\N	\N	\N	2	f	\N
115075	\N	Determination of intra-ethnic differences in the polymorphisms of thiopurine S-methyltransferase in Chinese.	{"Zhang Jian-Ping","Zhou Shu-Feng","Chen Xiao","Huang Min"}	Clinica chimica acta; international journal of clinical chemistry	3	\N	\N	2006	16223474	\N	\N	\N	2	f	\N
115142	\N	Influence of the variable number of tandem repeats located in the promoter region of the thiopurine methyltransferase gene on enzymatic activity.	{"Alves S","Amorim A","Ferreira F","Prata M J"}	Clinical pharmacology and therapeutics	8	\N	\N	2001	11503011	\N	\N	\N	2	f	\N
115150	\N	Thiopurine S-methyltransferase phenotype-genotype correlation in hemodialyzed patients.	{"Chrzanowska Maria","Kurzawski Mateusz","Droździk Marek","Mazik Marta","Oko Andrzej","Czekalski Stanisław"}	Pharmacological reports : PR	0	\N	\N	2006	17220558	\N	\N	\N	2	f	\N
115160	\N	Prevalence of thiopurine S-methyltransferase gene polymorphisms in patients with inflammatory bowel disease from the island of Crete, Greece.	{"Coucoutsi Constantina","Emmanouil George","Goulielmos George","Sfakianaki Ourania","Koutroubakis Ioannis E","Kouroumalis Elias A"}	European journal of gastroenterology & hepatology	11	\N	\N	2017	28857898	\N	\N	\N	2	f	\N
115168	\N	Phenotype and genotype for thiopurine methyltransferase activity in the French Caucasian population: impact of age.	{"Ganiere-Monteil Catherine","Medard Yves","Lejus Corinne","Bruneau Béatrice","Pineau Alain","Fenneteau Odile","Bourin Michel","Jacqz-Aigrain Evelyne"}	European journal of clinical pharmacology	4	\N	\N	2004	15022030	\N	\N	\N	2	f	\N
115176	\N	Monitoring of long-term thiopurine therapy among adults with inflammatory bowel disease.	{"Hindorf U","Lyrenäs E","Nilsson A","Schmiegelow K"}	Scandinavian journal of gastroenterology	11	\N	\N	2004	15545169	\N	\N	\N	2	f	\N
115183	\N	TPMT but not ITPA gene polymorphism influences the risk of azathioprine intolerance in renal transplant recipients.	{"Kurzawski Mateusz","Dziewanowski Krzysztof","Lener Agnieszka","Drozdzik Marek"}	European journal of clinical pharmacology	5	\N	\N	2009	19229528	\N	\N	\N	2	f	\N
115192	\N	Analysis of thiopurine methyltransferase variant alleles in childhood acute lymphoblastic leukaemia.	{"McLeod H L","Coulthard S","Thomas A E","Pritchard S C","King D J","Richards S M","Eden O B","Hall A G","Gibson B E"}	British journal of haematology	6	\N	\N	1999	10354134	\N	\N	\N	2	f	\N
115200	\N	Thiopurine methyltransferase genotype distribution in patients with Crohn's disease.	{"Reuther L O","Sonne J","Larsen N","Dahlerup J F","Thomsen O O","Schmiegelow K"}	Alimentary pharmacology & therapeutics	1	\N	\N	2003	12492733	\N	\N	\N	2	f	\N
115204	\N	Frequency of the thiopurine S-methyltransferase alleles in the ancient genetic population isolate of Sardinia.	{"Rossino R","Vincis C","Alves S","Prata M J","Macis M D","Nucaro A L","Schirru E","Congia M"}	Journal of clinical pharmacy and therapeutics	6	\N	\N	2006	16789994	\N	\N	\N	2	f	\N
115214	\N	High-resolution melting analysis of the TPMT gene: a study in the Polish population.	{"Skrzypczak-Zielinska Marzena","Borun Pawel","Milanowska Katarzyna","Jakubowska-Burek Ludwika","Zakerska Oliwia","Dobrowolska-Zachwieja Agnieszka","Plawski Andrzej","Froster Ursula G","Szalata Marlena","Slomski Ryszard"}	Genetic testing and molecular biomarkers	2	\N	\N	2013	23252704	\N	\N	\N	2	f	\N
115222	\N	Differential association of the N-propeptide of collagen IIA (PIIANP) and collagen II C-telopeptide (CTX-II) with synovitis and erosions in early and longstanding rheumatoid arthritis.	{"Christensen A F","Lottenburger T","Lindegaard H","Christgau S","Hørslev-Petersen K","Junker P"}	Clinical and experimental rheumatology	0	\N	\N	2009	19473573	\N	\N	\N	2	f	\N
115254	\N	Allelic variants of the thiopurine methyltransferase (TPMT) gene in the Colombian population.	{"Isaza C","Henao J","López A M","Cacabelos R"}	Methods and findings in experimental and clinical pharmacology	0	\N	\N	2003	12949626	\N	\N	\N	2	f	\N
115263	\N	Thiopurine S-methyltransferase (TPMT) gene polymorphism in Brazilian children with acute lymphoblastic leukemia: association with clinical and laboratory data.	{"Silva Marcilene Rezende","de Oliveira Benigna Maria","Viana Marcos Borato","Murao Mitiko","Romanha Alvaro José"}	Therapeutic drug monitoring	12	\N	\N	2008	19057372	\N	\N	\N	2	f	\N
115269	\N	Thiopurine methyltransferase genotyping in Palestinian childhood acute lymphoblastic leukemia patients.	{"Ayesh Basim Mohammad","Harb Wael Mohammad","Abed Abdalla Assaf"}	BMC hematology	4	\N	\N	2013	24499706	\N	\N	\N	2	f	\N
115273	\N	Distribution of TPMT risk alleles for thiopurine [correction of thioupurine] toxicity in the Israeli population.	{"Efrati Edna","Adler Lior","Krivoy Norberto","Sprecher Eli"}	European journal of clinical pharmacology	3	\N	\N	2009	19048244	\N	\N	\N	2	f	\N
115281	\N	The frequency and distribution of thiopurine S-methyltransferase alleles in south Iranian population.	{"Moini Maryam","Ghaderi Fatemeh","Sagheb Mohamad Mehdi","Tavasolli Ali Reza","Azarpira Negar","Darai Masumeh","Geramizadeh Bita"}	Molecular biology reports	4	\N	\N	2012	21938428	\N	\N	\N	2	f	\N
115291	\N	TPMT alleles in the Moroccans.	{"Janati Idrissi Meryem","Samri Imane","Khabbal Youssef","El Hassouni Mohammed","Ouldim Karim"}	Clinics and research in hepatology and gastroenterology	9	\N	\N	2015	25573490	\N	\N	\N	2	f	\N
115327	\N	\N	{gnomAD}	\N	\N	\N	\N	\N	\N	\N	\N	http://gnomad.broadinstitute.org/variant/13-48619856-G-A	1	f	\N
115329	\N	\N	{gnomAD}	\N	\N	\N	\N	\N	\N	\N	\N	http://gnomad.broadinstitute.org/variant/13-48611934-G-A	1	f	\N
115331	\N	\N	{gnomAD}	\N	\N	\N	\N	\N	\N	\N	\N	http://gnomad.broadinstitute.org/variant/13-48611983-G-C	1	f	\N
115333	\N	\N	{"ensembl gnomAD exomes"}	\N	\N	\N	\N	\N	\N	\N	\N	http://grch37.ensembl.org/Homo_sapiens/Variation/Population?db=core;r=13:48611419-48612424;v=rs746071566;vdb=variation;vf=111839965	1	f	\N
115295	\N	Clinical implication of thiopurine methyltransferase polymorphism in children with acute lymphoblastic leukemia: A preliminary Egyptian study.	{"El-Rashedy Farida H","Ragab Seham Mohammed","Dawood Ashraf A","Temraz Shaymaa A"}	Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology	0	\N	\N	2015	26811598	\N	\N	\N	2	f	\N
115304	\N	Treatment of diplopia.	{"Phillips Paul H"}	Seminars in neurology	7	\N	\N	2007	17577869	\N	\N	\N	2	f	\N
115317	\N	Do the distribution patterns of polymorphisms at the thiopurine S-methyltransferase locus in sub-Saharan populations need revision? Hints from Cabinda and Mozambique.	{"Oliveira E","Quental S","Alves S","Amorim A","Prata M J"}	European journal of clinical pharmacology	7	\N	\N	2007	17473918	\N	\N	\N	2	f	\N
115645	\N	Genetic polymorphism of cytochrome P450 2C19 in Mexican Americans: a cross-ethnic comparative study.	{"Luo Huai-Rong","Poland Russell E","Lin Keh-Ming","Wan Yu-Jui Yvonne"}	Clinical pharmacology and therapeutics	7	\N	\N	2006	16815315	\N	\N	\N	2	f	\N
115652	\N	Multi-ethnic distribution of clinically relevant CYP2C genotypes and haplotypes.	{"Martis S","Peter I","Hulot J-S","Kornreich R","Desnick R J","Scott S A"}	The pharmacogenomics journal	8	\N	\N	2013	22491019	\N	\N	\N	2	f	\N
115661	\N	Canadian Native Indians exhibit unique CYP2A6 and CYP2C19 mutant allele frequencies.	{"Nowak M P","Sellers E M","Tyndale R F"}	Clinical pharmacology and therapeutics	10	\N	\N	1998	9797794	\N	\N	\N	2	f	\N
115665	\N	Distribution of CYP2C polymorphisms in an Amerindian population of Brazil.	{"Vargens Daniela D","Petzl-Erler Maria-Luiza","Suarez-Kurtz Guilherme"}	Basic & clinical pharmacology & toxicology	4	\N	\N	2012	21977947	\N	\N	\N	2	f	\N
115676	\N	CYP2C19 genetic mutations in North Indians.	{"Lamba J K","Dhiman R K","Kohli K K"}	Clinical pharmacology and therapeutics	9	\N	\N	2000	11014415	\N	\N	\N	2	f	\N
115684	\N	The effect of the CYP2C19 genotype on the hydroxylation index of omeprazole in South Indians.	{"Rosemary J","Adithan C","Padmaja N","Shashindran C H","Gerard N","Krishnamoorthy R"}	European journal of clinical pharmacology	3	\N	\N	2005	15662508	\N	\N	\N	2	f	\N
115688	\N	Association of poor metabolizers of cytochrome P450 2C19 with head and neck cancer and poor treatment response.	{"Yadav Sunishtha S","Ruwali Munindra","Shah Parag P","Mathur Neeraj","Singh Ram L","Pant Mohan C","Parmar Devendra"}	Mutation research	9	\N	\N	2008	18644391	\N	\N	\N	2	f	\N
115698	\N	Interaction of drug metabolizing cytochrome P450 2D6 poor metabolizers with cytochrome P450 2C9 and 2C19 genotypes modify the susceptibility to head and neck cancer and treatment response.	{"Yadav Sunishtha S","Ruwali Munindra","Pant Mohan C","Shukla Pragya","Singh Ram L","Parmar Devendra"}	Mutation research	2	\N	\N	2010	19954746	\N	\N	\N	2	f	\N
115702	\N	Influence of CYP2C9 and CYP2C19 genetic polymorphisms on phenytoin-induced neurological toxicity in Indian epileptic patients.	{"Kesavan Ramasamy","Narayan Sunil K","Adithan Chandrasekaran"}	European journal of clinical pharmacology	7	\N	\N	2010	20390258	\N	\N	\N	2	f	\N
115710	\N	Genetic polymorphisms of CYP2C19 influences the response to clopidogrel in ischemic heart disease patients in the South Indian Tamilian population.	{"Subraja K","Dkhar S A","Priyadharsini R","Ravindra B K","Shewade D G","Satheesh S","Sridhar M G","Narayan S K","Adithan C"}	European journal of clinical pharmacology	3	\N	\N	2013	22955794	\N	\N	\N	2	f	\N
115718	\N	Correlation of CYP2C19 genotype with plasma voriconazole levels: a preliminary retrospective study in Indians.	{"Chawla Prerna K","Nanday Shweta R","Dherai Alpa J","Soman Rajeev","Lokhande Rohan V","Naik Prasad R","Ashavaid Tester F"}	International journal of clinical pharmacy	10	\N	\N	2015	26024717	\N	\N	\N	2	f	\N
115728	\N	Genotyping of S-mephenytoin 4'-hydroxylation in an extended Japanese population.	{"Kubota T","Chiba K","Ishizaki T"}	Clinical pharmacology and therapeutics	12	\N	\N	1996	8988068	\N	\N	\N	2	f	\N
115730	\N	Evidence that poor metabolizers of (S)-mephenytoin could be identified by haplotypes of CYP2C19 in Japanese.	{"Takakubo F","Kuwano A","Kondo I"}	Pharmacogenetics	6	\N	\N	1996	8807668	\N	\N	\N	2	f	\N
115741	\N	Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer.	{"Furuta T","Ohashi K","Kamata T","Takashima M","Kosuge K","Kawasaki T","Hanai H","Kubota T","Ishizaki T","Kaneko E"}	Annals of internal medicine	12	\N	\N	1998	9867757	\N	\N	\N	2	f	\N
115747	\N	Association of polymorphisms in the cytochrome P450 (CYP) 2C19 and 2C18 genes in Japanese epileptic patients.	{"Mamiya K","Ieiri I","Miyahara S","Imai J","Furuumi H","Fukumaki Y","Ninomiya H","Tashiro N","Yamada H","Higuchi S"}	Pharmacogenetics	2	\N	\N	1998	9511186	\N	\N	\N	2	f	\N
115753	\N	Genetic differences in CYP2C19 single nucleotide polymorphisms among four Asian populations.	{"Yamada S","Onda M","Kato S","Matsuda N","Matsuhisa T","Yamada N","Miki M","Matsukura N"}	Journal of gastroenterology	10	\N	\N	2001	11686476	\N	\N	\N	2	f	\N
115759	\N	Identification of N-acetyltransferase 2 and CYP2C19 genotypes for hair, buccal cell swabs, or fingernails compared with blood.	{"Tanigawara Y","Kita T","Hirono M","Sakaeda T","Komada F","Okumura K"}	Therapeutic drug monitoring	8	\N	\N	2001	11477314	\N	\N	\N	2	f	\N
115770	\N	Analysis of the CYP2C19 polymorphism in a North-eastern Thai population.	{"Tassaneeyakul Wichittra","Tawalee Arporn","Tassaneeyakul Wongwiwat","Kukongviriyapan Veerapol","Blaisdell Joyce","Goldstein Joyce A","Gaysornsiri Dhanu"}	Pharmacogenetics	4	\N	\N	2002	11927837	\N	\N	\N	2	f	\N
114457	\N	To Genotype or Phenotype for Personalized Medicine? CYP450 Drug Metabolizing Enzyme Genotype-Phenotype Concordance and Discordance in the Ecuadorian Population.	{"De Andrés Fernando","Terán Santiago","Hernández Francisco","Terán Enrique","LLerena Adrián"}	Omics : a journal of integrative biology	12	\N	\N	2016	27849442	\N	\N	\N	2	f	\N
115776	\N	Pharmacokinetics of lansoprazole in Chinese healthy subjects in relation to CYP2C19 genotypes.	{"Hu Yu-Rong","Qiao Hai-Ling","Kan Quan-Cheng"}	Acta pharmacologica Sinica	8	\N	\N	2004	15301728	\N	\N	\N	2	f	\N
115785	\N	A novel single nucleotide polymorphism (SNP) of the CYP2C19 gene in a Japanese subject with lowered capacity of mephobarbital 4'-hydroxylation.	{"Morita Jun","Kobayashi Kaoru","Wanibuchi Atsuko","Kimura Miyuki","Irie Shin","Ishizaki Takashi","Chiba Kan"}	Drug metabolism and pharmacokinetics	6	\N	\N	2004	15499191	\N	\N	\N	2	f	\N
115796	\N	High-throughput detection of multiple genetic polymorphisms influencing drug metabolism with mismatch primers in allele-specific polymerase chain reaction.	{"Ishiguro Akihiro","Kubota Takahiro","Soya Yoshihiro","Sasaki Hiroshi","Yagyu Osamu","Takarada Yutaka","Iga Tatsuji"}	Analytical biochemistry	2	\N	\N	2005	15691505	\N	\N	\N	2	f	\N
115802	\N	Limited frequency of the CYP2C19*17 allele and its minor role in a Japanese population.	{"Sugimoto Katsuyoshi","Uno Tsukasa","Yamazaki Hiroshi","Tateishi Tomonori"}	British journal of clinical pharmacology	3	\N	\N	2008	18241287	\N	\N	\N	2	f	\N
115807	\N	Phenotype-genotype relationship and clinical effects of citalopram in Chinese patients.	{"Yin Ophelia Q P","Wing Yun-Kwok","Wing Yun-Kowk","Cheung Yuet","Wang Zhi-Jun","Lam Siu-Ling","Chiu Helen F K","Chow Moses S S"}	Journal of clinical psychopharmacology	8	\N	\N	2006	16855453	\N	\N	\N	2	f	\N
115819	\N	Cyp2c19 genotype and omeprazole hydroxylation phenotype in Chinese Li population.	{"Wang Jiu-Hui","Li Pei-Qiong","Fu Qiong-Yao","Li Qiu-Xiang","Cai Wang-Wei"}	Clinical and experimental pharmacology & physiology	0	\N	\N	2007	17439410	\N	\N	\N	2	f	\N
115823	\N	CYP2C19 polymorphism affects personality traits of Japanese females.	{"Ishii Genki","Suzuki Akihito","Oshino Shingo","Shiraishi Hiroaki","Otani Koichi"}	Neuroscience letters	1	\N	\N	2007	17052843	\N	\N	\N	2	f	\N
115831	\N	Contributions of CYP2C9/CYP2C19 genotypes and drug interaction to the phenytoin treatment in the Korean epileptic patients in the clinical setting.	{"Lee Soo-Youn","Lee Seung-Tae","Kim Jong-Won"}	Journal of biochemistry and molecular biology	5	\N	\N	2007	17562299	\N	\N	\N	2	f	\N
115842	\N	Effect of the CYP2C19 polymorphism on the eradication rate of Helicobacter pylori infection by 7-day triple therapy with regular proton pump inhibitor dosage.	{"Kang Jung Mook","Kim Nayoung","Lee Dong Ho","Park Young Soo","Kim Joo Sung","Chang In Jin","Song In Sung","Jung Hyun Chae"}	Journal of gastroenterology and hepatology	8	\N	\N	2008	18637061	\N	\N	\N	2	f	\N
115857	\N	Association study of genetic polymorphism in ABCC4 with cyclophosphamide-induced adverse drug reactions in breast cancer patients.	{"Low Siew-Kee","Kiyotani Kazuma","Mushiroda Taisei","Daigo Yataro","Nakamura Yusuke","Zembutsu Hitoshi"}	Journal of human genetics	10	\N	\N	2009	19696793	\N	\N	\N	2	f	\N
115865	\N	The CYP2C19*2 and CYP2C19*3 polymorphisms are associated with high post-treatment platelet reactivity in Asian patients with acute coronary syndrome.	{"Kim I-S","Choi B-R","Jeong Y-H","Kwak C H","Kim S"}	Journal of thrombosis and haemostasis : JTH	5	\N	\N	2009	19220726	\N	\N	\N	2	f	\N
115872	\N	Pharmacogenetics of esomeprazole or rabeprazole-based triple therapy in Helicobacter pylori eradication in Hong Kong non-ulcer dyspepsia Chinese subjects.	{"Lee V W Y","Chau T S","Chan A K W","Lee K K C","Waye M M Y","Ling T K W","Chan F K L"}	Journal of clinical pharmacy and therapeutics	6	\N	\N	2010	20831535	\N	\N	\N	2	f	\N
115886	\N	Pre-procedural platelet reactivity after clopidogrel loading in korean patients undergoing scheduled percutaneous coronary intervention.	{"Kang Min-Kyung","Jeong Young-Hoon","Yoon Seong-Eun","Koh Jin-Sin","Kim In-Suk","Park Yongwhi","Hwang Seok-Jae","Kwak Choong Hwan","Hwang Jin-Yong"}	Journal of atherosclerosis and thrombosis	11	\N	\N	2010	20724801	\N	\N	\N	2	f	\N
115893	\N	CYP2C19 activity comparison between Swedes and Koreans: effect of genotype, sex, oral contraceptive use, and smoking.	{"Ramsjö Margareta","Aklillu Eleni","Bohman Lilleba","Ingelman-Sundberg Magnus","Roh Hyung-Keun","Bertilsson Leif"}	European journal of clinical pharmacology	9	\N	\N	2010	20499227	\N	\N	\N	2	f	\N
115900	\N	Analysis of 50 SNPs in CYP2D6, CYP2C19, CYP2C9, CYP3A4 and CYP1A2 by MALDI-TOF mass spectrometry in Chinese Han population.	{"Shi Yan","Xiang Ping","Li Li","Shen Min"}	Forensic science international	4	\N	\N	2011	21071160	\N	\N	\N	2	f	\N
115909	\N	Genetic polymorphisms and novel allelic variants of CYP2C19 in the Chinese Han population.	{"Hu Li-Ming","Dai Da-Peng","Hu Guo-Xin","Yang Jie-Fu","Xu Ren-Ai","Yang Li-Ping","Qian Jian-Chang","Ge Ren-Shan","Cai Jian-Ping"}	Pharmacogenomics	11	\N	\N	2012	23148634	\N	\N	\N	2	f	\N
115926	\N	CYP2C19 polymorphisms and coronary heart disease risk factors synergistically impact clopidogrel response variety after percutaneous coronary intervention.	{"Liu Tao","Yin Tao","Li Yan","Song Li-Qiang","Yu Jin","Si Rui","Zhang Ying-Mei","He Yuan","Guo Wen-Yi","Wang Hai-Chang"}	Coronary artery disease	8	\N	\N	2014	24608794	\N	\N	\N	2	f	\N
115934	\N	Influence of CYP2C19 polymorphisms on platelet reactivity and clinical outcomes in ischemic stroke patients treated with clopidogrel.	{"Qiu Li-Na","Sun Yan","Wang Lin","Han Rui-Fa","Xia Xiao-Shuang","Liu Jie","Li Xin"}	European journal of pharmacology	1	\N	\N	2015	25489921	\N	\N	\N	2	f	\N
115943	\N	Chronic kidney disease status modifies the association of CYP2C19 polymorphism in predicting clinical outcomes following coronary stent implantation.	{"Tabata Noriaki","Hokimoto Seiji","Akasaka Tomonori","Arima Yuichiro","Kaikita Koichi","Kumagae Naoki","Morita Kazunori","Miyazaki Hiroko","Oniki Kentaro","Nakagawa Kazuko","Matsui Kunihiko","Ogawa Hisao"}	Thrombosis research	11	\N	\N	2014	25201060	\N	\N	\N	2	f	\N
115949	\N	CYP2C19*2 and Other Allelic Variants Affecting Platelet Response to Clopidogrel Tested by Thrombelastography in Patients with Acute Coronary Syndrome.	{"Liu Jian","Nie Xiao-Yan","Zhang Yong","Lu Yun","Shi Lu-Wen","Wang Wei-Min"}	Chinese medical journal	8	\N	\N	2015	26265611	\N	\N	\N	2	f	\N
116048	\N	Pharmacogenetics of acenocoumarol: CYP2C9, CYP2C19, CYP1A2, CYP3A4, CYP3A5 and ABCB1 gene polymorphisms and dose requirements.	{"Saraeva R B","Paskaleva I D","Doncheva E","Eap C B","Ganev V S"}	Journal of clinical pharmacy and therapeutics	12	\N	\N	2007	18021343	\N	\N	\N	2	f	\N
116055	\N	Pharmacogenetically relevant polymorphisms in Portugal.	{"Oliveira E","Marsh S","van Booven D J","Amorim A","Prata M J","McLeod H L"}	Pharmacogenomics	7	\N	\N	2007	18240903	\N	\N	\N	2	f	\N
116062	\N	Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.	{"Ekhart Corine","Doodeman Valerie D","Rodenhuis Sjoerd","Smits Paul H M","Beijnen Jos H","Huitema Alwin D R"}	Pharmacogenetics and genomics	6	\N	\N	2008	18496131	\N	\N	\N	2	f	\N
116072	\N	CYP2C19 and nongenetic factors predict poor responsiveness to clopidogrel loading dose after coronary stent implantation.	{"Geisler Tobias","Schaeffeler Elke","Dippon Juergen","Winter Stefan","Buse Verena","Bischofs Christian","Zuern Christine","Moerike Klaus","Gawaz Meinrad","Schwab Matthias"}	Pharmacogenomics	9	\N	\N	2008	18781853	\N	\N	\N	2	f	\N
116076	\N	Serum concentrations of sertraline and N-desmethyl sertraline in relation to CYP2C19 genotype in psychiatric patients.	{"Rudberg I","Hermann M","Refsum H","Molden E"}	European journal of clinical pharmacology	12	\N	\N	2008	18677622	\N	\N	\N	2	f	\N
116084	\N	Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.	{"Bohanec Grabar Petra","Rozman Blaz","Tomsic Matija","Suput Dasa","Logar Dusan","Dolzan Vita"}	European journal of clinical pharmacology	9	\N	\N	2008	18496682	\N	\N	\N	2	f	\N
116091	\N	Frequency of CYP3A4, CYP3A5, CYP2C9, and CYP2C19 variant alleles in patients receiving clopidogrel that experience repeat acute coronary syndrome.	{"Brackbill Marcia L","Kidd Robert S","Abdoo April D","Warner James G","Harralson Arthur F"}	Heart and vessels	3	\N	\N	2009	19337788	\N	\N	\N	2	f	\N
116379	\N	Haplotypes frequencies of CYP2B6 in Malaysia.	{"Musa N","Zulkafli M I","Talib N","Mohamad N","Fauzi H","Ismail R"}	Journal of postgraduate medicine	0	\N	\N	2012	23298916	\N	\N	\N	2	f	\N
116099	\N	Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention.	{"Sibbing Dirk","Stegherr Julia","Latz Wolfgang","Koch Werner","Mehilli Julinda","Dörrler Katharina","Morath Tanja","Schömig Albert","Kastrati Adnan","von Beckerath Nicolas"}	European heart journal	4	\N	\N	2009	19193675	\N	\N	\N	2	f	\N
116111	\N	Analysis of CYP2C9*2, CYP2C19*2, and CYP2D6*4 polymorphisms in patients with type 2 diabetes mellitus.	{"Semiz Sabina","Dujic Tanja","Ostanek Barbara","Prnjavorac Besim","Bego Tamer","Malenica Maja","Marc Janja","Causevic Adlija"}	Bosnian journal of basic medical sciences	11	\N	\N	2010	21108610	\N	\N	\N	2	f	\N
116122	\N	CYP2C19*2 polymorphism is associated with increased survival in breast cancer patients using tamoxifen.	{"Ruiter Rikje","Bijl Monique J","van Schaik Ron H N","Berns Els M J J","Hofman Albert","Coebergh Jan-Willem W","van Noord Charlotte","Visser Loes E","Stricker Bruno H Ch"}	Pharmacogenomics	10	\N	\N	2010	21047200	\N	\N	\N	2	f	\N
116126	\N	Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide.	{"Bray J","Sludden J","Griffin M J","Cole M","Verrill M","Jamieson D","Boddy A V"}	British journal of cancer	3	\N	\N	2010	20179710	\N	\N	\N	2	f	\N
116135	\N	Isolated and interactive impact of common CYP2C19 genetic variants on the antiplatelet effect of chronic clopidogrel therapy.	{"Sibbing D","Gebhard D","Koch W","Braun S","Stegherr J","Morath T","Von Beckerath N","Mehilli J","Schömig A","Schuster T","Kastrati A"}	Journal of thrombosis and haemostasis : JTH	8	\N	\N	2010	20492469	\N	\N	\N	2	f	\N
115976	\N	Allele frequency of CYP2C19 in a Portuguese population.	{"Ruas J L","Lechner M C"}	Pharmacogenetics	8	\N	\N	1997	9295062	\N	\N	\N	2	f	\N
115984	\N	Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer.	{"Gjerde Jennifer","Geisler Jürgen","Lundgren Steinar","Ekse Dagfinn","Varhaug Jan Erik","Mellgren Gunnar","Steen Vidar M","Lien Ernst A"}	BMC cancer	6	\N	\N	2010	20565970	\N	\N	\N	2	f	\N
115990	\N	No association between familial Alzheimer disease and cytochrome P450 polymorphisms.	{"Yamada H","Dahl M L","Viitanen M","Winblad B","Sjöqvist F","Lannfelt L"}	Alzheimer disease and associated disorders	9	\N	\N	1998	9772024	\N	\N	\N	2	f	\N
115999	\N	Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance.	{"Scordo Maria Gabriella","Pengo Vittorio","Spina Edoardo","Dahl Marja Liisa","Gusella Milena","Padrini Roberto"}	Clinical pharmacology and therapeutics	12	\N	\N	2002	12496751	\N	\N	\N	2	f	\N
116010	\N	Allelic variants of drug metabolizing enzymes as risk factors in psoriasis.	{"Richter-Hintz Dagmar","Their Ricarda","Steinwachs Swantje","Kronenberg Sven","Fritsche Ellen","Sachs Bernd","Wulferink Marty","Tonn Torsten","Esser Charlotte"}	The Journal of investigative dermatology	5	\N	\N	2003	12713578	\N	\N	\N	2	f	\N
116015	\N	CYP2C19 polymorphism is a major predictor of treatment failure in white patients by use of lansoprazole-based quadruple therapy for eradication of Helicobacter pylori.	{"Schwab Matthias","Schaeffeler Elke","Klotz Ulrich","Treiber Gerhard"}	Clinical pharmacology and therapeutics	9	\N	\N	2004	15371981	\N	\N	\N	2	f	\N
116023	\N	Association of cyclophosphamide pharmacokinetics to polymorphic cytochrome P450 2C19.	{"Timm R","Kaiser R","Lötsch J","Heider U","Sezer O","Weisz K","Montemurro M","Roots I","Cascorbi I"}	The pharmacogenomics journal	0	\N	\N	2005	16116487	\N	\N	\N	2	f	\N
116033	\N	Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment.	{"Crettol Séverine","Déglon Jean-Jacques","Besson Jacques","Croquette-Krokkar Marina","Gothuey Isabelle","Hämmig Robert","Monnat Martine","Hüttemann Hardy","Baumann Pierre","Eap Chin B"}	Clinical pharmacology and therapeutics	12	\N	\N	2005	16338275	\N	\N	\N	2	f	\N
116040	\N	Heterozygous mutation in CYP2C19 significantly increases the concentration/dose ratio of racemic citalopram and escitalopram (S-citalopram).	{"Rudberg Ida","Hendset Magnhild","Uthus Linda Hårstad","Molden Espen","Refsum Helge"}	Therapeutic drug monitoring	2	\N	\N	2006	16418702	\N	\N	\N	2	f	\N
116836	\N	Ethnic differences in CYP2C9*2 (Arg144Cys) and CYP2C9*3 (Ile359Leu) genotypes in Japanese and Israeli populations.	{"Nakai Kenji","Habano Wataru","Nakai Keiko","Fukushima Noriko","Suwabe Akira","Moriya Shogo","Osano Kaoru","Gurwitz David"}	Life sciences	11	\N	\N	2005	16111713	\N	\N	\N	2	f	\N
116148	\N	Genetic factors associated with drug-resistance of epilepsy: relevance of stratification by patient age and aetiology of epilepsy.	{"Sánchez M Blanca","Herranz José L","Leno Carlos","Arteaga Rosa","Oterino Agustín","Valdizán Elsa M","Nicolás José M","Adín Javier","Armijo Juan A"}	Seizure	3	\N	\N	2010	20064729	\N	\N	\N	2	f	\N
116156	\N	Association between CYP2C19*17 and metabolism of amitriptyline, citalopram and clomipramine in Dutch hospitalized patients.	{"de Vos A","van der Weide J","Loovers H M"}	The pharmacogenomics journal	10	\N	\N	2011	20531370	\N	\N	\N	2	f	\N
116166	\N	Xenobiotic sensor- and metabolism-related gene variants in environmental sensitivity-related illnesses: a survey on the Italian population.	{"Caccamo Daniela","Cesareo Eleonora","Mariani Serena","Raskovic Desanka","Ientile Riccardo","Currò Monica","Korkina Liudmila","De Luca Chiara"}	Oxidative medicine and cellular longevity	0	\N	\N	2013	23936614	\N	\N	\N	2	f	\N
116176	\N	Genetic polymorphisms of CYP2C8, CYP2C9 and CYP2C19 in Ecuadorian Mestizo and Spaniard populations: a comparative study.	{"Vicente Jorge","González-Andrade Fabricio","Soriano Antonia","Fanlo Ana","Martínez-Jarreta Begoña","Sinués Blanca"}	Molecular biology reports	3	\N	\N	2014	24430292	\N	\N	\N	2	f	\N
116188	\N	Prevalence and significance of CYP2C19*2 and CYP2C19*17 alleles in a New Zealand acute coronary syndrome population.	{"Larsen P D","Johnston L R","Holley A","La Flamme A C","Smyth L","Chua E W","Kennedy M A","Harding S A"}	Internal medicine journal	5	\N	\N	2015	25583161	\N	\N	\N	2	f	\N
116192	\N	Pharmacogenetic testing in population of South Ural.	{"Barysheva V O","Ketova G G"}	The International journal of risk & safety in medicine	0	\N	\N	2015	26639695	\N	\N	\N	2	f	\N
116198	\N	Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians.	{"Kohlrausch Fabiana B","Carracedo Ángel","Hutz Mara H"}	Molecular biology reports	3	\N	\N	2014	24443221	\N	\N	\N	2	f	\N
116214	\N	Frequencies of Functional Polymorphisms in Three Pharmacokinetic Genes of Clinical Interest within the Admixed Puerto Rican Population.	{"Orengo-Mercado Carmelo","Nieves Bianca","López Lizbeth","Vallés-Ortiz Nabila","Renta Jessicca Y","Santiago-Borrero Pedro J","Cadilla Carmen L","Duconge Jorge"}	Journal of pharmacogenomics & pharmacoproteomics	3	\N	\N	2013	24040574	\N	\N	\N	2	f	\N
116223	\N	Pharmacogenomic assessment of Mexican and Peruvian populations.	{"Marsh Sharon","King Cristi R","Van Booven Derek J","Revollo Jane Y","Gilman Robert H","McLeod Howard L"}	Pharmacogenomics	0	\N	\N	2015	25916516	\N	\N	\N	2	f	\N
116232	\N	Phenotypic-genotypic analysis of CYP2C19 in the Jewish Israeli population.	{"Sviri S","Shpizen S","Leitersdorf E","Levy M","Caraco Y"}	Clinical pharmacology and therapeutics	3	\N	\N	1999	10096259	\N	\N	\N	2	f	\N
116240	\N	Investigation of allele and genotype frequencies of CYP2C9, CYP2C19 and VKORC1 in Iran.	{"Azarpira Negar","Namazi Soha","Hendijani Fatemeh","Banan Maryam","Darai Masumeh"}	Pharmacological reports : PR	0	\N	\N	2010	20885015	\N	\N	\N	2	f	\N
116246	\N	Prevalence of CYP2C19 polymorphisms in the Lebanese population.	{"Djaffar Jureidini Isabelle","Chamseddine Nabil","Keleshian Sose","Naoufal Rania","Zahed Laila","Hakime Noha"}	Molecular biology reports	11	\N	\N	2011	21380557	\N	\N	\N	2	f	\N
116251	\N	Genetic polymorphism of CYP2C19 in a Jordanian population: influence of allele frequencies of CYP2C19*1 and CYP2C19*2 on the pharmacokinetic profile of lansoprazole.	{"Zalloum Imad","Hakooz Nancy","Arafat Tawfiq"}	Molecular biology reports	4	\N	\N	2012	21769476	\N	\N	\N	2	f	\N
116259	\N	Genotype and allele frequency of CYP2C19*17 in a healthy Iranian population.	{"Payan Maryam","Tajik Nader","Rouini Mohammad Reza","Ghahremani Mohammad Hossein"}	Medical journal of the Islamic Republic of Iran	0	\N	\N	2015	26793660	\N	\N	\N	2	f	\N
116264	\N	CYP2C19 polymorphisms in patients with gastric and colorectal carcinoma.	{"Tamer L","Ercan B","Ercan S","Ateş N","Ateş C","Ocal K","Dirlik M","Aydin S","Atik U"}	International journal of gastrointestinal cancer	0	\N	\N	2006	17290075	\N	\N	\N	2	f	\N
116272	\N	The prevalence of CYP2C19 mutations in Turkish patients with dyspepsia.	{"Celebi Altay","Kocaman Orhan","Savli Hakan","Aygün Cem","Konduk Buğra Tolga","Sentürk Omer","Hülagu Sadettin"}	The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology	9	\N	\N	2009	19821196	\N	\N	\N	2	f	\N
116282	\N	Allele and genotype frequencies of CYP2B6 and CYP2C19 polymorphisms in Egyptian agricultural workers.	{"Ellison Corie A","Abou El-Ella Soheir S","Tawfik Maha","Lein Pamela J","Olson James R"}	Journal of toxicology and environmental health. Part A	0	\N	\N	2012	22352331	\N	\N	\N	2	f	\N
116286	\N	Implication of Xenobiotic Metabolizing Enzyme gene (CYP2E1, CYP2C19, CYP2D6, mEH and NAT2) polymorphisms in breast carcinoma.	{"Khedhaier Achraf","Hassen Elham","Bouaouina Noureddine","Gabbouj Sallouha","Ahmed Slim Ben","Chouchane Lotfi"}	BMC cancer	4	\N	\N	2008	18423013	\N	\N	\N	2	f	\N
116323	\N	A high incidence of polymorphic CYP2C19 variants in archival blood samples from Papua New Guinea.	{"Hsu Huai-Ling","Woad Kathryn J","Woodfield D Graeme","Helsby Nuala A"}	Human genomics	9	\N	\N	2008	19129087	\N	\N	\N	2	f	\N
116326	\N	Phenotyping and genotyping of S-mephenytoin hydroxylase (cytochrome P450 2C19) in a Shona population of Zimbabwe.	{"Masimirembwa C","Bertilsson L","Johansson I","Hasler J A","Ingelman-Sundberg M"}	Clinical pharmacology and therapeutics	6	\N	\N	1995	7781265	\N	\N	\N	2	f	\N
116338	\N	Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population.	{"Kudzi William","Dodoo Alexander No","Mills Jeremy J"}	BMC medical genetics	12	\N	\N	2009	19954515	\N	\N	\N	2	f	\N
116356	\N	Evaluation of predictive CYP2C19 genotyping assays relative to measured phenotype in a South African cohort.	{"Dodgen Tyren M","Drögemöller Britt I","Wright Galen E B","Warnich Louise","Steffens Francois E","Cromarty A Duncan","Alessandrini Marco","Pepper Michael S"}	Pharmacogenomics	0	\N	\N	2015	26244421	\N	\N	\N	2	f	\N
116226	\N	CYP2C9, CYP2C19, ABCB1 genetic polymorphisms and phenytoin plasma concentrations in Mexican-Mestizo patients with epilepsy.	{"Ortega-Vázquez A","Dorado P","Fricke-Galindo I","Jung-Cook H","Monroy-Jaramillo N","Martínez-Juárez I E","Familiar-López I","Peñas-Lledó E","LLerena A","López-López M"}	The pharmacogenomics journal	6	\N	\N	2016	26122019	\N	\N	\N	2	f	\N
116681	\N	Identification and functional characterization of a new CYP2C9 variant (CYP2C9*5) expressed among African Americans.	{"Dickmann L J","Rettie A E","Kneller M B","Kim R B","Wood A J","Stein C M","Wilkinson G R","Schwarz U I"}	Molecular pharmacology	8	\N	\N	2001	11455026	\N	\N	\N	2	f	\N
116687	\N	In-vitro and in-vivo effects of the CYP2C9*11 polymorphism on warfarin metabolism and dose.	{"Tai Guoying","Farin Frederico","Rieder Mark J","Dreisbach Albert W","Veenstra David L","Verlinde Christophe L M J","Rettie Allan E"}	Pharmacogenetics and genomics	7	\N	\N	2005	15970795	\N	\N	\N	2	f	\N
116693	\N	Pyrosequencing of the CYP2C9 -1766T>C polymorphism as a means of detecting the CYP2C9*8 allele.	{"Patel Shitalben R","Langaee Taimour Y","Wong Shan S","Cavallari Larisa H"}	Pharmacogenomics	9	\N	\N	2014	25410896	\N	\N	\N	2	f	\N
116377	\N	\N	{gnomAD}	\N	\N	\N	\N	\N	\N	\N	\N	http://gnomad.broadinstitute.org/	1	f	\N
116702	\N	CYP2C9 polymorphism and warfarin sensitivity in Taiwan Chinese.	{"Chern Herng-Der","Ueng Tzuu-Huei","Fu Yi-Ping","Cheng Chun-Wen"}	Clinica chimica acta; international journal of clinical chemistry	5	\N	\N	2006	16413010	\N	\N	\N	2	f	\N
116590	\N	CYP2C9 and VKORC1 polymorphisms are differently distributed in the Brazilian population according to self-declared ethnicity or genetic ancestry.	{"Soares Renata Alonso Gadi","Santos Paulo Caleb Junior Lima","Machado-Coelho George Luiz Lins","do Nascimento Raimundo Marques","Mill Jose Geraldo","Krieger Jose Eduardo","Pereira Alexandre Costa"}	Genetic testing and molecular biomarkers	8	\N	\N	2012	22808915	\N	\N	\N	2	f	\N
116735	\N	Influence of admixture components on CYP2C9*2 allele frequency in eight indigenous populations from Northwest Mexico.	{"Sosa-Macías M","Lazalde-Ramos B P","Galaviz-Hernández C","Rangel-Villalobos H","Salazar-Flores J","Martínez-Sevilla V M","Martínez-Fierro M L","Dorado P","Wong M L","Licinio J","LLerena A"}	The pharmacogenomics journal	12	\N	\N	2013	23358499	\N	\N	\N	2	f	\N
116751	\N	Cytochrome P4502C9 (CYP2C9) allele frequencies in Canadian Native Indian and Inuit populations.	{"Gaedigk A","Casley W L","Tyndale R F","Sellers E M","Jurima-Romet M","Leeder J S"}	Canadian journal of physiology and pharmacology	10	\N	\N	2001	11697742	\N	\N	\N	2	f	\N
116776	\N	Influence of CYP2C9 gene polymorphisms on response to glibenclamide in type 2 diabetes mellitus patients.	{"Surendiran A","Pradhan S C","Agrawal Aparna","Subrahmanyam D K S","Rajan S","Anichavezhi D","Adithan C"}	European journal of clinical pharmacology	8	\N	\N	2011	21336994	\N	\N	\N	2	f	\N
116579	\N	Combined CYP2C9, VKORC1 and CYP4F2 frequencies among racial and ethnic groups.	{"Scott Stuart A","Khasawneh Rame","Peter Inga","Kornreich Ruth","Desnick Robert J"}	Pharmacogenomics	6	\N	\N	2010	20504253	\N	\N	\N	2	f	\N
116647	\N	Influence of CYP2C9 and VKORC1 polymorphisms on warfarin and acenocoumarol in a sample of Lebanese people.	{"Esmerian Maria O","Mitri Zahi","Habbal Mohammad-Zuheir","Geryess Eddy","Zaatari Ghazi","Alam Samir","Skouri Hadi N","Mahfouz Rami A","Taher Ali","Zgheib Nathalie K"}	Journal of clinical pharmacology	10	\N	\N	2011	21148049	\N	\N	\N	2	f	\N
116660	\N	Distribution of CYP2C9 and VKORC1 risk alleles for warfarin sensitivity and resistance in the Israeli population.	{"Efrati Edna","Elkin Hela","Sprecher Eli","Krivoy Norberto"}	Current drug safety	7	\N	\N	2010	20210733	\N	\N	\N	2	f	\N
117206	\N	Comprehensive overview of the pharmacogenetic diversity in Ashkenazi Jews.	{"Zhou Yitian","Lauschke Volker M"}	Journal of medical genetics	9	\N	\N	2018	29970487	\N	\N	\N	2	f	\N
116465	\N	Screening for UGT1A1 Genotype in Study A5257 Would Have Markedly Reduced Premature Discontinuation of Atazanavir for Hyperbilirubinemia.	{"Vardhanabhuti Saran","Ribaudo Heather J","Landovitz Raphael J","Ofotokun Ighovwerha","Lennox Jeffrey L","Currier Judith S","Olson Lana M","Haas David W"}	Open forum infectious diseases	9	\N	\N	2015	26180834	\N	\N	\N	2	f	\N
116474	\N	Genetic polymorphisms of UDP-glucuronosyltransferase in Asians: UGT1A1*28 is a common allele in Indians.	{"Balram Chowbay","Sabapathy Kanaga","Fei Gao","Khoo Kei S","Lee Edmund J D"}	Pharmacogenetics	1	\N	\N	2002	11773869	\N	\N	\N	2	f	\N
116510	\N	Prevalence of clinically relevant UGT1A alleles and haplotypes in African populations.	{"Horsfall Laura J","Zeitlyn David","Tarekegn Ayele","Bekele Endashaw","Thomas Mark G","Bradman Neil","Swallow Dallas M"}	Annals of human genetics	3	\N	\N	2011	21309756	\N	\N	\N	2	f	\N
116655	\N	The VKORC1 Asp36Tyr variant and VKORC1 haplotype diversity in Ashkenazi and Ethiopian populations.	{"Sominsky Sophia","Korostishevsky Michael","Kurnik Daniel","Aklillu Eleni","Cohen Yoram","Ken-Dror Gie","Loebstein Ronen","Halkin Hillel","Gak Eva"}	Journal of applied genetics	5	\N	\N	2014	24425227	\N	\N	\N	2	f	\N
116422	\N	Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver.	{"Lang T","Klein K","Fischer J","Nüssler A K","Neuhaus P","Hofmann U","Eichelbaum M","Schwab M","Zanger U M"}	Pharmacogenetics	7	\N	\N	2001	11470993	\N	\N	\N	2	f	\N
116369	\N	Cytochrome P450 CYP2B6 genotypes and haplotypes in a Colombian population: identification of novel variant CYP2B6 alleles.	{"Restrepo Juan Gonzalo","Martínez Carmen","García-Agúndez Augusto","Gaviria Elmer","Laguna José Julio","García-Martín Elena","Agúndez José A G"}	Pharmacogenetics and genomics	12	\N	\N	2011	21886015	\N	\N	\N	2	f	\N
116435	\N	Genetic variability of CYP2B6 polymorphisms in southeast Iranian population: implications for malaria and HIV/AIDS treatment.	{"Zakeri Sedigheh","Amiri Nasrin","Pirahmadi Sakineh","Dinparast Djadid Navid"}	Archives of Iranian medicine	10	\N	\N	2014	25305768	\N	\N	\N	2	f	\N
116449	\N	High predictive value of CYP2B6 SNPs for steady-state plasma efavirenz levels in South African HIV/AIDS patients.	{"Swart Marelize","Skelton Michelle","Ren Yuan","Smith Peter","Takuva Simbabrashe","Dandara Collet"}	Pharmacogenetics and genomics	8	\N	\N	2013	23778320	\N	\N	\N	2	f	\N
116794	\N	Influence of VKORC1 and CYP2C9 Polymorphisms on Daily Acenocoumarol Dose Requirement in South Indian Patients With Mechanical Heart Valves.	{"Kalpana S R","Bharath G","Manjunath C N","Christopher Rita"}	Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis	10	\N	\N	2017	27335128	\N	\N	\N	2	f	\N
116803	\N	A prospective study to assess the association between genotype, phenotype and Prakriti in individuals on phenytoin monotherapy.	{"Thaker Saket J","Gandhe Prajakta P","Godbole Charuta J","Bendkhale Shital R","Mali Nitin B","Thatte Urmila M","Gogtay Nithya J"}	Journal of Ayurveda and integrative medicine	0	\N	\N	2017	28302415	\N	\N	\N	2	f	\N
116809	\N	Malaysian Indians are genetically similar to Caucasians: CYP2C9 polymorphism.	{"Zainuddin Z","Teh L K","Suhaimi A W M","Ismail R"}	Journal of clinical pharmacy and therapeutics	4	\N	\N	2006	16635054	\N	\N	\N	2	f	\N
116816	\N	Allele and genotype frequency of CYP2C9 in Tamilnadu population.	{"Adithan C","Gerard N","Vasu S","Balakrishnan R","Shashindran C H","Krishnamoorthy R"}	European journal of clinical pharmacology	11	\N	\N	2003	14504850	\N	\N	\N	2	f	\N
116824	\N	Influence of CYP2C9 and VKORC1 gene polymorphisms on warfarin dosage, over anticoagulation and other adverse outcomes in Indian population.	{"Gaikwad Tejasvita","Ghosh Kanjaksha","Kulkarni Bipin","Kulkarni Vrinda","Ross Cecil","Shetty Shrimati"}	European journal of pharmacology	6	\N	\N	2013	23602689	\N	\N	\N	2	f	\N
116841	\N	CYP2C9 polymorphism analysis in Han Chinese populations: building the largest allele frequency database.	{"Dai D-P","Xu R-A","Hu L-M","Wang S-H","Geng P-W","Yang J-F","Yang L-P","Qian J-C","Wang Z-S","Zhu G-H","Zhang X-H","Ge R-S","Hu G-X","Cai J-P"}	The pharmacogenomics journal	2	\N	\N	2014	23400009	\N	\N	\N	2	f	\N
116858	\N	Relationship of P450 2C9 genetic polymorphisms in Chinese and the pharmacokinetics of tolbutamide.	{"Chen K","Wang R","Wen S-Y","Li J","Wang S-Q"}	Journal of clinical pharmacy and therapeutics	6	\N	\N	2005	15896241	\N	\N	\N	2	f	\N
116862	\N	The welfare cost of violence across countries.	{"Soares Rodrigo R"}	Journal of health economics	9	\N	\N	2006	16325292	\N	\N	\N	2	f	\N
116876	\N	Effects of the CYP2C9*13 allele on the pharmacokinetics of losartan in healthy male subjects.	{"Li Z","Wang G","Wang L-S","Zhang W","Tan Z-R","Fan L","Chen B-L","Li Q","Liu J","Tu J-H","Hu D-L","Liu Z-Q","Zhou H-H"}	Xenobiotica; the fate of foreign compounds in biological systems	10	\N	\N	2009	19604036	\N	\N	\N	2	f	\N
116885	\N	Frequency of CYP2C9 variant alleles, including CYP2C9*13 in a Korean population and effect on glimepiride pharmacokinetics.	{"Lee H W","Lim M-s","Lee J","Jegal M-Y","Kim D-W","Lee W-K","Jang I-J","Shin J-G","Yoon Y-R"}	Journal of clinical pharmacy and therapeutics	2	\N	\N	2012	21208246	\N	\N	\N	2	f	\N
116890	\N	Population pharmacokinetic analysis of glimepiride with CYP2C9 genetic polymorphism in healthy Korean subjects.	{"Yoo Hee-Doo","Kim Mi-Suk","Cho Hea-Young","Lee Yong-Bok"}	European journal of clinical pharmacology	9	\N	\N	2011	21476064	\N	\N	\N	2	f	\N
116898	\N	Polymorphisms of Aspirin-Metabolizing Enzymes CYP2C9, NAT2 and UGT1A6 in Aspirin-Intolerant Urticaria.	{"Palikhe Nami Shrestha","Kim Seung-Hyun","Nam Young Hee","Ye Young-Min","Park Hae-Sim"}	Allergy, asthma & immunology research	10	\N	\N	2011	21966608	\N	\N	\N	2	f	\N
116909	\N	Variability of warfarin dose response associated with CYP2C9 and VKORC1 gene polymorphisms in Chinese patients.	{"Ye Changqing","Jin Haiqiang","Zhang Rui","Sun Yongan","Wang Zhaoxia","Sun Weiping","Sun Wei","Peng Qing","Liu Ran","Huang Yining"}	The Journal of international medical research	2	\N	\N	2014	24287930	\N	\N	\N	2	f	\N
116915	\N	Influence of genetic polymorphisms on the pharmacokinetics of celecoxib and its two main metabolites in healthy Chinese subjects.	{"Liu Ruijuan","Gong Chuting","Tao Lei","Yang Wen","Zheng Xiaohong","Ma Pengcheng","Ding Li"}	European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences	11	\N	\N	2015	26360837	\N	\N	\N	2	f	\N
116923	\N	Immunocytochemical investigation of the subcellular distribution of some secretory products in human salivary glands.	{"Lantini M S","Cossu M"}	European journal of morphology	8	\N	\N	1998	9825928	\N	\N	\N	2	f	\N
116933	\N	Genetic polymorphism of CYP2C9 in a Vietnamese Kinh population.	{"Lee Sang Seop","Kim Kang-Mi","Thi-Le Huong","Yea Sung-Su","Cha In-June","Shin Jae-Gook"}	Therapeutic drug monitoring	4	\N	\N	2005	15795654	\N	\N	\N	2	f	\N
116948	\N	Genetic polymorphism analysis of the drug-metabolizing enzyme CYP2C9 in a Chinese Tibetan population.	{"Jin Tianbo","Geng Tingting","He Na","Shi Xugang","Wang Li","Yuan Dongya","Kang Longli"}	Gene	8	\N	\N	2015	25958051	\N	\N	\N	2	f	\N
116960	\N	Frequency of cytochrome P450 2C9 mutant alleles in a Korean population.	{"Yoon Y R","Shon J H","Kim M K","Lim Y C","Lee H R","Park J Y","Cha I J","Shin J G"}	British journal of clinical pharmacology	3	\N	\N	2001	11298075	\N	\N	\N	2	f	\N
116978	\N	High allele frequency of CYP2C9*3 (rs1057910) in a Negrito's subtribe population in Malaysia; Aboriginal people of Jahai.	{"Rosdi Rasmaizatul Akma","Mohd Yusoff Narazah","Ismail Rusli","Soo Choon Tan","Saleem Mohamed","Musa Nurfadhlina","Yusoff Surini"}	Annals of human biology	9	\N	\N	2016	26402341	\N	\N	\N	2	f	\N
116998	\N	Frequency of CYP2C9 polymorphisms in Polynesian people and potential relevance to management of gout with benzbromarone.	{"Roberts Rebecca L","Wallace Mary C","Wright Daniel F B","Cadzow Murray","Dalbeth Nicola","Jones Peter B","Stamp Lisa K","Harrison Andrew A","Black Michael A","Merriman Tony R"}	Joint bone spine	3	\N	\N	2014	23932726	\N	\N	\N	2	f	\N
117015	\N	CYP2C9 genotypes and diclofenac metabolism in Spanish healthy volunteers.	{"Dorado Pedro","Berecz Roland","Norberto Maria-Jesús","Yasar Umit","Dahl Marja-Liisa","LLerena Adrián"}	European journal of clinical pharmacology	7	\N	\N	2003	12734606	\N	\N	\N	2	f	\N
117022	\N	CYP2C9 genotypes and the pharmacokinetics of tenoxicam in Brazilians.	{"Vianna-Jorge Rosane","Perini Jamila A","Rondinelli Edson","Suarez-Kurtz Guilherme"}	Clinical pharmacology and therapeutics	7	\N	\N	2004	15229460	\N	\N	\N	2	f	\N
117201	\N	The allele frequency of CYP2C9 and VKORC1 in the Southern Khorasan population.	{"Razavi Fariba Emadian","Zarban Asghar","Hajipoor Fatemeh","Naseri Mohsen"}	Research in pharmaceutical sciences	6	\N	\N	2017	28626479	\N	\N	\N	2	f	\N
117203	\N	Genetic Polymorphism of CYP2C9 Among Sistani Ethnic Group in Gorgan.	{"Marjani Abdoljalal","Gharanjik Aman Mohammad"}	Indian journal of clinical biochemistry : IJCB	4	\N	\N	2018	29651213	\N	\N	\N	2	f	\N
117215	\N	Frequency of CYP2C9 genotypes among Omani patients receiving warfarin and its correlation with warfarin dose.	{"Tanira Musbah O","Al-Mukhaini Mohammed K","Al-Hinai Ali T","Al Balushi Khalid A","Ahmed Ikhlas S"}	Community genetics	0	\N	\N	2007	17167248	\N	\N	\N	2	f	\N
117236	\N	CYP2C9, CYP2C19, ABCB1 (MDR1) genetic polymorphisms and phenytoin metabolism in a Black Beninese population.	{"Allabi Aurel C","Gala Jean-Luc","Horsmans Yves"}	Pharmacogenetics and genomics	11	\N	\N	2005	16220110	\N	\N	\N	2	f	\N
117537	\N	Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants.	{"Ho Richard H","Choi Leena","Lee Wooin","Mayo Gail","Schwarz Ute I","Tirona Rommel G","Bailey David G","Stein C Michael","Kim Richard B"}	Pharmacogenetics and genomics	8	\N	\N	2007	17622941	\N	\N	\N	2	f	\N
117546	\N	Genetic variations of the SLCO1B1 gene in the Chinese, Malay and Indian populations of Singapore.	{"Ho Woon Fei","Koo Seok Hwee","Yee Jie Yin","Lee Edmund Jon Deoon"}	Drug metabolism and pharmacokinetics	0	\N	\N	2008	19122343	\N	\N	\N	2	f	\N
117555	\N	Influence of OATP1B1 genotype on the pharmacokinetics of rosuvastatin in Koreans.	{"Choi J H","Lee M G","Cho J-Y","Lee J-E","Kim K H","Park K"}	Clinical pharmacology and therapeutics	2	\N	\N	2008	17568401	\N	\N	\N	2	f	\N
117559	\N	Organic anion transporting polypeptide-1B1 haplotypes in Chinese patients.	{"Xu Lin-Yong","He Yi-Jing","Zhang Wei","Deng Sheng","Li Qing","Zhang Wei-Xia","Liu Zhao-Qian","Wang Dan","Huang Yuan-Fei","Zhou Hong-Hao","Sun Zhen-Qiu"}	Acta pharmacologica Sinica	10	\N	\N	2007	17883959	\N	\N	\N	2	f	\N
117571	\N	Effect of organic anion-transporting polypeptide 1B1 (OATP1B1) polymorphism on the single- and multiple-dose pharmacokinetics of enalapril in healthy Chinese adult men.	{"Tian Lei","Liu Hong","Xie Shuang","Jiang Juanjuan","Han Lulu","Huang Yiling","Li Yishi"}	Clinical therapeutics	5	\N	\N	2011	21665049	\N	\N	\N	2	f	\N
117039	\N	Pharmacokinetic studies of enantiomers of ibuprofen and its chiral metabolites in humans with different variants of genes coding CYP2C8 and CYP2C9 isoenzymes.	{"Karaźniewicz-Łada M","Luczak M","Główka F"}	Xenobiotica; the fate of foreign compounds in biological systems	6	\N	\N	2009	19480553	\N	\N	\N	2	f	\N
117046	\N	Impact of clinical factors and CYP2C9 variants for the risk of severe sulfonylurea-induced hypoglycemia.	{"Holstein Andreas","Hahn Michael","Patzer Olaf","Seeringer Angela","Kovacs Peter","Stingl Julia"}	European journal of clinical pharmacology	5	\N	\N	2011	21213107	\N	\N	\N	2	f	\N
117054	\N	A clinically significant interaction between warfarin and simvastatin is unique to carriers of the CYP2C9*3 allele.	{"Andersson Marine L","Eliasson Erik","Lindh Jonatan D"}	Pharmacogenomics	5	\N	\N	2012	22594507	\N	\N	\N	2	f	\N
117061	\N	CYP2C9 genotype vs. metabolic phenotype for individual drug dosing--a correlation analysis using flurbiprofen as probe drug.	{"Vogl Silvia","Lutz Roman W","Schönfelder Gilbert","Lutz Werner K"}	PloS one	0	\N	\N	2015	25775139	\N	\N	\N	2	f	\N
117072	\N	Validation of methods for CYP2C9 genotyping: frequencies of mutant alleles in a Swedish population.	{"Yasar U","Eliasson E","Dahl M L","Johansson I","Ingelman-Sundberg M","Sjöqvist F"}	Biochemical and biophysical research communications	1	\N	\N	1999	9920790	\N	\N	\N	2	f	\N
117078	\N	Allelic variants in the CYP2C9 and VKORC1 loci and interindividual variability in the anticoagulant dose effect of warfarin in Italians.	{"Borgiani Paola","Ciccacci Cinzia","Forte Vittorio","Romano Silvia","Federici Giorgio","Novelli Giuseppe"}	Pharmacogenomics	11	\N	\N	2007	18034619	\N	\N	\N	2	f	\N
117089	\N	Polymorphisms of cytochrome p450 genes in three ethnic groups from Russia.	{"Korytina Gülnaz","Kochetova Olga","Akhmadishina Leysan","Viktorova Elena","Victorova Tatyana"}	Balkan medical journal	9	\N	\N	2012	25207010	\N	\N	\N	2	f	\N
117103	\N	The frequency of CYP2C9, VKORC1, and CYP4F2 polymorphisms in Russian patients with high thrombotic risk.	{"Ivashchenko Dmitriy","Rusin Ilya","Sychev Dmitriy","Grachev Andrey"}	Medicina (Kaunas, Lithuania)	0	\N	\N	2013	24858991	\N	\N	\N	2	f	\N
117112	\N	Cigarette smoking, TP53 Arg72Pro, TP53BP1 Asp353Glu and the risk of lung cancer in a Japanese population.	{"Kiyohara Chikako","Horiuchi Takahiko","Miyake Yoshihiro","Takayama Koichi","Nakanishi Yoichi"}	Oncology reports	5	\N	\N	2010	20372852	\N	\N	\N	2	f	\N
117116	\N	High frequency of mutations related to impaired CYP2C9 metabolism in a Caucasian population.	{"García-Martín E","Martínez C","Ladero J M","Gamito F J","Agúndez J A"}	European journal of clinical pharmacology	4	\N	\N	2001	11372590	\N	\N	\N	2	f	\N
117144	\N	Losartan hydroxylation phenotype in an Ecuadorian population: influence of CYP2C9 genetic polymorphism, habits and gender.	{"Dorado Pedro","Beltrán Leonardo J","Machín Esther","Peñas-Lledó Eva M","Terán Enrique","Llerena Adrián","CEIBA.FP Consortium of the Ibero-American Network of Pharmacogenetics and Pharmacogenomics RIBEF"}	Pharmacogenomics	11	\N	\N	2012	23171336	\N	\N	\N	2	f	\N
117159	\N	VKORC1 V66M mutation in African Brazilian patients resistant to oral anticoagulant therapy.	{"Orsi Fernanda A","Annichino Bizzacchi Joyce M","de Paula Erich V","Ozelo Margareth C","Langley Michael R","Weck Karen E"}	Thrombosis research	9	\N	\N	2010	20615525	\N	\N	\N	2	f	\N
117166	\N	Impact of CYP2C9 and VKORC1 genetic polymorphisms upon warfarin dose requirements in Egyptian patients with acute coronary syndrome.	{"Ghozlan Manal F","Foad Dina A","Darwish Yasser W","Saad Abeer A"}	Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis	7	\N	\N	2015	25699611	\N	\N	\N	2	f	\N
117174	\N	Frequency of VKORC1 (C1173T) and CYP2C9 genetic polymorphisms in Egyptians and their influence on warfarin maintenance dose: proposal for a new dosing regimen.	{"El Din M S","Amin D G","Ragab S B","Ashour E E","Mohamed M H","Mohamed A M"}	International journal of laboratory hematology	10	\N	\N	2012	22533669	\N	\N	\N	2	f	\N
117578	\N	Rapid identification of three functionally relevant polymorphisms in the OATP1B1 transporter gene using Pyrosequencing.	{"Rohrbacher Maren","Kirchhof Anja","Skarke Carsten","Geisslinger Gerd","Lötsch Jörn"}	Pharmacogenomics	3	\N	\N	2006	16515396	\N	\N	\N	2	f	\N
117586	\N	Comparison of SLCO1B1 sequence variability among German, Turkish, and African populations.	{"Mwinyi Jessica","Köpke Karla","Schaefer Melanie","Roots Ivar","Gerloff Thomas"}	European journal of clinical pharmacology	3	\N	\N	2008	18185926	\N	\N	\N	2	f	\N
116414	\N	Multiple novel nonsynonymous CYP2B6 gene polymorphisms in Caucasians: demonstration of phenotypic null alleles.	{"Lang Thomas","Klein Kathrin","Richter Tanja","Zibat Arne","Kerb Reinhold","Eichelbaum Michel","Schwab Matthias","Zanger Ulrich M"}	The Journal of pharmacology and experimental therapeutics	10	\N	\N	2004	15190123	\N	\N	\N	2	f	\N
116416	\N	Haplotype structure and allele frequencies of CYP2B6 in Spaniards and Central Americans.	{"Arenaz Izaskun","Vicente Jorge","Fanlo Ana","Vásquez Patricia","Medina Juan Carlos","Conde Blanca","González-Andrade Fabricio","Sinués Blanca"}	Fundamental & clinical pharmacology	4	\N	\N	2010	19682083	\N	\N	\N	2	f	\N
116420	\N	Identification of CYP2B6 sequence variants by use of multiplex PCR with allele-specific genotyping.	{"Jacob Robyn M","Johnstone Elaine C","Neville Matt J","Walton Robert T"}	Clinical chemistry	8	\N	\N	2004	15178651	\N	\N	\N	2	f	\N
115958	\N	Association of Cytochrome P450 Genetic Variants with Clopidogrel Resistance and Outcomes in Acute Ischemic Stroke.	{"Yi Xingyang","Lin Jing","Wang Yanfen","Zhou Qiang","Wang Chun","Cheng Wen","Chi Lifen"}	Journal of atherosclerosis and thrombosis	10	\N	\N	2016	26961113	\N	\N	\N	2	f	\N
116362	\N	Worldwide variation in human drug-metabolism enzyme genes CYP2B6 and UGT2B7: implications for HIV/AIDS treatment.	{"Li Jing","Menard Vincent","Benish Rebekah L","Jurevic Richard J","Guillemette Chantal","Stoneking Mark","Zimmerman Peter A","Mehlotra Rajeev K"}	Pharmacogenomics	4	\N	\N	2012	22462748	\N	\N	\N	2	f	\N
116365	\N	Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS Clinical Trials Group study.	{"Ribaudo Heather J","Liu Huan","Schwab Matthias","Schaeffeler Elke","Eichelbaum Michel","Motsinger-Reif Alison A","Ritchie Marylyn D","Zanger Ulrich M","Acosta Edward P","Morse Gene D","Gulick Roy M","Robbins Gregory K","Clifford David","Haas David W"}	The Journal of infectious diseases	9	\N	\N	2010	20662624	\N	\N	\N	2	f	\N
116367	\N	Genetic variability of CYP2B6 in populations of African and Asian origin: allele frequencies, novel functional variants, and possible implications for anti-HIV therapy with efavirenz.	{"Klein Kathrin","Lang Thomas","Saussele Tanja","Barbosa-Sicard Eduardo","Schunck Wolf-Hagen","Eichelbaum Michel","Schwab Matthias","Zanger Ulrich M"}	Pharmacogenetics and genomics	12	\N	\N	2005	16272958	\N	\N	\N	2	f	\N
113537	\N	A global reference for human genetic variation.	{"1000 Genomes Project Consortium","Auton Adam","Brooks Lisa D","Durbin Richard M","Garrison Erik P","Kang Hyun Min","Korbel Jan O","Marchini Jonathan L","McCarthy Shane","McVean Gil A","Abecasis Gonçalo R"}	Nature	10	\N	\N	2015	26432245	\N	\N	\N	2	f	\N
116396	\N	Genetic polymorphisms of cytochrome P450 2B6 gene in Han Chinese.	{"Guan Su","Huang Min","Chan Eli","Chen Xiao","Duan Wei","Zhou Shu-Feng"}	European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences	9	\N	\N	2006	16815693	\N	\N	\N	2	f	\N
114023	\N	Allele and genotype frequencies of CYP2B6 and CYP3A5 in the Japanese population.	{"Hiratsuka Masahiro","Takekuma Yoh","Endo Naomi","Narahara Kaori","Hamdy Samar Ismail","Kishikawa Yukinaga","Matsuura Masaki","Agatsuma Yasuyuki","Inoue Tomoko","Mizugaki Michinao"}	European journal of clinical pharmacology	9	\N	\N	2002	12242601	\N	\N	\N	2	f	\N
116411	\N	Predictive value of known and novel alleles of CYP2B6 for efavirenz plasma concentrations in HIV-infected individuals.	{"Rotger M","Tegude H","Colombo S","Cavassini M","Furrer H","Décosterd L","Blievernicht J","Saussele T","Günthard H F","Schwab M","Eichelbaum M","Telenti A","Zanger U M"}	Clinical pharmacology and therapeutics	4	\N	\N	2007	17235330	\N	\N	\N	2	f	\N
116437	\N	Prevalence of CYP2B6 alleles in malaria-endemic populations of West Africa and Papua New Guinea.	{"Mehlotra Rajeev K","Ziats Mark N","Bockarie Moses J","Zimmerman Peter A"}	European journal of clinical pharmacology	4	\N	\N	2006	16506047	\N	\N	\N	2	f	\N
116446	\N	CYP2B6 genotype, but not rifampicin-based anti-TB cotreatments, explains variability in long-term efavirenz plasma exposure.	{"Mukonzo Jackson K","Nanzigu Sarah","Waako Paul","Ogwal-Okeng Jasper","Gustafson Lars L","Aklillu Eleni"}	Pharmacogenomics	8	\N	\N	2014	25303294	\N	\N	\N	2	f	\N
116452	\N	CYP2B6 genotype is a strong predictor of systemic exposure to efavirenz in HIV-infected Zimbabweans.	{"Maimbo Milimo","Kiyotani Kazuma","Mushiroda Taisei","Masimirembwa Collen","Nakamura Yusuke"}	European journal of clinical pharmacology	3	\N	\N	2012	21901344	\N	\N	\N	2	f	\N
116454	\N	A novel polymorphism in ABCB1 gene, CYP2B6*6 and sex predict single-dose efavirenz population pharmacokinetics in Ugandans.	{"Mukonzo Jackson K","Röshammar Daniel","Waako Paul","Andersson Maria","Fukasawa Takashi","Milani Lili","Svensson Jan Olof","Ogwal-Okeng Jasper","Gustafsson Lars L","Aklillu Eleni"}	British journal of clinical pharmacology	11	\N	\N	2009	19916993	\N	\N	\N	2	f	\N
116459	\N	CYP2B6 genotype-based efavirenz dose recommendations during rifampicin-based antituberculosis cotreatment for a sub-Saharan Africa population.	{"Mukonzo Jackson K","Bisaso Ronald K","Ogwal-Okeng Jasper","Gustafsson Lars L","Owen Joel S","Aklillu Eleni"}	Pharmacogenomics	4	\N	\N	2016	27045425	\N	\N	\N	2	f	\N
115639	\N	Genetic polymorphism of S-mephenytoin 4'-hydroxylation in African-Americans.	{"Edeki T I","Goldstein J A","de Morais S M","Hajiloo L","Butler M","Chapdelaine P","Wilkinson G R"}	Pharmacogenetics	8	\N	\N	1996	8873222	\N	\N	\N	2	f	\N
115641	\N	Determination of CYP2C19 phenotype in black Americans with omeprazole: correlation with genotype.	{"Marinac J S","Balian J D","Foxworth J W","Willsie S K","Daus J C","Owen R","Flockhart D A"}	Clinical pharmacology and therapeutics	8	\N	\N	1996	8823231	\N	\N	\N	2	f	\N
115643	\N	Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populations.	{"Goldstein J A","Ishizaki T","Chiba K","de Morais S M","Bell D","Krahn P M","Evans D A"}	Pharmacogenetics	2	\N	\N	1997	9110363	\N	\N	\N	2	f	\N
114389	\N	DNA microarray technology in the clinical environment: the AmpliChip CYP450 test for CYP2D6 and CYP2C19 genotyping.	{"de Leon Jose","Susce Margaret T","Johnson Maria","Hardin Mike","Maw Lorraine","Shao Alison","Allen Antonette C P","Chiafari Francis A","Hillman Grantland","Nikoloff D Michele"}	CNS spectrums	1	\N	\N	2009	19169185	\N	\N	\N	2	f	\N
115648	\N	Impact of the CYP2C19*17 allele on the pharmacokinetics of omeprazole and pantoprazole in children: evidence for a differential effect.	{"Kearns Gregory L","Leeder J Steven","Gaedigk Andrea"}	Drug metabolism and disposition: the biological fate of chemicals	6	\N	\N	2010	20223877	\N	\N	\N	2	f	\N
115650	\N	Testing for variants in CYP2C19: population frequencies and testing experience in a clinical laboratory.	{"Strom Charles M","Goos Dana","Crossley Beryl","Zhang Ke","Buller-Burkle Arlene","Jarvis Michael","Quan Franklin","Peng Mei","Sun Weimin"}	Genetics in medicine : official journal of the American College of Medical Genetics	1	\N	\N	2012	22237437	\N	\N	\N	2	f	\N
115654	\N	The influence of the CYP2C19*10 allele on clopidogrel activation and CYP2C19*2 genotyping.	{"Langaee Taimour Y","Zhu Hao-Jie","Wang Xinwen","El Rouby Nihal","Markowitz John S","Goldstein Joyce A","Johnson Julie A"}	Pharmacogenetics and genomics	8	\N	\N	2014	24945780	\N	\N	\N	2	f	\N
115656	\N	Cytochrome p450 gene variants, race, and mortality among clopidogrel-treated patients after acute myocardial infarction.	{"Cresci Sharon","Depta Jeremiah P","Lenzini Petra A","Li Allie Y","Lanfear David E","Province Michael A","Spertus John A","Bach Richard G"}	Circulation. Cardiovascular genetics	6	\N	\N	2014	24762860	\N	\N	\N	2	f	\N
115658	\N	The CYP2C19 Intron 2 Branch Point SNP is the Ancestral Polymorphism Contributing to the Poor Metabolizer Phenotype in Livers with CYP2C19*35 and CYP2C19*2 Alleles.	{"Chaudhry Amarjit S","Prasad Bhagwat","Shirasaka Yoshiyuki","Fohner Alison","Finkelstein David","Fan Yiping","Wang Shuoguo","Wu Gang","Aklillu Eleni","Sim Sarah C","Thummel Kenneth E","Schuetz Erin G"}	Drug metabolism and disposition: the biological fate of chemicals	8	\N	\N	2015	26021325	\N	\N	\N	2	f	\N
115663	\N	CYP2C19 and ABCB1 gene polymorphisms are differently distributed according to ethnicity in the Brazilian general population.	{"Santos Paulo C J L","Soares Renata A G","Santos Diogo B G","Nascimento Raimundo M","Coelho George L L M","Nicolau José C","Mill José G","Krieger José E","Pereira Alexandre C"}	BMC medical genetics	1	\N	\N	2011	21247447	\N	\N	\N	2	f	\N
114461	\N	Distribution of CYP2D6 and CYP2C19 polymorphisms associated with poor metabolizer phenotype in five Amerindian groups and western Mestizos from Mexico.	{"Salazar-Flores Joel","Torres-Reyes Luis A","Martínez-Cortés Gabriela","Rubi-Castellanos Rodrigo","Sosa-Macías Martha","Muñoz-Valle José F","González-González César","Ramírez Angélica","Román Raquel","Méndez José L","Barrera Andrés","Torres Alfredo","Medina Rafael","Rangel-Villalobos Héctor"}	Genetic testing and molecular biomarkers	9	\N	\N	2012	22913530	\N	\N	\N	2	f	\N
115671	\N	Prevalence of CYP2C19 variant alleles and pharmacodynamic variability of aspirin and clopidogrel in Native Americans.	{"Oestreich Julie H","Best Lyle G","Dobesh Paul P"}	American heart journal	3	\N	\N	2014	24576527	\N	\N	\N	2	f	\N
115673	\N	CYP450 Genotype/Phenotype Concordance in Mexican Amerindian Indigenous Populations-Where to from Here for Global Precision Medicine?	{"de Andrés Fernando","Sosa-Macías Martha","Ramos Blanca Patricia Lazalde","Naranjo María-Eugenia G","LLerena Adrián"}	Omics : a journal of integrative biology	9	\N	\N	2017	28873029	\N	\N	\N	2	f	\N
114444	\N	Pharmacogenetics of Cytochrome P450 Enzymes in American Indian and Caucasian Children Admitted to a Psychiatric Hospital.	{"McGrane Ian R","Loveland Joshua G"}	Journal of child and adolescent psychopharmacology	5	\N	\N	2016	26871369	\N	\N	\N	2	f	\N
115678	\N	Allele and genotype frequency of CYP2C19 in a Tamilian population.	{"Adithan C","Gerard N","Vasu S","Rosemary J","Shashindran C H","Krishnamoorthy R"}	British journal of clinical pharmacology	9	\N	\N	2003	12919183	\N	\N	\N	2	f	\N
115680	\N	CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population.	{"Jose Rosemary","Chandrasekaran Adithan","Sam Soya Sisy","Gerard Nathalie","Chanolean Shashindran","Abraham Benny K","Satyanarayanamoorthy K","Peter Anitha","Rajagopal Krishnamoorthy"}	Fundamental & clinical pharmacology	2	\N	\N	2005	15660966	\N	\N	\N	2	f	\N
115686	\N	Genetic polymorphism of CYP2C19 in Maharashtrian population.	{"Ghodke Yogita","Joshi Kalpana","Arya Yashendra","Radkar Anjali","Chiplunkar Aditi","Shintre Pooja","Patwardhan Bhushan"}	European journal of epidemiology	0	\N	\N	2007	17978853	\N	\N	\N	2	f	\N
115690	\N	Importance of CYP2C19 genetic polymorphism in the eradication of Helicobacter pylori in north Indians.	{"Chaudhry A S","Kochhar R","Kohli K K"}	The Indian journal of medical research	10	\N	\N	2009	19942749	\N	\N	\N	2	f	\N
115692	\N	Influence of the genetic polymorphisms in the 5' flanking and exonic regions of CYP2C19 on proguanil oxidation.	{"Satyanarayana Chakradhara Rao Uppugunduri","Devendran Anichavezhi","Jayaraman Muthukumaran","Mannu Jayakanthan","Mathur Premendu P","Gopal Shewade Deepak","Rajagopal Krishnamoorthy","Chandrasekaran Adithan"}	Drug metabolism and pharmacokinetics	0	\N	\N	2009	20045989	\N	\N	\N	2	f	\N
115694	\N	Genetic variations and haplotypes of the 5' regulatory region of CYP2C19 in South Indian population.	{"Satyanarayana Chakradhara Rao Uppugunduri","Devendran Anichavezhi","Sundaram Rajan","Gopal Shewade Deepak","Rajagopal Krishnamoorthy","Chandrasekaran Adithan"}	Drug metabolism and pharmacokinetics	0	\N	\N	2009	19430176	\N	\N	\N	2	f	\N
115766	\N	CYP2C19 genotype and S-mephenytoin 4'-hydroxylation phenotype in a Chinese Dai population.	{"He Nan","Yan Feng-Xiang","Huang Song-Lin","Wang Wei","Xiao Zhou-Sheng","Liu Zhao-Qian","Zhou Hong-Hao"}	European journal of clinical pharmacology	4	\N	\N	2002	11956668	\N	\N	\N	2	f	\N
115696	\N	Genetic profile of patients with epilepsy on first-line antiepileptic drugs and potential directions for personalized treatment.	{"Grover Sandeep","Gourie-Devi Mandaville","Baghel Ruchi","Sharma Sangeeta","Bala Kiran","Gupta Meena","Narayanasamy Krishnamoorthy","Varma Binuja","Gupta Meenal","Kaur Kavita","Talwar Puneet","Kaur Harpreet","Giddaluru Sudheer","Sharma Abhay","Brahmachari Samir K","Indian Genome Variation Consortium","Kukreti Ritushree"}	Pharmacogenomics	7	\N	\N	2010	20602612	\N	\N	\N	2	f	\N
115700	\N	Genotype frequencies of selected drug metabolizing enzymes and ABC drug transporters among breast cancer patients on FAC chemotherapy.	{"Afsar Nasir Ali","Haenisch Sierk","Mateen Ahmed","Usman Ahmed","Ufer Mike","Ahmed Khwaja Zafar","Ahmad Hakimuddin Razi","Cascorbi Ingolf"}	Basic & clinical pharmacology & toxicology	7	\N	\N	2010	20102361	\N	\N	\N	2	f	\N
115704	\N	CYP2C19 polymorphism as a predictor of personalized therapy in South Indian population.	{"Siddapuram Siva Prasad","Banerjee Rupa","Tandan Manu","Prathap Nitesh","Mitnal Sasikala","Duvvuru Nageshwar Reddy"}	The Journal of the Association of Physicians of India	8	\N	\N	2011	21887904	\N	\N	\N	2	f	\N
115706	\N	Distribution of CYP2C19*17 allele and genotypes in an Indian population.	{"Anichavezhi D","Chakradhara Rao U S","Shewade D G","Krishnamoorthy R","Adithan C"}	Journal of clinical pharmacy and therapeutics	6	\N	\N	2012	21916910	\N	\N	\N	2	f	\N
115708	\N	CYP2C19 and PON1 polymorphisms regulating clopidogrel bioactivation in Chinese, Malay and Indian subjects.	{"Chan Mark Y","Tan Karen","Tan Huay-Cheem","Huan Pei-Tee","Li Bei","Phua Qian-Hui","Lee Hong-Kai","Lee Chi-Hang","Low Adrian","Becker Richard C","Ong Wen-Chong","Richards Mark A","Salim Agus","Tai E-Shyong","Koay Evelyn"}	Pharmacogenomics	4	\N	\N	2012	22462746	\N	\N	\N	2	f	\N
115712	\N	Pharmacogenetic landscape of clopidogrel in north Indians suggest distinct interpopulation differences in allele frequencies.	{"Giri Anil K","Khan Nazir M","Basu Analabha","Tandon Nikhil","Scaria Vinod","Bharadwaj Dwaipayan"}	Pharmacogenomics	4	\N	\N	2014	24798721	\N	\N	\N	2	f	\N
115714	\N	Frequency distribution of high risk alleles of CYP2C19, CYP2E1, CYP3A4 genes in Haryana population.	{"Gulati Sachin","Yadav Anita","Kumar Neeraj",Kanupriya,"Kumar Gaurav","Aggarwal Neeraj","Gupta Ranjan"}	Environmental toxicology and pharmacology	5	\N	\N	2014	24814262	\N	\N	\N	2	f	\N
115716	\N	Association of CYP2C19, CYP3A5 and GPIIb/IIIa gene polymorphisms with Aspirin and Clopidogrel Resistance in a cohort of Indian patients with Coronary Artery Disease.	{"Arya V","Mahajan P","Saraf A","Mohanty A","Sawhney J P S","Bhargava M"}	International journal of laboratory hematology	12	\N	\N	2015	26264906	\N	\N	\N	2	f	\N
115720	\N	Role of CYP2C19 gene polymorphism in acute alcohol withdrawal treatment with loading dose of diazepam in a South Indian population.	{"Jose Manu","Mathaiyan Jayanthi","Kattimani Shivanand","Adithan Surendiran","Chandrasekaran Adithan"}	European journal of clinical pharmacology	7	\N	\N	2016	27099220	\N	\N	\N	2	f	\N
115722	\N	Genetic diversity of variants involved in drug response and metabolism in Sri Lankan populations: implications for clinical implementation of pharmacogenomics.	{"Chan Sze Ling","Samaranayake Nilakshi","Ross Colin J D","Toh Meng Tiak","Carleton Bruce","Hayden Michael R","Teo Yik Ying","Dissanayake Vajira H W","Brunham Liam R"}	Pharmacogenetics and genomics	1	\N	\N	2016	26444257	\N	\N	\N	2	f	\N
115726	\N	Frequencies of genotypes and alleles of the functional SNPs in CYP2C19 and CYP2E1 in mainland Chinese Kazakh, Uygur and Han populations.	{"Wang Shu-Mei","Zhu An-Ping","Li Dan","Wang Zhen","Zhang Ping","Zhang Guo-Liang"}	Journal of human genetics	6	\N	\N	2009	19444287	\N	\N	\N	2	f	\N
115732	\N	Genotype analysis of the CYP2C19 gene in the Japanese population.	{"Tsuneoka Y","Fukushima K","Matsuo Y","Ichikawa Y","Watanabe Y"}	Life sciences	0	\N	\N	1996	8890945	\N	\N	\N	2	f	\N
115734	\N	CYP2C19 genotype and phenotype determined by omeprazole in a Korean population.	{"Roh H K","Dahl M L","Tybring G","Yamada H","Cha Y N","Bertilsson L"}	Pharmacogenetics	12	\N	\N	1996	9014204	\N	\N	\N	2	f	\N
115736	\N	Differences in the incidence of the CYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant allele.	{"Xiao Z S","Goldstein J A","Xie H G","Blaisdell J","Wang W","Jiang C H","Yan F X","He N","Huang S L","Xu Z H","Zhou H H"}	The Journal of pharmacology and experimental therapeutics	4	\N	\N	1997	9103550	\N	\N	\N	2	f	\N
115743	\N	Genetic polymorphism of cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese population.	{"Kimura M","Ieiri I","Mamiya K","Urae A","Higuchi S"}	Therapeutic drug monitoring	6	\N	\N	1998	9631918	\N	\N	\N	2	f	\N
115745	\N	The effects of genetic polymorphisms of CYP2C9 and CYP2C19 on phenytoin metabolism in Japanese adult patients with epilepsy: studies in stereoselective hydroxylation and population pharmacokinetics.	{"Mamiya K","Ieiri I","Shimamoto J","Yukawa E","Imai J","Ninomiya H","Yamada H","Otsubo K","Higuchi S","Tashiro N"}	Epilepsia	12	\N	\N	1998	9860067	\N	\N	\N	2	f	\N
115749	\N	Frequencies of defective CYP2C19 alleles in a Hong Kong Chinese population: detection of the rare allele CYP2C19*4.	{"Garcia-Barceló M","Chow L Y","Kum Chiu H F","Wing Y K","Shing Lee D T","Lam K L","Waye M M"}	Clinical chemistry	12	\N	\N	1999	10585366	\N	\N	\N	2	f	\N
115751	\N	CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori.	{"Tanigawara Y","Aoyama N","Kita T","Shirakawa K","Komada F","Kasuga M","Okumura K"}	Clinical pharmacology and therapeutics	11	\N	\N	1999	10579481	\N	\N	\N	2	f	\N
115755	\N	Effects of genotypic differences in CYP2C19 status on cure rates for Helicobacter pylori infection by dual therapy with rabeprazole plus amoxicillin.	{"Furuta T","Shirai N","Takashima M","Xiao F","Hanai H","Nakagawa K","Sugimura H","Ohashi K","Ishizaki T"}	Pharmacogenetics	6	\N	\N	2001	11434512	\N	\N	\N	2	f	\N
115757	\N	Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.	{"Furuta T","Shirai N","Takashima M","Xiao F","Hanai H","Sugimura H","Ohashi K","Ishizaki T","Kaneko E"}	Clinical pharmacology and therapeutics	3	\N	\N	2001	11240980	\N	\N	\N	2	f	\N
115762	\N	The effect of CYP2C19 and CYP2D6 genotypes on the metabolism of clomipramine in Japanese psychiatric patients.	{"Yokono A","Morita S","Someya T","Hirokane G","Okawa M","Shimoda K"}	Journal of clinical psychopharmacology	12	\N	\N	2001	11763000	\N	\N	\N	2	f	\N
115768	\N	Effect of cytochrome P4502C19 genotypic differences on cure rates for gastroesophageal reflux disease by lansoprazole.	{"Furuta Takahisa","Shirai Naohito","Watanabe Fumitoshi","Honda Satoru","Takeuchi Ken","Iida Takayuki","Sato Yoshihiko","Kajimura Masayoshi","Futami Hajime","Takayanagi Shigekazu","Yamada Masami","Ohashi Kyoichi","Ishizaki Takashi","Hanai Hiroyuki"}	Clinical pharmacology and therapeutics	10	\N	\N	2002	12386647	\N	\N	\N	2	f	\N
115772	\N	Genotyping of cytochrome p450 isoform genes is useful for forensic identification of cadaver.	{"Ogawa Kento","Suno Manabu","Shimizu Keiko","Yoshida Masatsugu","Awaya Toshio","Matsubara Kazuo","Shiono Hiroshi"}	Legal medicine (Tokyo, Japan)	9	\N	\N	2003	14568772	\N	\N	\N	2	f	\N
115774	\N	Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection in relation to CYP2C19 genotype.	{"Lee Sang Bae","Park Sang Jong","Ryu Ji Kon","Lee Jin Kwang","Kim Hoi Jin","Bae Jin Soo","Jung Hyun Seung","Park Sil Moo"}	The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi	12	\N	\N	2003	14695703	\N	\N	\N	2	f	\N
115778	\N	Genetic polymorphism of cytochrome P450 2C19 in healthy Malaysian subjects.	{"Pang Y S","Yang Y S","Wong L P","Lee T C","Mustafa A M","Mohamed Z","Lang Chim C"}	British journal of clinical pharmacology	9	\N	\N	2004	15327595	\N	\N	\N	2	f	\N
115780	\N	Genetic polymorphism analysis of cytochrome P4502C19 in Chinese Uigur and Han populations.	{"Niu Chun Yan","Luo Jin Yan","Hao Zhi Ming"}	Chinese journal of digestive diseases	0	\N	\N	2004	15612662	\N	\N	\N	2	f	\N
115783	\N	Polymorphism of interleukin-1beta affects the eradication rates of Helicobacter pylori by triple therapy.	{"Furuta Takahisa","Shirai Naohito","Xiao Fang","El-Omar Emad M","Rabkin Charles S","Sugimura Haruhiko","Ishizaki Takashi","Ohashi Kyoichi"}	Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association	1	\N	\N	2004	15017629	\N	\N	\N	2	f	\N
115788	\N	Dosage recommendation of phenytoin for patients with epilepsy with different CYP2C9/CYP2C19 polymorphisms.	{"Hung Chin-Chuan","Lin Chun-Jung","Chen Chih-Chuan","Chang Chee-Jen","Liou Horng-Huei"}	Therapeutic drug monitoring	10	\N	\N	2004	15385837	\N	\N	\N	2	f	\N
115790	\N	Genetic variations and haplotypes of CYP2C19 in a Japanese population.	{"Fukushima-Uesaka Hiromi","Saito Yoshiro","Maekawa Keiko","Ozawa Shogo","Hasegawa Ryuichi","Kajio Hiroshi","Kuzuya Nobuaki","Yasuda Kazuki","Kawamoto Manabu","Kamatani Naoyuki","Suzuki Kazuko","Yanagawa Tatsuo","Tohkin Masahiro","Sawada Jun-Ichi"}	Drug metabolism and pharmacokinetics	8	\N	\N	2005	16141610	\N	\N	\N	2	f	\N
115792	\N	Influence of CYP2C19 polymorphism and Helicobacter pylori genotype determined from gastric tissue samples on response to triple therapy for H pylori infection.	{"Furuta Takahisa","Sagehashi Yukiko","Shirai Naohito","Sugimoto Mitsushige","Nakamura Akiko","Kodaira Makoto","Kenmotsu Kazumi","Nagano Makoto","Egashira Tohru","Ueda Koji","Yoneyama Masao","Ohashi Kyoichi","Ishizaki Takashi","Hishida Akira"}	Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association	6	\N	\N	2005	15952098	\N	\N	\N	2	f	\N
115794	\N	CYP2C19 genotype affects diazepam pharmacokinetics and emergence from general anesthesia.	{"Inomata Shinichi","Nagashima Atsushi","Itagaki Fumio","Homma Masato","Nishimura Masuhiro","Osaka Yoshiko","Okuyama Kazuhiko","Tanaka Einosuke","Nakamura Takako","Kohda Yukinao","Naito Shinsaku","Miyabe Masayuki","Toyooka Hidenori"}	Clinical pharmacology and therapeutics	12	\N	\N	2005	16338280	\N	\N	\N	2	f	\N
115798	\N	Concomitant dosing of famotidine with a triple therapy increases the cure rates of Helicobacter pylori infections in patients with the homozygous extensive metabolizer genotype of CYP2C19.	{"Okudaira K","Furuta T","Shirai N","Sugimoto M","Miura S"}	Alimentary pharmacology & therapeutics	2	\N	\N	2005	15710002	\N	\N	\N	2	f	\N
115800	\N	Poor metabolizer genotype status of CYP2C19 is a risk factor for developing gastric cancer in Japanese patients with Helicobacter pylori infection.	{"Sugimoto M","Furuta T","Shirai N","Nakamura A","Kajimura M","Sugimura H","Hishida A","Ishizaki T"}	Alimentary pharmacology & therapeutics	11	\N	\N	2005	16268979	\N	\N	\N	2	f	\N
115804	\N	CYP2C19 genetic polymorphism in Thai, Burmese and Karen populations.	{"Tassaneeyakul Wichittra","Mahatthanatrakul Werawath","Niwatananun Kanokporn","Na-Bangchang Kesara","Tawalee Arporn","Krikreangsak Nathawut","Cykleng Utaiwan","Tassaneeyakul Wongwiwat"}	Drug metabolism and pharmacokinetics	8	\N	\N	2006	16946555	\N	\N	\N	2	f	\N
113953	\N	The high prevalence of the poor and ultrarapid metabolite alleles of CYP2D6, CYP2C9, CYP2C19, CYP3A4, and CYP3A5 in Taiwanese population.	{"Liou Ya-Huei","Lin Chien-Ting","Wu Ying-Jye","Wu Lawrence Shih-Hsin"}	Journal of human genetics	0	\N	\N	2006	16924387	\N	\N	\N	2	f	\N
115810	\N	Multiple regression analysis of pharmacogenetic variability of carvedilol disposition in 54 healthy Japanese volunteers.	{"Honda Mutsuko","Ogura Yumi","Toyoda Wakako","Taguchi Masato","Nozawa Takashi","Inoue Hiroshi","Hashimoto Yukiya"}	Biological & pharmaceutical bulletin	4	\N	\N	2006	16595916	\N	\N	\N	2	f	\N
115812	\N	Novel mutations in the cytochrome P450 2C19 gene: a pitfall of the PCR-RFLP method for identifying a common mutation.	{"Ohkubo Yumiko","Ueta Akihito","Ando Naoki","Ito Tetsuya","Yamaguchi Sachiko","Mizuno Kantaro","Sumi Satoshi","Maeda Tohru","Yamazaki Daiju","Kurono Yukihisa","Fujimoto Shinji","Togari Hajime"}	Journal of human genetics	0	\N	\N	2006	16307177	\N	\N	\N	2	f	\N
115817	\N	CYP450 polymorphisms predict clinic outcomes to vinorelbine-based chemotherapy in patients with non-small-cell lung cancer.	{"Pan Ji-Hong","Han Jin-Xiang","Wu Jian-Mei","Sheng Li-Jun","Huang Hai-Nan"}	Acta oncologica (Stockholm, Sweden)	0	\N	\N	2007	17450472	\N	\N	\N	2	f	\N
115821	\N	Pharmacogenomics-based tailored versus standard therapeutic regimen for eradication of H. pylori.	{"Furuta T","Shirai N","Kodaira M","Sugimoto M","Nogaki A","Kuriyama S","Iwaizumi M","Yamade M","Terakawa I","Ohashi K","Ishizaki T","Hishida A"}	Clinical pharmacology and therapeutics	4	\N	\N	2007	17215846	\N	\N	\N	2	f	\N
115825	\N	Influence of rabeprazole and lansoprazole on the pharmacokinetics of tacrolimus in relation to CYP2C19, CYP3A5 and MDR1 polymorphisms in renal transplant recipients.	{"Miura Masatomo","Inoue Kazuyuki","Kagaya Hideaki","Satoh Shigeru","Tada Hitoshi","Sagae Yoshinori","Habuchi Tomonori","Suzuki Toshio"}	Biopharmaceutics & drug disposition	5	\N	\N	2007	17377957	\N	\N	\N	2	f	\N
115827	\N	Genetic polymorphisms of CYP2B6 affect the pharmacokinetics/pharmacodynamics of cyclophosphamide in Japanese cancer patients.	{"Nakajima Miki","Komagata Sayaka","Fujiki Yuto","Kanada Yoshihiro","Ebi Hiromichi","Itoh Kuniaki","Mukai Hirofumi","Yokoi Tsuyoshi","Minami Hironobu"}	Pharmacogenetics and genomics	6	\N	\N	2007	17502835	\N	\N	\N	2	f	\N
115829	\N	Association between cytochrome P450 (CYP) 2C19 polymorphisms and harm avoidance in Japanese.	{"Yasui-Furukori Norio","Kaneda Ayako","Iwashima Kumiko","Saito Manabu","Nakagami Taku","Tsuchimine Shoko","Kaneko Sunao"}	American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics	9	\N	\N	2007	17357148	\N	\N	\N	2	f	\N
115833	\N	Comparisons of CYP2C19 genetic polymorphisms between Korean and Vietnamese populations.	{"Lee Sang Seop","Lee Su-Jun","Gwak Jungsug","Jung Hyun-Ju","Thi-Le Houng","Song Im-Sook","Kim Eun-Young","Shin Jae-Gook"}	Therapeutic drug monitoring	8	\N	\N	2007	17667801	\N	\N	\N	2	f	\N
115836	\N	Genetic polymorphism analysis of CYP2C19 in Chinese Han populations from different geographic areas of mainland China.	{"Chen Lingling","Qin Shengying","Xie Jing","Tang Jimin","Yang Lun","Shen Wen","Zhao Xinzhi","Du Jing","He Guang","Feng Guoyin","He Lin","Xing Qinghe"}	Pharmacogenomics	6	\N	\N	2008	18518848	\N	\N	\N	2	f	\N
114548	\N	Pharmacokinetics/genotype associations for major cytochrome P450 enzymes in native and first- and third-generation Japanese populations: comparison with Korean, Chinese, and Caucasian populations.	{"Myrand S P","Sekiguchi K","Man M Z","Lin X","Tzeng R-Y","Teng C-H","Hee B","Garrett M","Kikkawa H","Lin C-Y","Eddy S M","Dostalik J","Mount J","Azuma J","Fujio Y","Jang I-J","Shin S-G","Bleavins M R","Williams J A","Paulauskis J D","Wilner K D"}	Clinical pharmacology and therapeutics	9	\N	\N	2008	18231117	\N	\N	\N	2	f	\N
115845	\N	Effects of CYP2C19 and CYP2C9 genotypes on pharmacokinetic variability of valproic acid in Chinese epileptic patients: nonlinear mixed-effect modeling.	{"Jiang Dechun","Bai Xiangrong","Zhang Qingxia","Lu Wei","Wang Yuqin","Li Lin","Müller Markus"}	European journal of clinical pharmacology	12	\N	\N	2009	19756559	\N	\N	\N	2	f	\N
115847	\N	VKORC1 diplotype-derived dosing model to explain variability in warfarin dose requirements in Asian patients.	{"Sandanaraj Edwin","Lal Suman","Cheung Yin Bun","Xiang Xiaoqiang","Kong Ming Chai","Lee Lai Heng","Ooi London Lucien","Chowbay Balram"}	Drug metabolism and pharmacokinetics	0	\N	\N	2009	19745563	\N	\N	\N	2	f	\N
114554	\N	Genetic polymorphism, linkage disequilibrium, haplotype structure and novel allele analysis of CYP2C19 and CYP2D6 in Han Chinese.	{"Zhou Q","Yu X M","Lin H B","Wang L","Yun Q Z","Hu S N","Wang D-M"}	The pharmacogenomics journal	12	\N	\N	2009	19636337	\N	\N	\N	2	f	\N
115852	\N	CYP2C19 genotype is associated with symptomatic recurrence of GERD during maintenance therapy with low-dose lansoprazole.	{"Furuta Takahisa","Sugimoto Mitsushige","Kodaira Chise","Nishino Masafumi","Yamade Mihoko","Ikuma Mutsuhiro","Shirai Naohito","Watanabe Hiroshi","Umemura Kazuo","Kimura Michio","Hishida Akira"}	European journal of clinical pharmacology	7	\N	\N	2009	19259653	\N	\N	\N	2	f	\N
115854	\N	Absence of influence of concomitant administration of rabeprazole on the pharmacokinetics of tacrolimus in adult living-donor liver transplant patients: a case-control study.	{"Hosohata Keiko","Masuda Satohiro","Yonezawa Atsushi","Sugimoto Mitsuhiro","Takada Yasutsugu","Kaido Toshimi","Ogura Yasuhiro","Oike Fumitaka","Uemoto Shinji","Inui Ken-ichi"}	Drug metabolism and pharmacokinetics	0	\N	\N	2009	19881258	\N	\N	\N	2	f	\N
115860	\N	Genetic polymorphisms of CYP2D6 10 and CYP2C19 2, 3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen.	{"Okishiro Masatsugu","Taguchi Tetsuya","Jin Kim Seung","Shimazu Kenzo","Tamaki Yasuhiro","Noguchi Shinzaburo"}	Cancer	3	\N	\N	2009	19156902	\N	\N	\N	2	f	\N
115862	\N	Pharmacogenetic polymorphisms in Brazilian-born, first-generation Japanese descendants.	{"Perini J A","Vargens D D","Santana I S C","Moriguchi E H","Ribeiro-Dos-Santos A K C","Tsutsumi M","Suarez-Kurtz G"}	Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas	12	\N	\N	2009	19882083	\N	\N	\N	2	f	\N
115867	\N	Genetic polymorphisms of drug-metabolizing enzymes and anti-TB drug-induced hepatitis.	{"Kim Sang-Heon","Kim Sang-Hoon","Bahn Joon-Woo","Kim Yoon-Keun","Chang Yoon-Seok","Shin Eun-Soon","Kim Youn-Seup","Park Jae-Seuk","Kim Bo-Hyung","Jang In-Jin","Song Junghan","Kim Seung-Hyun","Park Hae-Sim","Min Kyung-Up","Jee Young-Koo"}	Pharmacogenomics	11	\N	\N	2009	19891553	\N	\N	\N	2	f	\N
115869	\N	Relation of genetic polymorphisms in the cytochrome P450 gene with clopidogrel resistance after drug-eluting stent implantation in Koreans.	{"Lee Jung Myung","Park Sungha","Shin Dong-Jik","Choi Donghoon","Shim Chi Young","Ko Young-Guk","Kim Jung-Sun","Shin Eun-Soon","Chang Chong Won","Lee Jong-Eun","Jang Yangsoo"}	The American journal of cardiology	7	\N	\N	2009	19576320	\N	\N	\N	2	f	\N
114656	\N	Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam.	{"Veiga M I","Asimus S","Ferreira P E","Martins J P","Cavaco I","Ribeiro V","Hai T N","Petzold M G","Björkman A","Ashton M","Gil J P"}	European journal of clinical pharmacology	4	\N	\N	2009	18979093	\N	\N	\N	2	f	\N
114558	\N	Genetic variation in metabolizing enzyme and transporter genes: comprehensive assessment in 3 major East Asian subpopulations with comparison to Caucasians and Africans.	{"Man Michael","Farmen Mark","Dumaual Carmen","Teng Choo Hua","Moser Brian","Irie Shin","Noh Gyu Jeong","Njau Reuben","Close Sandra","Wise Stephen","Hockett Richard"}	Journal of clinical pharmacology	8	\N	\N	2010	20173083	\N	\N	\N	2	f	\N
115875	\N	Association of interaction between smoking and CYP 2C19*3 polymorphism with coronary artery disease in a Uighur population.	{"Yang Yi-Ning","Wang Xin-Lei","Ma Yi-Tong","Xie Xiang","Fu Zhen-Yan","Li Xiao-Mei","Chen Bang-Dang","Liu Fen"}	Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis	10	\N	\N	2010	20460345	\N	\N	\N	2	f	\N
115880	\N	Influence of CYP2C19 and ABCB1 polymorphisms on plasma concentrations of lansoprazole enantiomers after enteral administration.	{"Miura Masatomo","Motoyama Satoru","Hinai Yudai","Niioka Takenori","Endo Masahiro","Hayakari Makoto","Ogawa Jun-ichi"}	Xenobiotica; the fate of foreign compounds in biological systems	9	\N	\N	2010	20528170	\N	\N	\N	2	f	\N
115882	\N	Cytochrome 2C19 polymorphism and response to adjunctive cilostazol versus high maintenance-dose clopidogrel in patients undergoing percutaneous coronary intervention.	{"Hwang Seok-Jae","Jeong Young-Hoon","Kim In-Suk","Park Ki-Soo","Kang Min-Kyung","Koh Jin-Sin","Park Jeong Rang","Park Yongwhi","Koh Eun-Ha","Kwak Choong Hwan","Hwang Jin-Yong","Kim Sunjoo"}	Circulation. Cardiovascular interventions	10	\N	\N	2010	20823393	\N	\N	\N	2	f	\N
115884	\N	Carriage of cytochrome 2C19 polymorphism is associated with risk of high post-treatment platelet reactivity on high maintenance-dose clopidogrel of 150 mg/day: results of the ACCEL-DOUBLE (Accelerated Platelet Inhibition by a Double Dose of Clopidogrel According to Gene Polymorphism) study.	{"Jeong Young-Hoon","Kim In-Suk","Park Yongwhi","Kang Min-Kyung","Koh Jin-Sin","Hwang Seok-Jae","Kwak Choong Hwan","Hwang Jin-Yong"}	JACC. Cardiovascular interventions	7	\N	\N	2010	20650435	\N	\N	\N	2	f	\N
115888	\N	Assessment of CYP2C19 genetic polymorphisms in a Korean population using a simultaneous multiplex pyrosequencing method to simultaneously detect the CYP2C19*2, CYP2C19*3, and CYP2C19*17 alleles.	{"Kim K-A","Song W-K","Kim K-R","Park J-Y"}	Journal of clinical pharmacy and therapeutics	12	\N	\N	2010	21054462	\N	\N	\N	2	f	\N
115890	\N	The Influence of CYP2C19 Polymorphism on Eradication of Helicobacter pylori: A Prospective Randomized Study of Lansoprazole and Rabeprazole.	{"Lee Jeong Hoon","Jung Hwoon-Yong","Choi Kee Don","Song Ho June","Lee Gin Hyug","Kim Jin-Ho"}	Gut and liver	6	\N	\N	2010	20559522	\N	\N	\N	2	f	\N
115895	\N	Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response.	{"Tsai Ming-Hsien","Lin Keh-Ming","Hsiao Mei-Chun","Shen Winston W","Lu Mong-Liang","Tang Hwa-Sheng","Fang Chun-Kai","Wu Chi-Shin","Lu Shao-Chun","Liu Shu Chih","Chen Chun-Yu","Liu Yu-Li"}	Pharmacogenomics	4	\N	\N	2010	20350136	\N	\N	\N	2	f	\N
115897	\N	Association of genetic polymorphisms of CYP 2C19 with hypertension in a Chinese Han population.	{"Ma Yu","Ni Wen","Zhu Wenzhong","Xiong Yuanchang","Deng Xiaoming"}	Blood pressure	6	\N	\N	2011	21332417	\N	\N	\N	2	f	\N
115902	\N	Impact of CYP2C19 polymorphism on residual platelet reactivity in patients with coronary heart disease during antiplatelet therapy.	{"Yamamoto Koichiro","Hokimoto Seiji","Chitose Tadasuke","Morita Kazunori","Ono Takamichi","Kaikita Koichi","Tsujita Kenichi","Abe Tomohide","Deguchi Mariko","Miyagawa Haruna","Saruwatari Junji","Sumida Hitoshi","Sugiyama Seigo","Nakagawa Kazuko","Ogawa Hisao"}	Journal of cardiology	3	\N	\N	2011	21168310	\N	\N	\N	2	f	\N
115904	\N	The cytochrome 2C19*2 and *3 alleles attenuate response to clopidogrel similarly in East Asian patients undergoing elective percutaneous coronary intervention.	{"Hwang Seok-Jae","Jeong Young-Hoon","Kim In-Suk","Koh Jin-Sin","Kang Min-Kyung","Park Yongwhi","Kwak Choong Hwan","Hwang Jin-Yong"}	Thrombosis research	1	\N	\N	2011	21075428	\N	\N	\N	2	f	\N
115906	\N	Pharmacogenetics of cyclophosphamide and CYP2C19 polymorphism in Thai systemic lupus erythematosus.	{"Ngamjanyaporn Pintip","Thakkinstian Ammarin","Verasertniyom Oravan","Chatchaipun Porntip","Vanichapuntu Monchand","Nantiruj Kanokrat","Totemchokchyakarn Kitti","Attia John","Janwityanujit Suchela"}	Rheumatology international	9	\N	\N	2011	20358205	\N	\N	\N	2	f	\N
114560	\N	Allele and genotype frequencies of CYP3A4, CYP2C19, and CYP2D6 in Han, Uighur, Hui, and Mongolian Chinese populations.	{"Zuo Liang Jin","Guo Tao","Xia Dong Ya","Jia Li Hui"}	Genetic testing and molecular biomarkers	2	\N	\N	2012	22224559	\N	\N	\N	2	f	\N
115920	\N	Clinical Impact of Cytochrome P450 2C19 Genotype on the Treatment of Invasive Aspergillosis under Routine Therapeutic Drug Monitoring of Voriconazole in a Korean Population.	{"Kim Si-Hyun","Lee Dong-Gun","Kwon Jae-Cheol","Lee Hyo-Jin","Cho Sung-Yeon","Park Chulmin","Kwon Eun-Young","Park Sun Hee","Choi Su-Mi","Choi Jung-Hyun","Yoo Jin-Hong"}	Infection & chemotherapy	12	\N	\N	2013	24475354	\N	\N	\N	2	f	\N
115922	\N	Genetic polymorphisms of metabolic enzymes and the pharmacokinetics of indapamide in Taiwanese subjects.	{"Wang Teng-Hsu","Hsiong Cheng-Huei","Ho Hsin-Tien","Shih Tung-Yuan","Yen San-Jan","Wang Hui-Hung","Wu Jer-Yuarn","Kuo Benjamin Pei-Chung","Chen Yuan-Tsong","Ho Shung-Tai","Hu Oliver Yoa-Pu"}	The AAPS journal	3	\N	\N	2014	24357089	\N	\N	\N	2	f	\N
115924	\N	CYP2C19 polymorphisms in the Thai population and the clinical response to clopidogrel in patients with atherothrombotic-risk factors.	{"Sukasem Chonlaphat","Tunthong Ramaimon","Chamnanphon Montri","Santon Siwalee","Jantararoungtong Thawinee","Koomdee Napatrupron","Prommas Santirhat","Puangpetch Apichaya","Vathesatogkit Prin"}	Pharmacogenomics and personalized medicine	0	\N	\N	2013	24019752	\N	\N	\N	2	f	\N
115928	\N	Comparison of loading with maintenance dose of clopidogrel on platelet reactivity in Chinese with different CYP2C19 genotypes prior to percutaneous coronary intervention.	{"Zhang Xiaoxing","Yan Lirong","Wang Dongxue","Li Yan","Han Lulu","Tian Lei","Liu Hong","Li Yishi"}	Chinese medical journal	0	\N	\N	2014	25043069	\N	\N	\N	2	f	\N
115930	\N	Therapeutic effects and adverse drug reactions are affected by icotinib exposure and CYP2C19 and EGFR genotypes in Chinese non-small cell lung cancer patients.	{"Chen Jia","Zheng Xin","Liu Dong-Yang","Zhao Qian","Wu Yi-Wen","Tan Fen-Lai","Wang Yin-Xiang","Jiang Ji","Hu Pei"}	Asian Pacific journal of cancer prevention : APJCP	0	\N	\N	2014	25227813	\N	\N	\N	2	f	\N
115932	\N	Analysis of the CYP2C19 genetic polymorphism in Han and Uyghur patients with cardiovascular and cerebrovascular diseases in the Kashi area of Xinjiang.	{"Li Yadong","Yang Heyin","Zou Xiaoguang","Xiong Lijun","Li Zhen","Luo Jianzhang","Zhao Bo","Liu Wen","Du Xili"}	Medical science monitor : international medical journal of experimental and clinical research	11	\N	\N	2014	25381554	\N	\N	\N	2	f	\N
115937	\N	Detection of cytochrome P450 2C19 gene polymorphism from noninvasive samples by cycling probe technology.	{"Nakagawa Saori","Kuwabara Naoko","Takamatsu Yu","Shimoeda Sadahiko","Ohta Shin","Yamato Susumu"}	Annals of clinical biochemistry	3	\N	\N	2014	24048716	\N	\N	\N	2	f	\N
115939	\N	Impact of CYP2C19 polymorphism on platelet function tests and coagulation and inflammatory biomarkers in patients undergoing percutaneous coronary intervention.	{"Kaikita Koichi","Ono Takamichi","Iwashita Satomi","Nakayama Naoki","Sato Koji","Horio Eiji","Nakamura Shinichi","Tsujita Kenichi","Tayama Shinji","Hokimoto Seiji","Sakamoto Tomohiro","Nakao Koichi","Oshima Shuichi","Sugiyama Seigo","Ogawa Hisao"}	Journal of atherosclerosis and thrombosis	0	\N	\N	2014	24088578	\N	\N	\N	2	f	\N
115941	\N	Sitafloxacin-based third-line rescue regimens for Helicobacter pylori infection in Japan.	{"Furuta Takahisa","Sugimoto Mitsushige","Kodaira Chise","Nishino Masafumi","Yamade Mihoko","Uotani Takahiro","Sahara Shu","Ichikawa Hitomi","Yamada Takanori","Osawa Satoshi","Sugimoto Ken","Watanabe Hiroshi","Umemura Kazuo"}	Journal of gastroenterology and hepatology	3	\N	\N	2014	24224808	\N	\N	\N	2	f	\N
115945	\N	Association between the microarray-based CYP2C19 genotyping assay and the platelet function test in cardiovascular patients receiving clopidogrel.	{"Choi J-L","Kim B-R","Kim J-E","Woo K-S","Kim K-H","Kim J-M","Kim M-H","Han J-Y"}	International journal of laboratory hematology	10	\N	\N	2014	24589079	\N	\N	\N	2	f	\N
115947	\N	Effects of cytochrome P450 2C19 and paraoxonase 1 polymorphisms on antiplatelet response to clopidogrel therapy in patients with coronary artery disease.	{"Tresukosol Damrus","Suktitipat Bhoom","Hunnangkul Saowalak","Kamkaew Ruttakarn","Poldee Saiphon","Tassaneetrithep Boonrat","Likidlilid Atip"}	PloS one	0	\N	\N	2014	25329996	\N	\N	\N	2	f	\N
115951	\N	Genetic polymorphisms of the drug-metabolizing enzyme CYP2C19 in the Uyghur population in northwest China.	{"Jin Tianbo","Zhang Mingxia","Yang Hua","Geng Tingting","Zhang Ning","Feng Tian","Ma Yajuan","Yuan Dongya","Kang Longli"}	Xenobiotica; the fate of foreign compounds in biological systems	7	\N	\N	2016	26526657	\N	\N	\N	2	f	\N
114567	\N	Analysis of genetic variations in CYP2C9, CYP2C19, CYP2D6 and CYP3A5 genes using oligonucleotide microarray.	{"Dong Yuanyuan","Xiao Huasheng","Wang Qi","Zhang Chunxiu","Liu Xiuming","Yao Na","Sheng Haihui","Li Haiyan"}	International journal of clinical and experimental medicine	0	\N	\N	2015	26770516	\N	\N	\N	2	f	\N
115956	\N	CYP2C19 genotype and early ischemic lesion recurrence in stroke patients treated with clopidogrel.	{"Jeong Tae-Dong","Kim Seung Min","Kim Hyo Jin","Lee Woochang","Kwon Sun U","Min Won-Ki","Kang Dong-Wha","Chun Sail"}	Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association	2	\N	\N	2015	25529343	\N	\N	\N	2	f	\N
115960	\N	Genotype‑phenotype analysis of CYP2C19 in the Tibetan population and its potential clinical implications in drug therapy.	{"Jin Tianbo","Zhang Xiyang","Geng Tingting","Shi Xugang","Wang Li","Yuan Dongya","Kang Longli"}	Molecular medicine reports	3	\N	\N	2016	26781306	\N	\N	\N	2	f	\N
114092	\N	Global pharmacogenetics: genetic substructure of Eurasian populations and its effect on variants of drug-metabolizing enzymes.	{"Makeeva Oksana","Stepanov Vadim","Puzyrev Valery","Goldstein David B","Grossman Iris"}	Pharmacogenomics	7	\N	\N	2008	18597650	\N	\N	\N	2	f	\N
113880	\N	Responsiveness to low-dose warfarin associated with genetic variants of VKORC1, CYP2C9, CYP2C19, and CYP4F2 in an Indonesian population.	{"Rusdiana T","Araki T","Nakamura T","Subarnas A","Yamamoto K"}	European journal of clinical pharmacology	3	\N	\N	2013	22855348	\N	\N	\N	2	f	\N
115971	\N	Phenotyping of CYP2C19 with enantiospecific HPLC-quantification of R- and S-mephenytoin and comparison with the intron4/exon5 G-->A-splice site mutation.	{"Brockmöller J","Rost K L","Gross D","Schenkel A","Roots I"}	Pharmacogenetics	4	\N	\N	1995	7663532	\N	\N	\N	2	f	\N
115973	\N	Use of omeprazole as a probe drug for CYP2C19 phenotype in Swedish Caucasians: comparison with S-mephenytoin hydroxylation phenotype and CYP2C19 genotype.	{"Chang M","Dahl M L","Tybring G","Götharson E","Bertilsson L"}	Pharmacogenetics	12	\N	\N	1995	8747407	\N	\N	\N	2	f	\N
115978	\N	Genotypes for the cytochrome P450 enzymes CYP2D6 and CYP2C19 in human longevitY. Role of CYP2D6 and CYP2C19 in longevity.	{"Bathum L","Andersen-Ranberg K","Boldsen J","Brøsen K","Jeune B"}	European journal of clinical pharmacology	7	\N	\N	1998	9754988	\N	\N	\N	2	f	\N
117114	\N	Lower frequency of CYP2C9*2 in Mexican-Americans compared to Spaniards.	{"LLerena A","Dorado P","O'Kirwan F","Jepson R","Licinio J","Wong M-L"}	The pharmacogenomics journal	0	\N	\N	2004	15452553	\N	\N	\N	2	f	\N
115980	\N	A new genetic defect in human CYP2C19: mutation of the initiation codon is responsible for poor metabolism of S-mephenytoin.	{"Ferguson R J","De Morais S M","Benhamou S","Bouchardy C","Blaisdell J","Ibeanu G","Wilkinson G R","Sarich T C","Wright J M","Dayer P","Goldstein J A"}	The Journal of pharmacology and experimental therapeutics	1	\N	\N	1998	9435198	\N	\N	\N	2	f	\N
115982	\N	An additional defective allele, CYP2C19*5, contributes to the S-mephenytoin poor metabolizer phenotype in Caucasians.	{"Ibeanu G C","Blaisdell J","Ghanayem B I","Beyeler C","Benhamou S","Bouchardy C","Wilkinson G R","Dayer P","Daly A K","Goldstein J A"}	Pharmacogenetics	4	\N	\N	1998	10022751	\N	\N	\N	2	f	\N
115986	\N	CYP2C19 genotype and phenotype determined with omeprazole in patients with acid-related disorders with and without Helicobacter pylori infection.	{"Sagar M","Seensalu R","Tybring G","Dahl M L","Bertilsson L"}	Scandinavian journal of gastroenterology	10	\N	\N	1998	9829356	\N	\N	\N	2	f	\N
115988	\N	CYP2D6 and CYP2C19 genotypes in an elderly Swedish population.	{"Yamada H","Dahl M L","Lannfelt L","Viitanen M","Winblad B","Sjöqvist F"}	European journal of clinical pharmacology	8	\N	\N	1998	9776439	\N	\N	\N	2	f	\N
115992	\N	A novel transversion in the intron 5 donor splice junction of CYP2C19 and a sequence polymorphism in exon 3 contribute to the poor metabolizer phenotype for the anticonvulsant drug S-mephenytoin.	{"Ibeanu G C","Blaisdell J","Ferguson R J","Ghanayem B I","Brosen K","Benhamou S","Bouchardy C","Wilkinson G R","Dayer P","Goldstein J A"}	The Journal of pharmacology and experimental therapeutics	8	\N	\N	1999	10411572	\N	\N	\N	2	f	\N
115994	\N	Poor metabolizers at the cytochrome P450 2D6 and 2C19 loci are at increased risk of developing adult acute leukaemia.	{"Roddam P L","Rollinson S","Kane E","Roman E","Moorman A","Cartwright R","Morgan G J"}	Pharmacogenetics	10	\N	\N	2000	11037802	\N	\N	\N	2	f	\N
114688	\N	The prevalence of CYP2D6 and CYP2C19 genotypes in a population of healthy Dutch volunteers.	{"Tamminga W J","Wemer J","Oosterhuis B","de Zeeuw R A","de Leij L F","Jonkman J H"}	European journal of clinical pharmacology	12	\N	\N	2001	11829201	\N	\N	\N	2	f	\N
115997	\N	A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer.	{"Sachse Christoph","Smith Gillian","Wilkie Murray J V","Barrett Jennifer H","Waxman Robin","Sullivan Frank","Forman David","Bishop D Timothy","Wolf C Roland","Colorectal Cancer Study Group"}	Carcinogenesis	11	\N	\N	2002	12419832	\N	\N	\N	2	f	\N
116107	\N	Relation of cytochrome P450 2C19 loss-of-function polymorphism to occurrence of drug-eluting coronary stent thrombosis.	{"Giusti Betti","Gori Anna Maria","Marcucci Rossella","Saracini Claudia","Sestini Ilaria","Paniccia Rita","Buonamici Piergiovanni","Antoniucci David","Abbate Rosanna","Gensini Gian Franco"}	The American journal of cardiology	3	\N	\N	2009	19268736	\N	\N	\N	2	f	\N
116001	\N	Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study.	{"Fellay Jacques","Marzolini Catia","Meaden Emma R","Back David J","Buclin Thierry","Chave Jean Philippe","Decosterd Laurent A","Furrer Hansjakob","Opravil Milos","Pantaleo Giuseppe","Retelska Dorota","Ruiz Lidia","Schinkel Alfred H","Vernazza Pietro","Eap Chin B","Telenti Amalio","Swiss HIV Cohort Study"}	Lancet (London, England)	1	\N	\N	2002	11809184	\N	\N	\N	2	f	\N
116003	\N	Genetic polymorphisms of CYP2C9 and CYP2C19 in the Beninese and Belgian populations.	{"Allabi Aurel C","Gala Jean-Luc","Desager Jean-Pierre","Heusterspreute Michel","Horsmans Yves"}	British journal of clinical pharmacology	12	\N	\N	2003	14616425	\N	\N	\N	2	f	\N
116005	\N	CYP2C19 pharmacogenetics in the clinical use of proton-pump inhibitors for gastro-oesophageal reflux disease: variant alleles predict gastric acid suppression, but not oesophageal acid exposure or reflux symptoms.	{"Egan L J","Myhre G M","Mays D C","Dierkhising R A","Kammer P P","Murray J A"}	Alimentary pharmacology & therapeutics	6	\N	\N	2003	12823155	\N	\N	\N	2	f	\N
114674	\N	Genetic polymorphisms of cytochromes P450: CYP2C9, CYP2C19, and CYP2D6 in Croatian population.	{"Bozina Nada","Granić Paula","Lalić Zdenka","Tramisak Inja","Lovrić Mila","Stavljenić-Rukavina Ana"}	Croatian medical journal	8	\N	\N	2003	12950145	\N	\N	\N	2	f	\N
116008	\N	Cytochrome p450 3A4 messenger ribonucleic acid induction by rifampin in human peripheral blood mononuclear cells: correlation with alprazolam pharmacokinetics.	{"Gashaw Isabella","Kirchheiner Julia","Goldammer Mark","Bauer Steffen","Seidemann Julia","Zoller Konrad","Mrozikiewicz Przemyslaw M","Roots Ivar","Brockmöller Jürgen"}	Clinical pharmacology and therapeutics	11	\N	\N	2003	14586385	\N	\N	\N	2	f	\N
116012	\N	Association between blood carisoprodol:meprobamate concentration ratios and CYP2C19 genotype in carisoprodol-drugged drivers: decreased metabolic capacity in heterozygous CYP2C19*1/CYP2C19*2 subjects?	{"Bramness Jørgen G","Skurtveit Svetlana","Fauske Lars","Grung Merete","Molven Anders","Mørland Jørg","Steen Vidar M"}	Pharmacogenetics	7	\N	\N	2003	12835613	\N	\N	\N	2	f	\N
114767	\N	Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population.	{"Gaikovitch Elena A","Cascorbi Ingolf","Mrozikiewicz Przemyslaw M","Brockmöller Jürgen","Frötschl Roland","Köpke Karla","Gerloff Thomas","Chernov Jury N","Roots Ivar"}	European journal of clinical pharmacology	8	\N	\N	2003	12879168	\N	\N	\N	2	f	\N
114720	\N	Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.	{"Scordo Maria Gabriella","Caputi Achille P","D'Arrigo Concetta","Fava Giuseppina","Spina Edoardo"}	Pharmacological research	8	\N	\N	2004	15177309	\N	\N	\N	2	f	\N
116018	\N	Metabolic ratios of psychotropics as indication of cytochrome P450 2D6/2C19 genotype.	{"van der Weide Jan","van Baalen-Benedek Erica H","Kootstra-Ros Jenny E"}	Therapeutic drug monitoring	8	\N	\N	2005	16044105	\N	\N	\N	2	f	\N
114693	\N	Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population.	{"Halling Jónrit","Petersen Maria S","Damkier Per","Nielsen Flemming","Grandjean Philippe","Weihe Pál","Lundgren Stefan","Lundblad Mia Sandberg","Brøsen Kim"}	European journal of clinical pharmacology	8	\N	\N	2005	16025294	\N	\N	\N	2	f	\N
116257	\N	Hydroxylation index of omeprazole in relation to CYP2C19 polymorphism and sex in a healthy Iranian population.	{"Payan Maryam","Rouini Mohammad Reza","Tajik Nader","Ghahremani Mohammad Hossein","Tahvilian Reza"}	Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences	12	\N	\N	2014	25498969	\N	\N	\N	2	f	\N
116021	\N	Amitriptyline or not, that is the question: pharmacogenetic testing of CYP2D6 and CYP2C19 identifies patients with low or high risk for side effects in amitriptyline therapy.	{"Steimer Werner","Zöpf Konstanze","von Amelunxen Silvia","Pfeiffer Herbert","Bachofer Julia","Popp Johannes","Messner Barbara","Kissling Werner","Leucht Stefan"}	Clinical chemistry	2	\N	\N	2005	15590749	\N	\N	\N	2	f	\N
116025	\N	Esomeprazole-induced healing of gastroesophageal reflux disease is unrelated to the genotype of CYP2C19: evidence from clinical and pharmacokinetic data.	{"Schwab Matthias","Klotz Ulrich","Hofmann Ute","Schaeffeler Elke","Leodolter Andreas","Malfertheiner Peter","Treiber Gerhard"}	Clinical pharmacology and therapeutics	12	\N	\N	2005	16338278	\N	\N	\N	2	f	\N
116027	\N	Effect of CYP2C19 and MDR1 polymorphisms on cure rate in patients with acid-related disorders with Helicobacter pylori infection.	{"Gawrońska-Szklarz Barbara","Wrześniewska Joanna","Starzyńska Teresa","Pawlik Andrzej","Safranow Krzysztof","Ferenc Katarzyna","Droździk Marek"}	European journal of clinical pharmacology	7	\N	\N	2005	15976989	\N	\N	\N	2	f	\N
116029	\N	Evidence for a combined genetic effect of the 5-HT(1A) receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram.	{"Arias Bárbara","Catalán Rosa","Gastó Cristóbal","Gutiérrez Blanca","Fañanás Lourdes"}	Journal of psychopharmacology (Oxford, England)	3	\N	\N	2005	15728438	\N	\N	\N	2	f	\N
116031	\N	A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer.	{"Landi Stefano","Gemignani Federica","Moreno Victor","Gioia-Patricola Lydie","Chabrier Amélie","Guino Elisabeth","Navarro Matilde","de Oca Javier","Capellà Gabriel","Canzian Federico","Bellvitge Colorectal Cancer Study Group"}	Pharmacogenetics and genomics	8	\N	\N	2005	16006997	\N	\N	\N	2	f	\N
116036	\N	CYP2D6 and CYP2C19 genotypes and amitriptyline metabolite ratios in a series of medicolegal autopsies.	{"Koski Anna","Sistonen Johanna","Ojanperä Ilkka","Gergov Merja","Vuori Erkki","Sajantila Antti"}	Forensic science international	5	\N	\N	2006	16024198	\N	\N	\N	2	f	\N
116038	\N	Modulation of the central nervous effects of levomethadone by genetic polymorphisms potentially affecting its metabolism, distribution, and drug action.	{"Lötsch Jörn","Skarke Carsten","Wieting Johannes","Oertel Bruno Georg","Schmidt Helmut","Brockmöller Jürgen","Geisslinger Gerd"}	Clinical pharmacology and therapeutics	1	\N	\N	2006	16413243	\N	\N	\N	2	f	\N
116042	\N	Effect of CYP2C19*17 gene variant on Helicobacter pylori eradication in peptic ulcer patients.	{"Kurzawski Mateusz","Gawrońska-Szklarz Barbara","Wrześniewska Joanna","Siuda Andrzej","Starzyńska Teresa","Droździk Marek"}	European journal of clinical pharmacology	10	\N	\N	2006	16912869	\N	\N	\N	2	f	\N
116154	\N	Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial.	{"Wallentin Lars","James Stefan","Storey Robert F","Armstrong Martin","Barratt Bryan J","Horrow Jay","Husted Steen","Katus Hugo","Steg P Gabriel","Shah Svati H","Becker Richard C","PLATO investigators"}	Lancet (London, England)	10	\N	\N	2010	20801498	\N	\N	\N	2	f	\N
116053	\N	Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10 + 12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients.	{"Giusti Betti","Gori Anna Maria","Marcucci Rossella","Saracini Claudia","Sestini Ilaria","Paniccia Rita","Valente Serafina","Antoniucci Davide","Abbate Rosanna","Gensini Gian Franco"}	Pharmacogenetics and genomics	12	\N	\N	2007	18004210	\N	\N	\N	2	f	\N
116057	\N	Influence of CYP2C19 and CYP3A4 gene polymorphisms on clopidogrel responsiveness in healthy subjects.	{"Fontana P","Hulot J-S","De Moerloose P","Gaussem P"}	Journal of thrombosis and haemostasis : JTH	10	\N	\N	2007	17697139	\N	\N	\N	2	f	\N
116059	\N	The pharmacogenetics and pharmacodynamics of clopidogrel response: an analysis from the PRINC (Plavix Response in Coronary Intervention) trial.	{"Gladding Patrick","Webster Mark","Zeng Irene","Farrell Helen","Stewart Jim","Ruygrok Peter","Ormiston John","El-Jack Seif","Armstrong Guy","Kay Patrick","Scott Douglas","Gunes Arzu","Dahl Marja-Liisa"}	JACC. Cardiovascular interventions	12	\N	\N	2008	19463375	\N	\N	\N	2	f	\N
116064	\N	Relations between polymorphisms in drug-metabolising enzymes and toxicity of chemotherapy with cyclophosphamide, thiotepa and carboplatin.	{"Ekhart Corine","Rodenhuis Sjoerd","Smits Paul H M","Beijnen Jos H","Huitema Alwin D R"}	Pharmacogenetics and genomics	11	\N	\N	2008	18854779	\N	\N	\N	2	f	\N
116066	\N	Association of graded allele-specific changes in CYP2D6 function with imipramine dose requirement in a large group of depressed patients.	{"Schenk P W","van Fessem M A C","Verploegh-Van Rij S","Mathot R A A","van Gelder T","Vulto A G","van Vliet M","Lindemans J","Bruijn J A","van Schaik R H N"}	Molecular psychiatry	6	\N	\N	2008	17667959	\N	\N	\N	2	f	\N
116068	\N	Genetic Polymorphism of CYP2C19 gene in the Stanislas cohort. A link with inflammation.	{"Bertrand-Thiébault C","Berrahmoune H","Thompson A","Marie B","Droesch S","Siest G","Foernzler D","Visvikis-Siest S"}	Annals of human genetics	3	\N	\N	2008	18205890	\N	\N	\N	2	f	\N
116070	\N	Effect of cytochrome p450 polymorphisms on platelet reactivity after treatment with clopidogrel in acute coronary syndrome.	{"Frere Corinne","Cuisset Thomas","Morange Pierre-Emmanuel","Quilici Jacques","Camoin-Jau Laurence","Saut Noémie","Faille Dorothee","Lambert Marc","Juhan-Vague Irène","Bonnet Jean-Louis","Alessi Marie-Christine"}	The American journal of cardiology	4	\N	\N	2008	18394438	\N	\N	\N	2	f	\N
116074	\N	Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents.	{"Trenk Dietmar","Hochholzer Willibald","Fromm Martin F","Chialda Ligia-Emilia","Pahl Andreas","Valina Christian M","Stratz Christian","Schmiebusch Peter","Bestehorn Hans-Peter","Büttner Heinz Joachim","Neumann Franz-Josef"}	Journal of the American College of Cardiology	5	\N	\N	2008	18482659	\N	\N	\N	2	f	\N
116078	\N	Impact of the ultrarapid CYP2C19*17 allele on serum concentration of escitalopram in psychiatric patients.	{"Rudberg I","Mohebi B","Hermann M","Refsum H","Molden E"}	Clinical pharmacology and therapeutics	2	\N	\N	2008	17625515	\N	\N	\N	2	f	\N
116080	\N	Coexisting polymorphisms of P2Y12 and CYP2C19 genes as a risk factor for persistent platelet activation with clopidogrel.	{"Malek Lukasz A","Kisiel Bartlomiej","Spiewak Mateusz","Grabowski Marcin","Filipiak Krzysztof J","Kostrzewa Grazyna","Huczek Zenon","Ploski Rafal","Opolski Grzegorz"}	Circulation journal : official journal of the Japanese Circulation Society	7	\N	\N	2008	18577829	\N	\N	\N	2	f	\N
116082	\N	Polymorphisms in xenobiotic-metabolizing genes and the risk of chronic lymphocytic leukemia and non-Hodgkin's lymphoma in adult Russian patients.	{"Gra Olga A","Glotov Andrey S","Nikitin Eugene A","Glotov Oleg S","Kuznetsova Viktoria E","Chudinov Alexander V","Sudarikov Andrey B","Nasedkina Tatyana V"}	American journal of hematology	4	\N	\N	2008	18061941	\N	\N	\N	2	f	\N
116086	\N	Biological effect of increased maintenance dose of clopidogrel in cardiovascular outpatients and influence of the cytochrome P450 2C19*2 allele on clopidogrel responsiveness.	{"Fontana Pierre","Senouf David","Mach François"}	Thrombosis research	0	\N	\N	2008	17681590	\N	\N	\N	2	f	\N
116089	\N	Polymorphic drug metabolizing CYP-enzymes--a pathogenic factor in oral lichen planus?	{"Kragelund C","Hansen C","Reibel J","Nauntofte B","Broesen K","Pedersen A M L","Smidt D","Eiberg H","Torpet L A"}	Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology	1	\N	\N	2009	19192051	\N	\N	\N	2	f	\N
116093	\N	The CYP2C19*17 allele is associated with better platelet response to clopidogrel in patients admitted for non-ST acute coronary syndrome.	{"Frére C","Cuisset T","Gaborit B","Alessi M-C","Hulot J-S"}	Journal of thrombosis and haemostasis : JTH	8	\N	\N	2009	19496924	\N	\N	\N	2	f	\N
116095	\N	Genetic determinants of response to clopidogrel and cardiovascular events.	{"Simon Tabassome","Verstuyft Céline","Mary-Krause Murielle","Quteineh Lina","Drouet Elodie","Méneveau Nicolas","Steg P Gabriel","Ferrières Jean","Danchin Nicolas","Becquemont Laurent","French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) Investigators"}	The New England journal of medicine	1	\N	\N	2009	19106083	\N	\N	\N	2	f	\N
116097	\N	CYP2C19*17 is associated with decreased breast cancer risk.	{"Justenhoven Christina","Hamann Ute","Pierl Christiane B","Baisch Christian","Harth Volker","Rabstein Sylvia","Spickenheuer Anne","Pesch Beate","Brüning Thomas","Winter Stefan","Ko Yon-Dschun","Brauch Hiltrud"}	Breast cancer research and treatment	5	\N	\N	2009	18521743	\N	\N	\N	2	f	\N
116101	\N	Non-response to antiepileptic pharmacotherapy is associated with the ABCC2 -24C>T polymorphism in young and adult patients with epilepsy.	{"Ufer Mike","Mosyagin Igor","Muhle Hiltrud","Jacobsen Thies","Haenisch Sierk","Häsler Robert","Faltraco Frank","Remmler Cornelia","von Spiczak Sarah","Kroemer Heyo K","Runge Uwe","Boor Rainer","Stephani Ulrich","Cascorbi Ingolf"}	Pharmacogenetics and genomics	5	\N	\N	2009	19415824	\N	\N	\N	2	f	\N
116105	\N	Need for reassessment of reported CYP2C19 allele frequencies in various populations in view of CYP2C19*17 discovery: the case of Greece.	{"Ragia Georgia","Arvanitidis Kostas I","Tavridou Anna","Manolopoulos Vangelis G"}	Pharmacogenomics	1	\N	\N	2009	19102714	\N	\N	\N	2	f	\N
116109	\N	Investigation of the influence of CYP1A2 and CYP2C19 genetic polymorphism on 2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide (A77 1726) pharmacokinetics in leflunomide-treated patients with rheumatoid arthritis.	{"Bohanec Grabar Petra","Grabnar Iztok","Rozman Blaz","Logar Dusan","Tomsic Matija","Suput Dasa","Trdan Tina","Peterlin Masic Lucija","Mrhar Ales","Dolzan Vita"}	Drug metabolism and disposition: the biological fate of chemicals	10	\N	\N	2009	19581389	\N	\N	\N	2	f	\N
116115	\N	Allelic variations in CYP2B6 and CYP2C19 and survival of patients receiving cyclophosphamide prior to myeloablative hematopoietic stem cell transplantation.	{"Melanson Stacy E F","Stevenson Kristen","Kim Haesook","Antin Joseph H","Court Michael H","Ho Vincent T","Ritz Jerome","Soiffer Robert J","Kuo Frank C","Longtine Janina A","Jarolim Petr"}	American journal of hematology	12	\N	\N	2010	21108329	\N	\N	\N	2	f	\N
116117	\N	Linkage disequilibrium between the CYP2C19*17 allele and wildtype CYP2C8 and CYP2C9 alleles: identification of CYP2C haplotypes in healthy Nordic populations.	{"Pedersen Rasmus S","Brasch-Andersen Charlotte","Sim Sarah C","Bergmann Troels K","Halling Jónrit","Petersen Maria S","Weihe Pál","Edvardsen Hege","Kristensen Vessela N","Brøsen Kim","Ingelman-Sundberg Magnus"}	European journal of clinical pharmacology	12	\N	\N	2010	20665013	\N	\N	\N	2	f	\N
114686	\N	No influence of the polymorphisms CYP2C19 and CYP2D6 on the efficacy of cyclophosphamide, thalidomide, and bortezomib in patients with Multiple Myeloma.	{"Vangsted Annette J","Søeby Karen","Klausen Tobias W","Abildgaard Niels","Andersen Niels F","Gimsing Peter","Gregersen Henrik","Vogel Ulla","Werge Thomas","Rasmussen Henrik B"}	BMC cancer	8	\N	\N	2010	20684753	\N	\N	\N	2	f	\N
116120	\N	Besides CYP2C19*2, the variant allele CYP2C9*3 is associated with higher on-clopidogrel platelet reactivity in patients on dual antiplatelet therapy undergoing elective coronary stent implantation.	{"Harmsze Ankie","van Werkum Jochem W","Bouman Heleen J","Ruven Henk J","Breet Nicolien J","Ten Berg Jurrien M","Hackeng Christian M","Tjoeng Mathieu M","Klungel Olaf H","de Boer Anthonius","Deneer Vera H"}	Pharmacogenetics and genomics	1	\N	\N	2010	19934793	\N	\N	\N	2	f	\N
116124	\N	The CYP2C19*17 genotype is associated with lower imipramine plasma concentrations in a large group of depressed patients.	{"Schenk P W","van Vliet M","Mathot R A A","van Gelder T","Vulto A G","van Fessem M A C","Verploegh-Van Rij S","Lindemans J","Bruijn J A","van Schaik R H N"}	The pharmacogenomics journal	6	\N	\N	2010	19884907	\N	\N	\N	2	f	\N
116129	\N	Clopidogrel loading dose adjustment according to platelet reactivity monitoring in patients carrying the 2C19*2 loss of function polymorphism.	{"Bonello Laurent","Armero Sébastien","Ait Mokhtar Omar","Mancini Julien","Aldebert Philippe","Saut Noémie","Bonello Nathalie","Barragan Paul","Arques Stéphane","Giacomoni Marie-Paule","Bonello-Burignat Caroline","Bartholomei Marie-Noelle","Dignat-George Françoise","Camoin-Jau Laurence","Paganelli Franck"}	Journal of the American College of Cardiology	11	\N	\N	2010	20708365	\N	\N	\N	2	f	\N
116131	\N	Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.	{"MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk"}	Breast cancer research and treatment	1	\N	\N	2010	19424794	\N	\N	\N	2	f	\N
116133	\N	Impact of cytochrome P450 2C19 loss-of-function polymorphism and of major demographic characteristics on residual platelet function after loading and maintenance treatment with clopidogrel in patients undergoing elective coronary stent placement.	{"Hochholzer Willibald","Trenk Dietmar","Fromm Martin F","Valina Christian M","Stratz Christian","Bestehorn Hans-Peter","Büttner Heinz Joachim","Neumann Franz-Josef"}	Journal of the American College of Cardiology	6	\N	\N	2010	20510210	\N	\N	\N	2	f	\N
116137	\N	Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement.	{"Sibbing Dirk","Koch Werner","Gebhard Daniela","Schuster Tibor","Braun Siegmund","Stegherr Julia","Morath Tanja","Schömig Albert","von Beckerath Nicolas","Kastrati Adnan"}	Circulation	2	\N	\N	2010	20083681	\N	\N	\N	2	f	\N
116139	\N	Protective effect of the CYP2C19 *17 polymorphism with increased activation of clopidogrel on cardiovascular events.	{"Tiroch Klaus A","Sibbing Dirk","Koch Werner","Roosen-Runge Tobias","Mehilli Julinda","Schömig Albert","Kastrati Adnan"}	American heart journal	9	\N	\N	2010	20826260	\N	\N	\N	2	f	\N
116142	\N	Effects of CYP2C19, MDR1, and interleukin 1-B gene variants on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxicillin, and metronidazole.	{"Gawrońska-Szklarz Barbara","Siuda Andrzej","Kurzawski Mateusz","Bielicki Dariusz","Marlicz Wojciech","Droździk Marek"}	European journal of clinical pharmacology	7	\N	\N	2010	20376628	\N	\N	\N	2	f	\N
116144	\N	Cytochrome P450 2C19 polymorphism, suboptimal reperfusion and all-cause mortality in patients with acute myocardial infarction.	{"Małek Lukasz A","Przyłuski Jakub","Spiewak Mateusz","Kłopotowski Mariusz","Kostrzewa Grażyna","Kruk Mariusz","Płoski Rafał","Witkowski Adam","Rużyłło Witold"}	Cardiology	0	\N	\N	2010	20924183	\N	\N	\N	2	f	\N
116146	\N	Microarray-based detection of CYP1A1, CYP2C9, CYP2C19, CYP2D6, GSTT1, GSTM1, MTHFR, MTRR, NQO1, NAT2, HLA-DQA1, and AB0 allele frequencies in native Russians.	{"Gra Olga","Mityaeva Olga","Berdichevets Iryna","Kozhekbaeva Zhanna","Fesenko Denis","Kurbatova Olga","Goldenkova-Pavlova Irina","Nasedkina Tatyana"}	Genetic testing and molecular biomarkers	6	\N	\N	2010	20373852	\N	\N	\N	2	f	\N
116151	\N	Association between CYP2C19 polymorphism and depressive symptoms.	{"Sim Sarah C","Nordin Linn","Andersson Therese M-L","Virding Susanne","Olsson Marita","Pedersen Nancy L","Ingelman-Sundberg Magnus"}	American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics	9	\N	\N	2010	20468063	\N	\N	\N	2	f	\N
114796	\N	High frequency of occurrence of CYP2D6 gene duplication/multiduplication indicating ultrarapid metabolism among suicide cases.	{"Zackrisson A L","Lindblom B","Ahlner J"}	Clinical pharmacology and therapeutics	9	\N	\N	2010	19907421	\N	\N	\N	2	f	\N
114714	\N	Pilot study for the characterization of pharmacogenetically relevant CYP2D6, CYP2C19 and ABCB1 gene polymorphisms in the Hungarian population.	{"Rideg Orsolya","Háber Agota","Botz Lajos","Szücs Ferenc","Várnai Réka","Miseta Attila","Kovács Gábor L"}	Cell biochemistry and function	10	\N	\N	2011	21826689	\N	\N	\N	2	f	\N
114725	\N	Efficacy of tamoxifen based on cytochrome P450 2D6, CYP2C19 and SULT1A1 genotype in the Italian Tamoxifen Prevention Trial.	{"Serrano D","Lazzeroni M","Zambon C-F","Macis D","Maisonneuve P","Johansson H","Guerrieri-Gonzaga A","Plebani M","Basso D","Gjerde J","Mellgren G","Rotmensz N","Decensi A","Bonanni B"}	The pharmacogenomics journal	4	\N	\N	2011	20309015	\N	\N	\N	2	f	\N
116160	\N	CYP2C19 variation and citalopram response.	{"Mrazek David A","Biernacka Joanna M","O'Kane Dennis J","Black John L","Cunningham Julie M","Drews Maureen S","Snyder Karen A","Stevens Susanna R","Rush Augustus John","Weinshilboum Richard M"}	Pharmacogenetics and genomics	1	\N	\N	2011	21192344	\N	\N	\N	2	f	\N
116164	\N	High prevalence of CYP2C19*2 allele in Roma samples: study on Roma and Hungarian population samples with review of the literature.	{"Sipeky Csilla","Weber Agnes","Szabo Melinda","Melegh Bela I","Janicsek Ingrid","Tarlos Greta","Szabo Istvan","Sumegi Katalin","Melegh Bela"}	Molecular biology reports	8	\N	\N	2013	23645039	\N	\N	\N	2	f	\N
116168	\N	Characterization of the most common CYP2C9 and CYP2C19 allelic variants in the population from the Republic of Macedonia.	{"Jakovski K","Nestorovska A Kapedanovska","Labacevski N","Dimovski A J"}	Die Pharmazie	11	\N	\N	2013	24380239	\N	\N	\N	2	f	\N
116171	\N	A model predicting fluindione dose requirement in elderly inpatients including genotypes, body weight, and amiodarone.	{"Moreau Caroline","Pautas Eric","Duverlie Charlotte","Berndt Celia","Andro Marion","Mahé Isabelle","Emmerich Joseph","Lacut Karine","Le Gal Grégoire","Peyron Isabelle","Gouin-Thibault Isabelle","Golmard Jean-Louis","Loriot Marie-Anne","Siguret Virginie"}	Thrombosis and haemostasis	4	\N	\N	2014	24337438	\N	\N	\N	2	f	\N
116173	\N	Frequency of selected single nucleotide polymorphisms influencing the warfarin pharmacogenetics in Slovak population.	{"Krajčíová L'ubica","Petrovič Robert","Déžiová L'udmila","Chandoga Ján","Turčáni Peter"}	European journal of haematology	10	\N	\N	2014	24750390	\N	\N	\N	2	f	\N
116178	\N	Gender and functional CYP2C and NAT2 polymorphisms determine the metabolic profile of metamizole.	{"Martínez Carmen","Andreu Inmaculada","Amo Gemma","Miranda Miguel A","Esguevillas Gara","Torres María José","Blanca-López Natalia","Blanca Miguel","García-Martín Elena","Agúndez José A G"}	Biochemical pharmacology	12	\N	\N	2014	25241292	\N	\N	\N	2	f	\N
116180	\N	Evaluation of the relationship between polymorphisms in CYP2C19 and the pharmacokinetics of omeprazole, pantoprazole and rabeprazole.	{"Román Manuel","Ochoa Dolores","Sánchez-Rojas Sergio Daniel","Talegón Maria","Prieto-Pérez Rocio","Rivas Ângela","Abad-Santos Francisco","Cabaleiro Teresa"}	Pharmacogenomics	0	\N	\N	2014	25495411	\N	\N	\N	2	f	\N
115146	\N	Genotype and allele frequencies of drug-metabolizing enzymes and drug transporter genes affecting immunosuppressants in the Spanish white population.	{"Bosó Virginia","Herrero María J","Buso Enrique","Galán Juan","Almenar Luis","Sánchez-Lázaro Ignacio","Sánchez-Plumed Jaime","Bea Sergio","Prieto Martín","García María","Pastor Amparo","Sole Amparo","Poveda José Luis","Aliño Salvador F"}	Therapeutic drug monitoring	4	\N	\N	2014	24232128	\N	\N	\N	2	f	\N
116186	\N	Effect of clinical factors and gene polymorphism of CYP2C19*2, *17 and CYP4F2*3 on early stent thrombosis.	{"Kupstyte Nora","Zaliunas Remigijus","Tatarunas Vacis","Skipskis Vilius","Zaliaduonyte-Peksiene Diana","Grabauskyte Ingrida","Dovidaitiene Dovile","Bumblauskas Karolis","Gustiene Olivija","Lesauskaite Vaiva"}	Pharmacogenomics	0	\N	\N	2015	25712182	\N	\N	\N	2	f	\N
116190	\N	The frequency of CYP2C19 genetic polymorphisms in Russian patients with peptic ulcers treated with proton pump inhibitors.	{"Sychev D A","Denisenko N P","Sizova Z M","Grachev A V","Velikolug K A"}	Pharmacogenomics and personalized medicine	0	\N	\N	2015	26109874	\N	\N	\N	2	f	\N
116194	\N	Effect of CYP2C19 Polymorphisms on the Platelet Response to Clopidogrel and Influence on the Effect of High Versus Standard Dose Clopidogrel in Carotid Artery Stenting.	{"González A","Moniche F","Cayuela A","García-Lozano J R","Torrecillas F","Escudero-Martínez I","Gonzalez-Marcos J R","Mayol A","Montaner J"}	European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery	2	\N	\N	2016	26526111	\N	\N	\N	2	f	\N
116200	\N	Genetic polymorphism of CYP2C9 and CYP2C19 in a Bolivian population: an investigative and comparative study.	{"Bravo-Villalta Heydy V","Yamamoto Koujirou","Nakamura Katsunori","Bayá Ana","Okada Yuko","Horiuchi Ryuya"}	European journal of clinical pharmacology	5	\N	\N	2005	15776277	\N	\N	\N	2	f	\N
116203	\N	Phenotype-genotype analysis of CYP2C19 in Colombian mestizo individuals.	{"Isaza Carlos","Henao Julieta","Martínez José H Isaza","Sepúlveda Arias Juan C","Beltrán Leonardo"}	BMC clinical pharmacology	7	\N	\N	2007	17623107	\N	\N	\N	2	f	\N
116205	\N	Prevalence of CYP2C19 gene polymorphisms in the Puerto Rican population: a preliminary report.	{"Duconge Jorge","Cadilla Carmen L","Renta Jessica Y","Silén-Rivera Pamela","Piovanetti Paola","García-Berdecía Rafael","Castro-Rosario Liza M","Monzón Shalom","Vélez Linet","Rosas Guillermo","Guerra Jhon A","Santiago-Borrero Pedro J"}	Puerto Rico health sciences journal	12	\N	\N	2008	19069365	\N	\N	\N	2	f	\N
116209	\N	Global pharmacogenomics: Impact of population diversity on the distribution of polymorphisms in the CYP2C cluster among Brazilians.	{"Suarez-Kurtz G","Genro J P","de Moraes M O","Ojopi E B","Pena S D J","Perini J A","Ribeiro-dos-Santos A","Romano-Silva M A","Santana I","Struchiner C J"}	The pharmacogenomics journal	6	\N	\N	2012	21173785	\N	\N	\N	2	f	\N
116219	\N	Distribution of ABCB1, CYP3A5, CYP2C19, and P2RY12 gene polymorphisms in a Mexican Mestizos population.	{"Vargas-Alarcón Gilberto","Ramírez-Bello Julián","de la Peña Aurora","Calderón-Cruz Beatriz","Peña-Duque Marco Antonio","Martínez-Ríos Marco Antonio","Ramírez-Fuentes Silvestre","Pérez-Méndez Oscar","Fragoso José Manuel"}	Molecular biology reports	10	\N	\N	2014	25106522	\N	\N	\N	2	f	\N
116221	\N	Genetic variability of CYP2C19 in a Mexican population: contribution to the knowledge of the inheritance pattern of CYP2C19*17 to develop the ultrarapid metabolizer phenotype.	{"Favela-Mendoza Alma Faviola","Martinez-Cortes Gabriela","Hernandez-Zaragoza Marcelo","Salazar-Flores Joel","Muñoz-Valle Jose Francisco","Martinez-Sevilla Victor Manuel","Velazquez-Suarez Noemi Yolanda","Rangel-Villalobos Hector"}	Journal of genetics	3	\N	\N	2015	25846871	\N	\N	\N	2	f	\N
116229	\N	Evaluation of clopidogrel response variability and identification of the CYP2C19 polymorphism in Mexican patients.	{"Viveros Martha Eva","Areán Carlos","Gutiérrez Sergio","Vázquez Soledad","Cardiel Mario Humberto","Taboada Alejandra","Marín Gissela","Solorio Ruben","García Nalley"}	Archivos de cardiologia de Mexico	0	\N	\N	2016	26971130	\N	\N	\N	2	f	\N
114809	\N	Polymorphisms of CYP2C19 and CYP2D6 in Israeli ethnic groups.	{"Luo Huai-Rong","Aloumanis Vasileios","Lin Keh-Ming","Gurwitz David","Wan Yu-Jui Yvonne"}	American journal of pharmacogenomics : genomics-related research in drug development and clinical practice	0	\N	\N	2004	15651900	\N	\N	\N	2	f	\N
116235	\N	Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Iranian population.	{"Zand Negin","Tajik Nader","Moghaddam Alireza Salek","Milanian Iraj"}	Clinical and experimental pharmacology & physiology	0	\N	\N	2007	17201743	\N	\N	\N	2	f	\N
116237	\N	CYP2C19 genotypes in a population of healthy volunteers and in children with hematological malignancies in Gaza Strip.	{"Sameer Abu-Eid I","Amany Gharbieh M","Abdela Abed A","Fadel Sharif A"}	The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique	0	\N	\N	2009	19193970	\N	\N	\N	2	f	\N
116242	\N	The impact of genetic polymorphisms and patient characteristics on warfarin dose requirements: a cross-sectional study in Iran.	{"Namazi Soha","Azarpira Negar","Hendijani Fatemeh","Khorshid Maryam Banan","Vessal Ghazal","Mehdipour Ahmad Reza"}	Clinical therapeutics	6	\N	\N	2010	20637959	\N	\N	\N	2	f	\N
116244	\N	Role of cytochrome P450 2C19 genetic polymorphisms in the therapeutic efficacy of omeprazole in Iranian patients with erosive reflux esophagitis.	{"Zendehdel Nader","Biramijamal Firouzeh","Hossein-Nezhad Arash","Zendehdel Nasrin","Sarie Hamidreza","Doughaiemoghaddam Masoud","Pourshams Akram"}	Archives of Iranian medicine	9	\N	\N	2010	20804307	\N	\N	\N	2	f	\N
116248	\N	Allele and genotype frequencies of CYP2C9 within an Iranian population (Mazandaran).	{"Hashemi-Soteh Seyed Mohammad Bagher","Shahabi-Majd Naghi","Gholizadeh Ali-Reza","Shiran Mohammad-Reza"}	Genetic testing and molecular biomarkers	7	\N	\N	2012	22288731	\N	\N	\N	2	f	\N
114204	\N	Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population.	{"Yousef Al-Motassem","Bulatova Nailya R","Newman William","Hakooz Nancy","Ismail Said","Qusa Hisham","Zahran Farah","Anwar Ababneh Nidaa","Hasan Farah","Zaloom Imad","Khayat Ghada","Al-Zmili Rawan","Naffa Randa","Al-Diab Ola"}	Molecular biology reports	10	\N	\N	2012	22722998	\N	\N	\N	2	f	\N
116253	\N	Genetic Polymorphism of Cytochrome p450 (2C19) Enzyme in Iranian Turkman Ethnic Group.	{"Tabari Robabeh Ghiyas","Marjani Abdoljalal","Ataby Ogholdondy Agh","Mansourian Azad Reza","Samai Nader Mansour"}	Oman medical journal	7	\N	\N	2013	23904915	\N	\N	\N	2	f	\N
116255	\N	Investigation of CYP2C19 allele and genotype frequencies in Iranian population using experimental and computational approaches.	{"Saber Morteza Mahmoudi","Boroumand Mohammadali","Behmanesh Mehrdad"}	Thrombosis research	2	\N	\N	2014	24315317	\N	\N	\N	2	f	\N
116262	\N	The predictive value of MDR1, CYP2C9, and CYP2C19 polymorphisms for phenytoin plasma levels.	{"Kerb R","Aynacioglu A S","Brockmöller J","Schlagenhaufer R","Bauer S","Szekeres T","Hamwi A","Fritzer-Szekeres M","Baumgartner C","Ongen H Z","Güzelbey P","Roots I","Brinkmann U"}	The pharmacogenomics journal	0	\N	\N	2001	11908757	\N	\N	\N	2	f	\N
116266	\N	Cytochrome P450 polymorphisms in patients with Behcet's disease.	{"Tursen Umit","Tamer Lulufer","Api Hale","Yildirim Hatice","Baz Kiymet","Ikizoglu Guliz","Atik Ugur"}	International journal of dermatology	2	\N	\N	2007	17269966	\N	\N	\N	2	f	\N
116268	\N	Role of CYP2C9 and CYP2C19 polymorphisms in patients with atherosclerosis.	{"Ercan B","Ayaz L","Ciçek D","Tamer L"}	Cell biochemistry and function	4	\N	\N	2008	17868191	\N	\N	\N	2	f	\N
116270	\N	Role of CYP2C19 polymorphisms in patients with endometriosis.	{"Cayan Filiz","Ayaz Lokman","Aban Meral","Dilek Saffet","Gümüş Lülüfer Tamer"}	Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology	8	\N	\N	2009	19499406	\N	\N	\N	2	f	\N
116274	\N	Influence of CYP2C19 functional polymorphism on Helicobacter pylori eradication.	{"Ozdil Burhan","Akkiz Hikmet","Bayram Süleyman","Bekar Aynur","Akgöllü Ersin","Sandikçi Macit"}	The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology	3	\N	\N	2010	20533108	\N	\N	\N	2	f	\N
116276	\N	Genetic variations in the xenobiotic-metabolizing enzymes CYP1A1, CYP1A2, CYP2C9, CYP2C19 and susceptibility to colorectal cancer among Turkish people.	{"Özhan Gül","Mutur Mine","Ercan Gulcin","Alpertunga Buket"}	Genetic testing and molecular biomarkers	4	\N	\N	2014	24527758	\N	\N	\N	2	f	\N
116278	\N	Effect of cytochrome P450 2C19 polymorphisms on the Helicobacter pylori eradication rate following two-week triple therapy with pantoprazole or rabeprazole.	{"Ormeci A","Emrence Z","Baran B","Gokturk S","Soyer O M","Evirgen S","Akyuz F","Karaca C","Besisik F","Kaymakoglu S","Ustek D","Demir K"}	European review for medical and pharmacological sciences	3	\N	\N	2016	27010145	\N	\N	\N	2	f	\N
116280	\N	Allele and genotype frequencies of polymorphic cytochromes P450 (CYP2C9, CYP2C19, CYP2E1) and dihydropyrimidine dehydrogenase (DPYD) in the Egyptian population.	{"Hamdy Samar Ismail","Hiratsuka Masahiro","Narahara Kaori","El-Enany Mervat","Moursi Nadia","Ahmed Mohammed Salah-Eldin","Mizugaki Michinao"}	British journal of clinical pharmacology	6	\N	\N	2002	12047484	\N	\N	\N	2	f	\N
116284	\N	Genetic and Nongenetic Factors Affecting Clopidogrel Response in the Egyptian Population.	{"Khalil B M","Shahin M H","Solayman M H M","Langaee T","Schaalan M F","Gong Y","Hammad L N","Al-Mesallamy H O","Hamdy N M","El-Hammady W A","Johnson J A"}	Clinical and translational science	2	\N	\N	2016	26757134	\N	\N	\N	2	f	\N
116288	\N	High frequencies of CYP2C19 mutations and poor metabolism of proguanil in Vanuatu.	{"Kaneko A","Kaneko O","Taleo G","Björkman A","Kobayakawa T"}	Lancet (London, England)	3	\N	\N	1997	9093256	\N	\N	\N	2	f	\N
116292	\N	High and variable frequencies of CYP2C19 mutations: medical consequences of poor drug metabolism in Vanuatu and other Pacific islands.	{"Kaneko A","Lum J K","Yaviong L","Takahashi N","Ishizaki T","Bertilsson L","Kobayakawa T","Björkman A"}	Pharmacogenetics	10	\N	\N	1999	10591538	\N	\N	\N	2	f	\N
114839	\N	Allele and genotype frequencies of polymorphic cytochromes P4502D6, 2C19 and 2E1 in aborigines from western Australia.	{"Griese E U","Ilett K F","Kitteringham N R","Eichelbaum M","Powell H","Spargo R M","LeSouef P N","Musk A W","Minchin R F"}	Pharmacogenetics	2	\N	\N	2001	11207032	\N	\N	\N	2	f	\N
116318	\N	Analysis of Sepik populations of Papua New Guinea suggests an increase of CYP2C19 null allele frequencies during the colonization of Melanesia.	{"Masta Andrew","Lum J Koji","Tsukahara Takahiro","Hwaihwanje Ilomo","Kaneko Akira","Paniu Michael M","Sapuri Mathias","Takahashi Nobuyuki","Ishizaki Takashi","Kobayakawa Takatoshi","Hombhanje Francis W"}	Pharmacogenetics	11	\N	\N	2003	14583683	\N	\N	\N	2	f	\N
114842	\N	Allele frequency differences of cytochrome P450 polymorphisms in a sample of New Zealand Māori.	{"Lea Rod A","Roberts Rebecca L","Green Michael R","Kennedy Martin A","Chambers Geoffrey K"}	The New Zealand medical journal	4	\N	\N	2008	18425152	\N	\N	\N	2	f	\N
116328	\N	S-mephenytoin hydroxylation phenotype and CYP2C19 genotype among Ethiopians.	{"Persson I","Aklillu E","Rodrigues F","Bertilsson L","Ingelman-Sundberg M"}	Pharmacogenetics	12	\N	\N	1996	9014201	\N	\N	\N	2	f	\N
116330	\N	Bantu Tanzanians have a decreased capacity to metabolize omeprazole and mephenytoin in relation to their CYP2C19 genotype.	{"Herrlin K","Massele A Y","Jande M","Alm C","Tybring G","Abdi Y A","Wennerholm A","Johansson I","Dahl M L","Bertilsson L","Gustafsson L L"}	Clinical pharmacology and therapeutics	10	\N	\N	1998	9797796	\N	\N	\N	2	f	\N
114425	\N	Genetic polymorphism of CYP2D6 and CYP2C19 in east- and southern African populations including psychiatric patients.	{"Dandara C","Masimirembwa C M","Magimba A","Sayi J","Kaaya S","Sommers D K","Snyman J R","Hasler J A"}	European journal of clinical pharmacology	4	\N	\N	2001	11372584	\N	\N	\N	2	f	\N
116340	\N	Cytochrome P450 2C19 genetic polymorphisms in Ugandans.	{"Miura Jun","Obua Celestino","Abbo Catherine","Kaneko Sunao","Tateishi Tomonori"}	European journal of clinical pharmacology	3	\N	\N	2009	19002442	\N	\N	\N	2	f	\N
116343	\N	Cytochrome P450 CYP2C19 genotypes in Nigerian sickle-cell disease patients and normal controls.	{"Babalola C P","Adejumo O","Ung D","Xu Z","Odetunde A","Kotila T","Falusi A G","Nagar S"}	Journal of clinical pharmacy and therapeutics	8	\N	\N	2010	20831548	\N	\N	\N	2	f	\N
116345	\N	Characterization of the genetic profile of CYP2C19 in two South African populations.	{"Drögemöller Britt I","Wright Galen E B","Niehaus Dana J H","Koen Liezl","Malan Stefanie","Da Silva Danielle M","Hillermann-Rebello Renate","La Grange Anthony M","Venter Mauritz","Warnich Louise"}	Pharmacogenomics	8	\N	\N	2010	20712527	\N	\N	\N	2	f	\N
114248	\N	Genetic variants in CYP (-1A2, -2C9, -2C19, -3A4 and -3A5), VKORC1 and ABCB1 genes in a black South African population: a window into diversity.	{"Dandara Collet","Lombard Zané","Du Plooy Ingrid","McLellan Tracy","Norris Shane A","Ramsay Michèle"}	Pharmacogenomics	12	\N	\N	2011	22118051	\N	\N	\N	2	f	\N
116944	\N	Distribution of CYP2C9*13 allele in the Chinese Han and the long-range haplotype containing CYP2C9*13 and CYP2C19*2.	{"Si Dayong","Wang Juan","Zhang Yifan","Zhong Dafang","Zhou Hui"}	Biopharmaceutics & drug disposition	9	\N	\N	2012	22886551	\N	\N	\N	2	f	\N
116348	\N	Introduction of the AmpliChip CYP450 Test to a South African cohort: a platform comparative prospective cohort study.	{"Dodgen Tyren M","Hochfeld Warren E","Fickl Heidi","Asfaha Sahle M","Durandt Chrisna","Rheeder Paul","Drögemöller Britt I","Wright Galen E B","Warnich Louise","Labuschagne Christiaan D J","van Schalkwyk Antoinette","Gaedigk Andrea","Pepper Michael S"}	BMC medical genetics	1	\N	\N	2013	23356658	\N	\N	\N	2	f	\N
116358	\N	Effects of Khat (Catha edulis) use on catalytic activities of major drug-metabolizing cytochrome P450 enzymes and implication of pharmacogenetic variations.	{"Bedada Worku","de Andrés Fernando","Engidawork Ephrem","Hussein Jemal","LLerena Adrián","Aklillu Eleni"}	Scientific reports	8	\N	\N	2018	30143732	\N	\N	\N	2	f	\N
116570	\N	Poor warfarin dose prediction with pharmacogenetic algorithms that exclude genotypes important for African Americans.	{"Drozda Katarzyna","Wong Shan","Patel Shitalben R","Bress Adam P","Nutescu Edith A","Kittles Rick A","Cavallari Larisa H"}	Pharmacogenetics and genomics	2	\N	\N	2015	25461246	\N	\N	\N	2	f	\N
116574	\N	Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study.	{"Perera Minoli A","Cavallari Larisa H","Limdi Nita A","Gamazon Eric R","Konkashbaev Anuar","Daneshjou Roxana","Pluzhnikov Anna","Crawford Dana C","Wang Jelai","Liu Nianjun","Tatonetti Nicholas","Bourgeois Stephane","Takahashi Harumi","Bradford Yukiko","Burkley Benjamin M","Desnick Robert J","Halperin Jonathan L","Khalifa Sherief I","Langaee Taimour Y","Lubitz Steven A","Nutescu Edith A","Oetjens Matthew","Shahin Mohamed H","Patel Shitalben R","Sagreiya Hersh","Tector Matthew","Weck Karen E","Rieder Mark J","Scott Stuart A","Wu Alan H B","Burmester James K","Wadelius Mia","Deloukas Panos","Wagner Michael J","Mushiroda Taisei","Kubo Michiaki","Roden Dan M","Cox Nancy J","Altman Russ B","Klein Teri E","Nakamura Yusuke","Johnson Julie A"}	Lancet (London, England)	8	\N	\N	2013	23755828	\N	\N	\N	2	f	\N
116678	\N	CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosing.	{"Scott Stuart A","Jaremko Malgorzata","Lubitz Steven A","Kornreich Ruth","Halperin Jonathan L","Desnick Robert J"}	Pharmacogenomics	8	\N	\N	2009	19663669	\N	\N	\N	2	f	\N
116581	\N	Influence of CYP2C9 and VKORC1 1173C/T genotype on the risk of hemorrhagic complications in African-American and European-American patients on warfarin.	{"Limdi N A","McGwin G","Goldstein J A","Beasley T M","Arnett D K","Adler B K","Baird M F","Acton R T"}	Clinical pharmacology and therapeutics	2	\N	\N	2008	17653141	\N	\N	\N	2	f	\N
116583	\N	Population differences in S-warfarin pharmacokinetics among African Americans, Asians and whites: their influence on pharmacogenetic dosing algorithms.	{"Kubo K","Ohara M","Tachikawa M","Cavallari L H","Lee M T M","Wen M S","Scordo M G","Nutescu E A","Perera M A","Miyajima A","Kaneko N","Pengo V","Padrini R","Chen Y T","Takahashi H"}	The pharmacogenomics journal	12	\N	\N	2017	27503578	\N	\N	\N	2	f	\N
116585	\N	Association of the GGCX (CAA)16/17 repeat polymorphism with higher warfarin dose requirements in African Americans.	{"Cavallari Larisa H","Perera Minoli","Wadelius Mia","Deloukas Panos","Taube Gelson","Patel Shitalben R","Aquino-Michaels Keston","Viana Marlos A G","Shapiro Nancy L","Nutescu Edith A"}	Pharmacogenetics and genomics	2	\N	\N	2012	22158446	\N	\N	\N	2	f	\N
113845	\N	Genetic and clinical predictors of warfarin dose requirements in African Americans.	{"Cavallari L H","Langaee T Y","Momary K M","Shapiro N L","Nutescu E A","Coty W A","Viana M A G","Patel S R","Johnson J A"}	Clinical pharmacology and therapeutics	4	\N	\N	2010	20072124	\N	\N	\N	2	f	\N
116689	\N	Influence of CYP2C9 Genotype on warfarin dose among African American and European Americans.	{"Limdi Na","Goldstein Ja","Blaisdell Ja","Beasley Tm","Rivers Ca","Acton Rt"}	Personalized medicine	5	\N	\N	2007	19802360	\N	\N	\N	2	f	\N
116691	\N	The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism.	{"Sullivan-Klose T H","Ghanayem B I","Bell D A","Zhang Z Y","Kaminsky L S","Shenfield G M","Miners J O","Birkett D J","Goldstein J A"}	Pharmacogenetics	8	\N	\N	1996	8873220	\N	\N	\N	2	f	\N
116695	\N	Factors influencing warfarin dose requirements in African-Americans.	{"Momary Kathryn M","Shapiro Nancy L","Viana Marlos Ag","Nutescu Edith A","Helgason Cathy M","Cavallari Larisa H"}	Pharmacogenomics	11	\N	\N	2007	18034618	\N	\N	\N	2	f	\N
116697	\N	Lung cancer risk in relation to the CYP2C9*1/CYP2C9*2 genetic polymorphism among African-Americans and Caucasians in Los Angeles County, California.	{"London S J","Daly A K","Leathart J B","Navidi W C","Idle J R"}	Pharmacogenetics	12	\N	\N	1996	9014202	\N	\N	\N	2	f	\N
116699	\N	The Prevalence of CYP2C8, 2C9, 2J2, and soluble epoxide hydrolase polymorphisms in African Americans with hypertension.	{"Dreisbach Albert W","Japa Shanker","Sigel Aster","Parenti Melissa B","Hess Arthur E","Srinouanprachanh Sengkeo L","Rettie Allan E","Kim Helen","Farin Federico M","Hamm L Lee","Lertora Juan J L"}	American journal of hypertension	10	\N	\N	2005	16202848	\N	\N	\N	2	f	\N
116704	\N	CYP2C9 allelic variants and frequencies in a pediatric sickle cell disease cohort: implications for NSAIDs pharmacotherapy.	{"Jaja Cheedy","Patel Niren","Scott Stuart A","Gibson Robert","Kutlar Abdullah"}	Clinical and translational science	10	\N	\N	2014	24889181	\N	\N	\N	2	f	\N
116706	\N	Preemptive Genotyping of CYP2C8 and CYP2C9 Allelic Variants Involved in NSAIDs Metabolism for Sickle Cell Disease Pain Management.	{"Jaja Cheedy","Bowman Latanya","Wells Leigh","Patel Niren","Xu Hongyan","Lyon Matt","Kutlar Abdullah"}	Clinical and translational science	8	\N	\N	2015	25640739	\N	\N	\N	2	f	\N
116708	\N	Pharmacogenetics in American Indian populations: analysis of CYP2D6, CYP3A4, CYP3A5, and CYP2C9 in the Confederated Salish and Kootenai Tribes.	{"Fohner Alison","Muzquiz LeeAnna I","Austin Melissa A","Gaedigk Andrea","Gordon Adam","Thornton Timothy","Rieder Mark J","Pershouse Mark A","Putnam Elizabeth A","Howlett Kevin","Beatty Patrick","Thummel Kenneth E","Woodahl Erica L"}	Pharmacogenetics and genomics	8	\N	\N	2013	23778323	\N	\N	\N	2	f	\N
113847	\N	Variation in genes controlling warfarin disposition and response in American Indian and Alaska Native people: CYP2C9, VKORC1, CYP4F2, CYP4F11, GGCX.	{"Fohner Alison E","Robinson Renee","Yracheta Joseph","Dillard Denise A","Schilling Brian","Khan Burhan","Hopkins Scarlett","Boyer Bert","Black Jynene","Wiener Howard","Tiwari Hemant K","Gordon Adam","Nickerson Deborah","Tsai Jesse M","Farin Federico M","Thornton Timothy A","Rettie Allan E","Thummel Kenneth E"}	Pharmacogenetics and genomics	7	\N	\N	2015	25946405	\N	\N	\N	2	f	\N
116714	\N	Genetic variability of CYP2C9*2 and CYP2C9*3 in seven indigenous groups from Mexico.	{"Sánchez-Pozos Katy","Rivera-Santiago Carolina","García-Rodríguez María Helena","Ortiz-López María Guadalupe","Peña-Espinoza Barbara Itzel","Granados-Silvestre María de Los Ángeles","Llerena Adrian","Menjívar Marta"}	Pharmacogenomics	10	\N	\N	2016	27790940	\N	\N	\N	2	f	\N
116723	\N	Combined CYP2C9, VKORC1 and CYP4F2 frequencies among Amerindians, Mozambicans and Brazilians.	{"Vargens Daniela D","Damasceno Albertino","Petzl-Erler Maria-Luiza","Suarez-Kurtz Guilherme"}	Pharmacogenomics	6	\N	\N	2011	21692610	\N	\N	\N	2	f	\N
116725	\N	CYP2C9 genotypes and the quality of anticoagulation control with warfarin therapy among Brazilian patients.	{"Lima M V","Ribeiro G S","Mesquita E T","Victer P R","Vianna-Jorge R"}	European journal of clinical pharmacology	1	\N	\N	2008	17955230	\N	\N	\N	2	f	\N
116728	\N	Allele frequency distribution of CYP2C9 2 and CYP2C9 3 polymorphisms in six Mexican populations.	{"Castelán-Martínez Osvaldo D","Hoyo-Vadillo Carlos","Sandoval-García Emmanuel","Sandoval-Ramírez Lucila","González-Ibarra Miriam","Solano-Solano Gloria","Gómez-Díaz Rita A","Parra Esteban J","Cruz Miguel","Valladares-Salgado Adán"}	Gene	7	\N	\N	2013	23587916	\N	\N	\N	2	f	\N
116744	\N	CYP2C9 allele frequency differences between populations of Mexican-Mestizo, Mexican-Tepehuano, and Spaniards.	{"Dorado P","Sosa-Macias M G","Peñas-Lledó E M","Alanis-Bañuelos R E","Wong M-L","Licinio J","Lares-Asseff I","Llerena A"}	The pharmacogenomics journal	4	\N	\N	2011	20458343	\N	\N	\N	2	f	\N
116746	\N	Genotype frequencies of VKORC1 and CYP2C9 in native and Mestizo populations from Mexico, potential impact for coumarin dosing.	{"Villegas-Torres Beatriz","Sánchez-Girón Francisco","Jaramillo-Villafuerte Karla","Soberón Xavier","Gonzalez-Covarrubias Vanessa"}	Gene	3	\N	\N	2015	25560189	\N	\N	\N	2	f	\N
114400	\N	Interethnic Variability in CYP2D6, CYP2C9, and CYP2C19 Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF-CEIBA Consortium Report on Population Pharmacogenomics.	{"Naranjo María-Eugenia G","Rodrigues-Soares Fernanda","Peñas-Lledó Eva M","Tarazona-Santos Eduardo","Fariñas Humberto","Rodeiro Idania","Terán Enrique","Grazina Manuela","Moya Graciela E","López-López Marisol","Sarmiento Alba P","Calzadilla Luis R","Ramírez-Roa Ronald","Ortiz-López Rocío","Estévez-Carrizo Francisco E","Sosa-Macías Martha","Barrantes Ramiro","LLerena Adrián","CEIBA-Consortium of the Ibero-American Network of Pharmacogenetics and Pharmacogenomics RIBEF"}	Omics : a journal of integrative biology	9	\N	\N	2018	30183544	\N	\N	\N	2	f	\N
113850	\N	Genetic epidemiology of pharmacogenetic variations in CYP2C9, CYP4F2 and VKORC1 genes associated with warfarin dosage in the Indian population.	{"Giri Anil K","Khan Nazir M","Grover Sandeep","Kaur Ismeet","Basu Analabha","Tandon Nikhil","Scaria Vinod","Consortium IGV",INDICO,"Kukreti Ritushree","Brahmachari Samir K","Bharadwaj Dwaipayan"}	Pharmacogenomics	7	\N	\N	2014	25155935	\N	\N	\N	2	f	\N
116603	\N	Contribution of VKORC1 and CYP2C9 polymorphisms in the interethnic variability of warfarin dose in Malaysian populations.	{"Gan Gin Gin","Phipps Maude E","Lee Michael M T","Lu Liang S","Subramaniam Rajallectchumy Y","Bee Ping C","Chang Sean H"}	Annals of hematology	6	\N	\N	2011	21110192	\N	\N	\N	2	f	\N
116774	\N	Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients.	{"Lim Joanne S L","Chen Xiang A","Singh Onkar","Yap Yoon S","Ng Raymond C H","Wong Nan S","Wong Mabel","Lee Edmund J D","Chowbay Balram"}	British journal of clinical pharmacology	5	\N	\N	2011	21480951	\N	\N	\N	2	f	\N
116778	\N	Pharmacogenomic association study on the role of drug metabolizing, drug transporters and drug target gene polymorphisms in drug-resistant epilepsy in a north Indian population.	{"Kumari Ritu","Lakhan Ram","Garg R K","Kalita J","Misra U K","Mittal Balraj"}	Indian journal of human genetics	5	\N	\N	2011	21747585	\N	\N	\N	2	f	\N
116780	\N	Effects of estradiol on voltage-gated sodium channels in mouse dorsal root ganglion neurons.	{"Wang Qiang","Cao Jie","Hu Fang","Lu Rongzhu","Wang Jun","Ding Haixia","Gao Rong","Xiao Hang"}	Brain research	5	\N	\N	2013	23473841	\N	\N	\N	2	f	\N
116782	\N	Cytochrome P450 (CYP2C9*2,*3) & vitamin-K epoxide reductase complex (VKORC1 -1639G<A) gene polymorphisms & their effect on acenocoumarol dose in patients with mechanical heart valve replacement.	{"Kaur Anupriya","Khan Farah","Agrawal Suraksha S","Kapoor Aditya","Agarwal Surendra K","Phadke Shubha R"}	The Indian journal of medical research	1	\N	\N	2013	23481074	\N	\N	\N	2	f	\N
116784	\N	Analysis of CYP2C9 polymorphisms (*2 and *3) in warfarin therapy patients in Pakistan. Association of CYP2C9 polymorphisms (*2 and*3) with warfarin dose, age, PT and INR.	{"Yasmeen Faiza","Ghafoor Muhammad Bilal","Khalid Abdul Wadood","Latif Waqas","Mohsin Shahida","Khaliq Shagufta"}	Journal of thrombosis and thrombolysis	8	\N	\N	2015	25904339	\N	\N	\N	2	f	\N
116786	\N	Clinical relevance of genetic polymorphism in CYP2C9 gene to pharmacodynamics and pharmacokinetics of phenytoin in epileptic patients: validatory pharmacogenomic approach to pharmacovigilance.	{"Kousar Shazia","Wafai Zahoor A","Wani Mushtaq A","Jan Tariq R","Andrabi Khurshid I"}	International journal of clinical pharmacology and therapeutics	7	\N	\N	2015	25943175	\N	\N	\N	2	f	\N
116789	\N	Evaluation of cytochrome P450 2C9 activity in normal, healthy, adult Western Indian population by both phenotyping and genotyping.	{"Swar Balkrishna D","Bendkhale Shital R","Rupawala Abbas","Sridharan Kannan","Gogtay Nithya J","Thatte Urmila M","Kshirsagar Nilima A"}	Indian journal of pharmacology	0	\N	\N	2016	27298492	\N	\N	\N	2	f	\N
116791	\N	Frequency of Common CYP2C9 Polymorphisms and Their Impact on Warfarin Dose Requirement in Pakistani Population.	{"Qayyum Aisha","Najmi Muzammil Hasan","Mansoor Qaisar","Farooqi Zia-Ur-Rehman","Naveed Abdul Khaliq","Hanif Andleeb","Kazmi Syed Ali Raza","Ismail Muhammad"}	Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis	10	\N	\N	2017	27313202	\N	\N	\N	2	f	\N
116796	\N	Effect of VKORC1 and CYP2C9 polymorphisms on warfarin dose requirement in Bangladeshi population.	{"Chowdhury Zahid Sadek","Shahjin Farah","Akter Farhana","Ahmed Maizbhauddin","Islam Mohammad Safiqul","Bin Sayeed Muhammad Shahdaat","Islam Reazul","Hasnat Abul"}	Pakistan journal of pharmaceutical sciences	3	\N	\N	2017	28649054	\N	\N	\N	2	f	\N
116798	\N	Distribution of CYP2C8 and CYP2C9 amino acid substitution alleles in South Indian diabetes patients: A genotypic and computational protein phenotype study.	{"Rao Durga Koteswara","Murthy Dwaraknath K","Shaik Nazia Sultana","Banaganapalli Babajan","Konda Kumaraswami","Rao Hanmantha P","Ganti Eswar","Ahmed Awan Zuhair","A El-Harouni Ashraf","Elango Ramu","Ali Khan Imran","Shaik Noor Ahmad"}	Clinical and experimental pharmacology & physiology	12	\N	\N	2017	28686288	\N	\N	\N	2	f	\N
116801	\N	Genotyping of CYP2C9 and VKORC1 polymorphisms predicts south Indian patients with deep vein thrombosis as fast metabolizers of warfarin/acenocoumarin.	{"Arunkumar Ganesan","Vishnuprabu Durairajpandian","Nupur Bitt","Vidyasagaran Thiruvengadam","Murugan Avaniyapuram Kannan","Munirajan Arasambattu Kannan"}	Drug discoveries & therapeutics	0	\N	\N	2017	28867752	\N	\N	\N	2	f	\N
116805	\N	Frequencies of CYP2C9 polymorphisms in North Indian population and their association with drug levels in children on phenytoin monotherapy.	{"Chaudhary Nagendra","Kabra Madhulika","Gulati Sheffali","Gupta Yogendra Kumar","Pandey Ravindra Mohan","Bhatia Bal Dev"}	BMC pediatrics	5	\N	\N	2016	27179628	\N	\N	\N	2	f	\N
116807	\N	Investigating the Role of Plasma Glucose Concentration as a Phenotypic Marker for CYP2C9 Genetic Variants, in the Diabetic Population of Gujarat.	{"Bhatt D","Chauhan N","Sharma A","Dhawan D","Bhatt R V","Phatak S","Padh H"}	Indian journal of pharmaceutical sciences	1	\N	\N	2014	24799741	\N	\N	\N	2	f	\N
116811	\N	Prevalence of genetic variants associated with cardiovascular disease risk and drug response in the Southern Indian population of Kerala.	{"Mahadevan Lakshmi","Yesudas Ancy","Sajesh P K","Revu S","Kumar Prasanna","Santhosh Devi","Santhosh Sam","Sashikumar J M","Gopalakrishnan V K","Boben Joji","Rajesh Changanamkandath"}	Indian journal of human genetics	4	\N	\N	2014	25400347	\N	\N	\N	2	f	\N
116813	\N	Variability in CYP2C9 allele frequency: a pilot study of its predicted impact on warfarin response among healthy South and North Indians.	{"Nahar Risha","Deb Roumi","Saxena Renu","Puri Ratna Dua","Verma Ishwar Chander"}	Pharmacological reports : PR	0	\N	\N	2013	23563037	\N	\N	\N	2	f	\N
116818	\N	Frequencies of VKORC1 -1639 G>A, CYP2C9*2 and CYP2C9*3 genetic variants in the Northern Indian population.	{"Rathore Saurabh S","Agarwal Surendra K","Pande Shantanu","Mittal Tulika","Mittal Balraj"}	Bioscience trends	12	\N	\N	2010	21248432	\N	\N	\N	2	f	\N
116820	\N	Impact of CYP2C9 genetic polymorphism on warfarin dose requirements in Pakistani population.	{"Siddiqi Aisha","Khan Dilshad Ahmad","Khan Farooq Ahmed","Naveed Abdul Khaliq"}	Pakistan journal of pharmaceutical sciences	10	\N	\N	2010	20884456	\N	\N	\N	2	f	\N
116826	\N	Interethnic differences of CYP2C9 alleles in healthy Hungarian and Roma population samples: relationship to worldwide allelic frequencies.	{"Sipeky Csilla","Lakner Lilla","Szabo Melinda","Takacs Istvan","Tamasi Viola","Polgar Noemi","Falus Andras","Melegh Bela"}	Blood cells, molecules & diseases	0	\N	\N	2009	19541511	\N	\N	\N	2	f	\N
116828	\N	Characterization of ADME genes variation in Roma and 20 populations worldwide.	{"Škarić-Jurić Tatjana","Tomas Željka","Zajc Petranović Matea","Božina Nada","Smolej Narančić Nina","Janićijević Branka","Salihović Marijana Peričić"}	PloS one	0	\N	\N	2018	30452466	\N	\N	\N	2	f	\N
116843	\N	Analysis of CYP2C9*5 in Caucasian, Oriental and black-African populations.	{"Yasar Umit","Aklillu Eleni","Canaparo Roberto","Sandberg Mia","Sayi Jane","Roh Hyung-Keun","Wennerholm Agneta"}	European journal of clinical pharmacology	11	\N	\N	2002	12451434	\N	\N	\N	2	f	\N
116616	\N	The influence of genetic polymorphisms and interacting drugs on initial response to warfarin in Chinese patients with heart valve replacement.	{"Zhong Shi-Long","Liu Yuan","Yu Xi-Yong","Xu Dan","Tan Hong-Hong","Lin Qiu-Xiong","Yang Min","Lao Hai-Yan","Lin Shu-Guang"}	European journal of clinical pharmacology	6	\N	\N	2011	21318593	\N	\N	\N	2	f	\N
113872	\N	A pharmacogenetics-based warfarin maintenance dosing algorithm from Northern Chinese patients.	{"Chen Jinxing","Shao Liying","Gong Ling","Luo Fang","Wang Jin'e","Shi Yi","Tan Yu","Chen Qianlong","Zhang Yu","Hui Rutai","Wang Yibo"}	PloS one	0	\N	\N	2014	25126975	\N	\N	\N	2	f	\N
113874	\N	Influence of genetic polymorphisms in cytochrome P450 oxidoreductase on the variability in stable warfarin maintenance dose in Han Chinese.	{"Zeng Wu-Tao","Xu Qing","Li Cheng-Hsun","Chen Wei-Yan","Sun Xiu-Ting","Wang Xiang","Yang Yi-Ying","Shi Hui","Yang Zhi-Sheng"}	European journal of clinical pharmacology	11	\N	\N	2016	27488389	\N	\N	\N	2	f	\N
113878	\N	CYP4F2 rs2108622: a minor significant genetic factor of warfarin dose in Han Chinese patients with mechanical heart valve replacement.	{"Cen Han-Jing","Zeng Wu-Tao","Leng Xiu-Yu","Huang Min","Chen Xiao","Li Jia-Li","Huang Zhi-Ying","Bi Hui-Chang","Wang Xue-Ding","He Yan-Ling","He Fan","Zhou Rui-Na","Zheng Qi-Shan","Zhao Li-Zi"}	British journal of clinical pharmacology	8	\N	\N	2010	20653676	\N	\N	\N	2	f	\N
116851	\N	Population differences in S-warfarin metabolism between CYP2C9 genotype-matched Caucasian and Japanese patients.	{"Takahashi Harumi","Wilkinson Grant R","Caraco Yoseph","Muszkat Mordechai","Kim Richard B","Kashima Toshitaka","Kimura Sosuke","Echizen Hirotoshi"}	Clinical pharmacology and therapeutics	3	\N	\N	2003	12621390	\N	\N	\N	2	f	\N
116853	\N	CYP2C polymorphisms, phenytoin metabolism and gingival overgrowth in epileptic subjects.	{"Soga Yoshihiko","Nishimura Fusanori","Ohtsuka Yoko","Araki Hiroaki","Iwamoto Yoshihiro","Naruishi Hisa","Shiomi Nobuyuki","Kobayashi Yoshitomo","Takashiba Shogo","Shimizu Kenji","Gomita Yutaka","Oka Eiji"}	Life sciences	1	\N	\N	2004	14659971	\N	\N	\N	2	f	\N
116860	\N	CYP2C9*3 allelic variant is associated with metabolism of irbesartan in Chinese population.	{"Hong Xiumei","Zhang Shanchun","Mao Guangyun","Jiang Shanqun","Zhang Yan","Yu Yunxian","Tang Genfu","Xing Houxun","Xu Xiping"}	European journal of clinical pharmacology	10	\N	\N	2005	16094537	\N	\N	\N	2	f	\N
116865	\N	Four novel defective alleles and comprehensive haplotype analysis of CYP2C9 in Japanese.	{"Maekawa Keiko","Fukushima-Uesaka Hiromi","Tohkin Masahiro","Hasegawa Ryuichi","Kajio Hiroshi","Kuzuya Nobuaki","Yasuda Kazuki","Kawamoto Manabu","Kamatani Naoyuki","Suzuki Kazuko","Yanagawa Tatsuo","Saito Yoshiro","Sawada Jun-ichi"}	Pharmacogenetics and genomics	7	\N	\N	2006	16788382	\N	\N	\N	2	f	\N
116867	\N	CYP2C9 and CYP2C19 polymorphic forms are related to increased indisulam exposure and higher risk of severe hematologic toxicity.	{"Zandvliet Anthe S","Huitema Alwin D R","Copalu William","Yamada Yasuhide","Tamura Tomohide","Beijnen Jos H","Schellens Jan H M"}	Clinical cancer research : an official journal of the American Association for Cancer Research	5	\N	\N	2007	17504998	\N	\N	\N	2	f	\N
116874	\N	Genetic variations of CYP2C9 in 724 Japanese individuals and their impact on the antihypertensive effects of losartan.	{"Yin Tong","Maekawa Keiko","Kamide Kei","Saito Yoshiro","Hanada Hironori","Miyashita Kotaro","Kokubo Yoshihiro","Akaiwa Yasuhisa","Otsubo Ryoichi","Nagatsuka Kazuyuki","Otsuki Toshiho","Horio Takeshi","Takiuchi Shin","Kawano Yuhei","Minematsu Kazuo","Naritomi Hiroaki","Tomoike Hitonobu","Sawada Jun-ichi","Miyata Toshiyuki"}	Hypertension research : official journal of the Japanese Society of Hypertension	8	\N	\N	2008	18971529	\N	\N	\N	2	f	\N
116878	\N	Genetic determinants of warfarin dosing in the Han-Chinese population.	{"Lee M T Michael","Chen Chien-Hsiun","Chou Ching-Heng","Lu Liang-Suei","Chuang Hui-Ping","Chen Ying-Ting","Saleem Amir N","Wen Ming-Shien","Chen Jin-Jer","Wu Jer-Yuarn","Chen Yuan-Tsong"}	Pharmacogenomics	12	\N	\N	2009	19958090	\N	\N	\N	2	f	\N
116880	\N	The influence of cytochrome oxidase CYP2A6, CYP2B6, and CYP2C9 polymorphisms on the plasma concentrations of valproic acid in epileptic patients.	{"Tan Lan","Yu Jin-Tai","Sun Yan-Ping","Ou Jiang-Rong","Song Jing-Hui","Yu Yang"}	Clinical neurology and neurosurgery	5	\N	\N	2010	20089352	\N	\N	\N	2	f	\N
116882	\N	VKORC1-1639G>A, CYP2C9, EPHX1691A>G genotype, body weight, and age are important predictors for warfarin maintenance doses in patients with mechanical heart valve prostheses in southwest China.	{"Gu Qiang","Kong Yan","Schneede Jörn","Xiao Ying-Bin","Chen Lin","Zhong Qian-Jin","Wang Xue-Feng","Hao Jia","Chen Bai-Cheng","Chen Jing-Jin"}	European journal of clinical pharmacology	12	\N	\N	2010	20842355	\N	\N	\N	2	f	\N
116887	\N	Clinical significance of combined CYP2C9 and VKORC1 genotypes in Japanese patients requiring warfarin.	{"Miyagata You","Nakai Kenji","Sugiyama Yoshiki"}	International heart journal	0	\N	\N	2011	21321468	\N	\N	\N	2	f	\N
116892	\N	Effects of ethnicity and vitamin D supplementation on vitamin D status and changes in bone mineral content in infants.	{"Abrams Steven A","Hawthorne Keli M","Rogers Stefanie P","Hicks Penni D","Carpenter Thomas O"}	BMC pediatrics	1	\N	\N	2012	22248486	\N	\N	\N	2	f	\N
116894	\N	Frequency of CYP2C9 alleles in Koreans and their effects on losartan pharmacokinetics.	{"Bae Jung-woo","Choi Chang-ik","Kim Mi-jeong","Oh Da-hee","Keum Seul-ki","Park Jung-in","Kim Bo-hye","Bang Hye-kyoung","Oh Sung-gon","Kang Byung-sung","Park Hyun-joo","Kim Hae-deun","Ha Ji-hey","Shin Hee-jung","Kim Young-hoon","Na Han-sung","Chung Myeon-woo","Jang Choon-gon","Lee Seok-yong"}	Acta pharmacologica Sinica	10	\N	\N	2011	21841812	\N	\N	\N	2	f	\N
116896	\N	The effect of CYP2C9, VKORC1 genotypes and old age on warfarin pharmacologic sensitivity in korean patients with thromboembolic disease.	{"Moon Hee-Won","Noh Jaekwang","Yun Yeo-Min","Kim Hahn Young","Yun Ik Jin","Song Junghan","Kim Jin Q"}	Annals of clinical and laboratory science	0	\N	\N	2011	22075505	\N	\N	\N	2	f	\N
116900	\N	Effects of UGT1A6, UGT2B7, and CYP2C9 genotypes on plasma concentrations of valproic acid in Chinese children with epilepsy.	{"Guo Yingjie","Hu Cheng","He Xiaojing","Qiu Feng","Zhao Limei"}	Drug metabolism and pharmacokinetics	0	\N	\N	2012	23099353	\N	\N	\N	2	f	\N
116902	\N	Effects of polymorphisms in six candidate genes on phenytoin maintenance therapy in Han Chinese patients.	{"Hung Chin-Chuan","Huang Hsiao-Ching","Gao Yun-Han","Chang Wei-Lun","Ho Jia-Ling","Chiou Mu-Han","Hsieh Yow-Wen","Liou Horng-Huei"}	Pharmacogenomics	9	\N	\N	2012	22966884	\N	\N	\N	2	f	\N
116905	\N	Role of CYP2C9 polymorphism in phenytoin-related metabolic abnormalities and subclinical atherosclerosis in young adult epileptic patients.	{"Phabphal Kanitpong","Geater Alan","Limapichart Kitti","Sathirapanya Pornchai","Setthawatcharawanich Suwanna"}	Seizure	3	\N	\N	2013	23159358	\N	\N	\N	2	f	\N
116907	\N	Effect of single nucleotide polymorphisms in cytochrome P450 isoenzyme and N-acetyltransferase 2 genes on the metabolism of artemisinin-based combination therapies in malaria patients from Cambodia and Tanzania.	{"Staehli Hodel Eva Maria","Csajka Chantal","Ariey Frédéric","Guidi Monia","Kabanywanyi Abdunoor Mulokozi","Duong Socheat","Decosterd Laurent Arthur","Olliaro Piero","Beck Hans-Peter","Genton Blaise"}	Antimicrobial agents and chemotherapy	2	\N	\N	2013	23229480	\N	\N	\N	2	f	\N
116911	\N	Effects of CYP2C9*1/*3 genotype on the pharmacokinetics of flurbiprofen in Korean subjects.	{"Lee Yun-Jeong","Byeon Ji-Yeong","Kim Young-Hoon","Kim Se-Hyung","Choi Chang-Ik","Bae Jung-Woo","Sohn Uy-Dong","Jang Choon-Gon","Lee Jeongmi","Lee Seok-Yong"}	Archives of pharmacal research	6	\N	\N	2015	25712887	\N	\N	\N	2	f	\N
116913	\N	Differences in CYP2C9 Genotype and Enzyme Activity Between Swedes and Koreans of Relevance for Personalized Medicine: Role of Ethnicity, Genotype, Smoking, Age, and Sex.	{"Hatta Fazleen H M","Lundblad Mia","Ramsjo Margareta","Kang Ju-Hee","Roh Hyung-Keun","Bertilsson Leif","Eliasson Erik","Aklillu Eleni"}	Omics : a journal of integrative biology	6	\N	\N	2015	25977991	\N	\N	\N	2	f	\N
116917	\N	Absence of ethnic differences in the pharmacokinetics of moxifloxacin, simvastatin, and meloxicam among three East Asian populations and Caucasians.	{"Hasunuma Tomoko","Tohkin Masahiro","Kaniwa Nahoko","Jang In-Jin","Yimin Cui","Kaneko Masaru","Saito Yoshiro","Takeuchi Masahiro","Watanabe Hiroshi","Yamazoe Yasushi","Uyama Yoshiaki","Kawai Shinichi"}	British journal of clinical pharmacology	6	\N	\N	2016	26774055	\N	\N	\N	2	f	\N
116921	\N	Association of CYP2C9, CYP2A6, ACSM2A, and CPT1A gene polymorphisms with adverse effects of valproic acid in Chinese patients with epilepsy.	{"Wang Can","Wang Ping","Yang Li-Ping","Pan Jing","Yang Xue","Ma Hong-Ying"}	Epilepsy research	5	\N	\N	2017	28315807	\N	\N	\N	2	f	\N
116925	\N	Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes.	{"Takahashi H","Kashima T","Nomizo Y","Muramoto N","Shimizu T","Nasu K","Kubota T","Kimura S","Echizen H"}	Clinical pharmacology and therapeutics	5	\N	\N	1998	9630825	\N	\N	\N	2	f	\N
116927	\N	Genetic polymorphism of the CYP2C subfamily and its effect on the pharmacokinetics of phenytoin in Japanese patients with epilepsy.	{"Odani A","Hashimoto Y","Otsuki Y","Uwai Y","Hattori H","Furusho K","Inui K"}	Clinical pharmacology and therapeutics	9	\N	\N	1997	9333104	\N	\N	\N	2	f	\N
116946	\N	Multiplex pyrosequencing method to determine CYP2C9*3, VKORC1*2, and CYP4F2*3 polymorphisms simultaneously: its application to a Korean population and comparisons with other ethnic groups.	{"Kim Kyoung-Ah","Song Wan-Geun","Lee Hae-Mi","Joo Hyun-Jin","Park Ji-Young"}	Molecular biology reports	11	\N	\N	2014	25069408	\N	\N	\N	2	f	\N
116950	\N	Allele and genotype frequencies of CYP2C9 in a Korean population.	{"Bae Jung-Woo","Kim Hyun-Kyung","Kim Ji-Hong","Yang Sang-In","Kim Mi-Jeong","Jang Choon-Gon","Park Young-Seo","Lee Seok-Yong"}	British journal of clinical pharmacology	10	\N	\N	2005	16187974	\N	\N	\N	2	f	\N
116952	\N	A systematic genetic polymorphism analysis of the CYP2C9 gene in four different geographical Han populations in mainland China.	{"Xiong Yuyu","Wang Ming","Fang Ke","Xing Qinghe","Feng Guoyin","Shen Lu","He Lin","Qin Shengying"}	Genomics	5	\N	\N	2011	21126569	\N	\N	\N	2	f	\N
116957	\N	CYP2C9 allele variants in Chinese hypertension patients and healthy controls.	{"Yu Bang-ning","Luo Chen-Hui","Wang Dan","Wang An","Li Zhi","Zhang Wei","Mo Wei","Zhou Hong-Hao"}	Clinica chimica acta; international journal of clinical chemistry	10	\N	\N	2004	15369736	\N	\N	\N	2	f	\N
116962	\N	Genetic polymorphisms analysis of drug-metabolizing enzyme CYP2C9 in the Uyghur population.	{"Jin Tianbo","Xun Xiaojie","Du Shuli","Geng Tingting","Wang Hong","Feng Tian","Chen Chen","Yuan Dongya","Kang Longli"}	Xenobiotica; the fate of foreign compounds in biological systems	8	\N	\N	2016	26610168	\N	\N	\N	2	f	\N
116964	\N	Cytochrome P450 2C9 (CYP2C9) polymorphisms in Chinese Li population.	{"Ding Yipeng","Yang Danlei","Zhou Long","He Ping","Yao Jinjian","Xie Pingdong","Lin Daobo","Sun Dingwei","Sun Pei","Li Quanni","Geng Tingting","Jin Tianbo"}	International journal of clinical and experimental medicine	0	\N	\N	2015	26885033	\N	\N	\N	2	f	\N
116968	\N	Gender specific association of CYP2C9*3 with hyperlipidaemia in Chinese.	{"Luo Chen-Hui","Wang An","Zhu Rong-Hua","Zhang Wei-Xia","Mo Wei","Yu Bang-Ning","Chen Guo-Lin","Ou-Yang Dong-Sheng","Duan Xiao-Hong","Abd El-Aty A M","Zhou Hong-Hao"}	British journal of clinical pharmacology	12	\N	\N	2005	16305587	\N	\N	\N	2	f	\N
116981	\N	Systematic characterization and comparison of the CYP2C9 variability of the Orang Asli in Malaysia with 12 populations.	{"Teh Lay Kek","Subramaniam Vinothini","Tuan Abdu Aziz Tuan Azlin","Lee Lian Shien","Ismail Mohamed Izwan","Yu Choo Yee","Ang Geik Yong","James Johari Richard","Ismet Rose Iszati","Sahak Noor Saadah","Ahmad Aminuddin","Rahman Thuhairah Abdul","Nor Ghazali Fadzilah Mohd","Shaari SyahrulAzlin","Omar Mustaffa","Ismail Adzrool Idzwan","Md Isa Kamarudzaman","Salleh Hood","Salleh Mohd Zaki"}	Drug metabolism and pharmacokinetics	8	\N	\N	2016	27325019	\N	\N	\N	2	f	\N
116984	\N	Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Mongolian population in China.	{"Yang Z F","Cui H W","Hasi T","Jia S Q","Gong M L","Su X L"}	Genetics and molecular research : GMR	9	\N	\N	2010	20845310	\N	\N	\N	2	f	\N
114365	\N	Analysis of the CYP2D6 gene polymorphism and enzyme activity in African-Americans in southern California.	{"Wan Y J","Poland R E","Han G","Konishi T","Zheng Y P","Berman N","Lin K M"}	Pharmacogenetics	8	\N	\N	2001	11505219	\N	\N	\N	2	f	\N
116986	\N	Polymorphic analysis of CYP2C9 gene in Vietnamese population.	{"Vu Nhung Phuong","Ma Thuong Thi Huyen","Tran Ngoc Thi Bich","Huynh Hue Thi Thu","Nguyen Ton Dang","Nguyen Duong Thuy","Van Nong Hai","Lee Ming Ta Michael","Nguyen Ha Hai"}	Molecular biology reports	10	\N	\N	2018	29978384	\N	\N	\N	2	f	\N
117005	\N	Genetic polymorphism of cytochrome P450 2C9 in a Caucasian and a black African population.	{"Scordo M G","Aklillu E","Yasar U","Dahl M L","Spina E","Ingelman-Sundberg M"}	British journal of clinical pharmacology	10	\N	\N	2001	11678789	\N	\N	\N	2	f	\N
116635	\N	The largest prospective warfarin-treated cohort supports genetic forecasting.	{"Wadelius Mia","Chen Leslie Y","Lindh Jonatan D","Eriksson Niclas","Ghori Mohammed J R","Bumpstead Suzannah","Holm Lennart","McGinnis Ralph","Rane Anders","Deloukas Panos"}	Blood	1	\N	\N	2009	18574025	\N	\N	\N	2	f	\N
113892	\N	Genetic factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) are predictor variables for warfarin response in very elderly, frail inpatients.	{"Pautas E","Moreau C","Gouin-Thibault I","Golmard J-L","Mahé I","Legendre C","Taillandier-Hériche E","Durand-Gasselin B","Houllier A-M","Verrier P","Beaune P","Loriot M-A","Siguret V"}	Clinical pharmacology and therapeutics	1	\N	\N	2010	19794411	\N	\N	\N	2	f	\N
113897	\N	Warfarin anticoagulant therapy: a Southern Italy pharmacogenetics-based dosing model.	{"Mazzaccara Cristina","Conti Valeria","Liguori Rosario","Simeon Vittorio","Toriello Mario","Severini Angelo","Perricone Corrado","Meccariello Alfonso","Meccariello Pasquale","Vitale Dino Franco","Filippelli Amelia","Sacchetti Lucia"}	PloS one	0	\N	\N	2013	23990957	\N	\N	\N	2	f	\N
117011	\N	The effect of genetic polymorphism of cytochrome P450 CYP2C9 on phenytoin dose requirement.	{"van der Weide J","Steijns L S","van Weelden M J","de Haan K"}	Pharmacogenetics	6	\N	\N	2001	11434505	\N	\N	\N	2	f	\N
117018	\N	Effect of CYP2D6 and CYP2C9 genotypes on fluoxetine and norfluoxetine plasma concentrations during steady-state conditions.	{"LLerena Adrián","Dorado Pedro","Berecz Roland","González Antonio P","Peñas-LLedó Eva M"}	European journal of clinical pharmacology	2	\N	\N	2004	14726986	\N	\N	\N	2	f	\N
117020	\N	The impact of CYP2C9 genetics and oral contraceptives on cytochrome P450 2C9 phenotype.	{"Sandberg Mia","Johansson Inger","Christensen Magnus","Rane Anders","Eliasson Erik"}	Drug metabolism and disposition: the biological fate of chemicals	5	\N	\N	2004	15100169	\N	\N	\N	2	f	\N
117024	\N	Interindividual variability in ibuprofen pharmacokinetics is related to interaction of cytochrome P450 2C8 and 2C9 amino acid polymorphisms.	{"García-Martín Elena","Martínez Carmen","Tabarés Beatriz","Frías Jesús","Agúndez José A G"}	Clinical pharmacology and therapeutics	8	\N	\N	2004	15289789	\N	\N	\N	2	f	\N
117028	\N	Influence of CYP2C9, 2C19 and 2D6 genetic polymorphisms on the steady-state plasma concentrations of the enantiomers of fluoxetine and norfluoxetine.	{"Scordo Maria G","Spina Edoardo","Dahl Marja-Liisa","Gatti Giuliana","Perucca Emilio"}	Basic & clinical pharmacology & toxicology	11	\N	\N	2005	16236141	\N	\N	\N	2	f	\N
117108	\N	Genetic polymorphisms in warfarin and tacrolimus-related genes VKORC1, CYP2C9 and CYP3A5 in the Greek-Cypriot population.	{"Hadjipanagi Despina","Chrysanthou Stephanie","Voskarides Konstantinos","Deltas Constantinos"}	BMC research notes	3	\N	\N	2014	24593903	\N	\N	\N	2	f	\N
117032	\N	Interaction of CYP2C8 and CYP2C9 genotypes modifies the risk for nonsteroidal anti-inflammatory drugs-related acute gastrointestinal bleeding.	{"Blanco Gerardo","Martínez Carmen","Ladero Jose M","Garcia-Martin Elena","Taxonera Carlos","Gamito Francisco G","Diaz-Rubio Manuel","Agundez Jose A G"}	Pharmacogenetics and genomics	1	\N	\N	2008	18216720	\N	\N	\N	2	f	\N
117035	\N	Influence of CYP2C8 and CYP2C9 polymorphisms on pharmacokinetic and pharmacodynamic parameters of racemic and enantiomeric forms of ibuprofen in healthy volunteers.	{"López-Rodríguez Rosario","Novalbos Jesús","Gallego-Sandín Sonia","Román-Martínez Manuel","Torrado Juan","Gisbert Javier P","Abad-Santos Francisco"}	Pharmacological research	7	\N	\N	2008	18694831	\N	\N	\N	2	f	\N
117037	\N	VKORC1 and CYP2C9 allelic variants influence acenocoumarol dose requirements in Greek patients.	{"Markatos Christos N","Grouzi Elissavet","Politou Marianna","Gialeraki Argyri","Merkouri Efrosyni","Panagou Ioannis","Spiliotopoulou Ioanna","Travlou Anthi"}	Pharmacogenomics	11	\N	\N	2008	19018719	\N	\N	\N	2	f	\N
117042	\N	Presence of CYP2C9*3 allele increases risk for hypoglycemia in Type 2 diabetic patients treated with sulfonylureas.	{"Ragia Georgia","Petridis Ioannis","Tavridou Anna","Christakidis Dimitrios","Manolopoulos Vangelis G"}	Pharmacogenomics	11	\N	\N	2009	19891554	\N	\N	\N	2	f	\N
117044	\N	VKORC1 -1639G>A and CYP2C9*3 are the major genetic predictors of phenprocoumon dose requirement.	{"Puehringer Helene","Loreth Ralph M","Klose Gudrun","Schreyer Brigitte","Krugluger Walter","Schneider Barbara","Oberkanins Christian"}	European journal of clinical pharmacology	6	\N	\N	2010	20376629	\N	\N	\N	2	f	\N
117049	\N	Influence of genetic, biological and pharmacological factors on warfarin dose in a Southern Brazilian population of European ancestry.	{"Botton Mariana Rodrigues","Bandinelli Eliane","Rohde Luis Eduardo Paim","Amon Luis Carlos","Hutz Mara Helena"}	British journal of clinical pharmacology	9	\N	\N	2011	21320153	\N	\N	\N	2	f	\N
117051	\N	Lipid-lowering effect of fluvastatin in relation to cytochrome P450 2C9 variant alleles frequently distributed in the Czech population.	{"Buzková Helena","Pechandová Kristina","Danzig Vilém","Vareka Tomá","Perlik Frantisek","Zak Ales","Slanar Ondrej"}	Medical science monitor : international medical journal of experimental and clinical research	8	\N	\N	2012	22847201	\N	\N	\N	2	f	\N
117056	\N	Visual diagnosis: abnormal nails in an infant.	{"Cunningham Natalie P","Green Peter J"}	Pediatrics in review	11	\N	\N	2012	23118323	\N	\N	\N	2	f	\N
117058	\N	Interethnic differences in the relevance of CYP2C9 genotype and environmental factors for diclofenac metabolism in Hispanics from Cuba and Spain.	{"Llerena A","Alvarez M","Dorado P","González I","Peñas-LLedó E","Pérez B","Cobaleda J","Calzadilla L R"}	The pharmacogenomics journal	6	\N	\N	2014	23959274	\N	\N	\N	2	f	\N
117064	\N	Influence of CYP2C9 polymorphism on the fall in International Normalized Ratio in patients interrupting warfarin therapy before elective surgery.	{"Abohelaika S","Wynne H","Avery P","Kamali F"}	Journal of thrombosis and haemostasis : JTH	8	\N	\N	2015	26010205	\N	\N	\N	2	f	\N
117067	\N	The effect of UGT1A9, CYP2B6 and CYP2C9 genes polymorphism on individual differences in propofol pharmacokinetics among Polish patients undergoing general anaesthesia.	{"Mikstacki Adam","Zakerska-Banaszak Oliwia","Skrzypczak-Zielinska Marzena","Tamowicz Barbara","Prendecki Michał","Dorszewska Jolanta","Molinska-Glura Marta","Waszak Malgorzata","Slomski Ryszard"}	Journal of applied genetics	5	\N	\N	2017	27826892	\N	\N	\N	2	f	\N
117069	\N	Role of CYP2C9, CYP2C19 and EPHX Polymorphism in the Pharmacokinetic of Phenytoin: A Study on Uruguayan Caucasian Subjects.	{"Guevara Natalia","Maldonado Cecilia","Uría Manuel","González Raquel","Ibarra Manuel","Alvariza Silvana","Carozzi Antonella","Azambuja Carlos","Fagiolino Pietro","Vázquez Marta"}	Pharmaceuticals (Basel, Switzerland)	8	\N	\N	2017	28820457	\N	\N	\N	2	f	\N
117074	\N	The effect of the cytochrome P450 CYP2C8 polymorphism on the disposition of (R)-ibuprofen enantiomer in healthy subjects.	{"Martínez Carmen","García-Martín Elena","Blanco Gerardo","Gamito Francisco J G","Ladero José M","Agúndez José A G"}	British journal of clinical pharmacology	1	\N	\N	2005	15606441	\N	\N	\N	2	f	\N
117081	\N	Warfarin and acenocoumarol dose requirements according to CYP2C9 genotyping in North-Italian patients.	{"Spreafico M","Peyvandi F","Pizzotti D","Moia M","Mannucci P M"}	Journal of thrombosis and haemostasis : JTH	10	\N	\N	2003	14521618	\N	\N	\N	2	f	\N
117085	\N	The frequency of cytochrome P450 2C9 genetic variants in the Russian population and their associations with individual sensitivity to warfarin therapy.	{"Pchelina Sofya N","Sirotkina Olga V","Taraskina Anastasiya E","Vavilova Tatyana V","Shwarzman Alexander L","Schwartz Eugene I"}	Thrombosis research	0	\N	\N	2005	15617742	\N	\N	\N	2	f	\N
117087	\N	Genetic determinants of acenocoumarol and warfarin maintenance dose requirements in Slavic population: a potential role of CYP4F2 and GGCX polymorphisms.	{"Wypasek Ewa","Branicka Agnieszka","Awsiuk Magdalena","Sadowski Jerzy","Undas Anetta"}	Thrombosis research	9	\N	\N	2014	25042728	\N	\N	\N	2	f	\N
117094	\N	Genetic Polymorphisms of Cytochrome P450 Enzymes and Transport Proteins in a Russian Population and Three Ethnic Groups of Dagestan.	{"Mirzaev Karin B","Sychev Dmitry A","Ryzhikova Kristina A","Konova Olga D","Mammaev Suleiman N","Gafurov Daniyal M","Shuev Grigorij N","Grishina Elena A","Sozaeva Zhannet A"}	Genetic testing and molecular biomarkers	12	\N	\N	2017	29023140	\N	\N	\N	2	f	\N
117099	\N	Genetic polymorphisms of CYP2C9, CYP2C19, and CYP3A5 in Kosovar population.	{"Krasniqi Valon","Dimovski Aleksandar","Bytyqi Hasime Qorraj","Eftimov Aleksandar","Šimičević Livija","Božina Nada"}	Arhiv za higijenu rada i toksikologiju	9	\N	\N	2017	28976882	\N	\N	\N	2	f	\N
114639	\N	Comparison of CYP2C9, CYP2C19, CYP2D6, ABCB1, and SLCO1B1 gene-polymorphism frequency in Russian and Nanai populations.	{"Sychev Dmitrij Alekseevitch","Shuev Grigorij Nikolaevich","Suleymanov Salavat Shejhovich","Ryzhikova Kristina Anatol'evna","Mirzaev Karin Badavievich","Grishina Elena Anatol'evna","Snalina Natalia Evgenievna","Sozaeva Zhannet Alimovna","Grabuzdov Anton Mikhailovich","Matsneva Irina Andreevna"}	Pharmacogenomics and personalized medicine	0	\N	\N	2017	28435307	\N	\N	\N	2	f	\N
117105	\N	Analysis of CYP2C9*2, CYP2C9*3 and VKORC1 -1639 G>A polymorphisms in a population from South-Eastern Europe.	{"Buzoianu Anca D","Trifa Adrian P","Mureşanu Dafin F","Crişan Sorin"}	Journal of cellular and molecular medicine	12	\N	\N	2012	22863573	\N	\N	\N	2	f	\N
117118	\N	CYP2C9 genotype modifies activity of the renin-angiotensin-aldosterone system in hypertensive men.	{"Donner Kati M","Hiltunen Timo P","Suonsyrjä Timo","Hannila-Handelberg Tuula","Tikkanen Ilkka","Antikainen Miia","Hirvonen Ari","Kontula Kimmo"}	Journal of hypertension	10	\N	\N	2009	19593208	\N	\N	\N	2	f	\N
114132	\N	Genetic polymorphisms of drug-metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population.	{"Arvanitidis Kostas","Ragia Georgia","Iordanidou Maria","Kyriaki Sofia","Xanthi Athanasia","Tavridou Anna","Manolopoulos Vangelis G"}	Fundamental & clinical pharmacology	8	\N	\N	2007	17635181	\N	\N	\N	2	f	\N
113905	\N	A Novel Admixture-Based Pharmacogenetic Approach to Refine Warfarin Dosing in Caribbean Hispanics.	{"Duconge Jorge","Ramos Alga S","Claudio-Campos Karla","Rivera-Miranda Giselle","Bermúdez-Bosch Luis","Renta Jessicca Y","Cadilla Carmen L","Cruz Iadelisse","Feliu Juan F","Vergara Cunegundo","Ruaño Gualberto"}	PloS one	0	\N	\N	2016	26745506	\N	\N	\N	2	f	\N
117137	\N	Pharmacogenomics of warfarin dose requirements in Hispanics.	{"Cavallari Larisa H","Momary Kathryn M","Patel Shitalben R","Shapiro Nancy L","Nutescu Edith","Viana Marlos A G"}	Blood cells, molecules & diseases	2	\N	\N	2011	21185752	\N	\N	\N	2	f	\N
117139	\N	CYP2C9 polymorphism in patients with epilepsy: genotypic frequency analyzes and phenytoin adverse reactions correlation.	{"Twardowschy Carlos Alexandre","Werneck Lineu César","Scola Rosana Herminia","De Paola Luciano","Silvado Carlos Eduardo"}	Arquivos de neuro-psiquiatria	4	\N	\N	2011	21537551	\N	\N	\N	2	f	\N
117141	\N	CYP2C9 and VKORC1 polymorphisms influence warfarin dose variability in patients on long-term anticoagulation.	{"Santos Paulo Caleb Junior Lima","Dinardo Carla Luana","Schettert Isolmar Tadeu","Soares Renata Alonso Gadi","Kawabata-Yoshihara Liz","Bensenor Isabela Martins","Krieger José Eduardo","Lotufo Paulo Andrade","Pereira Alexandre Costa"}	European journal of clinical pharmacology	4	\N	\N	2013	22990331	\N	\N	\N	2	f	\N
114506	\N	Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the chilean population: comparison with caucasian and asian populations.	{"Roco Angela","Quiñones Luis","Agúndez José A G","García-Martín Elena","Squicciarini Valentina","Miranda Carla","Garay Joselyn","Farfán Nancy","Saavedra Iván","Cáceres Dante","Ibarra Carol","Varela Nelson"}	Frontiers in genetics	0	\N	\N	2012	23130019	\N	\N	\N	2	f	\N
117149	\N	Prevalence of CYP2C9 variants in the Mexican population.	{"Aguilar Bernardo","Rojas Julio C","Collados Maria T"}	Archives of medical research	5	\N	\N	2008	18375260	\N	\N	\N	2	f	\N
117152	\N	Prevalence of CYP2C9 and VKORC1 alleles in the Argentine population and implications for prescribing dosages of anticoagulants.	{"Scibona P","Redal M A","Garfi L G","Arbelbide J","Argibay P F","Belloso W H"}	Genetics and molecular research : GMR	1	\N	\N	2012	22290467	\N	\N	\N	2	f	\N
114542	\N	Genetic polymorphism of CYP2D6 in Chinese subjects in Malaysia.	{"Ismail R","Teh L K","Amir J","Alwi Z","Lopez C G"}	Journal of clinical pharmacy and therapeutics	8	\N	\N	2003	12911679	\N	\N	\N	2	f	\N
117155	\N	CYP2C9 and CYP2C19 Allele and Haplotype Distributions in Four Mestizo Populations from Western Mexico: An Interethnic Comparative Study.	{"Saldaña-Cruz Ana Miriam","León-Moreno Lilia Carolina","Sánchez-Corona José","Santiago Daniel Alejandro Márquez-de","Mendoza-Carrera Francisco","Castro-Martínez Xochitl Helga","García-Zapién Alejandra Guadalupe","Morán-Moguel María Cristina","Flores-Martínez Silvia Esperanza"}	Genetic testing and molecular biomarkers	11	\N	\N	2016	27617498	\N	\N	\N	2	f	\N
117162	\N	Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.	{"Shahin Mohamed Hossam A","Khalifa Sherief I","Gong Yan","Hammad Lamiaa N","Sallam Mohamed T H","El Shafey Mostafa","Ali Shawky S","Mohamed Mohamed-Eslam F","Langaee Taimour","Johnson Julie A"}	Pharmacogenetics and genomics	3	\N	\N	2011	21228733	\N	\N	\N	2	f	\N
117164	\N	Effect of different genetics variants: CYP2C9*2, CYP2C9*3 of cytochrome P-450 CYP2C9 and 1639G>A of the VKORC1 gene; On acenocoumarol requirement in Moroccan patients.	{"Smires F Z","Habbal R","Moreau C","Assaidi A","Loriot M A","Nadifi S"}	Pathologie-biologie	6	\N	\N	2013	23201087	\N	\N	\N	2	f	\N
117168	\N	Characterization of drug-metabolizing enzymes CYP2C9, CYP2C19 polymorphisms in Tunisian, Kuwaiti and Bahraini populations.	{"Abdelhedi Rania","Bouayed Nouha Abdelmoula","Alfadhli Suad","Abid Leila","Rebai Ahmed","Kharrat Najla"}	Journal of genetics	12	\N	\N	2015	26690534	\N	\N	\N	2	f	\N
117170	\N	Genetic Polymorphism of Drug-Metabolizing Enzymes CYP2C9 and CYP2C19 in Moroccan Population.	{"Afilal Driss","Basselam Mohamed Amine","Brakez Zahra","Chouham Said","Brehm António","Izaabel El Hassan"}	Genetic testing and molecular biomarkers	5	\N	\N	2017	28282224	\N	\N	\N	2	f	\N
117172	\N	Frequency of CYP2C9 and VKORC1 gene polymorphisms and their influence on warfarin dose in Egyptian pediatric patients.	{"Kamal El-Din Mennat-Allah","Farhan Marwa Salah","El Shiha Randa Ibrahim","El-Kaffas Rania Mohammed Helmy","Mousa Somaia Mohammed"}	Paediatric drugs	8	\N	\N	2014	24797541	\N	\N	\N	2	f	\N
113908	\N	Warfarin pharmacogenetics: polymorphisms of the CYP2C9, CYP4F2, and VKORC1 loci in a genetically admixed Omani population.	{"Pathare Anil V","Al Zadjali Shoaib","Misquith Rhea","Alkindi Salam S","Panjwani Vinodh","Lapoumeroulie Claudine","Pravin Sahaya","Paldi Andras","Krishnamoorthy Rajagopal"}	Human biology	2	\N	\N	2012	22452429	\N	\N	\N	2	f	\N
116645	\N	Pharmacogenetics of coumarin dosing: prevalence of CYP2C9 and VKORC1 polymorphisms in the Lebanese population.	{"Djaffar-Jureidini Isabelle","Chamseddine Nabil","Keleshian Sose","Naoufal Rania","Zahed Laila","Hakime Noha"}	Genetic testing and molecular biomarkers	11	\N	\N	2011	21651319	\N	\N	\N	2	f	\N
116649	\N	Identification of CYP2C9 and VKORC1 polymorphisms in Iranian patients who are under warfarin therapy.	{"Poopak Behzad","Rabieipoor Saghar","Safari Nazila","Naraghi Emadedin","Sheikhsofla Fatemeh","Khosravipoor Gelareh"}	International journal of hematology-oncology and stem cell research	10	\N	\N	2015	26865929	\N	\N	\N	2	f	\N
117187	\N	Allele frequency of CYP2C9 gene polymorphisms in Iran.	{"Peyvandi F","Spreafico M","Karimi M","Zeinali S","Mannucci P M","Bianchi Bonomi A"}	Thrombosis and haemostasis	11	\N	\N	2002	12428110	\N	\N	\N	2	f	\N
116651	\N	Genotyping of CYP2C9 and VKORC1 in the Arabic population of Al-Ahsa, Saudi Arabia.	{"Alzahrani Abdullah M","Ragia Georgia","Hanieh Hamza","Manolopoulos Vangelis G"}	BioMed research international	0	\N	\N	2013	23586031	\N	\N	\N	2	f	\N
116657	\N	Warfarin pharmacogenetics: CYP2C9 and VKORC1 genotypes predict different sensitivity and resistance frequencies in the Ashkenazi and Sephardi Jewish populations.	{"Scott Stuart A","Edelmann Lisa","Kornreich Ruth","Desnick Robert J"}	American journal of human genetics	2	\N	\N	2008	18252229	\N	\N	\N	2	f	\N
117197	\N	CYP2C9 genetic variants and losartan oxidation in a Turkish population.	{"Babaoglu Melih O","Yasar Umit","Sandberg Mia","Eliasson Erik","Dahl Marja-Liisa","Kayaalp S Oguz","Bozkurt Atila"}	European journal of clinical pharmacology	7	\N	\N	2004	15197523	\N	\N	\N	2	f	\N
117199	\N	The effect of CYP2C9 and VKORC1 genetic polymorphisms on warfarin dose requirements in a pediatric population.	{"Dilge Taşkın Birce","Kula Serdar","Ergün Mehmet Ali","Altun Demet","Olguntürk Rana","Tunaoğlu Fatma Sedef","Oğuz Ayşe Deniz","Gürsel Türkiz"}	Anatolian journal of cardiology	10	\N	\N	2016	27182616	\N	\N	\N	2	f	\N
117210	\N	The prevalence of VKORC1 1639 G>A and CYP2C9*2*3 genotypes in patients that requiring anticoagulant therapy in Turkish population.	{"Silan Coskun","Dogan Omer Tamer","Silan Fatma","Kukulguven Fatma Mutlu","Asgun Halil Fatih","Ozdemir Semra","Uludag Ahmet","Atik Sinem","Gungor Buket","Akdur Seçil","Aksulu Hakki Engin","Ozdemir Oztürk"}	Molecular biology reports	12	\N	\N	2012	23065265	\N	\N	\N	2	f	\N
117212	\N	Lower CYP2C9 activity in Turkish patients with Behçet's disease compared to healthy subjects: a down-regulation due to inflammation?	{"Goktaş Mustafa Tugrul","Hatta Fazleen","Karaca Ozgur","Kalkisim Said","Kilic Levent","Akdogan Ali","Babaoglu Melih O","Bozkurt Atilla","Helldén Anders","Bertilsson Leif","Yasar Umit"}	European journal of clinical pharmacology	10	\N	\N	2015	26233334	\N	\N	\N	2	f	\N
114806	\N	CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population.	{"Scott Stuart A","Edelmann Lisa","Kornreich Ruth","Erazo Monica","Desnick Robert J"}	Pharmacogenomics	7	\N	\N	2007	18240905	\N	\N	\N	2	f	\N
117232	\N	VKORC1 Asp36Tyr warfarin resistance marker is common in Ethiopian individuals.	{"Aklillu Eleni","Leong Cheryl","Loebstein Ronen","Halkin Hillel","Gak Eva"}	Blood	4	\N	\N	2008	18362220	\N	\N	\N	2	f	\N
117238	\N	Effects of genetic variation at the CYP2C19/CYP2C9 locus on pharmacokinetics of chlorcycloguanil in adult Gambians.	{"Janha Ramatoulie E","Sisay-Joof Fatoumatta","Hamid-Adiamoh Majidah","Worwui Archibald","Chapman Hannah L","Opara Hyginus","Dunyo Sam","Milligan Paul","Rockett Kirk","Winstanley Peter","Pirmohamed Munir","Miller Ann K","Conway David J","Walton Robert T"}	Pharmacogenomics	9	\N	\N	2009	19761366	\N	\N	\N	2	f	\N
117241	\N	Genetic polymorphisms of patients on stable warfarin maintenance therapy in a Ghanaian population.	{"Kudzi William","Ahorhorlu Samuel Yao","Dzudzor Bartholomew","Olayemi Edeghonghon","Nartey Edmund Tetteh","Asmah Richard Harry"}	BMC research notes	12	\N	\N	2016	27938396	\N	\N	\N	2	f	\N
114363	\N	CYP2D6 phenotype-genotype relationships in African-Americans and Caucasians in Los Angeles.	{"Leathart J B","London S J","Steward A","Adams J D","Idle J R","Daly A K"}	Pharmacogenetics	12	\N	\N	1998	9918137	\N	\N	\N	2	f	\N
114369	\N	Discovery of a novel nonfunctional cytochrome P450 2D6 allele, CYP2D642, in African American subjects.	{"Gaedigk Andrea","Ndjountché Liliane","Gaedigk Roger","Leeder J Steven","Bradford L DiAnne"}	Clinical pharmacology and therapeutics	6	\N	\N	2003	12811367	\N	\N	\N	2	f	\N
114371	\N	Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans.	{"Gaedigk A","Bhathena A","Ndjountché L","Pearce R E","Abdel-Rahman S M","Alander S W","Bradford L DiAnne","Rogan P K","Leeder J Steven"}	The pharmacogenomics journal	0	\N	\N	2005	15768052	\N	\N	\N	2	f	\N
114373	\N	Limited association of the 2988g > a single nucleotide polymorphism with CYP2D641 in black subjects.	{"Gaedigk Andrea","Ndjountché Liliane","Leeder J Steven","Bradford L Dianne"}	Clinical pharmacology and therapeutics	3	\N	\N	2005	15735618	\N	\N	\N	2	f	\N
114379	\N	CYP2D6*36 gene arrangements within the cyp2d6 locus: association of CYP2D6*36 with poor metabolizer status.	{"Gaedigk Andrea","Bradford L Dianne","Alander Sarah W","Leeder J Steven"}	Drug metabolism and disposition: the biological fate of chemicals	4	\N	\N	2006	16415111	\N	\N	\N	2	f	\N
114381	\N	Cytochrome P4502D6 (CYP2D6) gene locus heterogeneity: characterization of gene duplication events.	{"Gaedigk A","Ndjountché L","Divakaran K","Dianne Bradford L","Zineh I","Oberlander T F","Brousseau D C","McCarver D G","Johnson J A","Alander S W","Wayne Riggs K","Steven Leeder J"}	Clinical pharmacology and therapeutics	2	\N	\N	2007	17259947	\N	\N	\N	2	f	\N
114385	\N	Identification and characterization of CYP2D6*56B, an allele associated with the poor metabolizer phenotype.	{"Gaedigk A","Eklund J D","Pearce R E","Leeder J S","Alander S W","Phillips M S","Bradford L D","Kennedy M J"}	Clinical pharmacology and therapeutics	6	\N	\N	2007	17392730	\N	\N	\N	2	f	\N
114391	\N	Discovery of the nonfunctional CYP2D6 31 allele in Spanish, Puerto Rican, and US Hispanic populations.	{"Gaedigk Andrea","Isidoro-García Maria","Pearce Robin E","Sánchez Santiago","García-Solaesa Virginia","Lorenzo-Romo Carolina","Gonzalez-Tejera Gloria","Corey Susan"}	European journal of clinical pharmacology	9	\N	\N	2010	20473659	\N	\N	\N	2	f	\N
114393	\N	Cytochrome P450 2D6 polymorphisms and predicted opioid metabolism in African American children with sickle cell disease.	{"Yee Marianne M","Josephson Cassandra","Hill Charles E","Harrington Rosiland","Castillejo Marta-Inés","Ramjit Ruan","Osunkwo Ifeyinwa"}	Journal of pediatric hematology/oncology	10	\N	\N	2013	23619115	\N	\N	\N	2	f	\N
114397	\N	CYP2D6 and CYP2C19 genotyping in psychiatric patients on psychotropic medication in the former Dutch Antilles.	{"Koopmans Anne B","Vinkers David J","Gelan Petra Ja","Hoek Hans W","van Harten Peter N"}	Pharmacogenomics	7	\N	\N	2017	28639468	\N	\N	\N	2	f	\N
114402	\N	Ethnic background and CYP2D6 genetic polymorphisms in Costa Ricans.	{"Céspedes-Garro Carolina","Jiménez-Arce Gerardo","Naranjo María-Eugenia G","Barrantes Ramiro","Llerena Adrián","CEIBA.FP Consortium of the Ibero-American Network of Pharmacogenetics & Pharmacogenomics RIBEF"}	Revista de biologia tropical	12	\N	\N	2014	25720195	\N	\N	\N	2	f	\N
114495	\N	Identification of CYP2D6 impaired functional alleles in Mexican Americans.	{"Luo Huai-Rong","Gaedigk Andrea","Aloumanis Vasileios","Wan Yu-Jui Yvonne"}	European journal of clinical pharmacology	12	\N	\N	2005	16283274	\N	\N	\N	2	f	\N
114404	\N	Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military Population.	{"Spring Michele D","Sousa Jason C","Li Qigui","Darko Christian A","Morrison Meshell N","Marcsisin Sean R","Mills Kristin T","Potter Brittney M","Paolino Kristopher M","Twomey Patrick S","Moon James E","Tosh Donna M","Cicatelli Susan B","Froude Jeffrey W","Pybus Brandon S","Oliver Thomas G","McCarthy William F","Waters Norman C","Smith Philip L","Reichard Gregory A","Bennett Jason W"}	The Journal of infectious diseases	10	\N	\N	2019	31549155	\N	\N	\N	2	f	\N
114408	\N	Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes in a Brazilian population.	{"Silveira Vanessa Da Silva","Canalle Renata","Scrideli Carlos Alberto","Queiroz Rosane Gomes de Paula","Tone Luiz Gonzaga"}	Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals	3	\N	\N	2009	19330589	\N	\N	\N	2	f	\N
114412	\N	Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles.	{"Aklillu E","Persson I","Bertilsson L","Johansson I","Rodrigues F","Ingelman-Sundberg M"}	The Journal of pharmacology and experimental therapeutics	7	\N	\N	1996	8764380	\N	\N	\N	2	f	\N
114417	\N	Analysis of the CYP2D6 gene mutations and their consequences for enzyme function in a West African population.	{"Griese E U","Asante-Poku S","Ofori-Adjei D","Mikus G","Eichelbaum M"}	Pharmacogenetics	12	\N	\N	1999	10634134	\N	\N	\N	2	f	\N
114419	\N	Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern Africa.	{"Awandu Shehu S","Raman Jaishree","Makhanthisa Takalani I","Kruger Philip","Frean John","Bousema Teun","Niemand Jandeli","Birkholtz Lyn-Marie"}	Malaria journal	3	\N	\N	2018	29558929	\N	\N	\N	2	f	\N
114428	\N	Decreased capacity for debrisoquine metabolism among black Tanzanians: analyses of the CYP2D6 genotype and phenotype.	{"Wennerholm A","Johansson I","Massele A Y","Lande M","Alm C","Aden-Abdi Y","Dahl M L","Ingelman-Sundberg M","Bertilsson L","Gustafsson L L"}	Pharmacogenetics	12	\N	\N	1999	10634133	\N	\N	\N	2	f	\N
114430	\N	Characterization of the CYP2D6*29 allele commonly present in a black Tanzanian population causing reduced catalytic activity.	{"Wennerholm A","Johansson I","Hidestrand M","Bertilsson L","Gustafsson L L","Ingelman-Sundberg M"}	Pharmacogenetics	7	\N	\N	2001	11470994	\N	\N	\N	2	f	\N
114432	\N	Elucidation of CYP2D6 genetic diversity in a unique African population: implications for the future application of pharmacogenetics in the Xhosa population.	{"Wright Galen E B","Niehaus Dana J H","Drögemöller Britt I","Koen Liezl","Gaedigk Andrea","Warnich Louise"}	Annals of human genetics	7	\N	\N	2010	20597905	\N	\N	\N	2	f	\N
114437	\N	Tiron protects against nicotine-induced lung and liver injury through antioxidant and anti-inflammatory actions in rats in vivo.	{"Khaled Shimaa","Makled Mirhan N","Nader Manar A"}	Life sciences	9	\N	\N	2020	32937159	\N	\N	\N	2	f	\N
114544	\N	Frequency of CYP2D6*10 and *14 alleles and their influence on the metabolic activity of CYP2D6 in a healthy Chinese population.	{"Cai W M","Chen B","Zhang W X"}	Clinical pharmacology and therapeutics	1	\N	\N	2007	17186005	\N	\N	\N	2	f	\N
114442	\N	Cytochrome P450 Genetic Variation Associated with Tamoxifen Biotransformation in American Indian and Alaska Native People.	{"Khan Burhan A","Robinson Renee","Fohner Alison E","Muzquiz LeeAnna I","Schilling Brian D","Beans Julie A","Olnes Matthew J","Trawicki Laura","Frydenlund Holly","Laukes Cindi","Beatty Patrick","Phillips Brian","Nickerson Deborah","Howlett Kevin","Dillard Denise A","Thornton Timothy A","Thummel Kenneth E","Woodahl Erica L"}	Clinical and translational science	2	\N	\N	2018	29436156	\N	\N	\N	2	f	\N
114447	\N	Allele and genotype frequencies of metabolic genes in Native Americans from Argentina and Paraguay.	{"Bailliet G","Santos M R","Alfaro E L","Dipierri J E","Demarchi D A","Carnese F R","Bianchi N O"}	Mutation research	3	\N	\N	2007	17194620	\N	\N	\N	2	f	\N
114449	\N	CYP2D6-related oxidation polymorphism in a Canadian Inuit population.	{"Jurima-Romet M","Foster B C","Casley W L","Rode A","Vloshinsky P","Huang H S","Geertsen S"}	Canadian journal of physiology and pharmacology	3	\N	\N	1997	9164697	\N	\N	\N	2	f	\N
114454	\N	Genetic polymorphisms of CYP2D6, CYP1A1 and CYP2E1 in the South-Amerindian population of Chile.	{"Muñoz S","Vollrath V","Vallejos M P","Miquel J F","Covarrubias C","Raddatz A","Chianale J"}	Pharmacogenetics	8	\N	\N	1998	9731721	\N	\N	\N	2	f	\N
114459	\N	Resequencing, haplotype construction and identification of novel variants of CYP2D6 in Mexican Mestizos.	{"Contreras Alejandra V","Monge-Cazares Tulia","Alfaro-Ruiz Luis","Hernandez-Morales Salvador","Miranda-Ortiz Haydee","Carrillo-Sanchez Karol","Jimenez-Sanchez Gerardo","Silva-Zolezzi Irma"}	Pharmacogenomics	5	\N	\N	2011	21391885	\N	\N	\N	2	f	\N
114468	\N	CYP2D6 genetic polymorphisms in Southern Mexican Mayan Lacandones and Mestizos from Chiapas.	{"López-López Marisol","Peñas-Lledó Eva","Dorado Pedro","Ortega Alberto","Corona Teresa","Ochoa Adriana","Yescas Petra","Alonso Elisa","LLerena Adrián"}	Pharmacogenomics	0	\N	\N	2014	25495408	\N	\N	\N	2	f	\N
114470	\N	CYP2D6 genotype and phenotype in Amerindians of Tepehuano origin and Mestizos of Durango, Mexico.	{"Sosa-Macías Martha","Elizondo Guillermo","Flores-Pérez Carmen","Flores-Pérez Janet","Bradley-Alvarez Francisco","Alanis-Bañuelos Ruth E","Lares-Asseff Ismael"}	Journal of clinical pharmacology	5	\N	\N	2006	16638736	\N	\N	\N	2	f	\N
114477	\N	Comparative evolutionary pharmacogenetics of CYP2D6 in Ngawbe and Embera Amerindians of Panama and Colombia: role of selection versus drift in world populations.	{"Jorge L F","Eichelbaum M","Griese E U","Inaba T","Arias T D"}	Pharmacogenetics	4	\N	\N	1999	10376769	\N	\N	\N	2	f	\N
114480	\N	CYP2D6 gene variants in urban/admixed and Amerindian populations of Venezuela: pharmacogenetics and anthropological implications.	{"Griman Pedro","Moran Yeinmy","Valero Gabriela","Loreto Mariana","Borjas Lisbeth","Chiurillo Miguel A"}	Annals of human biology	3	\N	\N	2012	22324840	\N	\N	\N	2	f	\N
114488	\N	Allelic variants of the CYP2D6: *4, *6 and *10 in a sample of resident from the Aragua state, Venezuela.	{"Flores-Angulo Carlos","Villegas Cecilia","Mora Yuselin","Martínez José Antonio","Oropeza Teresa","Moreno Nancy"}	Revista peruana de medicina experimental y salud publica	10	\N	\N	2015	26732924	\N	\N	\N	2	f	\N
114499	\N	Polymorphisms of xenobiotic metabolizing enzymes and DNA repair genes and outcome in childhood acute lymphoblastic leukemia.	{"da Silva Silveira Vanessa","Canalle Renata","Scrideli Carlos Alberto","Queiroz Rosane Gomes de Paula","Bettiol Heloisa","Valera Elvis Terci","Tone Luiz Gonzaga"}	Leukemia research	7	\N	\N	2009	19162321	\N	\N	\N	2	f	\N
114502	\N	Endoxifen levels and its association with CYP2D6 genotype and phenotype: evaluation of a southern Brazilian population under tamoxifen pharmacotherapy.	{"Antunes Marina V","Linden Rafael","Santos Tamyris V","Wallemacq Pierre","Haufroid Vincent","Classen Jean-François","Andreolla Huander","Costa Nathalia","Fontanive Tiago O","Rosa Daniela D"}	Therapeutic drug monitoring	8	\N	\N	2012	22777153	\N	\N	\N	2	f	\N
114504	\N	Distribution of CYP2D6 alleles and phenotypes in the Brazilian population.	{"Friedrich Deise C","Genro Júlia P","Sortica Vinicius A","Suarez-Kurtz Guilherme","de Moraes Maria Elizabete","Pena Sergio D J","dos Santos Andrea K Ribeiro","Romano-Silva Marco A","Hutz Mara H"}	PloS one	0	\N	\N	2014	25329392	\N	\N	\N	2	f	\N
114508	\N	Characterization of the CYP2D6 drug metabolizing phenotypes of the Chilean mestizo population through polymorphism analyses.	{"Varela Nelson","Quiñones Luis A","Stojanova Jana","Garay Joselyn","Cáceres Dante","Cespedes Silvia","Sasso Jaime","Miranda Carla"}	Pharmacological research	11	\N	\N	2015	26211952	\N	\N	\N	2	f	\N
114513	\N	Isolation, sequence and genotyping of the drug metabolizer CYP2D6 gene in the Colombian population.	{"Isaza C A","Henao J","López A M","Cacabelos R"}	Methods and findings in experimental and clinical pharmacology	11	\N	\N	2000	11294012	\N	\N	\N	2	f	\N
114517	\N	CYP2D6 genotype and debrisoquine hydroxylation phenotype in Cubans and Nicaraguans.	{"Llerena A","Dorado P","Ramírez R","González I","Alvarez M","Peñas-Lledó E M","Pérez B","Calzadilla L R"}	The pharmacogenomics journal	4	\N	\N	2012	21135868	\N	\N	\N	2	f	\N
114519	\N	Lessons from Cuba for Global Precision Medicine: CYP2D6 Genotype Is Not a Robust Predictor of CYP2D6 Ultrarapid Metabolism.	{"Dorado Pedro","González Idilio","Naranjo María Eugenia G","de Andrés Fernando","Peñas-Lledó Eva María","Calzadilla Luis Ramón","LLerena Adrián"}	Omics : a journal of integrative biology	1	\N	\N	2017	28271978	\N	\N	\N	2	f	\N
114523	\N	CYP2D6 genotype and phenotype determination in a Mexican Mestizo population.	{"López Marisol","Guerrero Jorge","Jung-Cook Helgi","Alonso María Elisa"}	European journal of clinical pharmacology	11	\N	\N	2005	16249913	\N	\N	\N	2	f	\N
114533	\N	Symptomatic and urodynamic responses in patients with reduced or no seminal emission during silodosin treatment for LUTS and BPH.	{"Roehrborn C G","Kaplan S A","Lepor H","Volinn W"}	Prostate cancer and prostatic diseases	6	\N	\N	2011	21135869	\N	\N	\N	2	f	\N
114535	\N	Physiogenomic analysis of the Puerto Rican population.	{"Ruaño Gualberto","Duconge Jorge","Windemuth Andreas","Cadilla Carmen L","Kocherla Mohan","Villagra David","Renta Jessica","Holford Theodore","Santiago-Borrero Pedro J"}	Pharmacogenomics	4	\N	\N	2009	19374515	\N	\N	\N	2	f	\N
114546	\N	Allelic distributions of CYP2D6 gene copy number variation in the Eastern Han Chinese population.	{"Sheng Hai-hui","Zeng Ai-ping","Zhu Wen-xiang","Zhu Ren-fang","Li Hong-mei","Zhu Zhi-dong","Qin Ying","Jin Wei","Liu Yan","Du Yun-lan","Sun Jian","Xiao Hua-sheng"}	Acta pharmacologica Sinica	2	\N	\N	2007	17241532	\N	\N	\N	2	f	\N
114556	\N	Robust CYP2D6 genotype assay including copy number variation using multiplex single-base extension for Asian populations.	{"Kim Eun-Young","Lee Sang-Seop","Jung Hyun-Ju","Jung Hye-Eun","Yeo Chang-Woo","Shon Ji-Hong","Shin Jae-Gook"}	Clinica chimica acta; international journal of clinical chemistry	12	\N	\N	2010	20828547	\N	\N	\N	2	f	\N
114563	\N	Statin therapy correlated CYP2D6 gene polymorphism and hyperlipidemia.	{"Li Juyi","Wang Xiufang","Zhang Zhaoqing","Zou Jili","Chen Yonggang","Wang Xiong","Wu Jinhu"}	Current medical research and opinion	2	\N	\N	2014	24156754	\N	\N	\N	2	f	\N
114565	\N	Korean, Japanese, and Chinese populations featured similar genes encoding drug-metabolizing enzymes and transporters: a DMET Plus microarray assessment.	{"Yi SoJeong","An Hyungmi","Lee Howard","Lee Sangin","Ieiri Ichiro","Lee Youngjo","Cho Joo-Youn","Hirota Takeshi","Fukae Masato","Yoshida Kenji","Nagatsuka Shinichiro","Kimura Miyuki","Irie Shin","Sugiyama Yuichi","Shin Dong Wan","Lim Kyoung Soo","Chung Jae-Yong","Yu Kyung-Sang","Jang In-Jin"}	Pharmacogenetics and genomics	10	\N	\N	2014	25029633	\N	\N	\N	2	f	\N
114572	\N	Genetic variations of human CYP2D6 in the Chinese Han population.	{"Qian Jian-Chang","Xu Xin-Min","Hu Guo-Xin","Dai Da-Peng","Xu Ren-Ai","Hu Li-Ming","Li Fang-Hong","Zhang Xiu-Hua","Yang Jie-Fu","Cai Jian-Ping"}	Pharmacogenomics	11	\N	\N	2013	24192122	\N	\N	\N	2	f	\N
114578	\N	CYP2D6 genotypes, endoxifen levels, and disease recurrence in 224 Filipino and Vietnamese women receiving adjuvant tamoxifen for operable breast cancer.	{"Love Richard R","Desta Zuerenesay","Flockhart David","Skaar Todd","Ogburn Evan T","Ramamoorthy Anuradha","Uy Gemma B","Laudico Adriano V","Van Dinh Nguyen","Quang Le Hong","Van To Ta","Young Gregory S","Hade Erinn","Jarjoura David"}	SpringerPlus	12	\N	\N	2013	23476897	\N	\N	\N	2	f	\N
114582	\N	Analysis of the CYP2D6 gene in relation to dextromethorphan O-demethylation capacity in a Japanese population.	{"Tateishi T","Chida M","Ariyoshi N","Mizorogi Y","Kamataki T","Kobayashi S"}	Clinical pharmacology and therapeutics	5	\N	\N	1999	10340923	\N	\N	\N	2	f	\N
114584	\N	Frequencies of CYP2D6 mutant alleles in a normal Japanese population and metabolic activity of dextromethorphan O-demethylation in different CYP2D6 genotypes.	{"Kubota T","Yamaura Y","Ohkawa N","Hara H","Chiba K"}	British journal of clinical pharmacology	7	\N	\N	2000	10886115	\N	\N	\N	2	f	\N
114588	\N	New allelic arrangement CYP2D6*36 x 2 found in a Japanese poor metabolizer of debrisoquine.	{"Chida Michihiro","Ariyoshi Noritaka","Yokoi Tsuyoshi","Nemoto Nobuo","Inaba Makoto","Kinoshita Moritoshi","Kamataki Tetsuya"}	Pharmacogenetics	11	\N	\N	2002	12439227	\N	\N	\N	2	f	\N
114592	\N	Two novel haplotypes of CYP2D6 gene in a Japanese population.	{"Yamazaki Hiroshi","Kiyotani Kazuma","Tsubuko Satoshi","Matsunaga Masayuki","Fujieda Masaki","Saito Tetsuya","Miura Jun","Kobayashi Shinichi","Kamataki Tetsuya"}	Drug metabolism and pharmacokinetics	0	\N	\N	2003	15618746	\N	\N	\N	2	f	\N
114594	\N	Novel nonsynonymous single nucleotide polymorphisms in the CYP2D6 gene.	{"Soyama Akiko","Kubo Takashi","Miyajima Atsuko","Saito Yoshiro","Shiseki Kisho","Komamura Kazuo","Ueno Kazuyuki","Kamakura Shiro","Kitakaze Masafumi","Tomoike Hitonobu","Ozawa Shogo","Sawada Jun-ichi"}	Drug metabolism and pharmacokinetics	8	\N	\N	2004	15499201	\N	\N	\N	2	f	\N
114598	\N	The frequency of candidate alleles for CYP2D6 genotyping in the Japanese population with an additional respect to the -1584C to G substitution.	{"Ikenaga Yuka","Fukuda Tsuyoshi","Fukuda Kazuhiro","Nishida Yuko","Naohara Masakazu","Maune Hiromi","Azuma Junichi"}	Drug metabolism and pharmacokinetics	4	\N	\N	2005	15855722	\N	\N	\N	2	f	\N
114603	\N	CYP2D6 genotyping for functional-gene dosage analysis by allele copy number detection.	{"Hosono Naoya","Kato Mamoru","Kiyotani Kazuma","Mushiroda Taisei","Takata Sadaaki","Sato Hiroko","Amitani Hanae","Tsuchiya Yumiko","Yamazaki Keiko","Tsunoda Tatsuhiko","Zembutsu Hitoshi","Nakamura Yusuke","Kubo Michiaki"}	Clinical chemistry	8	\N	\N	2009	19541866	\N	\N	\N	2	f	\N
114605	\N	Limited effects of frequent CYP2D6*36-*10 tandem duplication allele on in vivo dextromethorphan metabolism in a Japanese population.	{"Kiyotani Kazuma","Shimizu Makiko","Kumai Toshio","Kamataki Tetsuya","Kobayashi Shinichi","Yamazaki Hiroshi"}	European journal of clinical pharmacology	10	\N	\N	2010	20700584	\N	\N	\N	2	f	\N
114607	\N	Significant effect of polymorphisms in CYP2D6 and ABCC2 on clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients.	{"Kiyotani Kazuma","Mushiroda Taisei","Imamura Chiyo K","Hosono Naoya","Tsunoda Tatsuhiko","Kubo Michiaki","Tanigawara Yusuke","Flockhart David A","Desta Zeruesenay","Skaar Todd C","Aki Fuminori","Hirata Koichi","Takatsuka Yuichi","Okazaki Minoru","Ohsumi Shozo","Yamakawa Takashi","Sasa Mitsunori","Nakamura Yusuke","Zembutsu Hitoshi"}	Journal of clinical oncology : official journal of the American Society of Clinical Oncology	3	\N	\N	2010	20124171	\N	\N	\N	2	f	\N
114615	\N	Association between cytochrome P450 2D6 polymorphisms and body fluid methamphetamine concentrations in Japanese forensic autopsy cases.	{"Matsusue Aya","Ikeda Tomoya","Tani Naoto","Waters Brian","Hara Kenji","Kashiwagi Masayuki","Takayama Mio","Ikematsu Natsuki","Kubo Shin-Ichi","Ishikawa Takaki"}	Forensic science international	8	\N	\N	2018	29843110	\N	\N	\N	2	f	\N
114618	\N	Real time PCR detection of common CYP2D6 genetic variants and its application in a Karen population study.	{"Puaprasert Kanokpich","Chu Cindy","Saralamba Naowarat","Day Nicholas P J","Nosten Francois","White Nicholas J","Dondorp Arjen M","Imwong Mallika"}	Malaria journal	11	\N	\N	2018	30442143	\N	\N	\N	2	f	\N
114623	\N	Discovery of novel functional variants and extensive evaluation of CYP2D6 genetic polymorphisms in Koreans.	{"Lee Su-Jun","Lee Sang Seop","Jung Hyun-Ju","Kim Ho-Sook","Park Soo-Jin","Yeo Chang-Woo","Shin Jae-Gook"}	Drug metabolism and disposition: the biological fate of chemicals	7	\N	\N	2009	19364831	\N	\N	\N	2	f	\N
114815	\N	Frequencies of three CYP2D6 nonfunctional alleles (CYP2D6*3, *4, and *6) within an Iranian population (Mazandaran).	{"Hashemi-Soteh Seyed Mohammad Bagher","Sarzare Fatemeh","Merat Fatemeh","Salehifar Ebrahim","Shiran Mohammad-Reza"}	Genetic testing and molecular biomarkers	11	\N	\N	2011	21631295	\N	\N	\N	2	f	\N
114630	\N	CYP2D6 allele frequencies in Korean population, comparison with East Asian, Caucasian and African populations, and the comparison of metabolic activity of CYP2D6 genotypes.	{"Byeon Ji-Young","Kim Young-Hoon","Lee Choong-Min","Kim Se-Hyung","Chae Won-Ki","Jung Eui-Hyun","Choi Chang-Ik","Jang Choon-Gon","Lee Seok-Yong","Bae Jung-Woo","Lee Yun Jeong"}	Archives of pharmacal research	9	\N	\N	2018	30191460	\N	\N	\N	2	f	\N
114632	\N	Heterogeneity of the CYP2D6 gene among Malays in Malaysia.	{"Teh L K","Ismail R","Yusoff R","Hussein A","Isa M N","Rahman A R"}	Journal of clinical pharmacy and therapeutics	6	\N	\N	2001	11422605	\N	\N	\N	2	f	\N
114641	\N	Combination of multiplex PCR and DHPLC-based strategy for CYP2D6 genotyping scheme in Thais.	{"Suwannasri Payiarat","Thongnoppakhun Wanna","Pramyothin Pornpen","Assawamakin Anunchai","Limwongse Chanin"}	Clinical biochemistry	9	\N	\N	2011	21763299	\N	\N	\N	2	f	\N
114643	\N	Association of CYP2D6 and CYP2C19 polymorphisms and disease-free survival of Thai post-menopausal breast cancer patients who received adjuvant tamoxifen.	{"Chamnanphon Montri","Pechatanan Khunthong","Sirachainan Ekapob","Trachu Narumol","Chantratita Wasun","Pasomsub Ekawat","Noonpakdee Wilai","Sensorn Insee","Sukasem Chonlaphat"}	Pharmacogenomics and personalized medicine	0	\N	\N	2013	23776391	\N	\N	\N	2	f	\N
312209	\N	Comparison of genetic variation in drug ADME-related genes in Thais with Caucasian, African and Asian HapMap populations.	{"Jittikoon Jiraphun","Mahasirimongkol Surakameth","Charoenyingwattana Angkana","Chaikledkaew Usa","Tragulpiankit Pramote","Mangmool Supachoke","Inunchot Wimala","Somboonyosdes Chayapol","Wichukchinda Nuanjun","Sawanpanyalert Pathom","He Yijing","McLeod Howard L","Chantratita Wasun"}	Journal of human genetics	2	\N	\N	2016	26423926	\N	\N	\N	2	f	\N
114647	\N	Detection of CYP2D6 polymorphism using Luminex xTAG technology in autism spectrum disorder: CYP2D6 activity score and its association with risperidone levels.	{"Vanwong Natchaya","Ngamsamut Nattawat","Hongkaew Yaowaluck","Nuntamool Nopphadol","Puangpetch Apichaya","Chamnanphon Montri","Sinrachatanant Ananya","Limsila Penkhae","Sukasem Chonlaphat"}	Drug metabolism and pharmacokinetics	4	\N	\N	2016	26944100	\N	\N	\N	2	f	\N
114649	\N	Impact of CYP2D6 Polymorphism on Steady-State Plasma Levels of Risperidone and 9-Hydroxyrisperidone in Thai Children and Adolescents with Autism Spectrum Disorder.	{"Vanwong Natchaya","Ngamsamut Nattawat","Medhasi Sadeep","Puangpetch Apichaya","Chamnanphon Montri","Tan-Kam Teerarat","Hongkaew Yaowaluck","Limsila Penkhae","Sukasem Chonlaphat"}	Journal of child and adolescent psychopharmacology	3	\N	\N	2017	26780783	\N	\N	\N	2	f	\N
114653	\N	Polymorphisms and phenotypic analysis of cytochrome P450 2D6 in the Tibetan population.	{"Jin Tian-Bo","Ma Li-Feng","Zhang Jia-Yi","Yuan Dong-Ya","Sun Qiang","Zong Ting-Yong","Geng Ting-Ting","Cui Ya-Li","Kang Long-Li","Chen Chao"}	Gene	9	\N	\N	2013	23644254	\N	\N	\N	2	f	\N
114662	\N	CYP2D6 allele distribution in Macedonians, Albanians and Romanies in the Republic of Macedonia.	{"Kuzmanovska M","Dimishkovska M","Maleva Kostovska I","Noveski P","Sukarova Stefanovska E","Plaseska-Karanfilska D"}	Balkan journal of medical genetics : BJMG	12	\N	\N	2015	27785397	\N	\N	\N	2	f	\N
114664	\N	CYP2D6 genotyping by liquid chromatography-electrospray ionization mass spectrometry.	{"Beer Beate","Erb Robert","Pitterl Florian","Niederstätter Harald","Maroñas Olalla","Gesteira Alejandro","Carracedo Angel","Piatkov Irina","Oberacher Herbert"}	Analytical and bioanalytical chemistry	6	\N	\N	2011	21225252	\N	\N	\N	2	f	\N
114670	\N	New cytochrome P450 2D6*56 allele identified by genotype/phenotype analysis of cryopreserved human hepatocytes.	{"Li Li","Pan Run-Mei","Porter Todd D","Jensen Neil S","Silber Paul","Russo Guy","Tine John A","Heim John","Ring Barbara","Wedlund Peter J"}	Drug metabolism and disposition: the biological fate of chemicals	8	\N	\N	2006	16679388	\N	\N	\N	2	f	\N
114681	\N	Tramadol as a new probe for cytochrome P450 2D6 phenotyping: a population study.	{"Pedersen Rasmus Steen","Damkier Per","Brosen Kim"}	Clinical pharmacology and therapeutics	6	\N	\N	2005	15961977	\N	\N	\N	2	f	\N
114683	\N	CYP2D6 gene test in psychiatric patients and healthy volunteers.	{"Rasmussen J O","Christensen M","Svendsen J M","Skausig O","Hansen E L","Nielsen K A"}	Scandinavian journal of clinical and laboratory investigation	0	\N	\N	2006	16537246	\N	\N	\N	2	f	\N
114695	\N	Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scales.	{"Sistonen Johanna","Fuselli Silvia","Palo Jukka U","Chauhan Neelam","Padh Harish","Sajantila Antti"}	Pharmacogenetics and genomics	2	\N	\N	2009	19151603	\N	\N	\N	2	f	\N
114700	\N	Completed suicides of citalopram users-the role of CYP genotypes and adverse drug interactions.	{"Rahikainen Anna-Liina","Vauhkonen P","Pett H","Palo J U","Haukka J","Ojanperä I","Niemi M","Sajantila Antti"}	International journal of legal medicine	3	\N	\N	2019	30173302	\N	\N	\N	2	f	\N
114703	\N	Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution.	{"Marez D","Legrand M","Sabbagh N","Lo Guidice J M","Spire C","Lafitte J J","Meyer U A","Broly F"}	Pharmacogenetics	6	\N	\N	1997	9241659	\N	\N	\N	2	f	\N
114707	\N	Assessment of the predictive power of genotypes for the in-vivo catalytic function of CYP2D6 in a German population.	{"Griese E U","Zanger U M","Brudermanns U","Gaedigk A","Mikus G","Mörike K","Stüven T","Eichelbaum M"}	Pharmacogenetics	2	\N	\N	1998	9511177	\N	\N	\N	2	f	\N
114709	\N	A novel intronic mutation, 2988G>A, with high predictivity for impaired function of cytochrome P450 2D6 in white subjects.	{"Raimundo Sebastian","Toscano Claudia","Klein Kathrin","Fischer Joachim","Griese Ernst-Ulrich","Eichelbaum Michel","Schwab Matthias","Zanger Ulrich M"}	Clinical pharmacology and therapeutics	8	\N	\N	2004	15289790	\N	\N	\N	2	f	\N
114716	\N	Increased prevalence of functional minor allele variants of drug metabolizing CYP2B6 and CYP2D6 genes in Roma population samples.	{"Weber Agnes","Szalai Renata","Sipeky Csilla","Magyari Lili","Melegh Marton","Jaromi Luca","Matyas Petra","Duga Balazs","Kovesdi Erzsebet","Hadzsiev Kinga","Melegh Bela"}	Pharmacological reports : PR	6	\N	\N	2015	25933954	\N	\N	\N	2	f	\N
114718	\N	Patients with difficult-to-treat depression do not exhibit an increased frequency of CYP2D6 allele duplication.	{"Háber A","Rideg O","Osváth P","Fekete S","Szücs F","Fittler A","Kovács G L","Miseta A","Botz L"}	Pharmacopsychiatry	6	\N	\N	2013	23737191	\N	\N	\N	2	f	\N
114722	\N	Biological definition of multiple chemical sensitivity from redox state and cytokine profiling and not from polymorphisms of xenobiotic-metabolizing enzymes.	{"De Luca Chiara","Scordo Maria G","Cesareo Eleonora","Pastore Saveria","Mariani Serena","Maiani Gianluca","Stancato Andrea","Loreti Beatrice","Valacchi Giuseppe","Lubrano Carla","Raskovic Desanka","De Padova Luigia","Genovesi Giuseppe","Korkina Liudmila G"}	Toxicology and applied pharmacology	11	\N	\N	2010	20430047	\N	\N	\N	2	f	\N
114731	\N	CYP2D6 genotype can help to predict effectiveness and safety during opioid treatment for chronic low back pain: results from a retrospective study in an Italian cohort.	{"Dagostino Concetta","Allegri Massimo","Napolioni Valerio","D'Agnelli Simona","Bignami Elena","Mutti Antonio","van Schaik Ron Hn"}	Pharmacogenomics and personalized medicine	0	\N	\N	2018	30425549	\N	\N	\N	2	f	\N
114733	\N	Distribution of the most Common Genetic Variants Associated with a Variable Drug Response in the Population of the Republic of Macedonia.	{"Kapedanovska Nestorovska A","Jakovski K","Naumovska Z","Hiljadnikova Bajro M","Sterjev Z","Eftimov A","Matevska Geskovska N","Suturkova L","Dimitrovski K","Labacevski N","Dimovski A J"}	Balkan journal of medical genetics : BJMG	12	\N	\N	2014	25937793	\N	\N	\N	2	f	\N
114746	\N	The association of CYP2D6 genotype and postoperative nausea and vomiting in orthopedic trauma patients.	{"Wesmiller Susan W","Henker Richard A","Sereika Susan M","Donovan Heidi S","Meng Li","Gruen Gary S","Tarkin Ivan S","Conley Yvette P"}	Biological research for nursing	10	\N	\N	2013	22718526	\N	\N	\N	2	f	\N
114751	\N	Pharmacokinetics of diltiazem and its metabolites in relation to CYP2D6 genotype.	{"Molden Espen","Johansen Per Wiik","Bøe Grethe Helen","Bergan Stein","Christensen Hege","Rugstad Hans Erik","Rootwelt Helge","Reubsaet Leon","Lehne Gustav"}	Clinical pharmacology and therapeutics	9	\N	\N	2002	12235455	\N	\N	\N	2	f	\N
114753	\N	Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolism.	{"Gjerde J","Hauglid M","Breilid H","Lundgren S","Varhaug J E","Kisanga E R","Mellgren G","Steen V M","Lien E A"}	Annals of oncology : official journal of the European Society for Medical Oncology	1	\N	\N	2008	17947222	\N	\N	\N	2	f	\N
114757	\N	Characterization of pharmacogenetically relevant CYP2D6 and ABCB1 gene polymorphisms in a Portuguese population sample.	{"Correia C","Santos P","Coutinho A M","Vicente A M"}	Cell biochemistry and function	6	\N	\N	2009	19405050	\N	\N	\N	2	f	\N
312282	\N	Characterization of CYP2D6 genotypes and metabolic profiles in the Portuguese population: pharmacogenetic implications.	{"Albuquerque José","Ribeiro Carolina","Naranjo Maria Eugenia G","Llerena Adrián","Grazina Manuela","CEIBA.FP Consortium of the Ibero-American Network of Pharmacogenetics & Pharmacogenomics RIBEF §"}	Personalized medicine	9	\N	\N	2013	29768760	\N	\N	\N	2	f	\N
114769	\N	Effect of genotype and methylation of CYP2D6 on smoking behaviour.	{"Tiili Emmi M","Antikainen Miia S H","Mitiushkina Natalia V","Sukhovskaya Olga A","Imyanitov Evgeny N","Hirvonen Ari P"}	Pharmacogenetics and genomics	11	\N	\N	2015	26287939	\N	\N	\N	2	f	\N
114771	\N	Molecular diversity at the CYP2D6 locus in the Mediterranean region.	{"Fuselli Silvia","Dupanloup Isabelle","Frigato Elena","Cruciani Fulvio","Scozzari Rosaria","Moral Pedro","Sistonen Johanna","Sajantila Antti","Barbujani Guido"}	European journal of human genetics : EJHG	11	\N	\N	2004	15340360	\N	\N	\N	2	f	\N
114776	\N	Simultaneous genotyping of CYP2D6*3, *4, *5 and *6 polymorphisms in a Spanish population through multiplex long polymerase chain reaction and minisequencing multiplex single base extension analysis.	{"Crescenti A","Mas S","Gassó P","Baiget M","Bernardo M","Lafuente A"}	Clinical and experimental pharmacology & physiology	10	\N	\N	2007	17714084	\N	\N	\N	2	f	\N
114778	\N	Cyp2d6*3, *4, *5 and *6 polymorphisms and antipsychotic-induced extrapyramidal side-effects in patients receiving antipsychotic therapy.	{"Crescenti Anna","Mas Sergi","Gassó Patricia","Parellada Eduard","Bernardo Miquel","Lafuente Amalia"}	Clinical and experimental pharmacology & physiology	7	\N	\N	2008	18346175	\N	\N	\N	2	f	\N
114781	\N	CYP2D6 polymorphism screening in a selected population of Spain (La Alpujarra): no effect of geographical isolation.	{"Fernández-Santander Ana","Luna Francisco","Santiago Catalina","Rodríguez María Teresa","Bandrés Fernando","Ruiz Jonatan R","Lucia Alejandro","Gómez-Gallego Félix"}	Annals of human biology	4	\N	\N	2010	20205348	\N	\N	\N	2	f	\N
114787	\N	Influence of CYP2D6 polymorphisms on serum levels of tamoxifen metabolites in Spanish women with breast cancer.	{"Zafra-Ceres Mercedes","de Haro Tomas","Farez-Vidal Esther","Blancas Isabel","Bandres Fernando","de Dueñas Eduardo Martinez","Ochoa-Aranda Enrique","Gomez-Capilla Jose A","Gomez-Llorente Carolina"}	International journal of medical sciences	0	\N	\N	2013	23781139	\N	\N	\N	2	f	\N
114789	\N	Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients.	{"Mas Sergi","Gassó Patricia","Torra Mercé","Bioque Miquel","Lobo Antonio","González-Pinto Ana","Olmeda Maria Soledad","Corripio Iluminada","Vieta Eduard","Castro-Fornieles Josefina","Rodriguez-Jimenez Roberto","Bobes Julio","Usall Judith","Llerena Adrián","Saiz-Ruiz Jerónimo","Bernardo Miguel","Lafuente Amalia","PEPs Group"}	European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology	7	\N	\N	2017	28389049	\N	\N	\N	2	f	\N
114791	\N	Influence of CYP2D6, CYP3A4, CYP3A5 and ABCB1 Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers.	{"Belmonte Carmen","Ochoa Dolores","Román Manuel","Saiz-Rodríguez Miriam","Wojnicz Aneta","Gómez-Sánchez Clara Isabel","Martín-Vílchez Samuel","Abad-Santos Francisco"}	Basic & clinical pharmacology & toxicology	6	\N	\N	2018	29325225	\N	\N	\N	2	f	\N
114800	\N	The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction.	{"Rebsamen M C","Desmeules J","Daali Y","Chiappe A","Diemand A","Rey C","Chabert J","Dayer P","Hochstrasser D","Rossier M F"}	The pharmacogenomics journal	2	\N	\N	2009	18591960	\N	\N	\N	2	f	\N
114813	\N	Frequency of five important CYP2D6 alleles within an Iranian population (Eastern Azerbaijan).	{"Kouhi Hamed","Hamzeiy Hossein","Barar Jaleh","Asadi Masoud","Omidi Yadollah"}	Genetic testing and molecular biomarkers	10	\N	\N	2009	19715474	\N	\N	\N	2	f	\N
114063	\N	Frequencies of CYP3A5 genotypes and haplotypes in a Korean population.	{"Park S Y","Kang Y S","Jeong M S","Yoon H K","Han K O"}	Journal of clinical pharmacy and therapeutics	2	\N	\N	2008	18211618	\N	\N	\N	2	f	\N
114820	\N	High prevalence of CYP2D6*41 (G2988A) allele in Saudi Arabians.	{"Al-Dosari Mohammed S","Al-Jenoobi Fahad I","Alkharfy Khalid M","Alghamdi Amal M","Bagulb Khawla M","Parvez Mohammad K","Al-Mohizea Abdullah M","Al-Muhsen Saleh","Halwani Rabih"}	Environmental toxicology and pharmacology	11	\N	\N	2013	24121619	\N	\N	\N	2	f	\N
114827	\N	Frequency of mutated allele CYP2D6*4 in the Turkish population.	{"Koseler Aylin","Ilcol Yesim Ozarda","Ulus Ismail H"}	Pharmacology	0	\N	\N	2007	17374963	\N	\N	\N	2	f	\N
114831	\N	The frequencies of mutated alleles of CYP2D6 gene in a Turkish population.	{"Serin A","Canan H","Alper B","Gulmen M"}	Forensic science international	10	\N	\N	2012	22910059	\N	\N	\N	2	f	\N
114833	\N	Correlation of CYP2D6 allelic polymorphism to outcome of acute coronary syndrome in mid-Euphrates Iraqi patients on metoprolol therapy.	{"Swadi Asma A","Mohammad Bassim I","Hadi Najah R","Al-Aubaidy Hayder A"}	Gene	6	\N	\N	2019	30965129	\N	\N	\N	2	f	\N
114835	\N	Clinical Trial: CYP2D6 Related Dose Escalation of Tamoxifen in Breast Cancer Patients With Iranian Ethnic Background Resulted in Increased Concentrations of Tamoxifen and Its Metabolites.	{"Khalaj Zahra","Baratieh Zohreh","Nikpour Parvaneh","Schwab Matthias","Schaeffeler Elke","Mokarian Fariborz","Khanahmad Hossein","Salehi Rasoul","Mürdter Thomas E","Salehi Mansoor"}	Frontiers in pharmacology	0	\N	\N	2019	31178724	\N	\N	\N	2	f	\N
114844	\N	CYP2D6 and CYP2C19 in Papua New Guinea: High frequency of previously uncharacterized CYP2D6 alleles and heterozygote excess.	{"von Ahsen Nicolas","Tzvetkov Mladen","Karunajeewa Harin A","Gomorrai Servina","Ura Alice","Brockmöller Jürgen","Davis Timothy M E","Mueller Ivo","Ilett Kenneth F","Oellerich Michael"}	International journal of molecular epidemiology and genetics	8	\N	\N	2010	21532842	\N	\N	\N	2	f	\N
114851	\N	Polymorphisms at CYP and GST gene loci. Prevalence in the Indian population.	{"Buch S","Kotekar A","Kawle D","Bhisey R"}	European journal of clinical pharmacology	9	\N	\N	2001	11699625	\N	\N	\N	2	f	\N
114853	\N	Genetic polymorphism of CYP2D6: Malaysian Indians have the highest frequency for CYP2D6*4 in Asia.	{"Ismail R","Teh L K"}	European journal of clinical pharmacology	10	\N	\N	2001	11758642	\N	\N	\N	2	f	\N
114855	\N	CYP2D6 genetic polymorphism in South Indian populations.	{"Naveen Amrithraj Theophilus","Adithan Chandrasekaran","Soya Sisy Sam","Gerard Nathalie","Krishnamoorthy Rajagopal"}	Biological & pharmaceutical bulletin	8	\N	\N	2006	16880622	\N	\N	\N	2	f	\N
114863	\N	Association of polymorphism in cytochrome P450 2D6 and N-acetyltransferase-2 with Parkinson's disease.	{"Singh Madhu","Khanna Vinay K","Shukla Rakesh","Parmar Devendra"}	Disease markers	0	\N	\N	2010	20364044	\N	\N	\N	2	f	\N
114865	\N	Genetic polymorphisms of CYP2D6 increase the risk for recurrence of breast cancer in patients receiving tamoxifen as an adjuvant therapy.	{"Damodaran Solai Elango","Pradhan Suresh Chandra","Umamaheswaran Gurusamy","Kadambari Dharanipragada","Reddy K Sathyanarayana","Adithan Chandrasekaran"}	Cancer chemotherapy and pharmacology	7	\N	\N	2012	22623212	\N	\N	\N	2	f	\N
114870	\N	Gene variants of CYP1A1 and CYP2D6 and the risk of childhood acute lymphoblastic leukaemia; outcome of a case control study from Kashmir, India.	{"Nida Sadiq","Javid Bhat","Akbar Masood","Idrees Shah","Adil Wani","Ahmad Ganai Bashir"}	Molecular biology research communications	6	\N	\N	2017	28775993	\N	\N	\N	2	f	\N
114872	\N	Distribution of CYP2D6 genotypes in the Indian population - preliminary report.	{"Paradkar Minal U","Shah Swarup A V","Dherai Alpa J","Shetty Dhanashri","Ashavaid Tester F"}	Drug metabolism and personalized therapy	9	\N	\N	2018	30098281	\N	\N	\N	2	f	\N
114876	\N	Further evidence for the association of CYP2D6*4 gene polymorphism with Parkinson's disease: a case control study.	{Anwarullah,"Aslam Muhammad","Badshah Mazhar","Abbasi Rashda","Sultan Aneesa","Khan Kafaitullah","Ahmad Nafees","von Engelhardt Jakob"}	Genes and environment : the official journal of the Japanese Environmental Mutagen Society	0	\N	\N	2017	28680508	\N	\N	\N	2	f	\N
114880	\N	Resequencing CYP2D6 gene in Indian population: CYP2D6*41 identified as the major reduced function allele.	{"Manoharan Aarthi","Shewade Deepak Gopal","Ravindranath Pradeep Anand","Rajkumar Ravi Philip","Ramprasad Vedam L","Adithan Surendiran","Damodaran Solai Elango"}	Pharmacogenomics	7	\N	\N	2019	31368850	\N	\N	\N	2	f	\N
113921	\N	Novel polymorphisms associated with tacrolimus trough concentrations: results from a multicenter kidney transplant consortium.	{"Jacobson Pamala A","Oetting William S","Brearley Ann M","Leduc Robert","Guan Weihau","Schladt David","Matas Arthur J","Lamba Vishal","Julian Bruce A","Mannon Rosalyn B","Israni Ajay","DeKAF Investigators"}	Transplantation	2	\N	\N	2011	21206424	\N	\N	\N	2	f	\N
113923	\N	CYP3A5 genotype predicts renal CYP3A activity and blood pressure in healthy adults.	{"Givens Raymond C","Lin Yvonne S","Dowling Amy L S","Thummel Kenneth E","Lamba Jatinder K","Schuetz Erin G","Stewart Paul W","Watkins Paul B"}	Journal of applied physiology (Bethesda, Md. : 1985)	9	\N	\N	2003	12754175	\N	\N	\N	2	f	\N
113927	\N	Multiplex PCR-pyrosequencing assay for genotyping CYP3A5 polymorphisms.	{"Aquilante Christina L","Langaee Taimour Y","Anderson Peter L","Zineh Issam","Fletcher Courtney V"}	Clinica chimica acta; international journal of clinical chemistry	10	\N	\N	2006	16701601	\N	\N	\N	2	f	\N
113929	\N	Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression.	{"Kuehl P","Zhang J","Lin Y","Lamba J","Assem M","Schuetz J","Watkins P B","Daly A","Wrighton S A","Hall S D","Maurel P","Relling M","Brimer C","Yasuda K","Venkataramanan R","Strom S","Thummel K","Boguski M S","Schuetz E"}	Nature genetics	4	\N	\N	2001	11279519	\N	\N	\N	2	f	\N
113931	\N	An integrated map of genetic variation from 1,092 human genomes.	{"1000 Genomes Project Consortium","Abecasis Goncalo R","Auton Adam","Brooks Lisa D","DePristo Mark A","Durbin Richard M","Handsaker Robert E","Kang Hyun Min","Marth Gabor T","McVean Gil A"}	Nature	11	\N	\N	2012	23128226	\N	\N	\N	2	f	\N
113937	\N	Genotypes and phenotypes of CYP3A in Bangladeshi population.	{"Al Maruf Abdullah","Ahmed Maizbha Uddin","Yasmin Hasina","Ullah Md Ashik","Azad M A K","Daly Ann K","Hasnat Abul"}	Clinica chimica acta; international journal of clinical chemistry	3	\N	\N	2011	21114969	\N	\N	\N	2	f	\N
113939	\N	Association of CYP3A4, CYP3A5 polymorphisms with lung cancer risk in Bangladeshi population.	{"Islam Mohammad Safiqul","Mostofa A G M","Ahmed Maizbha Uddin","Bin Sayeed Muhammad Shahdaat","Hassan Md Rajib","Hasnat Abul"}	Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine	2	\N	\N	2014	24085358	\N	\N	\N	2	f	\N
113943	\N	Genetic polymorphisms of drug-metabolizing phase I enzymes CYP2E1, CYP2A6 and CYP3A5 in South Indian population.	{"Krishnakumar D","Gurusamy Umamaheswaran","Dhandapani Kayathri","Surendiran A","Baghel Ruchi","Kukreti Ritushree","Gangadhar Reneega","Prayaga Ushakiran","Manjunath S","Adithan C"}	Fundamental & clinical pharmacology	4	\N	\N	2012	21265876	\N	\N	\N	2	f	\N
113948	\N	Genetic polymorphism of CYP3A5 in Indian chronic myeloid leukemia patients.	{"Bajpai Prachi","Tripathi Anil Kumar","Agrawal Deepa"}	Molecular and cellular biochemistry	3	\N	\N	2010	19823770	\N	\N	\N	2	f	\N
113950	\N	Genetic polymorphisms in MDR1 and CYP3A5 and MDR1 haplotype in mainland Chinese Han, Uygur and Kazakh ethnic groups.	{"Li D","Zhang G-L","Lou Y-Q","Li Q","Wang X","Bu X-Y"}	Journal of clinical pharmacy and therapeutics	2	\N	\N	2007	17286792	\N	\N	\N	2	f	\N
113955	\N	Screening CYP3A single nucleotide polymorphisms in a Han Chinese population with a genotyping chip.	{"Liu Chin-Hung","Peck Konan","Huang Jin-Ding","Lin Min-Shung","Wang Chin-Hsiung","Hsu Wen-Pin","Wang Hong-Wen","Lee Hui-Ling","Lai Ming-Liang"}	Pharmacogenomics	10	\N	\N	2005	16207150	\N	\N	\N	2	f	\N
113960	\N	CYP3A5 genotypes affect tacrolimus pharmacokinetics and infectious complications in Chinese pediatric liver transplant patients.	{"Xue Feng","Han Longzhi","Chen Yikuan","Xi Zhifeng","Li Qigen","Xu Ning","Xia Yun","Streicher Katie","Zhang Jianjun","Xia Qiang"}	Pediatric transplantation	3	\N	\N	2014	24438215	\N	\N	\N	2	f	\N
113962	\N	Effect of CYP3A5*3 polymorphism on pharmacokinetic drug interaction between tacrolimus and amlodipine.	{"Zuo Xiao-cong","Zhou Ya-nan","Zhang Bi-kui","Yang Guo-ping","Cheng Ze-neng","Yuan Hong","Ouyang Dong-sheng","Liu Shi-kun","Barrett Jeffrey S","Li Pei-jiong","Liu Zhi","Tan Hong-yi","Guo Ren","Zhou Ling-yun","Xie Yue-liang","Li Zuo-jun","Li Jing","Wang Chun-jiang","Wang Jiang-lin"}	Drug metabolism and pharmacokinetics	0	\N	\N	2013	23438946	\N	\N	\N	2	f	\N
113966	\N	Genetic polymorphisms of CYP3A5 genes and concentration of the cyclosporine and tacrolimus.	{"Zhao Y","Song M","Guan D","Bi S","Meng J","Li Q","Wang W"}	Transplantation proceedings	0	\N	\N	2005	15808586	\N	\N	\N	2	f	\N
113968	\N	CYP3A4/5 polymorphisms affect the blood level of cyclosporine and tacrolimus in Chinese renal transplant recipients.	{"Li Dan-ying","Teng Rui-chen","Zhu Huai-jun","Fang Yun"}	International journal of clinical pharmacology and therapeutics	6	\N	\N	2013	23557867	\N	\N	\N	2	f	\N
113970	\N	Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: a population pharmacokinetic analysis.	{"Zuo Xiao-cong","Ng Chee M","Barrett Jeffrey S","Luo Ai-jing","Zhang Bi-kui","Deng Chen-hui","Xi Lan-yan","Cheng Ke","Ming Ying-zi","Yang Guo-ping","Pei Qi","Zhu Li-jun","Yuan Hong","Liao Hai-qiang","Ding Jun-jie","Wu Di","Zhou Ya-nan","Jing Ning-ning","Huang Zhi-jun"}	Pharmacogenetics and genomics	5	\N	\N	2013	23459029	\N	\N	\N	2	f	\N
113974	\N	Association of ABCB1, CYP3A4*18B and CYP3A5*3 genotypes with the pharmacokinetics of tacrolimus in healthy Chinese subjects: a population pharmacokinetic analysis.	{"Shi X-J","Geng F","Jiao Z","Cui X-Y","Qiu X-Y","Zhong M-K"}	Journal of clinical pharmacy and therapeutics	10	\N	\N	2011	21916909	\N	\N	\N	2	f	\N
113976	\N	Impact of interleukin-10 gene polymorphisms on tacrolimus dosing requirements in Chinese liver transplant patients during the early posttransplantation period.	{"Zhang Xiaoqing","Wang Zhaowen","Fan Junwei","Liu Gaolin","Peng Zhihai"}	European journal of clinical pharmacology	8	\N	\N	2011	21359536	\N	\N	\N	2	f	\N
113980	\N	Influence of CYP3A5 and MDR1(ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in Chinese renal transplant recipients.	{"Rong G","Jing L","Deng-Qing L","Hong-Shan Z","Shai-Hong Z","Xin-Min N"}	Transplantation proceedings	11	\N	\N	2010	21094796	\N	\N	\N	2	f	\N
113982	\N	Impact of the CYP3A5, CYP3A4, COMT, IL-10 and POR genetic polymorphisms on tacrolimus metabolism in Chinese renal transplant recipients.	{"Li Chuan-Jiang","Li Liang","Lin Li","Jiang Hai-Xia","Zhong Ze-Yan","Li Wei-Mo","Zhang Yan-Jun","Zheng Ping","Tan Xu-Hui","Zhou Lin"}	PloS one	0	\N	\N	2014	24465960	\N	\N	\N	2	f	\N
113986	\N	Polymorphisms of tumor necrosis factor-alpha, interleukin-10, cytochrome P450 3A5 and ABCB1 in Chinese liver transplant patients treated with immunosuppressant tacrolimus.	{"Li Dan","Zhu Ji-Ye","Gao Jie","Wang Xin","Lou Ya-Qing","Zhang Guo-Liang"}	Clinica chimica acta; international journal of clinical chemistry	8	\N	\N	2007	17568575	\N	\N	\N	2	f	\N
113988	\N	Population pharmacokinetics of tacrolimus and CYP3A5, MDR1 and IL-10 polymorphisms in adult liver transplant patients.	{"Li D","Lu W","Zhu J-Y","Gao J","Lou Y-Q","Zhang G-L"}	Journal of clinical pharmacy and therapeutics	10	\N	\N	2007	17875118	\N	\N	\N	2	f	\N
113990	\N	Influence of different allelic variants of the CYP3A and ABCB1 genes on the tacrolimus pharmacokinetic profile of Chinese renal transplant recipients.	{"Cheung Chi Yuen","Op den Buijsch Robert A M","Wong Kim Ming","Chan Hoi Wong","Chau Ka Foon","Li Chun Sang","Leung Kay Tai","Kwan Tze Hoi","de Vrie Johan E","Wijnen Petal Ahm","van Dieijen-Visser Marja P","Bekers Otto"}	Pharmacogenomics	6	\N	\N	2006	16753004	\N	\N	\N	2	f	\N
113994	\N	Influence of CYP3A5 and MDR1 polymorphisms on tacrolimus concentration in the early stage after renal transplantation.	{"Zhang Xin","Liu Zhi-hong","Zheng Jing-min","Chen Zhao-hong","Tang Zheng","Chen Jin-song","Li Lei-shi"}	Clinical transplantation	10	\N	\N	2005	16146556	\N	\N	\N	2	f	\N
113996	\N	Novel single nucleotide polymorphisms in interleukin 6 affect tacrolimus metabolism in liver transplant patients.	{"Chen Dawei","Fan Junwei","Guo Feng","Qin Shengying","Wang Zhaowen","Peng Zhihai"}	PloS one	0	\N	\N	2013	23991193	\N	\N	\N	2	f	\N
114000	\N	Influence of CYP3A5 gene polymorphisms of donor rather than recipient to tacrolimus individual dose requirement in liver transplantation.	{"Yu Songfeng","Wu Lihua","Jin Jing","Yan Sheng","Jiang Guoping","Xie Haiyang","Zheng Shusen"}	Transplantation	1	\N	\N	2006	16421475	\N	\N	\N	2	f	\N
114002	\N	Association of hemoglobin levels, CYP3A5, and NR1I3 gene polymorphisms with tacrolimus pharmacokinetics in liver transplant patients.	{"Chen Dawei","Guo Feng","Shi Jinxiu","Zhang Chenhui","Wang Zhaowen","Fan Junwei","Peng Zhihai"}	Drug metabolism and pharmacokinetics	0	\N	\N	2014	24351870	\N	\N	\N	2	f	\N
114004	\N	Pharmacokinetics of midazolam and 1'-hydroxymidazolam in Chinese with different CYP3A5 genotypes.	{"Shih Pei-Shan","Huang Jin-Ding"}	Drug metabolism and disposition: the biological fate of chemicals	12	\N	\N	2002	12433824	\N	\N	\N	2	f	\N
114011	\N	Genetic polymorphisms of pharmacogenomic VIP variants in the Kyrgyz population from northwest China.	{"Yunus Zulfiya","Liu Lijun","Wang Hong","Zhang Le","Li Xiaolan","Geng Tingting","Kang Longli","Jin Tianbo","Chen Chao"}	Gene	10	\N	\N	2013	23954225	\N	\N	\N	2	f	\N
114015	\N	Association between interleukin-18 promoter variants and tacrolimus pharmacokinetics in Chinese renal transplant patients.	{"Xing Jiazhen","Zhang Xiaoqing","Fan Junwei","Shen Bin","Men Tongyi","Wang Jianning"}	European journal of clinical pharmacology	2	\N	\N	2015	25487141	\N	\N	\N	2	f	\N
114017	\N	Influence of TLR4 rs1927907 locus polymorphisms on tacrolimus pharmacokinetics in the early stage after liver transplantation.	{"Wang Zhaowen","Wu Shaohan","Chen Dawei","Guo Feng","Zhong Lin","Fan Junwei","Peng Zhihai"}	European journal of clinical pharmacology	8	\N	\N	2014	24820765	\N	\N	\N	2	f	\N
114019	\N	Single nucleotide polymorphisms and haplotype frequencies of CYP3A5 in a Japanese population.	{"Saeki Mayumi","Saito Yoshiro","Nakamura Takahiro","Murayama Norie","Kim Su-Ryang","Ozawa Shogo","Komamura Kazuo","Ueno Kazuyuki","Kamakura Shiro","Nakajima Toshiharu","Saito Hirohisa","Kitamura Yutaka","Kamatani Naoyuki","Sawada Jun-ichi"}	Human mutation	6	\N	\N	2003	14961555	\N	\N	\N	2	f	\N
114025	\N	Pharmaceutical and genetic determinants for interindividual differences of tacrolimus bioavailability in renal transplant recipients.	{"Niioka Takenori","Kagaya Hideaki","Miura Masatomo","Numakura Kazuyuki","Saito Mitsuru","Inoue Takamitsu","Habuchi Tomonori","Satoh Shigeru"}	European journal of clinical pharmacology	9	\N	\N	2013	23733010	\N	\N	\N	2	f	\N
114027	\N	Impact of CYP3A5 genetic polymorphism on cross-reactivity in tacrolimus chemiluminescent immunoassay in kidney transplant recipients.	{"Hirano Kumi","Naito Takafumi","Mino Yasuaki","Takayama Tatsuya","Ozono Seiichiro","Kawakami Junichi"}	Clinica chimica acta; international journal of clinical chemistry	12	\N	\N	2012	22889968	\N	\N	\N	2	f	\N
114029	\N	Comparison of pharmacokinetics and pharmacogenetics of once- and twice-daily tacrolimus in the early stage after renal transplantation.	{"Niioka Takenori","Satoh Shigeru","Kagaya Hideaki","Numakura Kazuyuki","Inoue Takamitsu","Saito Mitsuru","Narita Shintaro","Tsuchiya Norihiko","Habuchi Tomonori","Miura Masatomo"}	Transplantation	11	\N	\N	2012	23073468	\N	\N	\N	2	f	\N
114033	\N	Impact of CYP3A5 genotype of recipients as well as donors on the tacrolimus pharmacokinetics and infectious complications after living-donor liver transplantation for Japanese adult recipients.	{"Muraki Yuichi","Usui Masanobu","Isaji Shuji","Mizuno Shugo","Nakatani Kaname","Yamada Tomomi","Iwamoto Takuya","Uemoto Shinji","Nobori Tsutomu","Okuda Masahiro"}	Annals of transplantation	0	\N	\N	2011	22210422	\N	\N	\N	2	f	\N
114035	\N	CYP3A5 *1 allele associated with tacrolimus trough concentrations but not subclinical acute rejection or chronic allograft nephropathy in Japanese renal transplant recipients.	{"Satoh Shigeru","Saito Mitsuru","Inoue Takamitsu","Kagaya Hideaki","Miura Masatomo","Inoue Kazuyuki","Komatsuda Atsushi","Tsuchiya Norihiko","Suzuki Toshio","Habuchi Tomonori"}	European journal of clinical pharmacology	5	\N	\N	2009	19125240	\N	\N	\N	2	f	\N
114037	\N	Lack of tacrolimus circadian pharmacokinetics and CYP3A5 pharmacogenetics in the early and maintenance stages in Japanese renal transplant recipients.	{"Satoh Shigeru","Kagaya Hideaki","Saito Mitsuru","Inoue Takamitsu","Miura Masatomo","Inoue Kazuyuki","Numakura Kazuyuki","Tsuchiya Norihiko","Tada Hitoshi","Suzuki Toshio","Habuchi Tomonori"}	British journal of clinical pharmacology	8	\N	\N	2008	18429967	\N	\N	\N	2	f	\N
114041	\N	Impact of CYP3A5 genetic polymorphisms on the pharmacokinetics and short-term remission in patients with ulcerative colitis treated with tacrolimus.	{"Hirai Fumihito","Takatsu Noritaka","Yano Yutaka","Satou Yuhou","Takahashi Haruhiko","Ishikawa Satoshi","Tsurumi Kozue","Hisabe Takashi","Matsui Toshiyuki"}	Journal of gastroenterology and hepatology	1	\N	\N	2014	24033383	\N	\N	\N	2	f	\N
114043	\N	Influence of CYP3A5 and ABCB1 gene polymorphisms on calcineurin inhibitor-related neurotoxicity after hematopoietic stem cell transplantation.	{"Yanagimachi Masakatsu","Naruto Takuya","Tanoshima Reo","Kato Hiromi","Yokosuka Tomoko","Kajiwara Ryosuke","Fujii Hisaki","Tanaka Fumiko","Goto Hiroaki","Yagihashi Tatsuhiko","Kosaki Kenjiro","Yokota Shumpei"}	Clinical transplantation	0	\N	\N	2010	20030680	\N	\N	\N	2	f	\N
114047	\N	Impact of CYP3A5 and MDR1(ABCB1) C3435T polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients.	{"Tada H","Tsuchiya N","Satoh S","Kagaya H","Li Z","Sato K","Miura M","Suzuki T","Kato T","Habuchi T"}	Transplantation proceedings	5	\N	\N	2005	15919447	\N	\N	\N	2	f	\N
114049	\N	Influence of CYP3A5 and MDR1 (ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients.	{"Tsuchiya Norihiko","Satoh Shigeru","Tada Hitoshi","Li Zhenhua","Ohyama Chikara","Sato Kazunari","Suzuki Toshio","Habuchi Tomonori","Kato Tetsuro"}	Transplantation	10	\N	\N	2004	15502717	\N	\N	\N	2	f	\N
114051	\N	CYP3A5*1-carrying graft liver reduces the concentration/oral dose ratio of tacrolimus in recipients of living-donor liver transplantation.	{"Goto Maki","Masuda Satohiro","Kiuchi Tetsuya","Ogura Yasuhiro","Oike Fumitaka","Okuda Masahiro","Tanaka Koichi","Inui Ken-ichi"}	Pharmacogenetics	7	\N	\N	2004	15226679	\N	\N	\N	2	f	\N
114055	\N	Capability of utilizing CYP3A5 polymorphisms to predict therapeutic dosage of tacrolimus at early stage post-renal transplantation.	{"Niioka Takenori","Kagaya Hideaki","Saito Mitsuru","Inoue Takamitsu","Numakura Kazuyuki","Habuchi Tomonori","Satoh Shigeru","Miura Masatomo"}	International journal of molecular sciences	1	\N	\N	2015	25594874	\N	\N	\N	2	f	\N
114059	\N	Population pharmacokinetic analysis of cilostazol in healthy subjects with genetic polymorphisms of CYP3A5, CYP2C19 and ABCB1.	{"Yoo Hee-Doo","Cho Hea-Young","Lee Yong-Bok"}	British journal of clinical pharmacology	1	\N	\N	2010	20078610	\N	\N	\N	2	f	\N
114065	\N	Identification of factors affecting tacrolimus level and 5-year clinical outcome in kidney transplant patients.	{"Kim In-Wha","Noh Hyejin","Ji Eunhee","Han Nayoung","Hong Su Hyun","Ha Jongwon","Burckart Gilbert J","Oh Jung Mi"}	Basic & clinical pharmacology & toxicology	10	\N	\N	2012	22469198	\N	\N	\N	2	f	\N
114067	\N	Combinational effect of intestinal and hepatic CYP3A5 genotypes on tacrolimus pharmacokinetics in recipients of living donor liver transplantation.	{"Ji Eunhee","Choi Leena","Suh Kyung-Suk","Cho Joo-Youn","Han Nayoung","Oh Jung Mi"}	Transplantation	10	\N	\N	2012	22992768	\N	\N	\N	2	f	\N
114071	\N	Clinical and genetic factors affecting tacrolimus trough levels and drug-related outcomes in Korean kidney transplant recipients.	{"Kim In-Wha","Moon Yoo Jin","Ji Eunhee","Kim Kyung Im","Han Nayoung","Kim Sung Ju","Shin Wan Gyoon","Ha Jongwon","Yoon Jeong-Hyun","Lee Hye Suk","Oh Jung Mi"}	European journal of clinical pharmacology	5	\N	\N	2012	22183771	\N	\N	\N	2	f	\N
114073	\N	Prediction of the tacrolimus population pharmacokinetic parameters according to CYP3A5 genotype and clinical factors using NONMEM in adult kidney transplant recipients.	{"Han Nayoung","Yun Hwi-yeol","Hong Jin-yi","Kim In-Wha","Ji Eunhee","Hong Su Hyun","Kim Yon Su","Ha Jongwon","Shin Wan Gyoon","Oh Jung Mi"}	European journal of clinical pharmacology	1	\N	\N	2013	22660440	\N	\N	\N	2	f	\N
114075	\N	CYP3A5 *1 allele: impacts on early acute rejection and graft function in tacrolimus-based renal transplant recipients.	{"Min Sang-Il","Kim Seong Yup","Ahn Sang Hyun","Min Seung-Kee","Kim Si Hwa","Kim Yon Su","Moon Kyung Chul","Oh Jung Mi","Kim Sang Joon","Ha Jongwon"}	Transplantation	12	\N	\N	2010	21076384	\N	\N	\N	2	f	\N
114079	\N	Tacrolimus concentrations in relation to CYP3A and ABCB1 polymorphisms among solid organ transplant recipients in Korea.	{"Jun Kyung Ran","Lee Woochang","Jang Mi Sook","Chun Sail","Song Gi-Won","Park Kwan Tae","Lee Sung Gyu","Han Duck Jong","Kang Changwon","Cho Dae-Yeon","Kim Jin Q","Min Won-Ki"}	Transplantation	4	\N	\N	2009	19384171	\N	\N	\N	2	f	\N
114081	\N	Influence of the CYP3A5 and MDR1 genetic polymorphisms on the pharmacokinetics of tacrolimus in healthy Korean subjects.	{"Choi Ji H","Lee Yoon J","Jang Seong B","Lee Jong-Eun","Kim Kyung H","Park Kyungsoo"}	British journal of clinical pharmacology	8	\N	\N	2007	17391324	\N	\N	\N	2	f	\N
114085	\N	Impact of cytochrome P450 3A and ATP-binding cassette subfamily B member 1 polymorphisms on tacrolimus dose-adjusted trough concentrations among Korean renal transplant recipients.	{"Cho J-H","Yoon Y-D","Park J-Y","Song E-J","Choi J-Y","Yoon S-H","Park S-H","Kim Y-L","Kim C-D"}	Transplantation proceedings	1	\N	\N	2012	22310591	\N	\N	\N	2	f	\N
114088	\N	Reduced variability of tacrolimus trough level in once-daily tacrolimus-based Taiwanese kidney transplant recipients with high-expressive genotype of cytochrome P450 3A5.	{"Wu M-J","Chang C-H","Cheng C-Y","Shu K-H","Chen C-H","Cheng C-H","Yu T-M","Chuang Y-W","Huang S-T","Tsai S-F","Ho H-C","Li J-R","Shiu Y-N","Fu Y-C"}	Transplantation proceedings	0	\N	\N	2014	24655974	\N	\N	\N	2	f	\N
114090	\N	Personalized tacrolimus doses determined by CYP3A5 genotype for induction and maintenance phases of kidney transplantation.	{"Vannaprasaht Suda","Reungjui Sirirat","Supanya Darika","Sirivongs Dhavee","Pongskul Cholatip","Avihingsanon Yingyos","Tassaneeyakul Wichittra"}	Clinical therapeutics	11	\N	\N	2013	24120259	\N	\N	\N	2	f	\N
114103	\N	In vivo CYP3A4 activity, CYP3A5 genotype, and hematocrit predict tacrolimus dose requirements and clearance in renal transplant patients.	{"de Jonge H","de Loor H","Verbeke K","Vanrenterghem Y","Kuypers D R"}	Clinical pharmacology and therapeutics	9	\N	\N	2012	22871995	\N	\N	\N	2	f	\N
114105	\N	The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients.	{"Haufroid Vincent","Mourad Michel","Van Kerckhove Valérie","Wawrzyniak Jeremie","De Meyer Martine","Eddour Djamila Chaib","Malaise Jacques","Lison Dominique","Squifflet Jean-Paul","Wallemacq Pierre"}	Pharmacogenetics	3	\N	\N	2004	15167702	\N	\N	\N	2	f	\N
114107	\N	Analysis of CYP3A4*1B and CYP3A5*3 polymorphisms in population of Bosnia and Herzegovina.	{"Semiz Sabina","Dujić Tanja","Ostanek Barbara","Prnjavorac Besim","Bego Tamer","Malenica Maja","Mlinar Barbara","Marc Janja","Causević Adlija"}	Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina	2	\N	\N	2011	21263403	\N	\N	\N	2	f	\N
114112	\N	CYP3A5 genetic polymorphisms in different ethnic populations.	{"Roy Jean-Nicholas","Lajoie Julie","Zijenah Lynn S","Barama Azemi","Poirier Charles","Ward Brian J","Roger Michel"}	Drug metabolism and disposition: the biological fate of chemicals	7	\N	\N	2005	15833928	\N	\N	\N	2	f	\N
114116	\N	Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus.	{"Hesselink Dennis A","van Schaik Ron H N","van der Heiden Ilse P","van der Werf Marloes","Gregoor Peter J H Smak","Lindemans Jan","Weimar Willem","van Gelder Teun"}	Clinical pharmacology and therapeutics	9	\N	\N	2003	12966368	\N	\N	\N	2	f	\N
114122	\N	Ethnic differences in the distribution of CYP3A5 gene polymorphisms.	{"Quaranta S","Chevalier D","Allorge D","Lo-Guidice J M","Migot-Nabias F","Kenani A","Imbenotte M","Broly F","Lacarelle B","Lhermitte M"}	Xenobiotica; the fate of foreign compounds in biological systems	12	\N	\N	2006	17162466	\N	\N	\N	2	f	\N
114124	\N	Population pharmacokinetics and pharmacogenetics of tacrolimus in de novo pediatric kidney transplant recipients.	{"Zhao W","Elie V","Roussey G","Brochard K","Niaudet P","Leroy V","Loirat C","Cochat P","Cloarec S","André J L","Garaix F","Bensman A","Fakhoury M","Jacqz-Aigrain E"}	Clinical pharmacology and therapeutics	12	\N	\N	2009	19865079	\N	\N	\N	2	f	\N
114126	\N	Differential impact of the CYP3A5*1 and CYP3A5*3 alleles on pre-dose concentrations of two tacrolimus formulations.	{"Wehland Markus","Bauer Steffen","Brakemeier Susanne","Burgwinkel Philip","Glander Petra","Kreutz Reinhold","Lorkowski Christine","Slowinski Torsten","Neumayer Hans H","Budde Klemens"}	Pharmacogenetics and genomics	4	\N	\N	2011	20818295	\N	\N	\N	2	f	\N
114130	\N	CYP3A5 genotype markedly influences the pharmacokinetics of tacrolimus and sirolimus in kidney transplant recipients.	{"Renders L","Frisman M","Ufer M","Mosyagin I","Haenisch S","Ott U","Caliebe A","Dechant M","Braun F","Kunzendorf U","Cascorbi I"}	Clinical pharmacology and therapeutics	2	\N	\N	2007	17192769	\N	\N	\N	2	f	\N
114134	\N	Influence of CYP3A5 and ABCB1 gene polymorphisms and other factors on tacrolimus dosing in Caucasian liver and kidney transplant patients.	{"Provenzani Alessio","Notarbartolo Monica","Labbozzetta Manuela","Poma Paola","Vizzini Giovanni","Salis Paola","Caccamo Chiara","Bertani Tullio","Palazzo Ugo","Polidori Piera","Gridelli Bruno","D'Alessandro Natale"}	International journal of molecular medicine	12	\N	\N	2011	21922127	\N	\N	\N	2	f	\N
114136	\N	The interactions of age, sex, body mass index, genetics, and steroid weight-based doses on tacrolimus dosing requirement after adult kidney transplantation.	{"Stratta P","Quaglia M","Cena T","Antoniotti R","Fenoglio R","Menegotto A","Ferrante D","Genazzani A","Terrazzino S","Magnani C"}	European journal of clinical pharmacology	5	\N	\N	2012	22101623	\N	\N	\N	2	f	\N
114140	\N	The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in Caucasian liver transplant patients.	{"Provenzani Alessio","Notarbartolo Monica","Labbozzetta Manuela","Poma Paola","Biondi Filippo","Sanguedolce Rosario","Vizzini Giovanni","Palazzo Ugo","Polidori Piera","Triolo Fabio","Gridelli Bruno","D'Alessandro Natale"}	Annals of transplantation	0	\N	\N	2009	19289993	\N	\N	\N	2	f	\N
114142	\N	Association between CYP3A5 polymorphisms and blood pressure in kidney transplant recipients receiving calcineurin inhibitors.	{"Ferraresso Mariano","Turolo Stefano","Ghio Luciana","Tirelli Amedea S","Belingheri Mirco","Villa Roberta","Groppali Elena","Edefonti Alberto"}	Clinical and experimental hypertension (New York, N.Y. : 1993)	0	\N	\N	2011	21851254	\N	\N	\N	2	f	\N
114144	\N	The effect of CYP3A5 polymorphisms on the pharmacokinetics of tacrolimus in adolescent kidney transplant recipients.	{"Tirelli Silvia","Ferraresso Mariano","Ghio Luciana","Meregalli Elisa","Martina Valentina","Belingheri Mirco","Mattiello Camilla","Torresani Emilio","Edefonti Alberto"}	Medical science monitor : international medical journal of experimental and clinical research	5	\N	\N	2008	18443548	\N	\N	\N	2	f	\N
114150	\N	CYP3A5 and CYP3A4, but not ABCB1 polymorphisms affect tacrolimus dose-adjusted trough concentrations in kidney transplant recipients.	{"Kurzawski Mateusz","Dąbrowska Justyna","Dziewanowski Krzysztof","Domański Leszek","Perużyńska Magdalena","Droździk Marek"}	Pharmacogenomics	2	\N	\N	2014	24444408	\N	\N	\N	2	f	\N
114155	\N	CYP3A5*3 and CYP3A4*1B allele distribution and genotype combinations: differences between Spaniards and Central Americans.	{"Sinues Blanca","Vicente Jorge","Fanlo Ana","Vasquez Patricia","Medina Juan Carlos","Mayayo Esteban","Conde Blanca","Arenaz Izaskun","Martinez-Jarreta Begoña"}	Therapeutic drug monitoring	8	\N	\N	2007	17667794	\N	\N	\N	2	f	\N
114157	\N	Differences in CYP3A5*3 genotype distribution and combinations with other polymorphisms between Spaniards and Other Caucasian populations.	{"Gervasini Guillermo","Vizcaino Sonia","Gasiba Carolina","Carrillo Juan Antonio","Benitez Julio"}	Therapeutic drug monitoring	12	\N	\N	2005	16306861	\N	\N	\N	2	f	\N
114159	\N	Impact of donor and recipient CYP3A5 and ABCB1 genetic polymorphisms on tacrolimus dosage requirements and rejection in Caucasian Spanish liver transplant patients.	{"Gómez-Bravo Miguel Angel","Salcedo Magdalena","Fondevila Constantino","Suarez Francisco","Castellote José","Rufian Sebastián","Pons José Antonio","Alamo José María","Millán Olga","Brunet Mercè"}	Journal of clinical pharmacology	11	\N	\N	2013	23900887	\N	\N	\N	2	f	\N
114163	\N	Increased hospital stay and allograft dysfunction in renal transplant recipients with Cyp2c19 AA variant in SNP rs4244285.	{"Bosó Virginia","Herrero María José","Bea Sergio","Galiana María","Marrero Patricia","Marqués María Remedios","Hernández Julio","Sánchez-Plumed Jaime","Poveda José Luis","Aliño Salvador F"}	Drug metabolism and disposition: the biological fate of chemicals	2	\N	\N	2013	23175667	\N	\N	\N	2	f	\N
114167	\N	Impact of genetic polymorphisms on tacrolimus pharmacokinetics and the clinical outcome of renal transplantation.	{"Gervasini Guillermo","Garcia Montserrat","Macias Rosa María","Cubero Juan Jose","Caravaca Francisco","Benitez Julio"}	Transplant international : official journal of the European Society for Organ Transplantation	4	\N	\N	2012	22369694	\N	\N	\N	2	f	\N
114169	\N	Pharmacogenetics of tacrolimus after renal transplantation: analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes.	{"Tavira Beatriz","Coto Eliecer","Garciá Eliecer Coto","Díaz-Corte Carmen","Ortega Francisco","Arias Manuel","Torres Armando","Díaz Juan M","Selgas Rafael","López-Larrea Carlos","Campistol Josep M","Alvarez Victoria","Alvarezca Victoria","REDINREN Pharmacogenetics group"}	Clinical chemistry and laboratory medicine	5	\N	\N	2011	21480817	\N	\N	\N	2	f	\N
114171	\N	Clinical relevance and prevalence of polymorphisms in CYP3A5 and MDR1 genes that encode tacrolimus biotransformation enzymes in liver transplant recipients.	{"Barrera-Pulido L","Aguilera-García I","Docobo-Pérez F","Alamo-Martínez J M","Pareja-Ciuró F","Nuñez-Roldán A","Gómez-Bravo M A","Bernardos-Rodríguez A"}	Transplantation proceedings	11	\N	\N	2008	19010156	\N	\N	\N	2	f	\N
114173	\N	CYP3A5 genotype has significant effect on quinine 3-hydroxylation in Tanzanians, who have lower total CYP3A activity than a Swedish population.	{"Mirghani Rajaa A","Sayi Jane","Aklillu Eleni","Allqvist Annika","Jande Mary","Wennerholm Agneta","Eriksen Jaran","Herben Virginie M M","Jones Barry C","Gustafsson Lars L","Bertilsson Leif"}	Pharmacogenetics and genomics	9	\N	\N	2006	16906018	\N	\N	\N	2	f	\N
114177	\N	Relationship of CYP3A5 genotype and ABCB1 diplotype to tacrolimus disposition in Brazilian kidney transplant patients.	{"Cusinato Diego Alberto C","Lacchini Riccardo","Romao Elen A","Moysés-Neto Miguel","Coelho Eduardo B"}	British journal of clinical pharmacology	8	\N	\N	2014	24528196	\N	\N	\N	2	f	\N
114179	\N	Global pharmacogenomics: distribution of CYP3A5 polymorphisms and phenotypes in the Brazilian population.	{"Suarez-Kurtz Guilherme","Vargens Daniela D","Santoro Ana Beatriz","Hutz Mara H","de Moraes Maria Elisabete","Pena Sérgio D J","Ribeiro-dos-Santos Ândrea","Romano-Silva Marco A","Struchiner Claudio José"}	PloS one	0	\N	\N	2014	24427273	\N	\N	\N	2	f	\N
114185	\N	CYP3A5 polymorphism in Mexican renal transplant recipients and its association with tacrolimus dosing.	{"García-Roca Pilar","Medeiros Mara","Reyes Herlinda","Rodríguez-Espino Benjamín Antonio","Alberú Josefina","Ortiz Lourdes","Vásquez-Perdomo Mayela","Elizondo Guillermo","Morales-Buenrostro Luis Eduardo","Mancilla Urrea Eduardo","Castañeda-Hernández Gilberto"}	Archives of medical research	5	\N	\N	2012	22704849	\N	\N	\N	2	f	\N
114193	\N	Frequencies of CYP3A5*1/*3 variants in a Moroccan population and effect on tacrolimus daily dose requirements in renal transplant patients.	{"Elmachad Mustapha","Elkabbaj Driss","Elkerch Fatiha","Laarabi Fatima Zahra","Barkat Amina","Oualim Zouhir","Sefiani Abdelaziz"}	Genetic testing and molecular biomarkers	6	\N	\N	2012	22304537	\N	\N	\N	2	f	\N
114202	\N	Association between tacrolimus concentration and genetic polymorphisms of CYP3A5 and ABCB1 during the early stage after liver transplant in an Iranian population.	{"Rahsaz Marjan","Azarpira Negar","Nikeghbalian Saman","Aghdaie Mahdokht H","Geramizadeh Bita","Moini Maryam","Banihashemi Mehrzad","Darai Masumeh","Malekpour Zahra","Malekhosseini Seid Ali"}	Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation	2	\N	\N	2012	22309416	\N	\N	\N	2	f	\N
114208	\N	A Markov chain model to evaluate the effect of CYP3A5 and ABCB1 polymorphisms on adverse events associated with tacrolimus in pediatric renal transplantation.	{"Sy Sherwin K B","Heuberger Jules","Shilbayeh Sireen","Conrado Daniela J","Derendorf Hartmut"}	The AAPS journal	10	\N	\N	2013	23990505	\N	\N	\N	2	f	\N
114210	\N	The impact of CYP3A5 and MDR1 polymorphisms on tacrolimus dosage requirements and trough concentrations in pediatric renal transplant recipients.	{"Shilbayeh Sireen","Zmeili Rawan","Almardini Reham Issa"}	Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia	11	\N	\N	2013	24231473	\N	\N	\N	2	f	\N
114227	\N	Sex and CYP3A5 genotype influence total CYP3A activity: high CYP3A activity and a unique distribution of CYP3A5 variant alleles in Ethiopians.	{"Gebeyehu E","Engidawork E","Bijnsdorp A","Aminy A","Diczfalusy U","Aklillu E"}	The pharmacogenomics journal	4	\N	\N	2011	20231858	\N	\N	\N	2	f	\N
114253	\N	Genetic polymorphisms in MDR1, CYP3A4 and CYP3A5 genes in a Ghanaian population: a plausible explanation for altered metabolism of ivermectin in humans?	{"Kudzi William","Dodoo Alexander N O","Mills Jeremy J"}	BMC medical genetics	7	\N	\N	2010	20630055	\N	\N	\N	2	f	\N
113839	\N	Influence of CYP4F2 rs2108622 (V433M) on warfarin dose requirement in Asian patients.	{"Singh Onkar","Sandanaraj Edwin","Subramanian Koilan","Lee Lai Heng","Chowbay Balram"}	Drug metabolism and pharmacokinetics	0	\N	\N	2011	21084764	\N	\N	\N	2	f	\N
113843	\N	Effect of NQO1 and CYP4F2 genotypes on warfarin dose requirements in Hispanic-Americans and African-Americans.	{"Bress Adam","Patel Shitalben R","Perera Minoli A","Campbell Richard T","Kittles Rick A","Cavallari Larisa H"}	Pharmacogenomics	12	\N	\N	2012	23215885	\N	\N	\N	2	f	\N
113895	\N	CYP4F2 genetic variant alters required warfarin dose.	{"Caldwell Michael D","Awad Tarif","Johnson Julie A","Gage Brian F","Falkowski Mat","Gardina Paul","Hubbard Jason","Turpaz Yaron","Langaee Taimour Y","Eby Charles","King Cristi R","Brower Amy","Schmelzer John R","Glurich Ingrid","Vidaillet Humberto J","Yale Steven H","Qi Zhang Kai","Berg Richard L","Burmester James K"}	Blood	4	\N	\N	2008	18250228	\N	\N	\N	2	f	\N
113899	\N	Effects of CYP4F2 polymorphism on response to warfarin during induction phase: a prospective, open-label, observational cohort study.	{"Bejarano-Achache Idit","Levy Liran","Mlynarsky Liat","Bialer Meir","Muszkat Mordechai","Caraco Yoseph"}	Clinical therapeutics	4	\N	\N	2012	22417713	\N	\N	\N	2	f	\N
113914	\N	Genome at juncture of early human migration: a systematic analysis of two whole genomes and thirteen exomes from Kuwaiti population subgroup of inferred Saudi Arabian tribe ancestry.	{"Alsmadi Osama","John Sumi E","Thareja Gaurav","Hebbar Prashantha","Antony Dinu","Behbehani Kazem","Thanaraj Thangavel Alphonse"}	PloS one	0	\N	\N	2014	24896259	\N	\N	\N	2	f	\N
117252	\N	Analysis of protein-coding genetic variation in 60,706 humans.	{"Lek Monkol","Karczewski Konrad J","Minikel Eric V","Samocha Kaitlin E","Banks Eric","Fennell Timothy","O'Donnell-Luria Anne H","Ware James S","Hill Andrew J","Cummings Beryl B","Tukiainen Taru","Birnbaum Daniel P","Kosmicki Jack A","Duncan Laramie E","Estrada Karol","Zhao Fengmei","Zou James","Pierce-Hoffman Emma","Berghout Joanne","Cooper David N","Deflaux Nicole","DePristo Mark","Do Ron","Flannick Jason","Fromer Menachem","Gauthier Laura","Goldstein Jackie","Gupta Namrata","Howrigan Daniel","Kiezun Adam","Kurki Mitja I","Moonshine Ami Levy","Natarajan Pradeep","Orozco Lorena","Peloso Gina M","Poplin Ryan","Rivas Manuel A","Ruano-Rubio Valentin","Rose Samuel A","Ruderfer Douglas M","Shakir Khalid","Stenson Peter D","Stevens Christine","Thomas Brett P","Tiao Grace","Tusie-Luna Maria T","Weisburd Ben","Won Hong-Hee","Yu Dongmei","Altshuler David M","Ardissino Diego","Boehnke Michael","Danesh John","Donnelly Stacey","Elosua Roberto","Florez Jose C","Gabriel Stacey B","Getz Gad","Glatt Stephen J","Hultman Christina M","Kathiresan Sekar","Laakso Markku","McCarroll Steven","McCarthy Mark I","McGovern Dermot","McPherson Ruth","Neale Benjamin M","Palotie Aarno","Purcell Shaun M","Saleheen Danish","Scharf Jeremiah M","Sklar Pamela","Sullivan Patrick F","Tuomilehto Jaakko","Tsuang Ming T","Watkins Hugh C","Wilson James G","Daly Mark J","MacArthur Daniel G","Exome Aggregation Consortium"}	Nature	8	\N	\N	2016	27535533	\N	\N	\N	2	f	\N
113528	\N	Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations.	{"González-Galarza Faviel F","Takeshita Louise Y C","Santos Eduardo J M","Kempson Felicity","Maia Maria Helena Thomaz","da Silva Andrea Luciana Soares","Teles e Silva André Luiz","Ghattaoraya Gurpreet S","Alfirevic Ana","Jones Andrew R","Middleton Derek"}	Nucleic acids research	1	\N	\N	2015	25414323	\N	\N	\N	2	f	\N
113539	\N	High-resolution HLA allele and haplotype frequencies in majority and minority populations of Costa Rica and Nicaragua: Differential admixture proportions in neighboring countries.	{"Arrieta-Bolaños E","Madrigal-Sánchez J J","Stein J E","Órlich-Pérez P","Moreira-Espinoza M J","Paredes-Carias E","Vanegas-Padilla Y","Salazar-Sánchez L","Madrigal J A","Marsh S G E","Shaw B E"}	HLA	6	\N	\N	2018	29687625	\N	\N	\N	2	f	\N
113559	\N	Study of Colombia North Wiwa El Encanto Amerindians HLA- genes: Pacific Islanders relatedness.	{"Arnaiz-Villena Antonio","Palacio-Grüber Jose","Juarez Ignacio","Muñiz Ester","Hernández Ennio","Bayona Brayan","Campos Cristina","Nuñez Jorge","Lopez-Nares Adrian","Martin-Villa Manuel","Silvera Carlos"}	Human immunology	7	\N	\N	2018	29729321	\N	\N	\N	2	f	\N
113563	\N	HLA-B*15:02 association with carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in an Indian population: a pooled-data analysis and meta-analysis.	{"Khor Amy Hui-Ping","Lim Kheng-Seang","Tan Chong-Tin","Wong Su-Ming","Ng Ching-Ching"}	Epilepsia	11	\N	\N	2014	25266342	\N	\N	\N	2	f	\N
113574	\N	Human leucocyte antigen (HLA)-A, -B, -C, -DRB1 and -DQB1 haplotype frequencies from 2491 cord blood units from Tamil speaking population from Tamil Nadu, India.	{"Narayan Saranya","Maiers Martin","Halagan Mike","Sathishkannan Arunadevi","Naganathan Chandramouleeswaran","Madbouly Abeer","Periathiruvadi Srinivasan"}	Molecular biology reports	12	\N	\N	2018	30229475	\N	\N	\N	2	f	\N
113576	\N	HLA Allele Frequencies in 5802 Koreans: Varied Allele Types Associated with SJS/TEN According to Culprit Drugs.	{"Park Hye Jung","Kim Young Joo","Kim Dong Hyun","Kim Junho","Park Kyung Hee","Park Jung Won","Lee Jae Hyun"}	Yonsei medical journal	1	\N	\N	2016	26632391	\N	\N	\N	2	f	\N
113578	\N	HLA-B allele and haplotype diversity among Thai patients identified by PCR-SSOP: evidence for high risk of drug-induced hypersensitivity.	{"Puangpetch Apichaya","Koomdee Napatrupron","Chamnanphol Montri","Jantararoungtong Thawinee","Santon Siwalee","Prommas Santirhat","Hongkaew Yaowaluck","Sukasem Chonlaphat"}	Frontiers in genetics	0	\N	\N	2014	25657656	\N	\N	\N	2	f	\N
113580	\N	HLA-A, HLA-B and HLA-DRB1 allele and haplotype frequencies of 10 918 Koreans from bone marrow donor registry in Korea.	{"Park H","Lee Y-J","Song E Y","Park M H"}	International journal of immunogenetics	10	\N	\N	2016	27511726	\N	\N	\N	2	f	\N
113582	\N	HLA-A, -B and -DRB1 allele and haplotype frequencies of 8333 Chinese Han from the Zhejiang province, China.	{"He Y","Zhang W","Chen N","Wang W","He J","Han Z","Tao S","Dong L","Zhu F","Lv H"}	International journal of immunogenetics	4	\N	\N	2016	26919533	\N	\N	\N	2	f	\N
115400	\N	Determination of HLA-A, -C, -B, -DRB1 allele and haplotype frequency in Japanese population based on family study.	{"Ikeda N","Kojima H","Nishikawa M","Hayashi K","Futagami T","Tsujino T","Kusunoki Y","Fujii N","Suegami S","Miyazaki Y","Middleton D","Tanaka H","Saji H"}	Tissue antigens	4	\N	\N	2015	25789826	\N	\N	\N	2	f	\N
113584	\N	The Adaptive Change of HLA-DRB1 Allele Frequencies Caused by Natural Selection in a Mongolian Population That Migrated to the South of China.	{"Sun Hao","Yang Zhaoqing","Lin Keqin","Liu Shuyuan","Huang Kai","Wang Xiuyun","Chu Jiayou","Huang Xiaoqin"}	PloS one	0	\N	\N	2015	26230582	\N	\N	\N	2	f	\N
113656	\N	Distribution of HLA-A, -B, and -C alleles and HLA/KIR combinations in Han population in China.	{"Shen Yunsong","Cao Danfeng","Li Yalin","Kulski J K","Shi Lei","Jiang Hongjun","Ma Qianli","Yu Jiankun","Zhou Jingxian","Yao Yufeng","Shi Li"}	Journal of immunology research	0	\N	\N	2014	24995346	\N	\N	\N	2	f	\N
113660	\N	HLA alleles and haplotypes in Burmese (Myanmarese) and Karen in Thailand.	{"Kongmaroeng C","Romphruk A","Puapairoj C","Leelayuwat C","Kulski J K","Inoko H","Dunn D S","Romphruk A V"}	Tissue antigens	9	\N	\N	2015	26265055	\N	\N	\N	2	f	\N
113665	\N	Allelic and haplotype diversity of HLA-A, HLA-B and HLA-DRB1 gene at high resolution in the Nanning Han population.	{"Pei YongFeng","Huang HuiNi","Li HengCong","Chen JieRun","Wu GuoGuang"}	International journal of immunogenetics	8	\N	\N	2018	29908012	\N	\N	\N	2	f	\N
113667	\N	HLA Pharmacogenetic Markers of Drug Hypersensitivity in a Thai Population.	{"Nakkam Nontaya","Konyoung Parinya","Kanjanawart Sirimas","Saksit Niwat","Kongpan Thachanan","Khaeso Kanyarat","Khunarkornsiri Usanee","Dornsena Areerat","Tassaneeyakul Wongwiwat","Tassaneeyakul Wichittra"}	Frontiers in genetics	0	\N	\N	2018	30127801	\N	\N	\N	2	f	\N
113669	\N	Full-length next-generation sequencing of HLA class I and II genes in a cohort from Thailand.	{"Geretz Aviva","Ehrenberg Philip K","Bouckenooghe Alain","Fernández Viña Marcelo A","Michael Nelson L","Chansinghakule Danaya","Limkittikul Kriengsak","Thomas Rasmi"}	Human immunology	11	\N	\N	2018	30243890	\N	\N	\N	2	f	\N
113673	\N	Prevalence of HLA-DQA1 alleles and haplotypes in blood donors resident in Wales.	{"Lemin A J","Darke C"}	International journal of immunogenetics	12	\N	\N	2014	25345618	\N	\N	\N	2	f	\N
113753	\N	HLA-A, -B, -C, -DRB1 and -DQB1 allele and haplotype frequencies in the Serbian population.	{"Andric Zorana","Popadic Dusan","Jovanovic Barbara","Jaglicic Ivana","Bojic Svetlana","Simonovic Ruzica"}	Human immunology	3	\N	\N	2014	24374041	\N	\N	\N	2	f	\N
113757	\N	High-resolution HLA-A, HLA-B, and HLA-DRB1 haplotype frequencies from the French Bone Marrow Donor Registry.	{"Gourraud Pierre-Antoine","Pappas Derek James","Baouz Amar","Balère Marie-Lorraine","Garnier Federico","Marry Evelyne"}	Human immunology	5	\N	\N	2015	25637665	\N	\N	\N	2	f	\N
113774	\N	Population variation of HLA genes in rural communities in Brazil, the Quilombos from the Vale do Ribeira, São Paulo - Brazil.	{"Nunes Kelly","Piovezan Bruno","Torres Margareth A","Pontes Gerlndia N","Kimura Lilian","Carnavalli Juliana E P","Mingroni Netto Regina Célia","Moraes Maria Elisa","Meyer Diogo"}	Human immunology	6	\N	\N	2016	27060779	\N	\N	\N	2	f	\N
115614	\N	Frequency of HLA-A alleles in the Syrian population genotyped by sequence-based typing.	{"Madania A","Ghoury I","Al-Ashkar W","Nweder S","Zarzour H"}	International journal of immunogenetics	10	\N	\N	2014	25053398	\N	\N	\N	2	f	\N
113814	\N	Human Leukocyte Antigen (HLA) Class I and II Polymorphism in Iranian Healthy Population from Yazd Province.	{"Nikbin Behrouz","Nicknam Mohammad Hossein","Hadinedoushan Hossein","Ansaripour Bita","Moradi Batol","Yekaninejad Mirsaeed","Aminikhah Mahdi","Ranjbar Mohammad Mehdi","Amirzargar Aliakbar"}	Iranian journal of allergy, asthma, and immunology	2	\N	\N	2017	28417619	\N	\N	\N	2	f	\N
113759	\N	HLA-A, -B, -C, -DRB1 and -DQB1 allele and haplotype frequencies in a population of 432 healthy unrelated individuals from Albania.	{"Sulcebe Genc","Shyti Erkena"}	Human immunology	8	\N	\N	2016	27262454	\N	\N	\N	2	f	\N
117595	\N	Frequency of the SLCO1B1 388A>G and the 521T>C polymorphism in Tanzania genotyped by a new LightCycler&reg;-based method.	{"Aklillu Eleni","Mugusi Sabina","Ngaimisi Eliford","Hoffmann Michael Marcus","König Sonja","Ziesenitz Victoria","Mikus Gerd","Haefeli Walter Emil","Weiss Johanna"}	European journal of clinical pharmacology	11	\N	\N	2011	21630030	\N	\N	\N	2	f	\N
115325	\N	NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity.	{"Moriyama Takaya","Nishii Rina","Perez-Andreu Virginia","Yang Wenjian","Klussmann Federico Antillon","Zhao Xujie","Lin Ting-Nien","Hoshitsuki Keito","Nersting Jacob","Kihira Kentaro","Hofmann Ute","Komada Yoshihiro","Kato Motohiro","McCorkle Robert","Li Lie","Koh Katsuyoshi","Najera Cesar Rolando","Kham Shirley Kow-Yin","Isobe Tomoya","Chen Zhiwei","Chiew Edwynn Kean-Hui","Bhojwani Deepa","Jeffries Cynthia","Lu Yan","Schwab Matthias","Inaba Hiroto","Pui Ching-Hon","Relling Mary V","Manabe Atsushi","Hori Hiroki","Schmiegelow Kjeld","Yeoh Allen E J","Evans William E","Yang Jun J"}	Nature genetics	4	\N	\N	2016	26878724	\N	\N	\N	2	f	\N
115335	\N	NUDT15 p.R139C variant is common and strongly associated with azathioprine-induced early leukopenia and severe alopecia in Korean patients with various neurological diseases.	{"Kim Sun-Young","Shin Jin-Hong","Park Jin-Sung","Kang Sa-Yoon","Nam Tai-Seung","Kim Jong Kuk","Park Ki-Jong","Huh So-Young","Oh Ji Seon","Kang Boram","Kim Dae-Seong"}	Journal of the neurological sciences	7	\N	\N	2017	28566182	\N	\N	\N	2	f	\N
117539	\N	Global analysis of genetic variation in SLCO1B1.	{"Pasanen Marja K","Neuvonen Pertti J","Niemi Mikko"}	Pharmacogenomics	1	\N	\N	2008	18154446	\N	\N	\N	2	f	\N
117541	\N	Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment.	{"Lee Edmund","Ryan Stephen","Birmingham Bruce","Zalikowski Julie","March Ruth","Ambrose Helen","Moore Rachael","Lee Caroline","Chen Yusong","Schneck Dennis"}	Clinical pharmacology and therapeutics	10	\N	\N	2005	16198652	\N	\N	\N	2	f	\N
117543	\N	Pharmacogenetics of SLCO1B1 gene and the impact of *1b and *15 haplotypes on irinotecan disposition in Asian cancer patients.	{"Xiang Xiaoqiang","Jada Srinivasa Rao","Li Hui Hua","Fan Lu","Tham Lai San","Wong Chiung Ing","Lee Soo Chin","Lim Robert","Zhou Qing Yu","Goh Boon Cher","Tan Eng Huat","Chowbay Balram"}	Pharmacogenetics and genomics	9	\N	\N	2006	16906022	\N	\N	\N	2	f	\N
117548	\N	Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese population and functional analysis.	{"Nozawa Takashi","Nakajima Miki","Tamai Ikumi","Noda Kumiko","Nezu Jun-Ichi","Sai Yoshimichi","Tsuji Akira","Yokoi Tsuyoshi"}	The Journal of pharmacology and experimental therapeutics	8	\N	\N	2002	12130747	\N	\N	\N	2	f	\N
117550	\N	Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics.	{"Nishizato Yohei","Ieiri Ichiro","Suzuki Hiroshi","Kimura Miyuki","Kawabata Kiyoshi","Hirota Takeshi","Takane Hiroshi","Irie Shin","Kusuhara Hiroyuki","Urasaki Yoko","Urae Akinori","Higuchi Shun","Otsubo Kenji","Sugiyama Yuichi"}	Clinical pharmacology and therapeutics	6	\N	\N	2003	12811365	\N	\N	\N	2	f	\N
117552	\N	Effect of OATP1B1 (SLCO1B1) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers.	{"Chung Jae-Yong","Cho Joo-Youn","Yu Kyung-Sang","Kim Jung-Ryul","Oh Dal-Seok","Jung Hye-Ryung","Lim Kyoung-Soo","Moon Ki-Ho","Shin Sang-Goo","Jang In-Jin"}	Clinical pharmacology and therapeutics	10	\N	\N	2005	16198653	\N	\N	\N	2	f	\N
117557	\N	Influence of the organic anion-transporting polypeptide 1B1 (OATP1B1) polymorphisms on irinotecan-pharmacokinetics and clinical outcome of patients with advanced non-small cell lung cancer.	{"Han Ji-Youn","Lim Hyeong-Seok","Shin Eun Soon","Yoo Yeon-Kyeong","Park Yong Hoon","Lee Jong-Eun","Kim Heung Tae","Lee Jin Soo"}	Lung cancer (Amsterdam, Netherlands)	1	\N	\N	2008	17766002	\N	\N	\N	2	f	\N
117561	\N	Duplex pyrosequencing assay of the 388A>G and 521T>C SLCO1B1 polymorphisms in three Asian populations.	{"Kim Eun-Young","Cho Doo-Yeoun","Shin Ho-Jung","Lee Sang-Seop","Shon Ji-Hong","Shin Jae-Gook","Shin Sang-Goo"}	Clinica chimica acta; international journal of clinical chemistry	2	\N	\N	2008	17996736	\N	\N	\N	2	f	\N
117566	\N	Genetic variations and frequencies of major haplotypes in SLCO1B1 encoding the transporter OATP1B1 in Japanese subjects: SLCO1B1*17 is more prevalent than *15.	{"Kim Su-Ryang","Saito Yoshiro","Sai Kimie","Kurose Kouichi","Maekawa Keiko","Kaniwa Nahoko","Ozawa Shogo","Kamatani Naoyuki","Shirao Kuniaki","Yamamoto Noboru","Hamaguchi Tetsuya","Kunitoh Hideo","Ohe Yuichiro","Yamada Yasuhide","Tamura Tomohide","Yoshida Teruhiko","Minami Hironobu","Ohtsu Atsushi","Saijo Nagahiro","Sawada Jun-ichi"}	Drug metabolism and pharmacokinetics	12	\N	\N	2007	18159134	\N	\N	\N	2	f	\N
117568	\N	Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients.	{"Miura Masatomo","Kagaya Hideaki","Satoh Shigeru","Inoue Kazuyuki","Saito Mitsuru","Habuchi Tomonori","Suzuki Toshio"}	Therapeutic drug monitoring	10	\N	\N	2008	18695635	\N	\N	\N	2	f	\N
117580	\N	Frequencies of single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide 1B1 SLCO1B1 gene in a Finnish population.	{"Pasanen Marja K","Backman Janne T","Neuvonen Pertti J","Niemi Mikko"}	European journal of clinical pharmacology	6	\N	\N	2006	16758257	\N	\N	\N	2	f	\N
117583	\N	The polymorphisms Asn130Asp and Val174Ala in OATP1B1 and the CYP2C9 allele *3 independently affect torsemide pharmacokinetics and pharmacodynamics.	{"Vormfelde S V","Toliat M R","Schirmer M","Meineke I","Nürnberg P","Brockmöller J"}	Clinical pharmacology and therapeutics	6	\N	\N	2008	18043684	\N	\N	\N	2	f	\N
117589	\N	The role of organic anion-transporting polypeptides and their common genetic variants in mycophenolic acid pharmacokinetics.	{"Picard N","Yee S W","Woillard J-B","Lebranchu Y","Le Meur Y","Giacomini K M","Marquet P"}	Clinical pharmacology and therapeutics	1	\N	\N	2010	19890249	\N	\N	\N	2	f	\N
117591	\N	Pharmacogenetic interactions between ABCB1 and SLCO1B1 tagging SNPs and the effectiveness of statins in the prevention of myocardial infarction.	{"Peters Bas J M","Rodin Andrei S","Klungel Olaf H","van Duijn Cornelia M","Stricker Bruno H Ch","van't Slot Ruben","de Boer Anthonius","Maitland-van der Zee Anke-Hilse"}	Pharmacogenomics	8	\N	\N	2010	20712525	\N	\N	\N	2	f	\N
117593	\N	Organic anion transporting polypeptide 1B1 (OATP1B1) and OATP1B3: genetic variability and haplotype analysis in white Canadians.	{"Boivin Andrée-Anne","Cardinal Héloïse","Barama Azemi","Pichette Vincent","Hébert Marie-Josée","Roger Michel"}	Drug metabolism and pharmacokinetics	0	\N	\N	2010	20877131	\N	\N	\N	2	f	\N
115070	\N	Gene mutation of thiopurine S-methyltransferase in Uygur Chinese.	{"Zhang Jian-Ping","Guan Yong-Yuan","Xu An-Long","Zhou Shu-Feng","Wu Jue-Heng","Wei Hong","Huang Min"}	European journal of clinical pharmacology	3	\N	\N	2004	14985891	\N	\N	\N	2	f	\N
114883	\N	An integrated map of structural variation in 2,504 human genomes.	{"Sudmant Peter H","Rausch Tobias","Gardner Eugene J","Handsaker Robert E","Abyzov Alexej","Huddleston John","Zhang Yan","Ye Kai","Jun Goo","Fritz Markus Hsi-Yang","Konkel Miriam K","Malhotra Ankit","Stütz Adrian M","Shi Xinghua","Casale Francesco Paolo","Chen Jieming","Hormozdiari Fereydoun","Dayama Gargi","Chen Ken","Malig Maika","Chaisson Mark J P","Walter Klaudia","Meiers Sascha","Kashin Seva","Garrison Erik","Auton Adam","Lam Hugo Y K","Mu Xinmeng Jasmine","Alkan Can","Antaki Danny","Bae Taejeong","Cerveira Eliza","Chines Peter","Chong Zechen","Clarke Laura","Dal Elif","Ding Li","Emery Sarah","Fan Xian","Gujral Madhusudan","Kahveci Fatma","Kidd Jeffrey M","Kong Yu","Lameijer Eric-Wubbo","McCarthy Shane","Flicek Paul","Gibbs Richard A","Marth Gabor","Mason Christopher E","Menelaou Androniki","Muzny Donna M","Nelson Bradley J","Noor Amina","Parrish Nicholas F","Pendleton Matthew","Quitadamo Andrew","Raeder Benjamin","Schadt Eric E","Romanovitch Mallory","Schlattl Andreas","Sebra Robert","Shabalin Andrey A","Untergasser Andreas","Walker Jerilyn A","Wang Min","Yu Fuli","Zhang Chengsheng","Zhang Jing","Zheng-Bradley Xiangqun","Zhou Wanding","Zichner Thomas","Sebat Jonathan","Batzer Mark A","McCarroll Steven A","1000 Genomes Project Consortium","Mills Ryan E","Gerstein Mark B","Bashir Ali","Stegle Oliver","Devine Scott E","Lee Charles","Eichler Evan E","Korbel Jan O"}	Nature	10	\N	\N	2015	26432246	\N	\N	\N	2	f	\N
114887	\N	Polymorphism of the thiopurine S-methyltransferase gene in African-Americans.	{"Hon Y Y","Fessing M Y","Pui C H","Relling M V","Krynetski E Y","Evans W E"}	Human molecular genetics	2	\N	\N	1999	9931346	\N	\N	\N	2	f	\N
116483	\N	Differences in UGT1A1, UGT1A7, and UGT1A9 polymorphisms between Uzbek and Japanese populations.	{"Maeda Hiromichi","Hazama Shoichi","Shavkat Abdiev","Okamoto Ken","Oba Koji","Sakamoto Junichi","Takahashi Kenichi","Oka Masaki","Nakamura Daisuke","Tsunedomi Ryouichi","Okayama Naoko","Mishima Hideyuki","Kobayashi Michiya"}	Molecular diagnosis & therapy	6	\N	\N	2014	24453052	\N	\N	\N	2	f	\N
114939	\N	The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations.	{"Collie-Duguid E S","Pritchard S C","Powrie R H","Sludden J","Collier D A","Li T","McLeod H L"}	Pharmacogenetics	2	\N	\N	1999	10208641	\N	\N	\N	2	f	\N
114941	\N	Prevalence of TPMT polymorphism in Indian patients requiring immunomodulator therapy and its clinical significance.	{"Davavala Sandeep Kirit","Desai Devendra C","Abraham Philip","Ashavaid Tester","Joshi Anand","Gupta Tarun"}	Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology	1	\N	\N	2014	23996738	\N	\N	\N	2	f	\N
114943	\N	Frequency of TPMT alleles in Indian patients with acute lymphatic leukemia and effect on the dose of 6-mercaptopurine.	{"Desire Salamun","Balasubramanian Poonkuzhali","Bajel Ashish","George Biju","Viswabandya Auro","Mathews Vikram","Srivastava Alok","Chandy Mammen"}	Medical oncology (Northwood, London, England)	12	\N	\N	2010	19830600	\N	\N	\N	2	f	\N
114947	\N	Application of SNaPshot for analysis of thiopurine methyltransferase gene polymorphism.	{"Kapoor Gauri","Maitra Arindam",Somlata,"Brahmachari Vani"}	The Indian journal of medical research	5	\N	\N	2009	19675376	\N	\N	\N	2	f	\N
114951	\N	Thiopurine methyltransferase polymorphisms in a multiracial asian population and children with acute lymphoblastic leukemia.	{"Kham S K Y","Tan P L","Tay A H N","Heng C K","Yeoh A E J","Quah Thuan-Chong"}	Journal of pediatric hematology/oncology	0	\N	\N	2002	12142782	\N	\N	\N	2	f	\N
114953	\N	Thiopurine S-methyltransferase activity in three major Asian populations: a population-based study in Singapore.	{"Kham Shirley Kow Yin","Soh Chin Kok","Liu Te Chih","Chan Yiong Huak","Ariffin Hany","Tan Poh Lin","Yeoh Allen Eng Juh"}	European journal of clinical pharmacology	4	\N	\N	2008	18193212	\N	\N	\N	2	f	\N
114957	\N	Thiopurine methyltransferase polymorphisms in children with acute lymphoblastic leukemia.	{"Linga Vijay Gandhi","Patchva Dorra Babu","Mallavarapu Krishna Mohan","Tulasi Venkata","Kalpathi Krishnamani Iyer","Pillai Ashok","Gundeti Sadashivudu","Rajappa Senthil J","Digumarti Raghunadharao"}	Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology	10	\N	\N	2014	25538405	\N	\N	\N	2	f	\N
114959	\N	Genotyping of eight polymorphic genes encoding drug-metabolizing enzymes and transporters using a customized oligonucleotide array.	{"Lu Yi","Kham Shirley Kow-Yin","Foo Toon-Chai","Ariffin Hany","Hany Ariffin","Quah Thuan-Chong","Yeoh Allen Eng-Juh"}	Analytical biochemistry	1	\N	\N	2007	17113562	\N	\N	\N	2	f	\N
114961	\N	Genetic determinants of the thiopurine methyltransferase intermediate activity phenotype in British Asians and Caucasians.	{"Marinaki Anthony M","Arenas Monica","Khan Zubair H","Lewis Cathryn M","Shobowale-Bakre El-Monsor","Escuredo Emilia","Fairbanks Lynette D","Mayberry John F","Wicks Antony C","Ansari Azhar","Sanderson Jeremy","Duley John A"}	Pharmacogenetics	2	\N	\N	2003	12563179	\N	\N	\N	2	f	\N
114965	\N	Inter and intra-ethnic differences in the distribution of the molecular variants of TPMT, UGT1A1 and MDR1 genes in the South Indian population.	{"Umamaheswaran Gurusamy","Krishna Kumar Dhakchinamoorthi","Kayathiri Dhandapani","Rajan Subramanian","Shewade Deepak Gopal","Dkhar Steven Aibor","Manjunath Sajjanavar","Ushakiran Prayaga","Reneega Gangadharan","Ritushree Kukreti","Adithan Chandrasekaran"}	Molecular biology reports	5	\N	\N	2012	22318545	\N	\N	\N	2	f	\N
114998	\N	Genetic polymorphisms of thiopurine S-methyltransferase and 6-mercaptopurine toxicity in Japanese children with acute lymphoblastic leukaemia.	{"Ando M","Ando Y","Hasegawa Y","Sekido Y","Shimokata K","Horibe K"}	Pharmacogenetics	4	\N	\N	2001	11337943	\N	\N	\N	2	f	\N
115000	\N	Analysis of thiopurine S-methyltransferase genotypes in Japanese patients with inflammatory bowel disease.	{"Ban Hiromitsu","Andoh Akira","Tanaka Aiko","Tsujikawa Tomoyuki","Sasaki Masaya","Saito Yasuharu","Fujiyama Yoshihide"}	Internal medicine (Tokyo, Japan)	0	\N	\N	2008	18827410	\N	\N	\N	2	f	\N
115004	\N	Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.	{"Cao Qian","Zhu Qin","Shang Yan","Gao Min","Si Jianmin"}	Digestion	0	\N	\N	2009	19252404	\N	\N	\N	2	f	\N
115006	\N	Molecular analysis of thiopurine S-methyltransferase alleles in South-east Asian populations.	{"Chang Jan-Gowth","Lee Long-Shyong","Chen Chih-Mei","Shih Mu-Chin","Wu Mei-Chen","Tsai Fuu-Jen","Liang Der-Cheng"}	Pharmacogenetics	4	\N	\N	2002	11927834	\N	\N	\N	2	f	\N
115009	\N	Association of thiopurine methyltransferase status with azathioprine side effects in Chinese patients with systemic lupus erythematosus.	{"Chen Dongying","Lian Fan","Yuan Shiwen","Wang Yixi","Zhan Zhongping","Ye Yujin","Qiu Qian","Xu Hanshi","Liang Liuqin","Yang Xiuyan"}	Clinical rheumatology	4	\N	\N	2014	24322830	\N	\N	\N	2	f	\N
115014	\N	Genetic analysis of thiopurine methyltransferase polymorphism in a Japanese population.	{"Hiratsuka M","Inoue T","Omori F","Agatsuma Y","Mizugaki M"}	Mutation research	3	\N	\N	2000	10751626	\N	\N	\N	2	f	\N
115016	\N	Frequency of thiopurine S-methyltransferase genetic variation in Thai children with acute leukemia.	{"Hongeng S","Sasanakul W","Chuansumrit A","Pakakasama S","Chattananon A","Hathirat P"}	Medical and pediatric oncology	10	\N	\N	2000	11025471	\N	\N	\N	2	f	\N
115020	\N	Correlation of genotypes for thiopurine methyltransferase and inosine triphosphate pyrophosphatase with long-term clinical outcomes in Korean patients with inflammatory bowel diseases during treatment with thiopurine drugs.	{"Jung Yoon Suk","Cheon Jae Hee","Park Jae Jun","Moon Chang Mo","Kim Eun Soo","Lee Jin Ha","Kim Seung Won","Kim Jae Hak","Hong Sung Pil","Kim Tae Il","Kim Won Ho"}	Journal of human genetics	2	\N	\N	2010	19960028	\N	\N	\N	2	f	\N
115024	\N	Influences of thiopurine methyltransferase genotype and activity on thiopurine-induced leukopenia in Korean patients with inflammatory bowel disease: a retrospective cohort study.	{"Kim Jae Hak","Cheon Jae Hee","Hong Seong Soo","Eun Chang Soo","Byeon Jeong-Sik","Hong Sung Yi","Kim Bo-Young","Kwon Soon-Ho","Kim Seung Won","Han Dong Soo","Yang Suk-Kyun","Kim Won Ho"}	Journal of clinical gastroenterology	0	\N	\N	2010	20308917	\N	\N	\N	2	f	\N
115026	\N	Pharmacogenetic analysis of pediatric patients with acute lymphoblastic leukemia: a possible association between survival rate and ITPA polymorphism.	{"Kim Hyery","Kang Hyoung Jin","Kim Hyo Jeong","Jang Mi Kyung","Kim Nam Hee","Oh Yongtaek","Han Byoung-Don","Choi Ji-Yeob","Kim Chul Woo","Lee Ji Won","Park Kyung Duk","Shin Hee Young","Ahn Hyo Seop"}	PloS one	0	\N	\N	2012	23029095	\N	\N	\N	2	f	\N
115028	\N	Complete sequence-based screening of TPMT variants in the Korean population.	{"Kim Hyun-Young","Lee Soo Hyun","Lee Mi-Na","Kim Jong-Won","Kim Young-Ho","Kim Mi Jin","Lee Yoo Min","Kang Ben","Choe Yon Ho","Lee Na Hee","Kim Dong Hwan","Yoo Keon Hee","Sung Ki Woong","Lee Soo-Youn","Koo Hong Hoe"}	Pharmacogenetics and genomics	3	\N	\N	2015	25564374	\N	\N	\N	2	f	\N
115032	\N	Frequency distribution of thiopurine S-methyltransferase activity in red blood cells of a healthy Japanese population.	{"Kubota Takahiro","Nishida Akihito","Takeuchi Ken","Iida Takayuki","Yokota Hiromitsu","Higashi Katsumi","Nakahara Kazuhiko","Hanai Hiroyuki","Iga Tatsuji"}	Therapeutic drug monitoring	6	\N	\N	2004	15167635	\N	\N	\N	2	f	\N
115036	\N	Duplex pyrosequencing of the TPMT*3C and TPMT*6 alleles in Korean and Vietnamese populations.	{"Lee Sang Seop","Kim Woo-Young","Jang Yin-Jin","Shin Jae-Gook"}	Clinica chimica acta; international journal of clinical chemistry	12	\N	\N	2008	18775689	\N	\N	\N	2	f	\N
115039	\N	Relationship between azathioprine dosage, 6-thioguanine nucleotide levels, and therapeutic response in pediatric patients with IBD treated with azathioprine.	{"Lee Mi-Na","Kang Ben","Choi So Yoon","Kim Mi Jin","Woo Sook Young","Kim Jong-Won","Choe Yon Ho","Lee Soo-Youn"}	Inflammatory bowel diseases	5	\N	\N	2015	25851563	\N	\N	\N	2	f	\N
115044	\N	Molecular analysis of the thiopurine S-methyltransferase alleles in Bolivians and Tibetans.	{"Lu H-F","Shih M-C","Hsueh S-C","Chen C-M","Chang J-Y","Chang J-G"}	Journal of clinical pharmacy and therapeutics	10	\N	\N	2005	16164497	\N	\N	\N	2	f	\N
115050	\N	Thiopurine methyltransferase genotype and phenotype status in Japanese patients with systemic lupus erythematosus.	{"Okada Yuko","Nakamura Katsunori","Kodama Tomoko","Ueki Kazue","Tsukada Yoshito","Maezawa Akira","Tsukamoto Norifumi","Nojima Yoshihisa","Ishizaki Takashi","Horiuchi Ryuya","Yamamoto Koujirou"}	Biological & pharmaceutical bulletin	11	\N	\N	2005	16272700	\N	\N	\N	2	f	\N
115052	\N	Accuracy of genotyping using the TaqMan PCR assay for single nucleotide polymorphisms responsible for thiopurine sensitivity in Japanese patients with inflammatory bowel disease.	{"Osaki Rie","Imaeda Hirotsugu","Ban Hiromitsu","Aomatsu Tomoki","Bamba Shigeki","Tsujikawa Tomoyuki","Sasaki Masaya","Fujiyama Yoshihide","Andoh Akira"}	Experimental and therapeutic medicine	9	\N	\N	2011	22977575	\N	\N	\N	2	f	\N
115054	\N	TPMT genotype and its clinical implication in renal transplant recipients with azathioprine treatment.	{"Song D-K","Zhao J","Zhang L-R"}	Journal of clinical pharmacy and therapeutics	12	\N	\N	2006	17176368	\N	\N	\N	2	f	\N
115056	\N	Thiopurine S-methyltransferase genetic polymorphism in the Thai population.	{"Srimartpirom Somrudee","Tassaneeyakul Wongwiwat","Kukongviriyapan Veerapol","Tassaneeyakul Wichittra"}	British journal of clinical pharmacology	7	\N	\N	2004	15206995	\N	\N	\N	2	f	\N
115058	\N	Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyltransferase genotype in Japanese patients with inflammatory bowel disease.	{"Takatsu Noritaka","Matsui Toshiyuki","Murakami Yuji","Ishihara Hiroshi","Hisabe Takashi","Nagahama Takashi","Maki Shinichirou","Beppu Takahiro","Takaki Yasuhiro","Hirai Fumihito","Yao Kenshi"}	Journal of gastroenterology and hepatology	7	\N	\N	2009	19682195	\N	\N	\N	2	f	\N
115060	\N	Thiopurine S-methyltransferase gene polymorphism in Japanese patients with autoimmune liver diseases.	{"Tamori Akihiro","Shinzaki Mayumi","Kosaka Saori","Hayashi Takehiro","Iwai Shuji","Enomoto Masaru","Habu Daiki","Sakaguchi Hiroki","Kawada Norifumi","Hino Masayuki","Shiomi Susumu","Nishiguchi Shuhei"}	Liver international : official journal of the International Association for the Study of the Liver	2	\N	\N	2007	17241387	\N	\N	\N	2	f	\N
115064	\N	Impact of the heterozygous TPMT*1/*3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in Thailand.	{"Vannaprasaht Suda","Angsuthum Susothorn","Avihingsanon Yingyos","Sirivongs Dhavee","Pongskul Cholatip","Makarawate Pattarapong","Praditpornsilpa Kearkiat","Tassaneeyakul Wongwiwat","Tassaneeyakul Wichittra"}	Clinical therapeutics	7	\N	\N	2009	19695401	\N	\N	\N	2	f	\N
115066	\N	Relationships between thiopurine S-methyltransferase polymorphism and azathioprine-related adverse drug reactions in Chinese renal transplant recipients.	{"Xin Hua-Wen","Xiong Hui","Wu Xiao-Chun","Li Qing","Xiong Lei","Yu Ai-Rong"}	European journal of clinical pharmacology	3	\N	\N	2009	19048245	\N	\N	\N	2	f	\N
115072	\N	Phenotyping and genotyping study of thiopurine S-methyltransferase in healthy Chinese children: a comparison of Han and Yao ethnic groups.	{"Zhang Jian-ping","Guan Yong-yuan","Wu Jue-heng","Xu An-long","Zhou Shufeng","Huang Min"}	British journal of clinical pharmacology	8	\N	\N	2004	15255798	\N	\N	\N	2	f	\N
115080	\N	Efficient screening method of the thiopurine methyltransferase polymorphisms for patients considering taking thiopurine drugs in a Chinese Han population in Henan Province (central China).	{"Zhang Li-Rong","Song Dong-Kui","Zhang Wei","Zhao Jun","Jia Lin-Jing","Xing Dong-Liang"}	Clinica chimica acta; international journal of clinical chemistry	2	\N	\N	2007	16952345	\N	\N	\N	2	f	\N
116485	\N	Comprehensive UGT1A1 genotyping in a Japanese population by pyrosequencing.	{"Saeki Mayumi","Saito Yoshiro","Jinno Hideto","Tohkin Masahiro","Kurose Kouichi","Kaniwa Nahoko","Komamura Kazuo","Ueno Kazuyuki","Kamakura Shiro","Kitakaze Masafumi","Ozawa Shogo","Sawada Jun-Ichi"}	Clinical chemistry	7	\N	\N	2003	12816917	\N	\N	\N	2	f	\N
115140	\N	Thiopurine methyltransferase pharmacogenetics: alternative molecular diagnosis and preliminary data from Northern Portugal.	{"Alves S","Prata M J","Ferreira F","Amorim A"}	Pharmacogenetics	4	\N	\N	1999	10376773	\N	\N	\N	2	f	\N
115144	\N	Thiopurine methyltransferase alleles in British and Ghanaian populations.	{"Ameyaw M M","Collie-Duguid E S","Powrie R H","Ofori-Adjei D","McLeod H L"}	Human molecular genetics	2	\N	\N	1999	9931345	\N	\N	\N	2	f	\N
115148	\N	Thiopurine S-Methyltransferase gene polymorphisms in a healthy Slovak population and pediatric patients with inflammatory bowel disease.	{"Chocholova Alica","Soltysova Andrea","Minarik Gabriel","Cierna Iveta","Sufliarska Sabina","Mladosievicova Beata"}	Nucleosides, nucleotides & nucleic acids	0	\N	\N	2013	23581716	\N	\N	\N	2	f	\N
115152	\N	Thiopurine S-methyltransferase phenotype-genotype correlation in children with acute lymphoblastic leukemia.	{"Chrzanowska Maria","Kuehn Marta","Januszkiewicz-Lewandowska Danuta","Kurzawski Mateusz","Droździk Marek"}	Acta poloniae pharmaceutica	0	\N	\N	2012	22594254	\N	\N	\N	2	f	\N
115155	\N	Allelic variants of the thiopurine S-methyltransferase deficiency in patients with ulcerative colitis and in healthy controls.	{"Corominas H","Domènech M","González D","Diaz C","Roca M","García-González M A","Peña S","Baiget M"}	The American journal of gastroenterology	9	\N	\N	2000	11007234	\N	\N	\N	2	f	\N
115158	\N	Is thiopurine methyltransferase genetic polymorphism a major factor for withdrawal of azathioprine in rheumatoid arthritis patients?	{"Corominas H","Domènech M","Laíz A","Gich I","Geli C","Díaz C","de Cuevillas F","Moreno M","Vázquez G","Baiget M"}	Rheumatology (Oxford, England)	1	\N	\N	2003	12509611	\N	\N	\N	2	f	\N
115162	\N	Prevalence of mutations in thiopurine S-methyltransferase gene among Slovak IBD patients.	{"Desatova B","Hlavaty T","Balakova D","Pav I","Celec P","Gregus M","Zakuciova M","Hlista M","Horakova M","Kadasi L","Huorka M","Batovsky M"}	Bratislavske lekarske listy	0	\N	\N	2013	23731044	\N	\N	\N	2	f	\N
115164	\N	Frequency of thiopurine methyltransferase mutation in patients of Mediterranean area with inflammatory bowel disease and autoimmune disorders.	{"Di Salvo Angela","Fabiano Carmelo","Mannara Vincenza","Dimarco Mariangela","Orlando Ambrogio","Affronti Marco","Macaluso Fabio Salvatore","Cottone Mario"}	Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver	12	\N	\N	2016	27665263	\N	\N	\N	2	f	\N
115166	\N	Analysis of thiopurine S-methyltransferase polymorphism in the population of Serbia and Montenegro and mercaptopurine therapy tolerance in childhood acute lymphoblastic leukemia.	{"Dokmanovic Lidija","Urosevic Jelena","Janic Dragana","Jovanovic Nada","Petrucev Branka","Tosic Natasa","Pavlovic Sonja"}	Therapeutic drug monitoring	12	\N	\N	2006	17164697	\N	\N	\N	2	f	\N
115170	\N	Thiopurine S-methyltransferase genotype and the use of thiopurines in paediatric inflammatory bowel disease Greek patients.	{"Gazouli M","Pachoula I","Panayotou I","Mantzaris G","Syriopoulou V P","Goutas N","Vlachodimitropoulos D","Anagnou N P","Roma-Giannikou E"}	Journal of clinical pharmacy and therapeutics	2	\N	\N	2010	20175817	\N	\N	\N	2	f	\N
115172	\N	Pyrosequencing of TPMT alleles in a general Swedish population and in patients with inflammatory bowel disease.	{"Haglund Sofie","Lindqvist Malin","Almer Sven","Peterson Curt","Taipalensuu Jan"}	Clinical chemistry	2	\N	\N	2004	14656901	\N	\N	\N	2	f	\N
115174	\N	Thiopurine methyltransferase (TPMT) heterozygosity and enzyme activity as predictive tests for the development of azathioprine-related adverse events.	{"Heckmann Jeannine M","Lambson Elisabetta M T","Little Francesca","Owen Elizabeth P"}	Journal of the neurological sciences	4	\N	\N	2005	15792824	\N	\N	\N	2	f	\N
115179	\N	Frequency distribution of thiopurine S-methyltransferase alleles in a polish population.	{"Kurzawski Mateusz","Gawronska-Szklarz Barbara","Drozdzik Marek"}	Therapeutic drug monitoring	10	\N	\N	2004	15385838	\N	\N	\N	2	f	\N
115181	\N	The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients.	{"Kurzawski Mateusz","Dziewanowski Krzysztof","Gawrońska-Szklarz Barbara","Domański Leszek","Droździk Marek"}	Therapeutic drug monitoring	8	\N	\N	2005	16044099	\N	\N	\N	2	f	\N
115185	\N	High prevalence of polymorphism and low activity of thiopurine methyltransferase in patients with inflammatory bowel disease.	{"Larussa Tiziana","Suraci Evelina","Lentini Margherita","Nazionale Immacolata","Gallo Luigia","Abenavoli Ludovico","Imeneo Maria","Costanzo Francesco Saverio","Cuda Giovanni","Luzza Francesco"}	European journal of internal medicine	4	\N	\N	2012	22385887	\N	\N	\N	2	f	\N
115189	\N	Detection of one single mutation predicts thiopurine S-methyltransferase activity in a population of Saami in northern Norway.	{"Loennechen T","Utsi E","Hartz I","Lysaa R","Kildalsen H","Aarbakke J"}	Clinical pharmacology and therapeutics	8	\N	\N	2001	11503013	\N	\N	\N	2	f	\N
115194	\N	Ethnic differences in thiopurine methyltransferase pharmacogenetics: evidence for allele specificity in Caucasian and Kenyan individuals.	{"McLeod H L","Pritchard S C","Githang'a J","Indalo A","Ameyaw M M","Powrie R H","Booth L","Collie-Duguid E S"}	Pharmacogenetics	12	\N	\N	1999	10634140	\N	\N	\N	2	f	\N
115196	\N	Thiopurine S-methyltransferase pharmacogenetics: genotype to phenotype correlation in the Slovenian population.	{"Milek M","Murn J","Jaksic Z","Lukac Bajalo J","Jazbec J","Mlinaric Rascan I"}	Pharmacology	0	\N	\N	2006	16691038	\N	\N	\N	2	f	\N
115198	\N	Rapid genotyping of common deficient thiopurine S-methyltransferase alleles using the DNA-microchip technique.	{"Nasedkina Tatyana V","Fedorova Olga E","Glotov Andrei S","Chupova Natalia V","Samochatova Elena V","Maiorova Olga A","Zemlyakova Valeria V","Roudneva Anastasia E","Chudinov Alexander V","Yurasov Roman A","Kozhekbaeva Janna M","Barsky Victor E","Krynetskiy Eugene Y","Krynetskaia Natalia F","Cheng Cheng","Ribeiro Raul C","Evans William E","Roumyantsev Alexander G","Zasedatelev Alexander S"}	European journal of human genetics : EJHG	9	\N	\N	2006	16724002	\N	\N	\N	2	f	\N
115202	\N	Genotype-phenotype correlation for thiopurine S-methyltransferase in healthy Italian subjects.	{"Rossi A M","Bianchi M","Guarnieri C","Barale R","Pacifici G M"}	European journal of clinical pharmacology	4	\N	\N	2001	11372592	\N	\N	\N	2	f	\N
115206	\N	TPMT genetic variations in populations of the Russian Federation.	{"Samochatova Elena V","Chupova Natalia V","Rudneva Anastassia","Makarova Olga","Nasedkina Tatyana V","Fedorova Olga E","Glotov Andrei S","Kozhekbaeva Zh","Maiorova Olga A","Roumyantsev Alexander G","Krynetski Eugene Y","Krynetskaia Natalia F","Evans William E","Ribeiro Raul C"}	Pediatric blood & cancer	2	\N	\N	2009	19034904	\N	\N	\N	2	f	\N
115208	\N	Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants.	{"Schaeffeler Elke","Fischer Christine","Brockmeier Dierk","Wernet Dorothee","Moerike Klaus","Eichelbaum Michel","Zanger Ulrich M","Schwab Matthias"}	Pharmacogenetics	7	\N	\N	2004	15226673	\N	\N	\N	2	f	\N
115210	\N	Three novel thiopurine S-methyltransferase allelic variants (TPMT*20, *21, *22) - association with decreased enzyme function.	{"Schaeffeler Elke","Eichelbaum Michel","Reinisch Walter","Zanger Ulrich M","Schwab Matthias"}	Human mutation	9	\N	\N	2006	16917910	\N	\N	\N	2	f	\N
115212	\N	Thiopurine S-methyltransferase pharmacogenetics in a large-scale healthy Italian-Caucasian population: differences in enzyme activity.	{"Serpe Loredana","Calvo Pier Luigi","Muntoni Elisabetta","D'Antico Sergio","Giaccone Mario","Avagnina Alessandra","Baldi Maurizio","Barbera Cristiana","Curti Franco","Pera Angelo","Eandi Mario","Zara Gian Paolo","Canaparo Roberto"}	Pharmacogenomics	11	\N	\N	2009	19891552	\N	\N	\N	2	f	\N
115216	\N	Polymorphisms of the TPMT gene in the Czech healthy population and patients with inflammatory bowel disease.	{"Slanar Ondrej","Bortlík Martin","Buzková Helena","Donoval Robert","Pechandová Kristina","Sebesta Ivan","Lukás Milan","Perlík Frantisek"}	Nucleosides, nucleotides & nucleic acids	6	\N	\N	2008	18600549	\N	\N	\N	2	f	\N
115218	\N	Genotypic and phenotypic analysis of the polymorphic thiopurine S-methyltransferase gene (TPMT) in a European population.	{"Spire-Vayron de la Moureyre C","Debuysere H","Mastain B","Vinner E","Marez D","Lo Guidice J M","Chevalier D","Brique S","Motte K","Colombel J F","Turck D","Noel C","Flipo R M","Pol A","Lhermitte M","Lafitte J J","Libersa C","Broly F"}	British journal of pharmacology	10	\N	\N	1998	9831928	\N	\N	\N	2	f	\N
115220	\N	TPMT and ITPA genetic variants in Lithuanian inflammatory bowel disease patients: Prevalence and azathioprine-related side effects.	{"Steponaitiene Ruta","Kupcinskas Juozas","Survilaite Santa","Varkalaite Greta","Jonaitis Laimas","Kiudelis Gediminas","Denapiene Goda","Valantinas Jonas","Skieceviciene Jurgita","Kupcinskas Limas"}	Advances in medical sciences	3	\N	\N	2016	26674571	\N	\N	\N	2	f	\N
115224	\N	Genetic analyses of thiopurine methyltransferase polymorphisms in Greenlandic and Danish populations.	{"Toft Nina","Nygaard Ulrikka","Gregers Jannie","Schmiegelow Kjeld"}	Acta paediatrica (Oslo, Norway : 1992)	12	\N	\N	2006	17129980	\N	\N	\N	2	f	\N
115252	\N	Prevalence of TPMT and ITPA gene polymorphisms and effect on mercaptopurine dosage in Chilean children with acute lymphoblastic leukemia.	{"Farfan Mauricio J","Salas Carolina","Canales Cristina","Silva Felipe","Villarroel Milena","Kopp Katherine","Torres Juan P","Santolaya María E","Morales Jorge"}	BMC cancer	4	\N	\N	2014	24774509	\N	\N	\N	2	f	\N
115256	\N	Analysis of Thiopurine S-Methyltransferase Deficient Alleles in Acute Lymphoblastic Leukemia Patients in Mexican Patients.	{"Jiménez-Morales Silvia","Ramírez-Florencio Mireya","Mejía-Aranguré Juan Manuel","Núñez-Enríquez Juan Carlos","Bekker-Mendez Carolina","Torres-Escalante José Luis","Flores-Lujano Janet","Jiménez-Hernández Elva","Del Carmen Rodríguez-Zepeda María","Leal Yelda A","González-Montalvo Pablo Miguel","Pantoja-Guillen Francisco","Peñaloza-Gonzalez José Gabriel","Gutiérrez-Juárez Erick Israel","Núñez-Villegas Nora Nancy","Pérez-Saldivar Maria Luisa","Guerra-Castillo Francisco Xavier","Flores-Villegas Luz Victoria","Ramos-Cervantes María Teresa","Fragoso José Manuel","García-Escalante María Guadalupe","Del Carmen Pinto-Escalante Doris","Ramírez-Bello Julián","Hidalgo-Miranda Alfredo"}	Archives of medical research	11	\N	\N	2016	28476189	\N	\N	\N	2	f	\N
115259	\N	High frequency of mutant thiopurine S-methyltransferase genotypes in Mexican patients with systemic lupus erythematosus and rheumatoid arthritis.	{"Ramirez-Florencio Mireya","Jiménez-Morales Silvia","Barbosa-Cobos Rosa Elda","López-Cano Daniela Josabeth","Ramírez-Bello Julian"}	Clinical rheumatology	4	\N	\N	2018	29264794	\N	\N	\N	2	f	\N
115261	\N	Pharmacogenetic screening of N-acetyltransferase 2, thiopurine s-methyltransferase, and 5,10-methylene-tetrahydrofolate reductase polymorphisms in Northwestern Mexicans.	{"Ramos Marco A","Mares Rosa E","Avalos Erick D","Hernández Anaid","Hernández Rogelio","Lameda Rodrigo","Malváez Analleli E","Rodríguez Carla A","Rodríguez Rosario"}	Genetic testing and molecular biomarkers	5	\N	\N	2011	21254844	\N	\N	\N	2	f	\N
115265	\N	Thiopurine S-methyltransferase gene (TMPT) polymorphisms in a Mexican population of healthy individuals and leukemic patients.	{"Taja-Chayeb Lucia","Vidal-Millán Silvia","Gutiérrez Olga","Ostrosky-Wegman Patricia","Dueñas-González Alfonso","Candelaria Myrna"}	Medical oncology (Northwood, London, England)	0	\N	\N	2008	18188716	\N	\N	\N	2	f	\N
115267	\N	Thiopurine methyltransferase polymorphisms and mercaptopurine tolerance in Turkish children with acute lymphoblastic leukemia.	{"Albayrak Meryem","Konyssova Uljan","Kaya Zuhre","Gursel Turkiz","Guntekin Sezen","Percin E Ferda","Kocak Ulker"}	Cancer chemotherapy and pharmacology	11	\N	\N	2011	21400026	\N	\N	\N	2	f	\N
115271	\N	Frequency of thiopurine S-methyltransferase (TPMT) alleles in southeast Iranian population.	{"Bahari Ali","Hashemi Mohammad","Bari Zohreh","Moazeni-Roodi Abdolkarim","Kaykhaei Mahmoud-Ali","Narouie Behzad"}	Nucleosides, nucleotides & nucleic acids	3	\N	\N	2010	20408054	\N	\N	\N	2	f	\N
115278	\N	Genetic analysis of thiopurine methyltransferase polymorphism in the Jordanian population.	{"Hakooz Nancy","Arafat Tawfiq","Payne Debbie","Ollier William","Pushpakom Sudeep","Andrews Julie","Newman William"}	European journal of clinical pharmacology	10	\N	\N	2010	20521035	\N	\N	\N	2	f	\N
115283	\N	Evaluating frequencies of thiopurine S-methyl transferase (TPMT) variant alleles in Israeli ethnic subpopulations using DNA analysis.	{"Ronen Ofri","Cohen Sara Bar","Rund Deborah"}	The Israel Medical Association journal : IMAJ	12	\N	\N	2010	21348397	\N	\N	\N	2	f	\N
115287	\N	The low frequency of defective TPMT alleles in Turkish population: a study on pediatric patients with acute lymphoblastic leukemia.	{"Tumer Tugba Boyunegmez","Ulusoy Gulen","Adali Orhan","Sahin Gurses","Gozdasoglu Sevgi","Arinç Emel"}	American journal of hematology	10	\N	\N	2007	17617792	\N	\N	\N	2	f	\N
115289	\N	Genetic polymorphisms of NQO1, CYP1A1 and TPMT and susceptibility to acute lymphoblastic leukemia in a Tunisian population.	{"Ouerhani Slah","Cherif Nouha","Bahri Ikbel","Safra Ines","Menif Samia","Abbes Salem"}	Molecular biology reports	2	\N	\N	2013	23065291	\N	\N	\N	2	f	\N
115293	\N	Allele frequency of inosine triphosphate pyrophosphatase (ITPA) and thiopurine-S-methyl transferase (TPMT) genes in the Tunisian population.	{"Melaouhia Salma","Fékih Monia","Garat Anne","Allorge Delphine","Ferchichi Henda","Klouz Anis","Boubaker Jalel","Broly Franck","Lakhal Mohamed"}	Clinics and research in hepatology and gastroenterology	4	\N	\N	2012	22225964	\N	\N	\N	2	f	\N
115297	\N	Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population.	{"Hamdy Samar I","Hiratsuka Masahiro","Narahara Kaori","Endo Naomi","El-Enany Mervat","Moursi Nadia","Ahmed Mohammed S-E","Mizugaki Michinao"}	British journal of clinical pharmacology	6	\N	\N	2003	12814450	\N	\N	\N	2	f	\N
115299	\N	Polymorphisms of the thiopurine S-methyltransferase gene among the Libyan population.	{"Zeglam Hamza Ben","Benhamer Abdrazak","Aboud Adel","Rtemi Haitem","Mattardi Meftah","Saleh Saleh Suleiman","Bashein Abdullah","Enattah Nabil"}	The Libyan journal of medicine	0	\N	\N	2015	25819542	\N	\N	\N	2	f	\N
115306	\N	Analysis of thiopurine S-methyltransferase phenotype-genotype in a Tunisian population with Crohn's disease.	{"Ben Salah Lynda","Belkhiria el Haj Amor Mouna","Chbili Chahra","Khlifi Saida","Fathallah Neila","Bougmiza Iheb","Ben Jazia Elhem","Houdret Nicole","Ben Salem Chaker","Saguem Saad"}	European journal of drug metabolism and pharmacokinetics	12	\N	\N	2013	23553048	\N	\N	\N	2	f	\N
115319	\N	Influence of ethnicity on pharmacogenetic variation in the Ghanaian population.	{"Yen-Revollo J L","Van Booven D J","Peters E J","Hoskins J M","Engen R M","Kannall H D","Ofori-Adjei D","McLeod H L","Marsh S"}	The pharmacogenomics journal	12	\N	\N	2009	19546880	\N	\N	\N	2	f	\N
116461	\N	Impact of UGT1A1 Gilbert variant on discontinuation of ritonavir-boosted atazanavir in AIDS Clinical Trials Group Study A5202.	{"Ribaudo Heather J","Daar Eric S","Tierney Camlin","Morse Gene D","Mollan Katie","Sax Paul E","Fischl Margaret A","Collier Ann C","Haas David W","DS Clinical Trials Group"}	The Journal of infectious diseases	2	\N	\N	2013	23148286	\N	\N	\N	2	f	\N
116463	\N	Genomewide association study of atazanavir pharmacokinetics and hyperbilirubinemia in AIDS Clinical Trials Group protocol A5202.	{"Johnson Daniel H","Venuto Charles","Ritchie Marylyn D","Morse Gene D","Daar Eric S","McLaren Paul J","Haas David W"}	Pharmacogenetics and genomics	4	\N	\N	2014	24557078	\N	\N	\N	2	f	\N
116467	\N	The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): hematologic and evolutionary implications.	{"Premawardhena A","Fisher C A","Liu Y T","Verma I C","de Silva S","Arambepola M","Clegg J B","Weatherall D J"}	Blood cells, molecules & diseases	0	\N	\N	2003	12850492	\N	\N	\N	2	f	\N
116472	\N	Polymorphisms of UGT1A1*6, UGT1A1*27 & UGT1A1*28 in three major ethnic groups from Malaysia.	{"Teh L K","Hashim H","Zakaria Z A","Salleh M Z"}	The Indian journal of medical research	8	\N	\N	2012	22960892	\N	\N	\N	2	f	\N
116487	\N	Single-nucleotide polymorphisms in the UDP-glucuronosyltransferase 1A-3' untranslated region are associated with atazanavir-induced nephrolithiasis in patients with HIV-1 infection: a pharmacogenetic study.	{"Nishijima Takeshi","Tsuchiya Kiyoto","Tanaka Noriko","Joya Akane","Hamada Yohei","Mizushima Daisuke","Aoki Takahiro","Watanabe Koji","Kinai Ei","Honda Haruhito","Yazaki Hirohisa","Tanuma Junko","Tsukada Kunihisa","Teruya Katsuji","Kikuchi Yoshimi","Oka Shinichi","Gatanaga Hiroyuki"}	The Journal of antimicrobial chemotherapy	12	\N	\N	2014	25151207	\N	\N	\N	2	f	\N
116508	\N	Frequent co-occurrence of the TATA box mutation associated with Gilbert's syndrome (UGT1A1*28) with other polymorphisms of the UDP-glucuronosyltransferase-1 locus (UGT1A6*2 and UGT1A7*3) in Caucasians and Egyptians.	{"Köhle Christoph","Möhrle Bernd","Münzel Peter A","Schwab Matthias","Wernet Dorothee","Badary Osama A","Bock Karl Walter"}	Biochemical pharmacology	5	\N	\N	2003	12732365	\N	\N	\N	2	f	\N
116531	\N	Distribution of selected gene polymorphisms of UGT1A1 in a Saudi population.	{"Alkharfy Khalid M","Alghamdi Amal M","Bagulb Khawla M","Al-Jenoobi Fahad I","Al-Mohizea Abdullah M","Al-Muhsen Saleh","Halwani Rabih","Parvez Mohammad K","Al-Dosari Mohammed S"}	Archives of medical science : AMS	8	\N	\N	2013	24049537	\N	\N	\N	2	f	\N
116572	\N	Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups.	{"Limdi Nita A","Wadelius Mia","Cavallari Larisa","Eriksson Niclas","Crawford Dana C","Lee Ming-Ta M","Chen Chien-Hsiun","Motsinger-Reif Alison","Sagreiya Hersh","Liu Nianjun","Wu Alan H B","Gage Brian F","Jorgensen Andrea","Pirmohamed Munir","Shin Jae-Gook","Suarez-Kurtz Guilherme","Kimmel Stephen E","Johnson Julie A","Klein Teri E","Wagner Michael J","International Warfarin Pharmacogenetics Consortium"}	Blood	5	\N	\N	2010	20203262	\N	\N	\N	2	f	\N
116605	\N	VKORC1 haplotypes in five East-Asian populations and Indians.	{"Lee Ming Ta Michael","Chen Chien-Hsiun","Chuang Hui-Ping","Lu Liang-Suei","Chou Ching-Heng","Chen Ying-Ting","Liu Chih-Yang","Wen Ming-Shien","Lu Jang-Jih","Chang Chi-Feng","Wu Jer-Yuarn","Chen Yuan-Tsong"}	Pharmacogenomics	10	\N	\N	2009	19842934	\N	\N	\N	2	f	\N
110000	100420	Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Rasburicase Therapy in the context of G6PD Deficiency Genotype	{"Relling Mary V","McDonagh Ellen M","Chang Tamara","Caudle Kelly E","McLeod Howard L","Haidar Cyrine E","Klein Teri","Luzzatto Lucio"}	Clinical pharmacology and therapeutics	5			2014	24787449	PMC4111801	10.1038/clpt.2014.97	\N	3	f	https://files.cpicpgx.org/data/guideline/publication/rasburicase/2014/24787449.pdf
110035	104243	Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Atomoxetine Therapy.	{"Brown Jacob T","Bishop Jeffrey R","Sangkuhl Katrin","Nurmi Erika L","Mueller Daniel J","Dinh Jean C","Gaedigk Andrea","Klein Teri E","Caudle Kelly E","McCracken James T","de Leon Jose","Steven Leeder J"}	Clinical pharmacology and therapeutics	2			2019	30801677	\N	\N	\N	61	f	https://files.cpicpgx.org/data/guideline/publication/atomoxetine/2019/30801677.pdf
3002041	\N	\N	{"Leonie M Hitchman"}	\N	\N	\N	\N	2022	36313436	\N	\N	\N	1	f	\N
3002063	\N	\N	{"Wendy Y Wang"}	\N	\N	\N	\N	2022	36294714	\N	\N	\N	1	f	\N
3001761	\N	\N	{"Twesigomwe David - see Notes"}	\N	\N	\N	\N	2022	36111505	\N	\N	\N	2	f	\N
110023	100409	Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Ivacaftor Therapy in the Context of CFTR Genotype	{"Clancy John P","Johnson Samuel G","Yee Sook Wah","McDonagh Ellen M","Caudle Kelly E","Klein Teri E","Cannavo Matthew","Giacomini Kathleen M"}	Clinical pharmacology and therapeutics	3			2014	24598717	PMC4026598	10.1038/clpt.2014.54	\N	59	f	https://files.cpicpgx.org/data/guideline/publication/ivacaftor/2014/24598717.pdf
110031	100416	Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype	{"Crews K R","Gaedigk A","Dunnenberger H M","Klein T E","Shen D D","Callaghan J T","Kharasch E D","Skaar T C"}	Clinical pharmacology and therapeutics	12			2011	22205192	PMC3289963	10.1038/clpt.2011.287	\N	59	f	https://files.cpicpgx.org/data/guideline/publication/codeine/2012/22205192.pdf
2510456	2405438	Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype.	{"Gammal Roseann S","Pirmohamed Munir","Somogyi Andrew A","Morris Sarah A","Formea Christine M","Elchynski Amanda L","Oshikoya Kazeem A","McLeod Howard L","Haidar Cyrine E","Whirl-Carrillo Michelle","Klein Teri E","Caudle Kelly E","Relling Mary V"}	Clinical pharmacology and therapeutics	9	\N	\N	2022	36049896	\N	10.1002/cpt.2735	\N	3	f	https://files.cpicpgx.org/data/guideline/publication/G6PD/2022/36049896.pdf
2675961	\N	Clinician adherence to pharmacogenomics prescribing recommendations in clinical decision support alerts.	{"Nguyen Jenny Q","Crews Kristine R","Moore Ben T","Kornegay Nancy M","Baker Donald K","Hasan Murad","Campbell Patrick K","Dean Shannon M","Relling Mary V","Hoffman James M","Haidar Cyrine E"}	Journal of the American Medical Informatics Association : JAMIA	10	\N	\N	2022	36228116	\N	10.1093/jamia/ocac187	\N	2	t	\N
3070387	100413	Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.	{"Bousman Chad A","Stevenson James M","Ramsey Laura B","Sangkuhl Katrin","Hicks J Kevin","Strawn Jeffrey R","Singh Ajeet B","Ruaño Gualberto","Mueller Daniel J","Tsermpini Evangelia Eirini","Brown Jacob T","Bell Gillian C","Leeder J Steven","Gaedigk Andrea","Scott Stuart A","Klein Teri E","Caudle Kelly E","Bishop Jeffrey R"}	Clinical pharmacology and therapeutics	4	\N	\N	2023	37032427	\N	10.1002/cpt.2903	https://files.cpicpgx.org/data/guideline/publication/serotonin_reuptake_inhibitor_antidepressants/2023/37032427.pdf	3	f	https://files.cpicpgx.org/data/guideline/publication/serotonin_reuptake_inhibitor_antidepressants/2023/37032427.pdf
110033	100416	Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for cytochrome P450 2D6 (CYP2D6) genotype and codeine therapy: 2014 Update	{"Crews Kristine R","Gaedigk Andrea","Dunnenberger Henry M","Leeder J Steve","Klein Teri E","Caudle Kelly E","Haidar Cyrine E","Shen Danny D","Callaghan John T","Sadhasivam Senthilkumar","Prows Cynthia A","Kharasch Evan D","Skaar Todd C"}	Clinical pharmacology and therapeutics	1			2014	24458010	PMC3975212	10.1038/clpt.2013.254	\N	59	f	https://files.cpicpgx.org/data/guideline/publication/codeine/2014/24458010.pdf
110036	104245	Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz-containing Antiretroviral Therapy.	{"Desta Zeruesenay","Gammal Roseann S","Gong Li","Whirl-Carrillo Michelle","Gaur Aditya H","Sukasem Chonlaphat","Hockings Jennifer","Myers Alan","Swart Marelize","Tyndale Rachel","Masimirembwa Collen","Iwuchukwu Otito F","Chirwa Sanika","Lennox Jeffrey","Gaedigk Andrea","Klein Teri","Haas David W"}	Clinical pharmacology and therapeutics	4			2019	31006110	\N	\N	\N	58	f	https://files.cpicpgx.org/data/guideline/publication/efavirenz/2019/31006110.pdf
110005	100411	Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450-2C19 (CYP2C19) Genotype and Clopidogrel Therapy	{"Scott S A","Sangkuhl K","Gardner E E","Stein C M","Hulot J-S","Johnson J A","Roden D M","Klein T E","Shuldiner A R"}	Clinical pharmacology and therapeutics	6			2011	21716271	PMC3234301	10.1038/clpt.2011.132	\N	59	f	https://files.cpicpgx.org/data/guideline/publication/clopidogrel/2011/21716271.pdf
571448	110058	Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and Nonsteroidal Anti-inflammatory Drugs.	{"Theken Katherine N","Lee Craig R","Gong Li","Caudle Kelly E","Formea Christine M","Gaedigk Andrea","Klein Teri E","Agúndez José A G","Grosser Tilo"}	Clinical pharmacology and therapeutics	3	\N	\N	2020	32189324	\N	10.1002/cpt.1830	\N	60	f	https://files.cpicpgx.org/data/guideline/publication/NSAID/2020/32189324.pdf
110028	100411	Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy: 2013 Update	{"Scott Stuart A","Sangkuhl Katrin","Stein C Michael","Hulot Jean-Sébastien","Mega Jessica L","Roden Dan M","Klein Teri E","Sabatine Marc S","Johnson Julie A","Shuldiner Alan R"}	Clinical pharmacology and therapeutics	5			2013	23698643	PMC3748366	10.1038/clpt.2013.105	\N	59	f	https://files.cpicpgx.org/data/guideline/publication/clopidogrel/2013/23698643.pdf
1608551	100411	Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update.	{"Lee Craig R","Luzum Jasmine A","Sangkuhl Katrin","Gammal Roseann S","Sabatine Marc S","Stein C Michael","Kisor David F","Limdi Nita A","Lee Yee Ming","Scott Stuart A","Hulot Jean-Sébastien","Roden Dan M","Gaedigk Andrea","Caudle Kelly E","Klein Teri E","Johnson Julie A","Shuldiner Alan R"}	Clinical pharmacology and therapeutics	1	\N	\N	2022	35034351	\N	10.1002/cpt.2526	\N	59	f	https://files.cpicpgx.org/data/guideline/publication/clopidogrel/2022/35034351.pdf
571447	110076	Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing.	{"Lima John J","Thomas Cameron D","Barbarino Julia","Desta Zeruesenay","Van Driest Sara L","El Rouby Nihal","Johnson Julie A","Cavallari Larisa H","Shakhnovich Valentina","Thacker David L","Scott Stuart A","Schwab Matthias","Uppugunduri Chakradhara Rao S","Formea Christine M","Franciosi James P","Sangkuhl Katrin","Gaedigk Andrea","Klein Teri E","Gammal Roseann S","Furuta Takahisa"}	Clinical pharmacology and therapeutics	8	\N	\N	2020	32770672	\N	10.1002/cpt.2015	\N	59	f	https://files.cpicpgx.org/data/guideline/publication/PPI/2020/32770672.pdf
110001	100410	Clinical Pharmacogenetics Implementation Consortium (CPIC®) Guideline for CYP2C19 and Voriconazole Therapy	{"Moriyama Brad","Obeng Aniwaa Owusu","Barbarino Julia","Penzak Scott R","Henning Stacey A","Scott Stuart A","Agúndez José A G","Wingard John R","McLeod Howard L","Klein Teri E","Cross Shane","Caudle Kelly E","Walsh Thomas J"}	Clinical pharmacology and therapeutics	12			2016	27981572	PMC5474211	10.1002/cpt.583	\N	59	f	https://files.cpicpgx.org/data/guideline/publication/voriconazole/2016/27981572.pdf
110030	100425	Clinical pharmacogenetics implementation consortium (cpic) guideline for pharmacogenetics-guided warfarin dosing: 2017 update	{"Johnson Julie A","Caudle Kelly E","Gong Li","Whirl-Carrillo Michelle","Stein C Michael","Scott Stuart A","Lee Ming Ta Michael","Gage Brian F","Kimmel Stephen E","Perera Minoli A","Anderson Jeffrey L","Pirmohamed Munir","Klein Teri E","Limdi Nita A","Cavallari Larisa H","Wadelius Mia"}	Clinical pharmacology and therapeutics	2			2017	28198005	PMC5546947	10.1002/cpt.668	\N	59	f	https://files.cpicpgx.org/data/guideline/publication/warfarin/2017/28198005.pdf
110014	100421	Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing	{"Martin M A","Klein T E","Dong B J","Pirmohamed M","Haas D W","Kroetz D L"}	Clinical pharmacology and therapeutics	2			2012	22378157	PMC3374459	10.1038/clpt.2011.355	\N	59	f	https://files.cpicpgx.org/data/guideline/publication/abacavir/2012/22378157.pdf
110015	100421	Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for HLA-B Genotype and Abacavir Dosing: 2014 update	{"Martin Michael A","Hoffman James M","Freimuth Robert R","Klein Teri E","Dong Betty J","Pirmohamed Munir","Hicks J Kevin","Wilkinson Mark R","Haas David W","Kroetz Deanna L"}	Clinical pharmacology and therapeutics	2			2014	24561393	PMC3994233	10.1038/clpt.2014.38	\N	59	f	https://files.cpicpgx.org/data/guideline/publication/abacavir/2014/24561393.pdf
110027	100422	Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen-B Genotype and Allopurinol Dosing	{"Hershfield M S","Callaghan J T","Tassaneeyakul W","Mushiroda T","Thorn C F","Klein T E","Lee M T M"}	Clinical pharmacology and therapeutics	10			2012	23232549	PMC3564416	10.1038/clpt.2012.209	\N	59	f	https://files.cpicpgx.org/data/guideline/publication/allopurinol/2013/23232549.pdf
110007	100424	Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for IFNL3 (IL28B) genotype and peginterferon alpha based regimens	{"Muir Andrew J","Gong Li","Johnson Samuel G","Michael Lee Ming Ta","Williams Marc S","Klein Teri E","Caudle Kelly E","Nelson David R"}	Clinical pharmacology and therapeutics	10			2013	24096968	PMC3904555	10.1038/clpt.2013.203	\N	59	f	https://files.cpicpgx.org/data/guideline/publication/pegintron/2013/24096968.pdf
110016	100425	Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing	{"Johnson J A","Gong L","Whirl-Carrillo M","Gage B F","Scott S A","Stein C M","Anderson J L","Kimmel S E","Lee M T M","Pirmohamed M","Wadelius M","Klein T E","Altman R B"}	Clinical pharmacology and therapeutics	9			2011	21900891	PMC3187550	10.1038/clpt.2011.185	\N	59	f	https://files.cpicpgx.org/data/guideline/publication/warfarin/2011/21900891.pdf
110034	100423	Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update.	{"Phillips Elizabeth J","Sukasem Chonlaphat","Whirl-Carrillo Michelle","Müller Daniel J","Dunnenberger Henry M","Chantratita Wasun","Goldspiel Barry","Chen Yuan-Tsong","Carleton Bruce C","George Alfred L","Mushiroda Taisei","Klein Teri","Gammal Roseann S","Pirmohamed Munir"}	Clinical pharmacology and therapeutics	4	574-581	103	2018	29392710	PMC5847474	10.1002/cpt.1004	\N	59	f	https://files.cpicpgx.org/data/guideline/publication/carbamazepine/2017/29392710.pdf
110026	100428	Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 update.	{"Relling Mary V","Schwab Matthias","Whirl-Carrillo Michelle","Suarez-Kurtz Guilherme","Pui Ching-Hon","Stein Charles M","Moyer Ann M","Evans William E","Klein Teri E","Antillon-Klussmann Federico Guillermo","Caudle Kelly E","Kato Motohiro","Yeoh Allen E J","Schmiegelow Kjeld","Yang Jun J"}	Clinical pharmacology and therapeutics	11			2018	30447069	\N	\N	\N	61	f	https://files.cpicpgx.org/data/guideline/publication/thiopurines/2018/30447069.pdf
110008	100429	Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing	{"Gammal Roseann S","Court Michael H","Haidar Cyrine E","Iwuchukwu Otito Frances","Gaur Aditya H","Alvarellos Maria","Guillemette Chantal","Lennox Jeffrey L","Whirl-Carrillo Michelle","Brummel Sean","Ratain Mark J","Klein Teri E","Schackman Bruce R","Caudle Kelly E","Haas David W"}	Clinical pharmacology and therapeutics	9			2015	26417955	PMC4785051	10.1002/cpt.269	\N	59	f	https://files.cpicpgx.org/data/guideline/publication/atazanavir/2015/26417955.pdf
5407447	5290480	Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy.	{"Duarte Julio D","Thomas Cameron D","Lee Craig R","Huddart Rachel","Agundez Jose A G","Baye Jordan F","Gaedigk Andrea","Klein Teri E","Lanfear David E","Monte Andrew A","Nagy Mohamed","Schwab Matthias","Stein C Michael","Uppugunduri Chakradhara Rao S","van Schaik Ron H N","Donnelly Roseann S","Caudle Kelly E","Luzum Jasmine A"}	Clinical pharmacology and therapeutics	7	\N	\N	2024	38951961	\N	10.1002/cpt.3351	\N	3	f	https://files.cpicpgx.org/data/guideline/publication/beta_blockers/2024/38951961.pdf
114759	\N	\N	{"Albuquerque et al"}	\N	\N	\N	\N	2013	\N	\N	10.2217/pme.13.56	\N	2	f	\N
110011	100414	Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants	{"Hicks J K","Swen J J","Thorn C F","Sangkuhl K","Kharasch E D","Ellingrod V L","Skaar T C","Müller D J","Gaedigk A","Stingl J C"}	Clinical pharmacology and therapeutics	1			2013	23486447	PMC3689226	10.1038/clpt.2013.2	\N	59	f	https://files.cpicpgx.org/data/guideline/publication/TCA/2013/23486447.pdf
110022	100426	The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update	{"Ramsey Laura B","Johnson Samuel G","Caudle Kelly E","Haidar Cyrine E","Voora Deepak","Wilke Russell A","Maxwell Whitney D","McLeod Howard L","Krauss Ronald M","Roden Dan M","Feng Qiping","Cooper-DeHoff Rhonda M","Gong Li","Klein Teri E","Wadelius Mia","Niemi Mikko"}	Clinical pharmacology and therapeutics	6			2014	24918167	PMC4169720	10.1038/clpt.2014.125	\N	59	f	https://files.cpicpgx.org/data/guideline/publication/simvastatin/2014/24918167.pdf
5407445	5290481	Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2B6 Genotype and Methadone Therapy.	{"Robinson Katherine M","Eum Seenae","Desta Zeruesenay","Tyndale Rachel F","Gaedigk Andrea","Crist Richard C","Haidar Cyrine E","Myers Alan L","Samer Caroline F","Somogyi Andrew A","Zubiaur Pablo","Iwuchukwu Otito F","Whirl-Carrillo Michelle","Klein Teri E","Caudle Kelly E","Donnelly Roseann S","Kharasch Evan D"}	Clinical pharmacology and therapeutics	6	\N	\N	2024	38863207	\N	10.1002/cpt.3338	\N	3	f	https://files.cpicpgx.org/data/guideline/publication/methadone/2024/38863207.pdf
110013	100417	Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Use of Ondansetron and Tropisetron	{"Bell Gillian C","Caudle Kelly E","Whirl-Carrillo Michelle","Gordon Ronald J","Hikino Keiko","Prows Cynthia A","Gaedigk Andrea","Agundez Jose A G","Sadhasivam Senthilkumar","Klein Teri E","Schwab Matthias"}	Clinical pharmacology and therapeutics	12			2016	28002639	PMC5479760	10.1002/cpt.598	\N	59	f	https://files.cpicpgx.org/data/guideline/publication/ondansetron/2016/28002639.pdf
110006	3070400	Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors	{"Hicks J Kevin","Bishop Jeffrey R","Sangkuhl Katrin","Müller Daniel J","Ji Yuan","Leckband Susan G","Leeder J Steven","Graham Rebecca L","Chiulli Dana L","LLerena Adrián","Skaar Todd C","Scott Stuart A","Stingl Julia C","Klein Teri E","Caudle Kelly E","Gaedigk Andrea"}	Clinical pharmacology and therapeutics	5			2015	25974703	PMC4512908	10.1002/cpt.147	\N	59	f	https://files.cpicpgx.org/data/guideline/publication/SSRI/2015/25974703.pdf
110003	100412	Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C9 and HLA-B Genotype and Phenytoin Dosing	{"Caudle Kelly E","Rettie Allan E","Whirl-Carrillo Michelle","Smith Lisa H","Mintzer Scott E","Lee Ming Ta Michael","Klein Teri E","Callaghan J Thomas"}	Clinical pharmacology and therapeutics	8			2014	25099164	PMC4206662	10.1038/clpt.2014.159	\N	59	f	https://files.cpicpgx.org/data/guideline/publication/phenytoin/2014/25099164.pdf
110010	100415	Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy.	{"Goetz Matthew P","Sangkuhl Katrin","Guchelaar Henk-Jan","Schwab Matthias","Province Michael","Whirl-Carrillo Michelle","Symmans W Fraser","McLeod Howard L","Ratain Mark J","Zembutsu Hitoshi","Gaedigk Andrea","van Schaik Ron H","Ingle James N","Caudle Kelly E","Klein Teri E"}	Clinical pharmacology and therapeutics	5			2018	29385237	PMC5931215	10.1002/cpt.1007	\N	59	f	https://files.cpicpgx.org/data/guideline/publication/tamoxifen/2017/29385237.pdf
110018	100422	Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update	{"Saito Y","Stamp L K","Caudle K E","Hershfield M S","McDonagh E M","Callaghan J T","Tassaneeyakul W","Mushiroda T","Kamatani N","Goldspiel B R","Phillips E J","Klein T E","Lee Mtm"}	Clinical pharmacology and therapeutics	6			2015	26094938	PMC4675696	10.1002/cpt.161	\N	59	f	https://files.cpicpgx.org/data/guideline/publication/allopurinol/2015/26094938.pdf
110077	100412	Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update.	{"Karnes Jason H","Rettie Allan E","Somogyi Andrew A","Huddart Rachel","Fohner Alison E","Formea Christine M","Lee Ming Ta Michael","Llerena Adrian","Whirl-Carrillo Michelle","Klein Teri E","Phillips Elizabeth J","Mintzer Scott","Gaedigk Andrea","Caudle Kelly E","Callaghan John T"}	Clinical pharmacology and therapeutics	8			2020	32779747	\N	\N	\N	59	f	https://files.cpicpgx.org/data/guideline/publication/phenytoin/2020/32779747.pdf
110017	100428	Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing	{"Relling M V","Gardner E E","Sandborn W J","Schmiegelow K","Pui C-H","Yee S W","Stein C M","Carrillo M","Evans W E","Klein T E"}	Clinical pharmacology and therapeutics	3	387-91	89	2011	21270794	PMC3098761	10.1038/clpt.2010.320	\N	59	f	https://files.cpicpgx.org/data/guideline/publication/thiopurines/2011/21270794.pdf
110024	100428	Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 Update	{"Relling M V","Gardner E E","Sandborn W J","Schmiegelow K","Pui C-H","Yee S W","Stein C M","Carrillo M","Evans W E","Hicks J K","Schwab M","Klein T E"}	Clinical pharmacology and therapeutics	1			2013	23422873	PMC3604643	10.1038/clpt.2013.4	\N	59	f	https://files.cpicpgx.org/data/guideline/publication/thiopurines/2013/23422873.pdf
417705	100416	Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6, OPRM1, and COMT genotype and select opioid therapy.	{"Crews Kristine R","Monte Andrew A","Huddart Rachel","Caudle Kelly E","Kharasch Evan D","Gaedigk Andrea","Dunnenberger Henry M","Leeder J Steven","Callaghan John T","Samer Caroline Flora","Klein Teri E","Haidar Cyrine E","Van Driest Sara L","Ruano Gualberto","Sangkuhl Katrin","Cavallari Larisa H","Müller Daniel J","Prows Cynthia A","Nagy Mohamed","Somogyi Andrew A","Skaar Todd C"}	Clinical pharmacology and therapeutics	1	\N	\N	2021	33387367	\N	10.1002/cpt.2149	\N	59	f	https://files.cpicpgx.org/data/guideline/publication/opioids/2020/33387367.pdf
110002	100418	Clinical pharmacogenetics implementation consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing	{"Birdwell Kelly A","Decker Brian","Barbarino Julia M","Peterson Josh F","Stein C Michael","Sadee Wolfgang","Wang Danxin","Vinks Alexander A","He Yijing","Swen Jesse J","Leeder J Steven","van Schaik R H N","Thummel Kenneth E","Klein Teri E","Caudle Kelly E","MacPhee Iain A M"}	Clinical pharmacology and therapeutics	3			2015	25801146	PMC4481158	10.1002/cpt.113	\N	59	f	https://files.cpicpgx.org/data/guideline/publication/tacrolimus/2015/25801146.pdf
110019	100419	Clinical Pharmacogenetics Implementation Consortium Guidelines for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing	{"Caudle Kelly E","Thorn Caroline F","Klein Teri E","Swen Jesse J","McLeod Howard L","Diasio Robert B","Schwab Matthias"}	Clinical pharmacology and therapeutics	8			2013	23988873	PMC3831181	10.1038/clpt.2013.172	\N	59	f	https://files.cpicpgx.org/data/guideline/publication/fluoropyrimidines/2013/23988873.pdf
110029	100419	Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update	{"Amstutz Ursula","Henricks Linda M","Offer Steven M","Barbarino Julia","Schellens Jan H M","Swen Jesse J","Klein Teri E","McLeod Howard L","Caudle Kelly E","Diasio Robert B","Schwab Matthias"}	Clinical pharmacology and therapeutics	11			2017	29152729	PMC5760397	10.1002/cpt.911	\N	59	f	https://files.cpicpgx.org/data/guideline/publication/fluoropyrimidines/2017/29152729.pdf
110009	100423	Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for HLA-B Genotype and Carbamazepine Dosing	{"Leckband Susan G","Kelsoe John R","Dunnenberger H Mark","George Alfred L","Tran Eric","Berger Reisel","Müller Daniel J","Whirl-Carrillo Michelle","Caudle Kelly E","Pirmohamed Munir"}	Clinical pharmacology and therapeutics	5			2013	23695185	PMC3748365	10.1038/clpt.2013.103	\N	59	f	https://files.cpicpgx.org/data/guideline/publication/carbamazepine/2013/23695185.pdf
876861	826283	Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for the use of aminoglycosides based on MT-RNR1 genotype.	{"McDermott John Henry","Wolf Joshua","Hoshitsuki Keito","Huddart Rachel","Caudle Kelly E","Whirl-Carrillo Michelle","Steyger Peter S","Smith Richard J H","Cody Neal","Rodriguez-Antona Cristina","Klein Teri E","Newman William G"}	Clinical pharmacology and therapeutics	5	\N	\N	2021	34032273	\N	10.1002/cpt.2309	\N	59	f	https://files.cpicpgx.org/data/guideline/publication/aminoglycosides/2021/34032273.pdf
110032	100427	Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the use of potent volatile anesthetic agents and succinylcholine in the context of RYR1 or CACNA1S genotypes	{"Gonsalves Stephen G","Dirksen Robert T","Sangkuhl Katrin","Pulk Rebecca","Alvarellos Maria","Vo Teresa","Hikino Keiko","Roden Dan","Klein Teri","Mark Poler S","Patel Sephalie","Caudle Kelly E","Gordon Ronald","Brandom Barbara","Biesecker Leslie G"}	Clinical pharmacology and therapeutics	11			2018	30499100	\N	\N	\N	61	f	https://files.cpicpgx.org/data/guideline/publication/volatile_anesthetic_succinylcholine/2018/30499100.pdf
110021	100426	The Clinical Pharmacogenomics Implementation Consortium: Guideline for SLCO1B1 and Simvastatin-Induced Myopathy	{"Wilke R A","Ramsey L B","Johnson S G","Maxwell W D","McLeod H L","Voora D","Krauss R M","Roden D M","Feng Q","Cooper-Dehoff R M","Gong L","Klein T E","Wadelius M","Niemi M"}	Clinical pharmacology and therapeutics	5			2012	22617227	PMC3384438	10.1038/clpt.2012.57	\N	59	f	https://files.cpicpgx.org/data/guideline/publication/simvastatin/2012/22617227.pdf
1508721	100426	The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1, ABCG2, and CYP2C9 and statin-associated musculoskeletal symptoms.	{"Cooper-DeHoff Rhonda M","Niemi Mikko","Ramsey Laura B","Luzum Jasmine A","Tarkiainen E Katriina","Straka Robert J","Gong Li","Tuteja Sony","Wilke Russell A","Wadelius Mia","Larson Eric A","Roden Dan M","Klein Teri E","Yee Sook Wah","Krauss Ronald M","Turner Richard M","Palaniappan Latha","Gaedigk Andrea","Giacomini Kathleen M","Caudle Kelly E","Voora Deepak"}	Clinical pharmacology and therapeutics	2	\N	\N	2022	35152405	\N	10.1002/cpt.2557	\N	60	f	https://files.cpicpgx.org/data/guideline/publication/statins/2022/publication.pdf
110004	100414	Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC®) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update	{"Kevin Hicks J","Sangkuhl Katrin","Swen Jesse J","Ellingrod Vicki L","Müller Daniel J","Shimoda Kazutaka","Bishop Jeffrey R","Kharasch Evan D","Skaar Todd C","Gaedigk Andrea","Dunnenberger Henry M","Klein Teri E","Caudle Kelly E","Stingl Julia C"}	Clinical pharmacology and therapeutics	12			2016	27997040	PMC5478479	10.1002/cpt.597	\N	59	f	https://files.cpicpgx.org/data/guideline/publication/TCA/2016/27997040.pdf
6605826	6478852	Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy.	{"Eadon Michael T","Hein David W","Andersen Michael A","Chapman Arlene B","Cooper-DeHoff Rhonda M","Desta Zeruesenay","Duarte Julio D","Elchynski Amanda L","Gaedigk Andrea","Karol Seth E","Limdi Nita A","Lteif Christelle","Sosinski Laura","Zubiaur Pablo","Whirl-Carrillo Michelle","Klein Teri E","Caudle Kelly E","Donnelly Roseann S","Agúndez José A G"}	Clinical pharmacology and therapeutics	9	\N	\N	2025	40974042	\N	10.1002/cpt.70071	\N	2	f	https://files.cpicpgx.org/data/guideline/publication/hydralazine/2025/40974042.pdf
\.


--
